UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-K

 

(Mark One)

x

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2015

OR

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-35338

 

Imperva, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

03-0460133

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

3400 Bridge Parkway, Suite 200

Redwood Shores, California 94065

(Address of Principal Executive Offices, including Zip Code)

(650) 345-9000

(Registrant’s Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Name of Each Exchange on Which Registered

Common Stock, par value $0.0001 per share

 

New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes   x     No   o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes   o     No   x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x     No   o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   x     No   o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

x

Accelerated filer

o

 

 

 

 

Non-accelerated filer

o   (Do not check if a smaller reporting company)

Smaller reporting company

o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes   o     No   x

The aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2015 (the last business day of the registrant’s most recently completed second fiscal quarter), based upon the closing price of the common stock reported by the New York Stock Exchange on such date, was approximately $1,800 million. Shares of common stock held by each executive officer and director of the registrant and the registrant’s co-founder who is a former executive officer and director have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

The number of outstanding shares of the registrant’s common stock as of February 17, 2016 was 32,308,341.

 

 

 

 


 

2015 ANNUAL REPORT ON FORM 10-K

TABLE OF CONTENTS

 

 

 

Page

PART I

 

Item 1.

Business

1

Item 1A.

Risk Factors

13

Item 1B.

Unresolved Staff Comments

30

Item 2.

Properties

30

Item 3.

Legal Proceedings

31

Item 4.

Mine Safety Disclosures

31

 

 

PART II

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

32

Item 6.

Selected Financial Data

35

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

37

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

57

Item 8.

Financial Statements and Supplementary Data

58

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

97

Item 9A.

Controls and Procedures

97

Item 9B.

Other Information

97

 

 

PART III

 

Item 10.

Directors, Executive Officers and Corporate Governance

98

Item 11.

Executive Compensation

98

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

98

Item 13.

Certain Relationships and Related Transactions, and Director Independence

98

Item 14.

Principal Accountant Fees and Services

98

 

 

PART IV

 

Item 15.

Exhibits and Financial Statement Schedules

98

Signatures

99

 

 

Documents Incorporated by Reference

 

Portions of the definitive proxy statement for our 2016 Annual Meeting of Stockholders are incorporated by reference in Part III of this Form 10-K.  We intend to file the definitive proxy statement with the Securities and Exchange Commission, or SEC, within 120 days of the year ended December 31, 2015.

 

Forward Looking Statements

The information in this Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Such statements are based upon current expectations that involve risks and uncertainties. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. For example, words such as “may,” “will,” “should,” “estimates,” “predicts,” “potential,” “continue,” “strategy,” “believes,” “anticipates,” “plans,” “expects,” “intends” and similar expressions are intended to identify forward-looking statements. Our actual results and the timing of certain events may differ significantly from the results discussed in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed elsewhere in this Annual Report on Form 10-K in the section titled “Risk Factors” and the risks discussed in our other filings with the SEC. We undertake no obligation to publicly release any revisions to the forward-looking statements after the date of this Annual Report on Form 10-K.

 

 

 

 


PART I

Item 1. Business

Overview

We are a leader in cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. Built to keep pace with the evolving threat landscape, our suite of cyber-security offerings are designed to enable organizations to discover data and application assets and vulnerabilities, to protect information wherever it lives and to comply with regulations. Our cyber-security solutions are also designed to fill the gaps left by existing endpoint and network or perimeter security solutions as organizations increasingly adopt “bring your own device” policies and move data and applications to the cloud.

Organizations are facing numerous challenges in providing the visibility and control required to protect business-critical applications and data from attack, theft and fraud from inside and outside the organization. Attacks, whether perpetrated by sophisticated hackers or malicious insiders, continue to increase in sophistication, scale and frequency. Additionally, organizations must comply with increasingly complex regulatory standards enacted to protect business-critical applications and data. Adoption of new technologies and architectures, such as mobile applications, web applications and big data, increases the complexity of, opens access to, and increases the vulnerability of business-critical data and applications. The increasing use of virtualization technologies and cloud delivery models, including unsanctioned, employee-adopted applications, known as “shadow IT,” is forcing organizations to operate outside of the traditional security model. We believe that these challenges are driving the need for cyber-security solutions that protect business-critical applications and data whether in the cloud or on premises.

Our Imperva SecureSphere platform provides database, file and web application security across various physical and virtual systems in data centers, including those in traditional on-premise data centers as well as in private, public and hybrid cloud computing environments. Our Imperva Incapsula product line provides cloud-based website security, denial of service protection and performance solutions that do not require software or hardware changes. Our Imperva Skyfence product line provides visibility into, and control over, cloud and Software-as-a-Service (“SaaS”) applications, including shadow IT, that are in growing use by enterprises of all sizes. In addition, all of our cloud offerings are designed to protect against the unique threats created as enterprises increasingly shift to deploying their applications and storing their data in the cloud to take advantage of the flexibility and cost-efficiency offered by cloud-based solutions.

As of December 31, 2015, Imperva had over 4,500 end user customers in more than 90 countries. We use the term customer in this Annual Report on Form 10-K to refer to our end user customers. In addition, our solutions are used to protect thousands of organizations through cloud-based deployments with our SaaS customers and managed security service providers (“MSSPs”) and hosting partners. We primarily sell our products and services through our network of over 300 channel partners worldwide, including both distributors and resellers, which provide sales and support leverage to our sales organization. As of December 31, 2015, we had approximately 923 employees, including 288 employees in research and development. We generated revenue of $234.3 million in 2015, an increase of 42.9% over the $164.0 million in revenue we generated in 2014. Net loss attributable to our stockholders was $48.9 million in 2015 as compared to $59.0 million in 2014.  

Our Strategy

Our goal is to extend our leadership position in the cyber-security market. Key elements of our growth strategy include:

 

·

Enhance and extend our leadership position through technological and product innovation. We intend to continue to invest in product upgrades and product line extensions as well as the development of new products and services that address emerging cyber-security and regulatory compliance requirements to maintain our technological advantages. We also intend to continue to invest in advanced threat research and increase our threat intelligence leadership as well as to continue our research and development efforts in cyber-security for cloud computing environments.

 

·

Continue to pursue cyber-security opportunities as businesses adopt cloud computing. Our solutions are used to protect thousands of organizations through cloud-based deployments with our SaaS customers, MSSPs and hosting partners. We intend to continue to focus on capturing the expected increases in spending on securing business-critical applications and data as enterprises pursue cloud computing initiatives for both external and internal facing applications. We intend to develop and expand our relationships with MSSPs and data center hosting providers, and to increase sales to SaaS providers.

 

·

Increase awareness of the importance of cyber-security and drive adoption of our solution. We believe the market for cyber-security is in its early stages and growing rapidly. We plan to continue to increase market awareness of the benefits of our cyber-security solutions and to invest in our brand to further extend our leadership in the cyber-security market. For example, we plan to continue to invest in a broad range of marketing programs that help connect us with potential buyers along paid, earned, shared and owned channels. To further this goal, we plan to leverage online and

1


 

offline advertising initiatives, targeted event participation, global public relations efforts, direct marketing, web events and participation in social media channels, such as LinkedIn, Facebook and Twitter.

 

·

Further penetrate our existing customer base. We intend to drive further penetration of our suite of cyber-security offerings within our existing customer base by deepening and broadening deployment of our offerings. Many of our customers initially deploy our solution for a limited portion of their business-critical applications and data, providing us with significant opportunities to sell them more of our products. This strategy has proved successful, as more than 55% of our revenues in 2015 were derived from repeat sales to existing customers. In addition, as a leading provider of cyber-security solutions, we believe we are well positioned to benefit as our customers expand the scope of their cyber-security and compliance initiatives both in the cloud and on premises. As of December 31, 2015, approximately 26% of our customers have purchased more than one of our SecureSphere offerings.

 

·

Invest in our global distribution network to expand our customer base. We intend to continue to invest significant resources to further strengthen our existing relationships with channel partners and to expand our network by adding new channel partners across the globe. As we expand our base of partners, we also intend to grow our direct touch sales team and enhance our marketing efforts to support our distribution network.

 

·

Increase our sales in the mid-market and small and medium-sized business (“SMB”) market. We believe there is a significant opportunity to provide cyber-security solutions to smaller businesses as they continue to face increasing security threats and more complex compliance mandates. We plan to continue to grow our business with mid-market enterprises and SMBs by expanding our distribution channels and our cloud-based offerings.

 

·

Pursue strategic opportunities. We intend to pursue targeted acquisition and partnership opportunities to continue to broaden our technology and offerings to better enable organizations to discover assets and vulnerabilities, to protect information wherever it lives and to comply with regulations.

Cloud and On-Premise Products

Our products include our Imperva SecureSphere platform for enterprise data centers and our Imperva Incapsula and Imperva Skyfence offerings for cloud-based security services.

Our SecureSphere product line secures business-critical applications and data in physical and virtual data centers from hackers and malicious insiders, provides an accelerated and cost-effective route to address regulatory compliance and establishes a repeatable process for data risk management. Our SecureSphere products are built on a common modular platform, which includes a single operating system and common code base. All of our SecureSphere products can be managed either individually as stand-alone appliances or collectively from our SecureSphere MX Management Servers, which provide centralized management, in-depth analytics and customizable reporting. Our SecureSphere MX Management Server product provides a single, centralized point for aggregating and managing SecureSphere security policies, real-time monitoring, logging, auditing and compliance reporting. With this product, administrators can simultaneously manage our database, file and web security products from a single console.

Our Incapsula service is purpose-built to deliver cloud-based Website Security (featuring a Payment Card Industry (“PCI”) certified Web Application Firewall), Distributed Denial of Service (“DDoS”) Protection and Load Balancing and Failover, all of which are fully integrated with, and built on top of, a global Content Delivery Network. Our Incapsula service is designed to be easy to deploy and accessible to businesses of all sizes that want to maximize the security, speed and availability of their websites. Without needing to purchase or install any hardware or software to use our Incapsula service, we estimate that most customers can set up our Incapsula service in less than ten minutes. Our customers typically begin using our Incapsula service by changing their website’s Domain Name System setting to route traffic to the Incapsula network. The global network of Incapsula servers apply security and optimization solutions to traffic on our customers’ websites according to the Incapsula service options they purchase. The screened, filtered and optimized traffic is then routed by the Incapsula network to the customer’s websites.

Our Skyfence service delivers real-time, automated visibility and control over corporate use of cloud and SaaS applications, including employee-adopted SaaS applications, often referred to as shadow IT, applications delivered by cloud providers, and IT-led or sanctioned applications such as Office 365. These applications are accessible from the Internet, which exposes them to the vulnerabilities intrinsic to public-facing applications. These applications also create security, regulatory and compliance challenges as the responsibility for housing and securing the data is transferred to a third party. We believe that today’s traditional perimeter and endpoint security products do not adequately address cyber-security for cloud applications and data. Our Skyfence service enforces access control policies, protects sensitive data from external and internal threats, and is designed to ensure compliance with standards by using proprietary network traffic analysis and Dynamic User Fingerprinting technology to profile normal user behavior and detect anomalies that could indicate cyber-attacks or internal threats. Our Skyfence solution provides organizations with the power to discover all of the cloud assets that are in use and to uniformly enforce security and compliance policies while controlling user access to sensitive data, privileged user activity and application programming interface (“API”) access to the service.

2


We sell our cloud-based products and services using subscription-based pricing plans. We also sell our ThreatRadar services as separate add-on, subscription services to our SecureSphere appliances.

We organize our SecureSphere, Incapsula and Skyfence product lines into customer-focused capability areas based on their ability to discover assets and vulnerabilities, to protect information wherever it lives – in the cloud or on premises– and to comply with regulations.

 

 

 

Discover

 

 

 

SecureSphere Database Assessment Server: Finds sensitive data and runs assessments

 

SecureSphere Database Assessment Server automates the process of discovering databases and sensitive business data on the network and performs a security assessment to identify risks to business-critical data. It identifies database vulnerabilities and measures compliance with industry standards and best practices using tests and assessment policies. By identifying where databases and sensitive data are located on the network, and which databases are vulnerable or misconfigured, Database Assessment Server helps organizations prioritize their database risk mitigation efforts.

 

 

 

Incapsula Backdoor Detection : Detects and blocks hackers from installing or operating backdoors

 

Incapsula Backdoor Protection detects and blocks attempts by hackers to install or operate a backdoor, which allows a hacker to remotely operate the website or server for future exploitation. It also notifies site administrators of the location of any backdoor so it can be removed.

 

 

 

Skyfence Cloud Discovery and Governance : Enables comprehensive visibility of cloud applications

 

Skyfence Cloud Discovery and Governance protects against blind spots created by the rapid adoption of cloud applications and the bring-your-own-application and shadow IT trends. Skyfence Cloud Discovery discovers and catalogs cloud applications accessed by users and provides organizations with detailed visibility into the usage, activities, and risk information associated with such catalogued applications.

 

 

 

Protect

 

 

 

 

 

SecureSphere

 

 

 

SecureSphere Web Application Firewall: Protects business-critical web applications and data

 

We believe that our SecureSphere Web Application Firewall (“WAF”) is one of the industry’s leading solutions for protecting web assets from application attacks. Our SecureSphere WAF protects our customers’ business-critical applications and data from large scale cyber-attacks, adapts to evolving threats to protect against data breaches and enables compliance with regulatory requirements. Based on the feature and traffic capacity requirements of our customers, our web application security products can be deployed as a physical or virtual appliance. Key capabilities of our SecureSphere WAF include dynamic identification of legitimate web application usage, fortification of web defenses with research-driven intelligence on current threats from our Application Defense Center (“ADC”), alerts and requests blocking as well as virtual patching of application vulnerabilities.

 

 

 

3


SecureSphere Database Firewall : Secures business-critical data in structured repositories

 

SecureSphere Database Firewall secures business-critical data in structured repositories in the data center. It provides comprehensive visibility and control over structured business data repositories, including database data usage, vulnerabilities and access rights and enables security, audit, risk and IT professionals to improve data security and address compliance requirements. SecureSphere Database Firewall can be deployed as a physical or virtual appliance, based on the feature and traffic capacity requirements of our customers. SecureSphere Database Firewall delivers all of the capabilities of SecureSphere Database Activity Monitor, and delivers real-time blocking of external attacks and internal threats from malicious users.

 

 

 

SecureSphere File Firewall : Protects file access activity to ensure business-critical data and applications are secured

 

SecureSphere File Firewall secures unstructured data, including spreadsheets, presentation slides, word processing documents, videos and PDFs that contain business-critical data and applications that our customers store in unstructured repositories, such as file servers, content management repositories, network-attached storage and storage area network devices. It provides full visibility and control over unstructured business data repositories, including file ownership, usage and access rights and enables security, audit, risk and IT professionals to improve file data security and address compliance requirements. SecureSphere File Firewall can be deployed as a physical or virtual appliance based on feature and traffic capacity requirements of our customers.

 

 

 

Camouflage

 

 

 

Imperva Camouflage data m asking : creates realistic, functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data.

 

Imperva Camouflage data masking is designed to reduce data breach risk by replacing sensitive data in non-production systems, including test and development systems or data warehouses and analytical data stores, with realistic fictional data. The fictional data maintains referential integrity and is statistically accurate enabling testing, analysis and business processes to operate normally. Imperva Camouflage data masking protects data from theft and helps ensure compliance with regulations and international policies dictating data privacy and transport.  Imperva licenses this product from Camouflage Software Inc.

 

 

 

ThreatRadar

 

 

 

ThreatRadar : Provides reputation and crowdsourced security intelligence services

 

ThreatRadar Reputation Services recognizes attack sources and dynamically adjusts web security policies within our SecureSphere WAF to provide protection against attacks. These attack sources may include known malicious traffic sources that have attacked other web applications, anonymous proxies that may be used by hackers to launch attacks, traffic sources that launch anonymous attacks and phishing URLs. Our dedicated security research team, ADC, globally tracks these different attack sources and compiles this information with third-party research on malicious sources into the ThreatRadar feeds.

 

 

 

4


 

 

ThreatRadar Community Defense, a part of ThreatRadar Reputation Services, delivers crowd-based threat intelligence to SecureSphere WAF. ThreatRadar Community Defense gathers attack data from SecureSphere deployments around the world and uses algorithms to translate this data into attack patterns, policies and reputation data. This security content is delivered in near real-time to fortify the entire community against emerging threats. ThreatRadar Reputation Services customers who choose to share anonymized attack data with Imperva receive ThreatRadar Community Defense free of charge.

 

 

 

 

 

ThreatRadar Bot Protection Services uses a client classification engine to analyze and classify incoming website traffic, and to distinguish between human and bot traffic. It also identifies good and bad bots and classifies traffic by browser type. The intelligence it collects during this process is then used by SecureSphere to drive WAF policy enforcement decisions. ThreatRadar Bot Protection Services are based on the Incapsula Client Classification Engine and associated Incapsula client classification feeds.

 

 

 

 

 

ThreatRadar Fraud Prevention Services is designed to enable organizations to rapidly provision and manage fraud detection solutions without needing to update web applications. By integrating with leading fraud security vendors, the SecureSphere WAF can transparently identify and help to stop fraudulent transactions. ThreatRadar Fraud Prevention also provides powerful monitoring and enforcement capabilities, allowing businesses to centrally manage SecureSphere WAF and fraud policies together.

 

 

 

 

 

ThreatRadar Account Takeover Protection is designed to protect web application accounts from being compromised by cybercriminals. ThreatRadar Account Takeover Protection combines awareness of credentials known to be compromised, knowledge of login device reputation and risk, detection of credential stuffing and dictionary attacks against passwords, and analysis of behavior across multiple devices and accounts. These capabilities combine to identify account takeover attempts and compromised accounts, and protect against hackers before they gain access to protected web applications and services. This real-time threat intelligence, combined with the existing ThreatRadar Reputation and Bot Protection services, enables SecureSphere Web Application Firewall to protect against account takeover attempts, and limits the ability of cyber criminals to access critical data and perform fraudulent transactions.

 

 

 

CounterBreach

 

 

 

CounterBreach : designed to protect enterprise data from theft and loss due to compromised, malicious and careless users

 

CounterBreach uses machine learning to analyze how users access data in order to spotlight dangerous data access and use. CounterBreach complements machine learning with non-invasive deception technology to identify compromised end-point devices. By dynamically learning normal data access patterns and then finding anomalies, CounterBreach proactively alerts IT teams to dangerous behavior.

 

 

 

5


 

 

CounterBreach provides a multi-layered solution that provides direct visibility into which users access what data, giving IT organizations insight into the ‘who,’ ‘what’ and ‘when’ of access to sensitive information; combines Imperva expertise in monitoring and protecting data with advanced machine learning to spotlight dangerous user data access activity and applies non-invasive deception techniques to identify compromised end-points.

 

 

 

 

 

CounterBreach is currently undergoing beta testing and is expected to be made generally available in the first half of 2016.

 

 

 

Incapsula

 

 

 

Incapsula Infrastructure Protection : Safeguards critical network infrastructure from volumetric and protocol-based DDoS attacks

 

Incapsula Infrastructure Protection helps protect elements of an organization’s critical infrastructure, including web, email and FTP, across entire subnet ranges. In the event of a DDoS attack, traffic is re-routed through Incapsula scrubbing centers using Border Gateway Protocol announcements. From that point on, Incapsula acts as the Internet Service Provider and advertises all protected IP range announcements. All incoming network traffic is inspected and filtered, and only legitimate traffic is securely forwarded to the enterprise network via Generic Routing Encapsulation tunneling.

 

 

 

Incapsula Website DDoS Protection : Detects and mitigates DDoS attacks launched at websites and web applications

 

Incapsula Website Protection uses DNS redirection to persistently reroute website traffic (HTTP/HTTPS) through the Incapsula network. Once traffic enters the Incapsula network, it is subject to progressively more stringent layers of inspection. Using sophisticated security rules and challenges, Incapsula ensures that DDoS attack traffic is identified and filtered out, while allowing legitimate traffic to flow unhindered to protected websites. At the same time, Incapsula also masks the origin server IPs to counter direct-to-IP attacks.

 

 

 

Incapsula Name Server Protection : Safeguards DNS servers from DDoS attacks

 

Incapsula Name Server Protection service is deployed in front of protected DNS servers, safeguarding them from all types of DNS-targeted DDoS attacks. The service employs a combination of reputation and rate-based heuristics to inspect the incoming flow of DNS queries and filter out malicious DNS packets, without impacting the activities of legitimate visitors.

 

 

 

Incapsula Website Security : Blocks attacks against web applications to promote website safety and availability

 

Incapsula Website Security combines a PCI-certified WAF with advanced bot detection and mitigation. It protects websites and applications against application layer hacking attempts and blocks scrapers, vulnerability scanners and content spammers that overload servers and steal content. Our cloud-based approach, coupled with crowdsourcing techniques, enables us to anonymously harness real data from our customer base to better understand the global attack landscape and continually improve security.

 

 

 

Incapsula Content Delivery Network : Optimizes website performance

 

Incapsula Content Delivery Network (“CDN”) is a globally distributed network of data centers that delivers full site acceleration through intelligent caching and content optimization tools. The CDN is application-aware and dynamically profiles website resources and identifies cacheable, dynamic and static content, including content that other CDNs consider to be uncacheable.

 

 

 

6


Incapsula Load Balancing : Balances web traffic load across multiple web servers

 

Incapsula Load Balancing provides layer 7 load balancing and failover as a service, so organizations can replace costly appliances with an enterprise-grade, cloud-based solution. The service supports in-datacenter and cross-datacenter high availability scenarios. It also provides real-time health monitoring to ensure that traffic is routed to a viable web server.

 

 

 

Skyfence

 

 

 

Skyfence Cloud Audit and Protection : Monitors user activity and protects cloud application data

 

Skyfence Cloud Audit and Protection is a cloud-based offering that provides real-time analytics and controls over corporate use of all SaaS applications. The offering protects sensitive data from external and insider threats, enforces security policies for SaaS accounts, monitors usage, protects against account takeovers and enforces data leak prevention policies for data in motion. Skyfence Cloud Audit and Protection uses proprietary network and traffic analysis and Dynamic User Fingerprinting technology to profile normal user behavior and detect anomalies that could indicate cyber-attacks or insider threats. The product can be configured to immediately alert, block, or require two-factor identity verification on any activity threshold or user action when it encounters suspicious activities and behaviors. We believe this gives IT security teams flexibility to enforce appropriate security policies across cloud applications.

 

 

 

Skyfence Web Audit and Protection : Audits users and protects accounts for production and customer-facing applications

 

Many organizations operate business-critical production applications that provide online services to customers. Skyfence Web Audit and Protection monitors and secures production applications running in the corporate data center and in public cloud computing environments, such as Amazon Web Services (“AWS”) and Microsoft Azure. The product offers essential capabilities for intelligent detection of anomalous behavior that signals an account takeover attempt. Automated policies are designed to ensure that detection and remediation of account-centric threats happen immediately and also support the creation of custom policies that define specific business rules. With Skyfence Web Audit and Protection, organizations can invoke identity verification using a one-time password challenge in response to any suspicious activity to provide access only to those who should have access. In addition, Skyfence tracks production application activity so that that user and administrator activity is monitored and consistent access logs are created. Skyfence Web Audit and Protection performs activity monitoring using a transparent deployment model that has no impact on user experience and requires no change to the monitored application.

 

 

 

Comply

 

 

 

 

 

SecureSphere

 

 

 

7


SecureSphere Database Activity Monitor : Efficiently demonstrates database compliance

 

SecureSphere Database Activity Monitor secures business-critical data in databases and data warehouses in the data center. SecureSphere Database Activity Monitor can be deployed as a physical or virtual appliance based on the feature and traffic capacity requirements of our customers. SecureSphere Database Activity Monitor covers the following major enterprise database platforms: Oracle, Oracle Exadata, Microsoft SQL Server, IBM DB2 (on Linux, UNIX, Windows, z/OS and DB2/400), IBM IMS on z/OS, IBM Informix, IBM Netezza, SAP Sybase, Teradata, Oracle MySQL, PostgreSQL, and Progress OpenEdge.

 

 

 

SecureSphere User Rights Management for Databases : Establishes automated access rights review process and demonstrates compliance

 

SecureSphere User Rights Management for Databases automatically aggregates user rights across heterogeneous databases. This enables organizations to establish an automated access rights review process, identify excessive user rights, and demonstrate compliance with regulations such as Sections 302 and 404 of the Sarbanes Oxley Act of 2002 (“SOX”) and requirements 7 and 8.5 of the PCI Data Security Standards (“PCI DSS”).

 

 

 

SecureSphere Agent for Big Data : Helps pass audits and avoid hefty non-compliance fines

 

SecureSphere collects and analyzes access activity to big data in real-time, and instantly notifies compliance, security and operations teams about any violation of data access policies. SecureSphere Agent for Big Data is fully integrated into SecureSphere Database Activity Monitor, and audit data from big data is processed and shown with audit data from other enterprise systems. This provides a complete, unified view of user access to sensitive data across databases, data warehouses and big data.

 

 

 

SecureSphere Agent for z/OS : Effectively and efficiently audits critical mainframe databases

 

SecureSphere Agent for z/OS monitors both DB2 and IMS databases and delivers comprehensive and efficient auditing of database activities and addresses regulatory requirements related to these critical systems.

 

 

 

SecureSphere File Activity Monitor : Provides visibility into file access activity to protect business-critical data

 

SecureSphere File Activity Monitor is designed to secure unstructured data, including spreadsheets, presentation slides, word processing documents, videos and PDFs containing business-critical data and applications that our customers store in unstructured repositories, such as file servers, network attached storage and storage area network devices. SecureSphere File Activity Monitor can be deployed as a physical or virtual appliance based on feature and traffic capacity requirements of our customers.

 

 

 

SecureSphere User Rights Management for Files : Streamlines and increases accuracy of complex access rights reviews

 

SecureSphere User Rights Management for Files enables organizations to manage user access rights across unstructured data stored on multiple different file systems. Sold as a part of the SecureSphere File Activity Monitor and SecureSphere File Firewall solutions, SecureSphere User Rights Management for Files aggregates user rights based on organizational context and actual file usage to illustrate what rights users have to sensitive files. This helps secure customer environments by evaluating user access rights, eliminating excessive privileges and disabling dormant accounts.

 

 

 

ADC Insights : Streamlines compliance for common business applications and regulatory requirements

 

ADC Insights provide predefined, application-specific policies and reports for regulations such as SOX, PCI DSS, and the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and for common business application platforms like SAP, Oracle E-Business Suite and PeopleSoft.

8


 

 

 

Skyfence

 

 

 

Skyfence Cloud Governance : Combines traditional cloud discovery and risk assessment with customer-specific risk factors

 

Skyfence Cloud Governance, a cloud-based offering, combines traditional cloud application discovery data with contextual risk factors to provide enterprise-class cloud risk assessments. Skyfence Cloud Governance goes beyond generic risk factors to identify specific conditions of a customer’s cloud implementation that pose threats including former employees with active accounts, users who may have excessive access rights, external users with access and unsecured cloud application configurations based on industry best practices and regulatory requirements. Using the product’s integrated remediation workflow tools, IT staff can remediate their risks to provide safe and productive use of the cloud.  The product also utilizes cloud service provider enabled APIs to identify risk and compliance exposure from data (for example, social security numbers, credit card numbers and personally identifiable information) at rest within applications such as Microsoft OneDrive, Box and Google Drive.

 

Technology

Our solutions include several proprietary technologies described below.

SecureSphere

 

·

Dynamic Profiling: Allows customers to create and monitor security policies based on actual application and database behavior, automatically recognizes valid application and database changes over time and automatically updates the profile according to these application and database changes.

 

·

Universal User Tracking: Helps customers achieve the primary requirements of any audit and security process by tracking the individual end user that accessed or modified business data, including web application user tracking, web to database user tracking, SQL connection user tracking and direct user tracking that collectively enable our solution to audit end users regardless of how they connect to the database.

 

·

Transparent Inspection: Provides application layer security without needing to intermediate web connections, allowing our solution to inspect traffic without compromising performance, latency or availability.

 

·

Correlated Attack Validation: Provides our customers with protection against malicious activity by analyzing multiple data points, tracking events over time and correlating disparate events to identify and block sophisticated attacks.

Skyfence

 

·

Dynamic User and Device Fingerprinting: Continuously profiles cloud access, users and their endpoints to develop a fingerprint based on user location, devices, activity and other parameters to prevent high risk insider attacks and external account takeover attacks.

Incapsula

 

·

Client Classification Engine: Analyzes and classifies all incoming traffic to a website, distinguishes between human and bot traffic, identifies “good” and “bad” bots, and classifies traffic by browser type. While this technology was originally developed on the Incapsula service, we recently incorporated the technology into our ThreatRadar Bot Protection Services, which is a SecureSphere add-on service.

Maintenance and Support

We offer our customers ongoing product support services for both hardware and software. These maintenance programs are typically sold to customers for one- to three-year terms at the time of the initial product sale and typically renew for successive one- to three-year periods. We offer premium levels of service which include advance replacement and greater call center availability. While

9


some of our channel partners provide tier one support, including MSSPs and data center hosting providers, in most instances we provide tier one level support and above.

Our ADC updates are included with maintenance and support contracts. The service consists of a content delivery mechanism by which we can distribute product content enhancements to our customers. Our ADC update servers deliver various types of security content to our appliances deployed in the field without the need for our customers to install a software patch or upgrade. Examples of ADC updates include new security signatures and policies for our WAF, new database assessment tests for our discovery and assessment server and new audit policy functionality for our database products.

Professional Services and Training

Our professional services consultants assist our customers in the deployment and configuration of our products. These fee-based services, provided by our professional services consultants, include providing advice on deployment planning, network design, product configuration and implementation, automating and customizing reports and tuning policies and configuration of our products for the particular characteristics of the customer’s environment. Additionally, we provide our customers with fee-based, hands-on training classes for our solution that are offered regularly and in different parts of the world.

Customers

We provide products and services to a variety of customers worldwide, including some of the world’s largest banks, retailers, insurers, technology and telecommunication companies and hospitals, as well as U.S. and other national, state and local government agencies. As of December 31, 2015, Imperva had over 4,500 customers in more than 90 countries. In addition, our solutions are used to protect thousands of organizations through cloud-based deployments with our SaaS customers and our MSSPs and hosting partners.

In 2015, we had one reseller that represented 18% of our total revenue, and in 2013, a different reseller represented 10% of our total revenue.  With the exception of these resellers, no customer has accounted for 10% or more of our total revenue in any year since 2004.  In 2015, 2014 and 2013, we generated approximately 64%, 58% and 61% of our revenue from customers in the Americas and approximately 36%, 42% and 39% from customers outside of the Americas, respectively. See Note 15 of “Notes to Consolidated Financial Statements” for information about segment disclosures and revenue by customer geographic regions.

Sales and Marketing

We believe that our hybrid sales model, which combines the leverage of a channel sales model with the account control of a direct sales model, has played an important role in our success to date. Our hybrid model employs a direct touch sales organization and an overlay channel sales team that actively assist our extensive network of channel partners throughout the sales process. We primarily sell our products and services to our customers through our channel partners, including distributors and resellers. In 2015, our channel partners originated over 45% of our sales and fulfilled almost 89% of our sales. Although our products are designed for turnkey deployment, they are highly customizable, which allows our channel partners to provide a variety of value added services to our customers. As of December 31, 2015, our network of channel partners included more than 300 resellers and distributors worldwide, including leading security value added resellers and some of the world’s largest hosting companies.

Sales

We support the sales of our products and services with a team of experienced channel account managers, sales professionals and sales engineers who provide business planning, joint marketing strategy, and pre-sales and operational sales support. Our overlay channel team is responsible for managing relationships with our resellers, MSSPs and distributors. Our sales professionals are responsible for assisting channel partners in gaining and supporting key customer accounts and acting as liaisons between the end customers and our marketing and product development organizations. Our sales professionals and sales engineers also directly engage with customers to address their unique security and deployment requirements. We also have an inside sales team that is principally focused on lead generation for our reseller partners and regional sales professionals. To support our broadly dispersed global channel and customer base, we had, as of December 31, 2015, sales personnel in 25 countries. We plan to continue to invest in our sales organization to support our growth, including through increased sales through our channel partners.

Marketing

Our marketing strategy is focused on building brand awareness, driving customer demand for our security solutions and enabling both our direct and channel sales models. We execute this strategy by leveraging a combination of internal marketing professionals and a network of regional and global channel partners. Our internal marketing organization is responsible for building brand awareness, driving demand generation, supporting channel enablement and product marketing, and working with our business operations team to support channel marketing and sales support programs. We focus our resources on targeted, integrated activities

10


that can be leveraged by partners worldwide to extend our reach. Our marketing efforts include public and analyst relations, on line a nd offline awareness building and demand generation, seminars, tradeshows, webinars, digital and website marketing, building sales tools and collateral information regarding product awards and technical certifications and social media outreach, including o ur data security blog.

Research and Development

Our research and development efforts focus primarily on improving and enhancing our existing security products and services, as well as developing new products, features and functionality and conducting advanced security research. We conduct our research and development activities primarily in Israel, with small engineering teams in Redwood Shores, California, Austin, Texas and Kiev, Ukraine. We believe this provides us with access to some of the best engineering talent in the security industry. As of December 31, 2015, we had 288 employees dedicated to research and development, including our advanced security research group, the ADC.

When considering product improvements and enhancements, we communicate with our customers and partners who provide significant feedback for product development and innovation. We regularly release new versions of our products incorporating these improvements and enhancements. Our research and development team works with our customer support group to resolve escalated support issues by providing consultation, bug fixes and patches. Our research and development team also provides technical assistance to our other departments, including to our sales team by overseeing product pilots for potential customers.

In addition to enhancing our products and services, our research and development organization includes our ADC team. We believe our ADC team is an important differentiator for us in the security marketplace. Our ADC team performs security analysis, tracks hackers and trends in the hacker community and undertakes vulnerability discovery, in addition to providing us with regulatory compliance expertise. ADC research combines extensive lab work with hands-on testing in real world environments to ensure that our products, through advanced data security technology, deliver up-to-date threat protection and leading compliance automation. Our ADC has discovered numerous commercial application vulnerabilities and has issued numerous security advisories, providing insight into both published and unpublished security threats to help commercial application and database vendors and security professionals. Our ADC’s “Hacker Intelligence Initiative” focuses on improving risk management by tracking hackers, developments in attack techniques and potential targets in known hacker forums and chat rooms and our ADC’s annual report, the Web Application Attack Report provides an in-depth view of the threat landscape for the year, including hacking trends, the latest cyber-crime business models and breach analysis by geography, industry and attack type.  The ADC’s research is also the foundation for many of our products, product features and services, including attack signature updates, database vulnerability assessments, pre-defined compliance reports and the engine and analysis behind our crowdsourced security intelligence service, ThreatRadar Community Defense. We deliver automated feeds from our ADC to our products in the field to ensure that our customers are always armed with the latest defenses against new threats, and the most recent regulatory compliance best practices.

Our research and development expense was $53.4 million, $43.1 million and $27.6 million in 2015, 2014 and 2013, respectively.

Intellectual Property

To protect our intellectual property, both domestically and abroad, we rely primarily on patent, trademark, copyright and trade secret laws. As of December 31, 2015, we had 24 issued patents and 14 pending patent applications in the United States. The claims for which we have sought patent protection relate primarily to methods, computer programs, devices and systems we have developed for our products. We also license software from third parties for integration into our products, including open source software and other software available on commercially reasonable terms.  Our industry is characterized by the existence of a large number of relevant patents and frequent claims and related litigation regarding patent and other intellectual property rights. For more information about risks related to our and third party intellectual property rights see the section entitled “Risk Factors—Risks Related to our Business— Assertions by third parties of infringement or other violations by us of their intellectual property rights could result in significant costs and substantially harm our business and operating results”; “—We rely on the availability of licenses to third-party software and other intellectual property, the loss of which could increase our costs and delay software shipments”; “—Some of our products contain “open source” software, and any failure to comply with the terms of one or more of these open source licenses could negatively affect our business”; and “—Failure to protect our proprietary technology and intellectual property rights could substantially harm our business and operating results.”

Manufacturing and Suppliers

Our security hardware appliance products are manufactured to our specifications by Caswell, Inc., a Taiwanese original design manufacturer of network appliance hardware products. We have entered into non-exclusive contracts to purchase these hardware appliances from American Portwell Technology, Inc. (a wholly owned subsidiary of Portwell, Inc.), and Dan-el Technologies Ltd., which are value-added distributors of products manufactured by Caswell, Inc. These contracts will remain in effect until terminated by

11


either party. Such contracts are terminable by us for any reason upon six months’ notice, by the value-added distributor s upon nine months’ notice or by either party for an uncured material breach. We currently work with American Portwell Technology and provide the value-added distributors with rolling product demand forecasts, but our contracts contain no obligation for us to purchase any minimum amount of products. We submit purchase orders that describe the types and quantities of our products to be manufactured, the delivery dates and other delivery terms. American Portwell Technology receives the hardware appliances fro m the manufacturer and configure s and install s our proprietary software on the appliances and then undertake s quality testing at their fulfillment centers. American Portwell Technology then ships our appliances directly to our distributors, resellers or cu stomers or our logistic partner, Base Logistics BV. We hold inventory in American Portwell Technology’s fulfillment centers and in our logistic partner’s warehouses, in anticipation of orders for new appliances and to support our advance replacement progra m with new and repaired appliances. In addition, our contract governs their use of our intellectual property and allocates the responsibilities for warranty repair, out of warranty repair and replacement costs with respect to damaged and defective products . We believe that having third parties manufacture, configure and test our products and provide a substantial portion of our logistics enables us to efficiently allocate capital, better adjust manufacturing volumes to meet changes in demand and more quickl y deliver products, allowing us to focus resources on our core competencies.

The hardware components included in our products are sourced from various suppliers by our manufacturer and are principally industry standard parts and components that are available from multiple vendors. We have limited sources of supply for certain key components of our products, such as semiconductors, printed circuit boards and hard disk drives, which exposes us to the risk of component shortages or unavailability. For more information on risks related to product manufacturing and availability of components, see the section entitled “Risk Factors–Risks Related to Our Business–Delays or interruptions in the manufacturing and delivery of SecureSphere appliances by our sole source manufacturer may harm our business.”

Competition

The market for cyber-security solutions is intensely competitive and we expect competition to increase in the future. Our primary competitors by product area include:

 

·

Database security. International Business Machines Corporation, Intel Security group of Intel Corporation (formerly McAfee, Inc.) and Oracle Corporation

 

·

File security. EMC Corporation, Symantec Corporation and Varonis Systems, Inc.

 

·

Web application security and DDoS. Akamai Technologies, Inc. and F5 Networks, Inc.

We believe that the principal competitive factors affecting the market for cyber-security solutions include breadth of product offerings, security effectiveness, manageability, reporting, technical features, performance, ease of use, price, professional services capabilities, distribution relationships and customer service and support. We believe that our solutions generally compete favorably with respect to such factors.

Employees

As of December 31, 2015, our total headcount was 923 employees, with 288 in research and development, 344 in sales and marketing, 115 in services and support, 63 in manufacturing operations and 113 in a general and administrative capacity. As of December 31, 2015, our headcount was 414 people in the United States, 409 in Israel and 100 in other countries. None of our employees is represented by a labor union with respect to his or her employment with us. We have not experienced any work stoppages, and we consider our relations with our employees to be good.

Available Information

Our Internet address is www.imperva.com. Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports are available on the Investor Relations section of our website free of charge, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information found on our website is not part of this or any other report we file with or furnish to the SEC. The SEC also maintains an Internet website that contains reports, proxy and information statements and other information regarding registrants, such as Imperva, that file electronically with the SEC. The address of the website is www.sec.gov. In addition, you may read and copy any filing that we make with the SEC at the public reference room maintained by the SEC, located at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information about the public reference room.

 

12


Item 1A. Ri sk Factors

Risks Related to Our Business

We have a history of losses, we may not become profitable and our revenue growth may not continue.

We have incurred net losses in each fiscal year since our inception, including net losses attributable to our stockholders of $25.2 million in 2013, $59.0 million in 2014 and $48.9 million in 2015. As a result, we had an accumulated deficit of $206.5 million at December 31, 2015. We may not become profitable in the future if we fail to increase revenue and manage our expenses, or if we incur unanticipated liabilities. Revenue growth may slow or revenue may decline for a number of possible reasons, including slowing demand for our products or services, increasing competition, a decrease in the growth of, or decline in, our overall market, or our failure to capitalize on growth opportunities or introduce new products and services. In addition, we have incurred, and anticipate that we will continue to incur, significant legal, accounting and other expenses relating to being a public company. If our revenues do not increase at a rate to proportionally offset these expected increases in operating expenses, our operating margins will suffer. Further, in future periods, our revenues could decline and, accordingly, we may not be able to achieve profitability and our losses may increase. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a consistent basis. Any failure by us to achieve, maintain or increase profitability and continue our revenue growth could cause the price of our common stock to materially decline.

Our quarterly operating results are likely to vary significantly and to be unpredictable, which could cause the trading price of our stock to decline.

Our revenues and operating results could vary significantly from period to period as a result of a variety of factors, many of which are outside of our control. As a result, comparing our revenues and operating results on a period-to-period basis may not be meaningful, and you should not rely on our past results as an indication of our future performance. We may not be able to accurately predict our future revenues or results of operations. We base our current and future expense levels on our operating plans and sales forecasts, and our operating costs are relatively fixed in the short-term. As a result, we may not be able to reduce our costs sufficiently to compensate for an unexpected shortfall in revenues, and even a small shortfall in revenues could disproportionately and adversely affect financial results for that quarter. In addition, we recognize revenues from sales to some customers or resellers when cash is received, which may be delayed because of issues with those customers or resellers. If our revenues or operating results fall below the expectations of investors or any securities analysts that cover our stock, the price of our common stock could decline substantially.

In addition to other risk factors listed in this section, factors that may individually or cumulatively affect our operating results from period to period include:

 

·

the level of demand for our products and services, and the timing of orders from our channel partners and customers;

 

·

the timing of sales and shipments of products during a quarter, which may depend on many factors such as inventory and logistics and our ability to ship new products on schedule and accurately forecast inventory requirements;

 

·

the mix of products sold, the mix of revenue between products and services, including subscription services, and the degree to which products and services are bundled and sold together for a package price;

 

·

the budgeting, procurement and work cycles of our customers, which may result in seasonal variation as our business and the market for solutions such as ours mature;

 

·

changes in customer renewal rates for our services;

 

·

general economic conditions, both domestically and in our foreign markets, and economic conditions specifically affecting industries in which our customers participate;

 

·

the timing of satisfying revenue recognition criteria for our sales, including shipping and delivery terms, particularly where we accrue the associated commission expense in a different period, which may be affected by the extent to which we bring on new resellers and distributors, and our ability to establish vendor-specific objective evidence of fair value, or VSOE, for new products and maintain VSOE for maintenance and services;

 

·

future accounting pronouncements or changes in our accounting policies; and

 

·

increases or decreases in our expenses caused by fluctuations in foreign currency exchange rates, since a significant portion of our expenses are incurred and paid in the Israeli shekel and other currencies besides the U.S. dollar.

13


Reliance on a concentration of shipments at the end of the quarter could cause our revenue to fall below expected levels, resulting in a decline in our stock price.

Historically, we have received a significant majority of a quarter’s sales orders and generated a significant majority of a quarter’s revenue during the last two weeks of the quarter. The fact that so many orders arrive at the end of a quarter means that our revenue may move from one quarter to the next if we cannot fulfill all of the orders and satisfy all of the revenue recognition criteria under our accounting policies before the quarter ends.

This pattern is a result of customer buying habits and the efforts of our sales force and channel partners to meet or exceed quarterly quotas. If expected revenue at the end of any quarter is delayed because anticipated purchase orders fail to materialize, our logistics partners fail to ship or deliver products on time, we fail to manage our inventory properly, we fail to release new products on schedule, or for any other reason, then our revenue for that quarter could fall below our expectations or those of securities analysts and investors, resulting in a decline in our stock price.

We rely on third party channel partners to generate a significant portion, and to fulfill a substantial majority, of our revenue, and if we fail to expand and manage our distribution channels, our revenues could decline and our growth prospects could suffer.

Historically our channel partners have originated more than 45%, and fulfilled 85% or more, of our revenue, and we expect that channel sales will represent a substantial portion of our revenues for the foreseeable future. Our ability to expand our distribution channels depends in part on our ability to educate our channel partners about our products and services, which are often complex. Our agreements with our channel partners are generally non-exclusive and many of our channel partners have more established relationships with our competitors. If our channel partners choose to place greater emphasis on products and services of their own or those offered by our competitors, our ability to grow our business and sell our products may be adversely affected. If our channel partners do not effectively market and sell our products and services, or if they fail to meet the needs of our customers, then our ability to grow our business and sell our products may be adversely affected. The loss of one or more of our larger channel partners, who may cease marketing our products with limited or no notice, and our possible inability to replace them could adversely affect our sales. Our failure to recruit additional channel partners, or any reduction or delay in their sales of our products and services or conflicts between channel sales and our direct sales and marketing activities could materially and adversely affect our results of operations.

We face intense competition, especially from larger, better-known companies and we may lack sufficient financial or other resources to maintain or improve our competitive position.

The market for cyber-security products is intensely competitive and we expect competition to intensify in the future. Our competitors include companies such as Akamai Technologies, Inc., F5 Networks, Inc., International Business Machines Corporation (“IBM”), Intel Security group of Intel Corporation (“Intel”), Oracle Corporation (“Oracle”), Symantec Corporation and other point solution security vendors.

Many of our existing and potential competitors may have substantial competitive advantages such as:

 

·

greater name recognition and longer operating histories;

 

·

larger sales and marketing budgets and resources and the capacity to leverage their sales efforts and marketing expenditures across a broader portfolio of products;

 

·

broader, deeper or otherwise more well-established relationships with customers and potential customers;

 

·

broader distribution networks and more established relationships with distributors;

 

·

wider geographic presence;

 

·

access to larger customer bases;

 

·

greater customer support resources;

 

·

greater resources to make acquisitions;

 

·

greater resources to develop and introduce products that compete with our products;

 

·

lower labor and development costs; and

 

·

substantially greater financial, technical and other resources.

As a result, they may be able to adapt more quickly and effectively to new or emerging technologies and changing opportunities, standards or customer requirements. In addition, these companies could reduce the price of their competing products, resulting in intensified pricing pressures within the markets in which we compete. Further, some of our larger competitors have substantially

14


broader product offerings and leverage their relationships based on other products or incorporate functionality into existing products in a manner that discour ages customers from purchasing our products.

Our competitors may offer a bundled product offering, and our customers may elect to accept this offering from our competitors, even if it has more limited functionality than our product offering, instead of adding the additional appliances required to implement our offering. The consolidation in our industry, such as IBM’s acquisition of Guardium, Inc., Oracle’s acquisition of Secerno, Ltd. and Intel’s acquisition of McAfee, Inc., increases the likelihood of competition based on integration or bundling, particularly where our competitors’ products and offerings are effectively integrated, and we believe that consolidation in our industry may increase the competitive pressures we face on all our products and services. If we are unable to sufficiently differentiate our products and services from the integrated or bundled products of our competitors, such as by offering enhanced functionality, performance or value, we may see a decrease in demand for those products or services, which would adversely affect our business, operating results and financial condition. Further, it is possible that continued industry consolidation may impact customers’ perceptions of the viability of smaller or even medium-sized software firms and consequently customers’ willingness to purchase from such firms. Similarly, if customers seek to concentrate their software purchases in the product portfolios of a few large providers or have already deployed products that are similar to ours, we may be at a competitive disadvantage notwithstanding the superior performance that we believe our products and services can deliver. Larger competitors are also often in a better position to withstand any significant reduction in capital spending by customers, and will therefore not be as susceptible to economic downturns.

Also, many of our smaller competitors that specialize in providing protection from a single type of cyber-security threat may deliver these specialized cyber-security products to the market more quickly than we can or may introduce innovative new products or enhancements before we do. Conditions in our markets could change rapidly and significantly as a result of technological advancements.

We may not compete successfully against our current or potential competitors. Companies competing with us may introduce products that have greater performance or functionality, are easier to implement or use, or incorporate technological advances that we have not yet developed or implemented. Our current and potential competitors may also establish cooperative relationships among themselves or with third parties that may further enhance their resources. In addition, companies competing with us may price their products more competitively than ours, or have an entirely different pricing or distribution model. Increased competition could result in fewer customer orders, price reductions, reduced operating margins and loss of market share. Further, we may be required to make substantial additional investments in research, development, marketing and sales in order to respond to such competitive threats, and we cannot assure you that we will be able to compete successfully in the future.

We operate in an evolving market that has not yet reached widespread adoption and where new or existing technologies that may be perceived to address the risks in different ways could gain wide adoption and supplant some or all of our products and services, making analysis of trends or predictions about our business difficult and potentially weakening our sales and our financial results.

We operate in new, rapidly evolving categories in the security industry that focus on securing our customers’ business-critical data and applications. We offer database, file and web application security in an integrated, modular cyber-security solution. Because we depend in part on the market’s acceptance of our products and customers may choose to acquire technologies that are not directly comparable to ours, it is difficult to evaluate trends that may affect our business, including how large the cyber-security market will be and what products customers will adopt. For example, organizations that use other security products, such as network firewalls, security information and event management products or data loss prevention solutions, may believe that these security solutions sufficiently protect access to sensitive data. Therefore, they may continue to devote their IT security budgets to these products and may not adopt our cyber-security solutions in addition to such products. If customers do not recognize the benefits that our cyber-security solutions offer in addition to other security products, then our revenue may not grow as anticipated or may decline, and our stock price could decline.

The introduction of products and services embodying new technologies could render some or all of our existing products and services obsolete or less attractive to customers. Other cyber-security technologies exist or could be developed in the future, and our business could be materially adversely affected if such technologies are widely adopted. We may not be able to successfully anticipate or adapt to changing technology or customer requirements on a timely basis, or at all. Currently less than 30% of our customers have purchased more than one of our database, file and web security product families. Even if customers purchase our products, they may not make repeat purchases or purchase other elements of our SecureSphere, Incapsula or Skyfence product lines, which may be exacerbated by the rapid evolution of our market. If we are unable to sell additional products from multiple product families to our customers, then our revenue may not grow as anticipated or may decline, and our stock price could decline. If we fail to keep up with technological changes or to convince our customers and potential customers of the value of our solutions even in light of new technologies, our business, financial condition and results of operations could be materially and adversely affected.

15


In addition, because of our rapidly evolving market, any predictions about our revenue in future periods may not be as accurate as they would be if we operated in a more established market.

If we do not successfully anticipate market needs and opportunities or changes in the legal, regulatory and industry standard landscape and make timely enhancements to our products and develop new products that meet those needs, we may not be able to compete effectively and our ability to generate revenues will suffer.

The cyber-security market is characterized by rapid technological advances, changes in customer requirements, including changing customer requirements driven by legal, regulatory and self-regulatory compliance mandates, frequent new product introductions and enhancements and evolving industry standards in computer hardware and software technology. Customers and industry analysts expect speedy introduction of software and new functionality to respond to new threats, requirements and risks and we may be unable to meet these expectations. As a result, we must continually improve our products and introduce new solutions in response to changes in operating systems, application software, computer and communications hardware, networking software, data center architectures, programming tools and computer language technology. Moreover, the technology in our products is especially complex because it needs to effectively identify and respond to methods of attack and theft, while minimizing the impact on network, database, file system and web application performance. In addition, our products must successfully interoperate with products from other vendors.

We cannot guarantee that we will be able to anticipate future market needs and opportunities or be able to develop product enhancements or new products to meet such needs or opportunities in a timely manner or at all. Since developing new products or new versions of, or add-ons to, existing products is complex, the timetable for their commercial release is difficult to predict and may vary from our historical experience, which could result in delays in their introduction from anticipated or announced release dates. We may not offer updates as rapidly as new threats affect our customers or our newly developed products or enhancements may have defects, errors or failures. If we do not quickly respond to the rapidly changing and rigorous needs of our customers by developing and introducing on a timely basis new and effective products, upgrades and services that can respond adequately to new security threats, our competitive position, business and growth prospects will be harmed.

Even if we are able to anticipate, develop and commercially introduce enhancements and new products, there can be no assurance that we will be successful in developing sufficient market awareness of them or that such enhancements or new products will achieve widespread market acceptance. For example, while the majority of our current revenues are derived from the sales of our SecureSphere appliances, we also offer cloud-based security services through Incapsula and Skyfence. The market for cloud-based security solutions is relatively new and it is uncertain whether Incapsula’s and Skyfence’s services will gain market acceptance. In addition, diversifying our product offerings will require significant investment and planning, will bring us more directly into competition with software providers that may be better established or have greater resources than we do, will require additional investments of time and resources in the development and training of our channel and strategic partners and will entail a significant risk of failure.

Further, one factor that drives demand for our products and services is the legal, regulatory and industry standard framework in which our customers operate, which we expect will continue to be a factor for the foreseeable future. For example, many of our customers purchase our web application security products to help them comply with the security standards developed and maintained by the Payment Card Industry Security Standards Council (the “PCI Council”), which apply to companies that process or store credit card information. Laws, regulations and industry standards are subject to drastic changes that, particularly in the case of industry standards, may arrive with little or no notice, and these could either help or hurt the demand for our products. If we are unable to adapt our products and services to changing regulatory standards in a timely manner, or if our products fail to assist our customers with their compliance initiatives, our customers may lose confidence in our products and could switch to competing solutions. In addition, if regulations and standards related to cyber-security are changed in a manner that makes them less onerous, our customers may view government and industry regulatory compliance as less critical to their businesses, and our customers may purchase fewer of our products and services, or none at all. In either case, our sales and financial results would suffer.

16


Real or perceived errors, failures or bugs in our products, particularly those that result in our customers experiencing security breaches, could adversely affect our reputation and business could be harmed.

Our products and services are very complex and have contained and may contain undetected defects or errors, especially when first introduced or when new versions are released. Defects in our products may impede or block network traffic or cause our products or services to fail to help secure business-critical data and applications. Defects in our products may lead to product returns and require us to implement design changes or software updates. Any defects or errors in our products, or the perception of such defects or errors, could result in:

 

·

expenditure of significant financial and product development resources in efforts to analyze, correct, eliminate or work around errors or defects;

 

·

loss of existing or potential customers or channel partners;

 

·

delayed or lost revenue;

 

·

delay or failure to attain market acceptance;

 

·

delay in the development or release of new products or services;

 

·

negative publicity, which will harm our reputation;

 

·

warranty claims against us, which could result in an increase in our provision for doubtful accounts;

 

·

an increase in collection cycles for accounts receivable or the expense and risk of litigation; and

 

·

harm to our results of operations.

Data thieves are sophisticated, often affiliated with organized crime and operate large scale and complex automated attacks. In addition, their techniques change frequently and generally are not recognized until launched against a target. If we fail to identify and respond to new and complex methods of attack and to update our products to detect or prevent such threats in time to protect our customers’ business-critical data and applications, our business and reputation will suffer.

In addition, many of our customers use our products in applications that are critical to their businesses and may have a greater sensitivity to defects in our products than to defects in other, less critical, software products. An actual or perceived security breach or theft of the business-critical data of one of our customers, regardless of whether the breach is attributable to the failure of our products or services, could adversely affect the market’s perception of our security products. Despite our best efforts, there is no guarantee that our products will be free of flaws or vulnerabilities, and, even if we discover these weaknesses, we may be unable to correct them promptly, if at all. Our customers may also misuse our products, which could result in a breach or theft of business-critical data.

Although we have limitation of liability provisions in our standard terms and conditions of sale, they may not fully or effectively protect us from claims as a result of federal, state or local laws or ordinances or unfavorable judicial decisions in the United States or other countries. The sale and support of our products also entail the risk of product liability claims. We maintain insurance to protect against certain claims associated with the use of our products, but our insurance coverage may not cover all claims asserted against us, or cover only a portion of such claims. In addition, even claims that ultimately are unsuccessful could result in our expenditure of funds in litigation and divert management’s time and other resources.

False detection of security breaches or false identification of malicious sources could adversely affect our business.

Our cyber-security products may falsely detect threats that do not actually exist. For example, our ThreatRadar Reputation Services product relies on information on attack sources aggregated from third-party data providers who monitor global malicious activity originating from anonymous proxies, specific IP addresses, botnets and phishing sites. If the information from these data providers is inaccurate, the potential for false positives increases. These false positives, while typical in the industry, may affect the perceived reliability of our products and may therefore adversely impact market acceptance of our products. If our products and services restrict access to important databases, files or applications based on falsely identifying users or traffic as an attack or otherwise unauthorized, then our customers’ businesses could be adversely effected. Any such false identification of users or traffic could result in negative publicity, loss of customers and sales, increased costs to remedy any problem and costly litigation.

Our success in acquiring and integrating other businesses, products or technologies could impact our financial position.

In order to remain competitive, we may seek to acquire additional businesses, products or technologies, any of which could be material to our business, operating results and financial condition. For example, we acquired assets from Tomium Software, LLC in January 2014, acquired Skyfence Networks Ltd. (“Skyfence”) in February 2014 and acquired the remaining portion of Incapsula that we did not already own in March 2014. The environment for acquisitions in the markets in which we operate is very competitive and

17


acquisition candidate purchase prices will likely exceed what we would prefer to pay, but may be required to pay in order to make an acquisition. Furthermore, we may not find suitable acquisition candidates, and acquisitions we complete may be difficult to successfully integrate into our overall business. Achieving the anticipated benefits of future acquisitions will depend in part upon whether we can integrate acquired operations, products and technology in a timely and cost-effective manner.

Acquisitions involve many risks, including the following:

 

·

an acquisition may negatively impact our results of operations because it:

 

·

may require us to incur charges and substantial debt or liabilities,

 

·

may cause adverse tax consequences, substantial depreciation or deferred compensation charges,

 

·

may result in acquired in-process research and development expenses or in the future may require the amortization, write-down or impairment of amounts related to deferred compensation, goodwill and other intangible assets, or

 

·

may not generate sufficient financial return to offset acquisition costs;

 

·

we may encounter difficulties or unforeseen expenditures in integrating the business, technologies, products, personnel or operations of any company that we acquire, particularly if key personnel of the acquired company decide not to work for us;

 

·

an acquisition and integration process is complex, expensive and time consuming, and may disrupt our ongoing business, divert resources, increase our expenses and distract our management;

 

·

an acquisition may result in a delay or reduction of customer purchases for both us and the company acquired due to customer uncertainty about continuity and effectiveness of service from either company;

 

·

we may encounter difficulties in, or may be unable to, successfully sell any acquired products;

 

·

we may obtain unanticipated or unknown liabilities or become exposed to unanticipated risks in connection with any acquisition; and

 

·

an acquisition may involve the entry into geographic or business markets in which we have little or no prior experience.

If we are unable to effectively execute acquisitions, our business, financial condition and results of operations could be adversely affected.

Our business and operations have experienced rapid growth, and if we do not appropriately manage any future growth, or are unable to improve our systems and processes, our operating results will be negatively affected.

We have experienced rapid growth over the last several years. For example, we grew from 580 employees as of December 31, 2013, to 723 employees as of December 31, 2014, and then grew each quarter in 2015, with 773 employees as of March 31, 2015, 787 employees as of June 30, 2015, 850 employees as of September 30, 2015, and 923 employees as of December 31, 2015. This growth has placed, and will continue to place, a strain on our employees, management systems and other resources. Managing our growth has required, and will continue to require, significant expenditures and allocation of valuable management resources. We rely heavily on information technology systems to help manage critical functions, such as order processing, revenue recognition, financial forecasts and inventory and supply chain management. To manage any future growth effectively, we must continue to improve our information technology and financial infrastructure, operating and administrative systems and controls, and continue to manage headcount, capital and processes in an efficient manner. We may not be able to successfully implement improvements to these systems and processes in a timely manner.

In addition, we rely heavily on hosted SaaS technologies from third parties in order to operate critical functions of our business, including enterprise resource planning services from NetSuite Inc. and customer relationship management services from salesforce.com, inc. If these services become unavailable due to extended outages or interruptions or because they are no longer available on commercially reasonable terms or prices, our expenses could increase, our ability to manage our finances could be interrupted and our processes for managing sales of our products and services and supporting our customers could be impaired until equivalent services, if available, are identified, obtained and integrated; all of which could harm our business. Also, our systems and processes may not prevent or detect all errors, omissions or fraud. Our failure to improve our systems and processes, or their failure to operate in the intended manner, may result in our inability to manage the growth of our business and to accurately forecast our revenue, expenses and earnings, or to prevent certain losses. Our productivity and the quality of our products and services may also be adversely affected if we do not integrate and train our new employees quickly and effectively. Any future growth would add complexity to our organization and require effective coordination across our organization. If we fail to achieve the necessary level of

18


efficiency in our organization as it grows or otherwi se fail to manage any future growth effectively, we could incur increased costs, and experience a loss of customer and investor confidence in our internal systems and processes, any of which could result in harm to our business, results of operations and f inancial condition.

If we are unable to hire, retain and motivate qualified personnel, our business would suffer.

We depend on the continued contributions of our senior management and other key employees to execute on our business plan, and to identify and pursue new opportunities and product innovations. The loss of services of senior management or other key employees, particularly Anthony Bettencourt, our Chairman, President and Chief Executive Officer, and Amichai Shulman, one of our founders and our Chief Technology Officer, could significantly delay or prevent the achievement of our development and strategic objectives.

Our future success depends, in part, on our ability to continue to attract and retain highly skilled technical, managerial, finance and other personnel, particularly in our sales and marketing, research and development and professional service departments. Any of our employees may terminate their employment at any time. Competition for highly skilled personnel is frequently intense, globally for sales personnel, as well as in the San Francisco Bay Area and in Tel Aviv, Israel, the locations in which we have a substantial presence and need for highly-skilled personnel. We may be unable to attract and retain suitably qualified individuals who are capable of meeting our growing technical, operational and managerial requirements, on a timely basis or at all, and we may be required to pay increased compensation in order to do so. If we are unable to attract and retain the qualified personnel we need to succeed, our business will suffer.

Volatility or lack of performance in our stock price may also affect our ability to attract and retain our key employees. Employees may be more likely to leave us if the shares or RSUs they hold have declined in value or if the exercise prices of the options that they hold exceed the market price of our common stock. If we are unable to retain our employees, our business, operating results and financial condition will be harmed.

Delays or interruptions in the manufacturing and delivery of SecureSphere appliances by our sole source manufacturer may harm our business.

Our hardware appliances are built by a single manufacturer. Our reliance on a sole manufacturer, particularly a foreign manufacturer, involves several risks, including a potential inability to obtain an adequate supply of appliances and limited control over pricing, quality and timely delivery of products. In addition, replacing this manufacturer may be difficult and could result in an inability or delay in obtaining products. As a result, we may be unable to fulfill customer orders and our operating results may fluctuate from period to period, particularly if a disruption occurs near the end of a fiscal period.

Our manufacturer’s ability to timely manufacture and ship our appliances in large quantities depends on a variety of factors. The manufacturer relies on a limited number of sources for the supply of functional components, such as semiconductors, printed circuit boards and hard disk drives. Functional component supply shortages or delays could prevent or delay the manufacture and shipment of appliances and, in the event of shortages or delays, we may not be able to procure alternative functional components on similar pricing terms, if at all. In addition, contractual restrictions or claims for infringement of intellectual property rights may restrict our manufacturer’s use of certain components. These restrictions or claims may require our manufacturer to utilize alternative components or obtain additional licenses or technologies, and may impede its ability to manufacture and deliver appliances on a timely or cost-effective basis. If at some point, the manufacturer is no longer financially viable, we may lose our source of supply with little or no notice or recourse. Further, even if quality products are timely manufactured, delays in shipping may occur, resulting in delayed satisfaction of a primary revenue recognition criterion.

In the event of an interruption from this manufacturer or any quality control issues with this manufacturer, we may be unable to develop alternate or secondary sources in a timely manner. If we are unable to procure our appliances in quantities sufficient to meet our requirements, we will not be able to deliver products to our channel partners and customers, which would materially and adversely affect present and future sales.

A failure to manage excess inventories or inventory shortages could result in decreased revenue and gross margins and harm our business.

We purchase products from our manufacturing partner outside of, and in advance of, reseller or customer orders and hold our products in inventory. If we fail to accurately predict demand and as a result our manufacturer maintains insufficient hardware or component inventory or excess inventory, we may be unable to timely deliver products to our distributors or customers or may have substantial inventory expense. Because our channel partners do not purchase our products in advance of customer orders, our difficulty in accurately forecasting demand for our hardware products may be exacerbated. There is a risk we may incorrectly forecast demand and may be unable to sell excess products ordered from our manufacturing partner. Inventory levels in excess of customer

19


demand may res ult in inventory write-downs, and the sale of excess inventory at discounted prices could significantly impair our brand image and have an adverse effect on our financial condition and results of operations.

Conversely, if we underestimate demand for our products or if our manufacturing partner fails to supply products we require in a timely manner, we may experience inventory shortages. Inventory shortages might delay shipments to resellers, distributors and customers or cause us to lose sales. Further, as the size of individual orders increases, the risk that we may be unable to deliver unforecasted orders also increases, particularly near the end of quarterly periods. These shortages may diminish the loyalty of our channel partners or customers.

The difficulty in forecasting demand also makes it difficult to estimate our future financial condition and results of operations from period to period. A failure to accurately predict the level of demand for our products could adversely affect our net revenues and net income, and we are unlikely to forecast such effects with any certainty in advance.

We have operations outside of the United States and a significant portion of our customers and suppliers are located outside of the United States, which subjects us to a number of risks associated with conducting international operations.

We market and sell our products throughout the world and have personnel in many parts of the world. In addition, we have sales offices and research and development facilities outside the United States and we conduct, and expect to continue to conduct, a significant amount of our business with companies that are located outside the United States, particularly in Israel, Asia and Europe. We also source our components for our products from various geographical regions and ship components from a foreign production facility. Therefore, we are subject to risks associated with having international sales and worldwide operations, including:

 

·

challenges caused by distance, language, cultural and ethical differences and the competitive environment;

 

·

multiple and conflicting laws and regulations, including complications due to unexpected changes in these laws and regulations;

 

·

trade and foreign exchange restrictions;

 

·

foreign currency exchange fluctuations and foreign exchange controls;

 

·

economic, social or political instability in foreign markets;

 

·

greater difficulty in enforcing contracts, accounts receivable collection and longer collection periods;

 

·

changes in regulatory requirements;

 

·

difficulties and costs of staffing and managing foreign operations or relationships with channel partners;

 

·

the uncertainty and limitation of protection for intellectual property rights in some countries;

 

·

costs of complying with U.S. and foreign laws and regulations, including import and export control laws, tariffs, trade barriers, economic sanctions and other regulatory or contractual limitations on our ability to sell our products in certain foreign markets, and the risks and costs of non-compliance or complaints of non-compliance;

 

·

heightened risks of unethical, unfair or corrupt business practices, actual or claimed, in certain geographies and of improper or fraudulent sales arrangements that may impact financial results and result in restatements of, and irregularities in, financial statements;

 

·

the potential that our operations in the U.S. may limit the acceptability of our products to some foreign governments, and vice versa;

 

·

the potential for acts of terrorism, hostilities or war;

 

·

management communication and integration problems resulting from cultural differences and geographic dispersion; and

 

·

multiple and possibly overlapping tax structures.

Our product and service sales may be subject to foreign governmental regulations, which vary substantially from country to country and change from time to time. Failure to comply with these regulations could adversely affect our business. Violations of laws or key control policies by our employees, contractors, channel partners or agents could result in delays in revenue recognition, financial reporting misstatements, fines, penalties or the prohibition of the importation or exportation of our products and services and could have a material adverse effect on our business and results of operations.

20


A portion of our revenue is generated by sales to government entities and such sales are subject to a number of challenges and risks.

Sales to U.S. and foreign federal, state and local governmental agency customers have accounted for approximately 13% of our bookings for the year ended December 31 2013, 15% of our bookings for the year ended December 31, 2014 and 13% for the year ended December 31, 2015, and we may in the future increase sales to government entities. Sales into government entities are subject to a number of risks. Selling to government entities can be highly competitive, expensive and time consuming, often requiring significant upfront time and expense without any assurance that we will complete a sale. Accordingly:

 

·

changes in fiscal or contracting policies or decreases and uncertainties in available government funding;

 

·

changes in government programs or applicable requirements;

 

·

the adoption of new laws or regulations or changes to existing laws or regulations;

 

·

changes in political or social attitudes with respect to security issues; and

 

·

potential delays or changes in the government appropriations process, including actions such as spending freezes implemented to address political or fiscal policy concerns,

could cause governments and governmental agencies to delay or refrain from purchasing our products and services in the future or otherwise have an adverse effect on our business, financial condition and results of operations.

Most of our sales to government entities have been made indirectly through our channel partners. Government entities may have contractual or other legal rights to terminate contracts with our distributors and resellers for convenience or due to a default, and any such termination may adversely impact our results of operations.

In addition, for purchases by the U.S. federal government, we must comply with laws and regulations relating to U.S. federal government contracting, which affect how we and our channel partners do business in connection with U.S. federal agencies. These laws and regulations may impose added costs on our business, and failure to comply with these or other applicable regulations and requirements, including non-compliance in the past, could lead to claims for damages from our channel partners, penalties, termination of contracts and suspension or debarment from government contracting for a period of time. Any such damages, penalties, disruption or limitation in our ability to do business with the U.S. federal government may adversely impact our results of operations.

Our business in countries with a history of corruption and transactions with foreign governments increase the risks associated with our international activities.

As we operate and sell internationally, we are subject to the U.S. Foreign Corrupt Practices Act, or the FCPA, and other laws that prohibit improper payments or offers of payments to foreign governments and their officials and political parties for the purpose of obtaining or retaining business. We have operations, deal with and make sales to governmental customers in countries known to experience corruption, particularly certain emerging countries in Africa, East Asia, Eastern Europe, South America and the Middle East. Our activities in these countries create the risk of unauthorized payments or offers of payments by one of our employees, consultants, sales agents or channel partners that could be in violation of various anti-corruption laws, even though these parties may not be under our control. While we have implemented safeguards to prevent these practices by our employees, consultants, sales agents and channel partners, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents or channel partners may engage in conduct for which we might be held responsible. Violations of the FCPA may result in severe criminal or civil sanctions, including suspension or debarment from U.S. government contracting, and we may be subject to other liabilities, which could negatively affect our business, operating results and financial condition.

We rely significantly on revenue from maintenance and support which may decline and, because we recognize revenue from such services over the term of the relevant service period, downturns or upturns in sales are not immediately reflected in full in our operating results.

Our maintenance and support revenue accounted for 32% of our total revenue for year ended December 31, 2013, 33% of our total revenue for 2014 and 28% of our total revenue for 2015. Sales of new maintenance and support contracts or renewal of such services contracts may decline or fluctuate as a result of a number of factors, including customers’ level of satisfaction with our products and services, the prices of our products and services, the prices of products and services offered by our competitors or reductions in our customers’ spending levels. If our sales of new or renewal services contracts decline, our revenue or revenue growth may decline and our business will suffer. In addition, we recognize service revenue ratably over the term of the relevant service period, which is usually one to three years. As a result, much of the revenue we report each quarter is the recognition of deferred revenue from services contracts entered into during previous quarters. Consequently, a decline in new or renewal services contracts in any one quarter will not be fully reflected in revenue in that quarter, but will negatively affect our revenue in future quarters.

21


Accordingly, the effect of significant downturns in new or renewal sales of our services would not be reflected in full in our results of operations until future periods.

If we are unable to increase sales to larger customers, our results of operations may suffer.

We continuously seek to increase sales of our products to large enterprises, managed security service providers (“MSSPs”), cloud hosting providers and government entities. Sales to large enterprises, MSSPs, cloud hosting providers and government entities involve risks that may not be present, or are present to a lesser extent, in sales to small to mid-sized entities. These risks include:

 

·

preexisting relationships with larger, entrenched providers of security solutions who have access to key decision makers within the organization and who also have the ability to bundle competing products with a broader product offering;

 

·

increased purchasing power and leverage held by large customers in negotiating contractual arrangements with us;

 

·

more stringent requirements in our support service contracts, including stricter support response times, and increased penalties for any failure to meet support requirements; and

 

·

longer sales cycles, including lengthening of sales cycles due to competitive pressures or the evaluation by customers of both our cloud security solutions from Incapsula and our on-premise products as potential alternatives, and the associated risk that substantial time and resources may be spent on a potential customer who elects not to purchase our products and services.

In addition, product purchases by large enterprises, MSSPs, cloud hosting providers and government entities are frequently subject to budget constraints, multiple approvals, and unplanned administrative, processing and other delays. Further, large enterprises, MSSPs, cloud hosting providers and government entities typically have longer implementation cycles; require greater product functionality and scalability and a broader range of services; demand that vendors take on a larger share of risks; sometimes require acceptance provisions that can lead to a delay in revenue recognition; and expect greater payment flexibility from vendors. Additionally, the ongoing increase in the number of security vendors competing for these entities’ business, who in some cases use overlapping or confusing messaging, may combine with these factors to extend the sales cycles for our products and services. All these factors can add risk to doing business with these customers. If our sales expectations for large customers do not materialize in a particular quarter or at all, then our business, financial condition and results of operations could be materially and adversely affected.

If our existing and potential customers migrate to hosted, cloud-based data centers that do not deploy our products, our revenues could suffer.

The majority of our current sales are made through a model in which our channel partners sell our cyber-security solutions to large enterprise customers that operate their own data centers and have the ability to choose the cyber-security solutions and configurations to fit their environment. If our large enterprise customers and potential customers choose to outsource the hosting of their data centers to large, multi-tenancy hosting providers like Rackspace Hosting, Inc., Amazon Web Services (“AWS”) and Savvis, Inc. (dba CenturyLink Technology Solutions), they may not be able to choose what cyber-security solutions are deployed in these hosted environments, and our current sales model may not be effective. Although we work with large hosting services providers, like Rackspace Hosting, Inc., AWS and Savvis, Inc., to integrate our cyber-security solutions into their hosting environments so that our solutions may be offered to their hosting customers, we cannot guarantee that all such hosting service providers will adopt our solutions, offer them as a choice to their customers or promote our solutions over those of our competitors. Even if these large hosting services providers integrate our cyber-security solutions into their hosting environments and promote our solutions, they may be able to negotiate larger discounts than individual enterprise customers and, consequently, the average selling price of our products may decrease and our revenue would suffer. Alternatively, they may offer services based on our competitors’ products at lower cost or bundled with other services that we do not offer, and their customers may choose those services even if they would otherwise choose our products if making a decision on a stand-alone basis.

We are exposed to fluctuations in currency exchange rates, which could negatively affect our financial condition and results of operations.

Our functional and reporting currency is the U.S. dollar and we generate a majority of our revenue in U.S. dollars. However, in 2013, 2014 and 2015, we incurred approximately 37%, 32% and 27%, respectively, of our expenses outside of the United States in foreign currencies, primarily the Israeli shekel, principally with respect to salaries and related personnel expenses associated with our Israeli operations. The exchange rate between the U.S. dollar and foreign currencies has fluctuated substantially in recent years and may continue to fluctuate substantially in the future. We expect that a majority of our revenues will continue to be generated in U.S. dollars for the foreseeable future and that a significant portion of our expenses, including personnel costs, as well as capital and operating expenditures, will continue to be denominated in Israeli shekels. Our results of operations may be adversely affected by foreign exchange fluctuations.

22


We use forward foreign exchange contracts to hedge or mitigate the effect of changes in foreign exchange rates on our operating expenses denominated in certain foreign currencies. Howe ver, this strategy cannot eliminate our exposure to foreign exchange rate fluctuations and involves costs and risks of its own, such as cash expenditures, ongoing management time and expertise, external costs to implement the strategy and potential account ing implications. Additionally, our hedging activities may contribute to increased losses as a result of volatility in foreign currency markets.

Assertions by third parties of infringement or other violations by us of their intellectual property rights could result in significant costs and substantially harm our business and operating results.

Patent and other intellectual property disputes are common in the IT security industry. Some companies in the IT security industry, including some of our competitors, own large numbers of patents, copyrights, trademarks and trade secrets, which they may use to assert claims against us. This disparity between our patent portfolio and the patent portfolios of our most significant competitors may increase the risk that they may sue us for patent infringement and may limit our ability to counterclaim for patent infringement or settle through patent cross-licenses. In addition, there are patent holding companies or other patent owners who are solely or primarily in the business of building portfolios of patents and asserting them against operating companies, often with little merit, and who have no relevant product revenues so that potential assertions of our patents (and potential patents) against such companies may provide little or no deterrence. Third parties have asserted and may in the future assert claims of infringement, misappropriation or other violations of intellectual property rights against us. For example, in May 2010, F5 Networks, Inc., an IT infrastructure company that competes with us in the web application firewall market, filed a lawsuit against us alleging patent infringement. In September 2010, we filed a counterclaim alleging patent infringement by F5 Networks, Inc. In February 2011, we entered into a settlement and license agreement with F5 Networks, Inc., which dismissed the litigation. Third parties may also assert such claims against our customers or channel partners whom we typically indemnify against claims that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties. As the numbers of products and competitors in our market increase and overlaps occur, claims of infringement, misappropriation and other violations of intellectual property rights may increase. Also, to the extent we hire personnel from competitors, we may be subject to allegations that they have been improperly solicited or have divulged proprietary or other confidential information.

We cannot assure you that we are not infringing or otherwise violating any third-party intellectual property rights. Further, any claim of infringement, misappropriation or other violation of intellectual property rights by a third party, even those without merit, could be asserted against us, cause us to incur substantial costs defending against the claim and could distract our management from our business. An adverse outcome of a dispute may require us to pay substantial damages, including treble damages, if we are found to have willfully infringed a third party’s patents or copyrights; cease making, licensing or using solutions that are alleged to infringe or misappropriate the intellectual property of others; expend additional development resources to attempt to redesign our products or services or otherwise to develop non-infringing technology, which may not be successful; enter into potentially unfavorable royalty or license agreements in order to obtain the right to use necessary technologies or intellectual property rights; and indemnify our customers and partners. Royalty or licensing agreements, if required or desirable, may be unavailable on terms acceptable to us, or at all, or may require significant royalty payments and other expenditures. In addition, some licenses may be non-exclusive, and therefore our competitors may have access to the same technology licensed to us. Any of these events could seriously harm our business, financial condition and results of operations.

We rely on the availability of licenses to third-party software and other intellectual property, the loss of which could increase our costs and delay software shipments.

Many of our products and services include software or other intellectual property licensed from third parties, and we also use software and other intellectual property licensed from third parties in our business. This exposes us to risks over which we may have little or no control. For example, a licensor may have errors or defects in its products that harm our business, may have difficulties keeping up with technological changes or may stop supporting the software or other intellectual property that it licenses to us. Also, it will be necessary in the future to renew licenses, expand the scope of existing licenses or seek new licenses, relating to various aspects of these products and services, or otherwise relating to our business, which may result in increased license fees. In addition, a direct or indirect licensor may assert that we or our customers are in breach of the terms of a license, which could, among other things, give such licensor the right to terminate a license or seek damages from us, or both. Moreover, the inclusion in our products and services of software or other intellectual property licensed from third parties on a nonexclusive basis could limit our ability to differentiate our products from those of our competitors.

Licensed software may not continue to be available on commercially reasonable terms, or at all. While we believe that there are currently adequate replacements for third-party software, any loss of the right to use any of this software could result in delays in producing or delivering our software until equivalent technology is identified and integrated, which delays could harm our business. Our business would be disrupted if any of the software we license from others or functional equivalents of this software were either no longer available to us or no longer offered to us on commercially reasonable terms. In either case, we would be required to either redesign our products to function with software available from other parties or to develop these components ourselves, which would

23


result in increased costs and could result in delays in our product shipments and the release of new product offerings. Furthermore, we might be forced to limi t the features available in our current or future products. If we fail to maintain or renegotiate any of these software licenses, we could face significant delays and diversion of resources in attempting to license and integrate a functional equivalent of the software. Any of these events could have a material adverse effect on our business, financial condition and results of operations.

Some of our products contain “open source” software, and any failure to comply with the terms of one or more of these open source licenses could negatively affect our business.

Certain of our products are distributed with software licensed under “open source” licenses. Some of these licenses contain requirements that we make available source code for modifications or derivative works we create based upon the open source software, and that we license these modifications or derivative works under the terms of a particular open source license or subject to certain license requirements. If we combine our proprietary software with open source software in a certain manner, we could, under certain provisions of the open source licenses, be required to release the source code of our proprietary software. In addition to risks related to license requirements, usage of open source software can subject us to greater risks than use of third-party commercial software, as licensors of open source software generally do not provide warranties or any indemnification for infringement of third party intellectual property rights. We have established processes to help alleviate these risks, including a review process for screening requests from our development organization for the use of open source software, but we cannot be sure that all open source software is submitted for approval prior to use in our products. In addition, open source license terms may be ambiguous and many of the risks associated with use of open source software cannot be eliminated, and could, if not properly addressed, negatively affect our business. If we were found to have inappropriately used open source software, we might be required to re-engineer our products, to release proprietary source code, to discontinue the sale of our products in the event re-engineering could not be accomplished on a timely basis or to take other remedial action that may divert resources away from our development efforts, any of which could adversely affect our business, operating results and financial condition. Disclosing the source code of our proprietary software could make it easier for malicious third parties to discover vulnerabilities in our cyber-security products and allow our competitors to create similar products with decreased development effort and time. Any of these events could have a material adverse effect on our reputation, business, financial condition and results of operations.

Failure to protect our proprietary technology and intellectual property rights could substantially harm our business and operating results.

Our success depends, in part, on our ability to protect proprietary methods and technologies that we develop under the intellectual property laws of the United States and other countries, so that we can prevent others from using our inventions and proprietary information. We attempt to protect our intellectual property under patent, trademark, copyright and trade secret laws, and through a combination of confidentiality procedures, contractual provisions and other methods, all of which offer only limited protection. If we fail to protect our intellectual property rights adequately, our competitors might gain access to our technology, and our business might be harmed. In addition, defending our intellectual property rights might entail significant expenses. Any of our patents, copyrights, trademarks or other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. Imperva and its subsidiaries had 24 issued patents and 14 patent applications pending as of December 31, 2015 in the United States. Our issued patents, which are limited in number compared to some of our competitors, may not provide us with any competitive advantages or may be challenged by third parties, and our patent applications may never be granted at all. Additionally, the process of obtaining patent protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. Further, for strategic and other reasons we may choose not to seek patent protection for certain innovations and may choose not to pursue patent protection in certain jurisdictions. Even if issued, there can be no assurance that our patents will adequately protect our intellectual property, as the legal standards relating to the validity, enforceability and scope of protection of patent and other intellectual property rights are uncertain.

Any patents that are issued may subsequently be invalidated or otherwise limited, enabling other companies to better develop products that compete with ours, which could adversely affect our competitive business position, business prospects and financial condition. In addition, issuance of a patent does not guarantee that we have a right to practice the patented invention. Patent applications in the United States are typically not published until 18 months after filing, or in some cases not at all, and publications of discoveries in industry-related literature lag behind actual discoveries. We cannot be certain that we were the first to make the inventions claimed in our issued patents or pending patent applications or otherwise used in our products, that we were the first to file for protection in our patent applications, or that third parties do not have blocking patents that could be used to prevent us from marketing or practicing our patented products or technology. Effective patent, trademark, copyright and trade secret protection may not be available to us in every country in which our products and services are available. The laws of some foreign countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our intellectual property.

24


We might be required to spend significant resources to monitor and protect our intellectual property rights. We may initiate claims or litigation against third parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. Any litigation, whether or not it is resolved in our favor, could result in significant expense to us and divert the efforts of our technical and management personnel, which may ad versely affect our business, operating results and financial condition.

We may become subject to claims for remuneration or royalties for assigned service invention rights by our Israeli employees, which could result in litigation and adversely affect our business.

We have entered into assignment of invention agreements with our Israeli employees pursuant to which such individuals agree to assign to us all rights to any inventions created in the scope of their employment or engagement with us. A significant portion of our intellectual property has been developed by our Israeli employees in the course of their employment for us. Under the Israeli Patents Law, 5727-1967 (the “Patents Law”), inventions conceived by an employee during the scope of his or her employment with a company are regarded as “service inventions,” which belong to the employer, absent a specific agreement between the employee and employer giving the employee service invention rights. The Patents Law also provides that if there is no such agreement between an employer and an employee, the Israeli Compensation and Royalties Committee (the “Committee”), a body constituted under the Patents Law, shall determine whether the employee is entitled to remuneration for his or her inventions. The Committee has previously held that employees may be entitled to remuneration for intellectual property that they develop during their service for a company despite their explicit waiver of such right. In a recent decision, however, the Committee overturned its position and upheld that an employee’s waiver of his right to remuneration is valid and binding. The plaintiff in this last case filed a petition with the Israeli Supreme Court requesting to remand the case to the Committee for a second review, but the Israeli Supreme Court decided on July 8, 2015 that the Committee acted within its administrative authority and that it would not intervene in the Committee’s decision. Even though the recent decision still stands, the Committee’s inconsistency raises doubt as to the outcome in different sets of circumstances. Thus, although our Israeli employees have agreed to assign to us service invention rights, we may face claims demanding remuneration in consideration for assigned inventions. As a consequence of such claims, we could be required to pay additional remuneration or royalties to our current and/or former Israeli employees, or be forced to litigate such claims, which could negatively affect our business.

Confidentiality agreements with partners, employees, consultants and others may not adequately prevent disclosure of trade secrets and other proprietary information.

In order to protect our proprietary technology, processes and methods, we rely in part on confidentiality agreements and other restrictions with our customers, partners, employees, consultants and others. These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Despite our efforts to protect our proprietary technology, processes and methods, unauthorized parties may attempt to misappropriate, reverse engineer or otherwise obtain and use them. We may be unable to determine the extent of any unauthorized use or infringement of our products, technologies or intellectual property rights. In addition, others may independently develop identical or substantially similar technology and in these cases we would not be able to assert any trade secret rights against those parties. Moreover, policing unauthorized use of our technologies, products and intellectual property is difficult, expensive and time-consuming, particularly in foreign countries where the laws may not be as protective of intellectual property rights as those in the United States and where mechanisms for enforcement of intellectual property rights may be weak. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position.

We are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets.

Our business activities are subject to various restrictions under U.S. export controls and trade and economic sanctions laws, including the U.S. Commerce Department’s Export Administration Regulations and economic and trade sanctions regulations maintained by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”). If we fail to comply with these laws and regulations, we could be subject to civil or criminal penalties and reputational harm. U.S. export control laws and economic sanctions laws also prohibit certain transactions with U.S. embargoed or sanctioned countries, governments, persons and entities.

Many of our products incorporate encryption technology and may be exported outside the U.S. only if we obtain an export license or qualify for an export license exception. Compliance with applicable regulatory requirements regarding the export of our products may prevent our customers with international operations from deploying our products throughout their global systems or, in some cases, prevent the export of our products to some countries altogether. Further, various countries regulate the import of encryption technology and appliance-based products and have enacted laws that could limit our ability to distribute products, could create delays in the introduction of our products in those countries or could limit our customers’ ability to implement our products in those countries.

25


Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products to U.S. embargoed or sanctioned countries, governments and persons. While we and our channel partners take precautions to prevent our products from being shipped to, downloaded or accessed by U.S. sanctions targets, our products could be shipped to, downloaded or accessed by persons loca ted in countries that are the subject of U.S. embargoes despite our efforts. Any such shipment or access could have negative consequences, including government investigations, penalties and reputational harm. In 2015, we discovered that some of our free do wnloadable software evaluation products may have been downloaded by a limited number of persons located in countries that are the subject of U.S. embargoes. We terminated the unauthorized accounts, filed an initial disclosure with the U.S. Commerce Departm ent’s Bureau of Industry and Security (“BIS”) and with OFAC and filed final reports with BIS and OFAC on September 2, 2015 and September 22, 2015, respectively. We have implemented new screening measures designed to prevent users in embargoed countries and prohibited persons from purchasing, downloading or accessing our free downloadable evaluation software or other products or services. OFAC issued a cautionary letter on October 14, 2015 as a final enforcement response to the apparent violations and did no t impose any monetary penalties. BIS has not yet responded to our voluntary disclosures and we cannot predict when the agency will complete its review and determine whether any violations occurred. While BIS could decide not to impose penalties and only is sue a no action or cautionary letter, we could face civil and criminal penalties and may suffer reputational harm if we are found to have violated U.S. sanctions or export control laws. Even though we take precautions to prevent transactions with U.S. sanc tions targets, any such measures, or any new measures we may implement in the future, may be ineffective. As a result, there is risk that in the future we could provide our products to or permit our products to be downloaded or accessed by such targets des pite these precautions. This could result in negative consequences to us, including government investigations, penalties and reputational harm.

In the future, there may be changes in our products or changes in export and import regulations or economic sanctions. Similarly there may be shifts in the enforcement or scope of existing regulations or restrictions or changes in the countries, governments, persons or technologies targeted by such regulations and restrictions. Such changes and shifts may create delays in the introduction and sale of our products in international markets, could result in decreased use of our products or, in some cases, prevent the sale of our products to certain countries, governments or persons altogether, including by current customers or potential customers. Any such limitation, delay, restriction or reduction could adversely affect our business, financial condition, results of operations and prospects.

Conditions in Israel may limit our ability to develop and sell our products. This could result in a decline in revenues.

Our principal research and development facilities are located in Israel. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as incidents of civil unrest, and a number of state and non-state actors have publicly committed to its destruction. Political, economic and military conditions in Israel could directly affect our operations. We could be adversely affected by any major hostilities involving Israel, including acts of terrorism or any other hostilities involving or threatening Israel, the interruption or curtailment of trade between Israel and its trading partners, a significant increase in inflation or a significant downturn in the economic or financial condition of Israel. Any on-going or future violence between Israel and the Palestinians, including a resumption of the conflict in Gaza, armed conflicts, terrorist activities, tension along the Israeli borders or with other countries in the region, including Iran, or political instability in the region could disrupt international trading activities in Israel and may materially and negatively affect our business and could harm our results of operations.

Certain countries, as well as certain companies and organizations, continue to participate in a boycott of Israeli firms, firms with large Israeli operations and others doing business with Israel and Israeli companies. In addition, such boycott, restrictive laws, policies or practices may change over time in unpredictable ways, and could, individually or in the aggregate, have a material adverse effect on our business in the future.

Some of our employees in Israel, including one of our executive officers, are obligated to perform annual military reserve duty in the Israel Defense Forces, depending on their age and position in the armed forces. Furthermore, they may be called to active reserve duty at any time under emergency circumstances for extended periods of time. For example, in 2014, approximately 51 of our employees in Israel were called for active reserve duty, each serving for an average of approximately two weeks. Our operations could be disrupted by the absence, for a significant period, of one or more of our executive officers or key employees due to military service, and any significant disruption in our operations could harm our business.

Our internal network system and website may be subject to intentional disruption that could adversely impact our reputation and future sales.

Because we are a leading provider of cyber-security products, hackers and others may try to access our data or compromise our systems. Similarly, experienced computer programmers may attempt to penetrate our network security or the security of our website and cause interruptions of our services. Because the techniques used by such computer programmers to access or sabotage networks change frequently and may not be recognized until launched against a target, we may be unable to anticipate these techniques. The theft and/or unauthorized use or publication of our trade secrets and other confidential business information as a result of such an event could adversely affect our competitive position, reputation, brand and future sales of our products, and could impair our ability

26


to operate our business, including our ability to provide subscription or maintenance and support services to our customers. We could suffer monetary and other losses and reputational harm in the event of such inciden ts.

Outages, interruptions or delays in hosting services could impair the delivery of our cloud-based security services and harm our business.

We operate infrastructure that supports our ThreatRadar and Security Operations Center (“SOC”) services and use third party hosting facilities for certain ThreatRadar services. Despite precautions taken within our own internal network and at these third party facilities, the occurrence of a natural disaster or an act of terrorism or other unanticipated problems could result in lengthy interruptions in our services.

The cloud-based security services that we provide through our subsidiary, Incapsula, are operated from a network of third party facilities that host the software and systems that operate these security services. Any damage to, or failure of, our internal systems or systems at third party hosting facilities could result in outages or interruptions in our cloud-based services. Outages or interruptions in our cloud-based security services may cause our customers and potential customers to believe our cloud-based security services are unreliable, cause us to issue credits or pay penalties, cause customers to terminate their subscriptions and adversely affect our renewal rates and our ability to attract new customers, ultimately harming our business and revenue.

Changes in our provision for income taxes or adverse outcomes resulting from examination of our income tax returns could adversely affect our results.

We are subject to income taxation in the United States and numerous foreign jurisdictions. Determining our provision for income taxes requires significant management judgment. In addition, our provision for income taxes is subject to volatility and could be adversely affected by many factors, including, among other things, changes to our operating or holding structure, changes in the amounts of earnings in jurisdictions with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities and changes in tax laws. We are subject to ongoing tax examinations in various jurisdictions. Tax authorities may disagree with our intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. While we regularly assess the likely outcomes of these examinations to determine the adequacy of our provision for income taxes, there can be no assurance that the outcomes of such examinations will not have a material impact on our operating results and cash flows.

Significant judgment is required to determine the recognition and measurement attributes prescribed in Accounting Standards Codification (“ASC”) 740-25 (formerly referred to as Financial Interpretation No. 48, “Accounting for Uncertainty in Income Taxes-an interpretation of FASB Statement No. 109”). In addition, ASC 740-25 applies to all income tax positions, including the potential recovery of previously paid taxes, which if settled unfavorably could adversely impact our provision for income taxes or additional paid-in capital. In addition, we are subject to the continuous examination of our income tax returns by the U.S. Internal Revenue Service and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. There can be no assurance that the outcomes from these continuous examinations will not have an adverse effect on our results of operations.

Our business is subject to the risks of earthquakes, fire, power outages, floods and other catastrophic events, and to interruption by manmade problems such as terrorism.

A significant natural disaster, such as an earthquake, fire or a flood, or a significant power outage could have a material adverse impact on our business, financial condition and results of operations. Our corporate headquarters are located in the San Francisco Bay Area, a region known for seismic activity, on land reclaimed from the bay that is susceptible to high liquefaction risk in the event of an earthquake. In addition, natural disasters could affect our manufacturing vendors or logistics providers’ ability to perform services such as manufacturing products on a timely basis and assisting with shipments on a timely basis. In the event our service providers’ information technology systems or manufacturing or logistics abilities are hindered by any of the events discussed above, shipments could be delayed, resulting in missing financial targets, such as revenue and shipment targets, for a particular quarter. Further, if a natural disaster occurs in a region from which we derive a significant portion of our revenue, customers in that region may delay or forego purchases of our products, which may materially and adversely impact our results of operations for a particular period. In addition, acts of terrorism could cause disruptions in our business or the business of our manufacturer, logistics providers, partners, customers or the economy as a whole. Given our typical concentration of sales at each quarter end, any disruption in the business of our manufacturer, logistics providers, partners or customers that impacts sales at the end of our quarter could have a significant adverse impact on our quarterly results. All of the aforementioned risks may be augmented if the business continuity plans for us and our suppliers prove to be inadequate. To the extent that any of the above results in delays or cancellations of customer orders, or the delay in the manufacture, deployment or shipment of our products, our business, financial condition and results of operations would be adversely affected.

27


Risks Related to Ownership of our Common Stock

If we fail to maintain an effective system of disclosure controls and procedures and internal controls over financial reporting, our ability to produce accurate financial statements or comply with applicable regulations could be impaired.

As a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), and the rules and regulations of the New York Stock Exchange. We expect that the requirements of these rules and regulations will continue to increase our legal, accounting and financial compliance costs, make some activities more difficult, time-consuming and costly and place strains on our personnel, systems and resources.

The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC’s rules and forms. Our current controls and any new controls that we develop may become inadequate because of changes in conditions, and the degree of compliance with the policies or procedures may deteriorate. In addition, weaknesses in our internal controls over financial reporting may be discovered in the future. Our filings with the SEC are subject to periodic review by the SEC, and our auditors are subject to periodic inspection by the Public Company Accounting Oversight Board. Any failure to maintain effective controls over financial reporting, any difficulties encountered in the implementation of additional controls or the improvement of existing controls, or any issues that emerge as a result of regulatory review, could harm our operating results or cause us to fail to meet our reporting obligations and may result in a revision or restatement of our prior period financial statements. Any failure to maintain effective internal controls also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we are required to include in our annual reports filed with the SEC under Section 404 of the Sarbanes-Oxley Act. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our common stock.

For example, in connection with the review of our unaudited interim condensed consolidated financial statements in our Form 10-Q filed with the SEC on November 7, 2014, management, including our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our disclosure controls and procedures as of September 30, 2014. Based on that assessment, management concluded that our disclosure controls and procedures were not effective as of September 30, 2014, because of a material weakness in internal control over financial reporting related to insufficient oversight and review controls to ensure the proper determination of stock-based compensation expense for certain complex equity awards that were not issued in the ordinary course. While these control deficiencies were remediated, we continue to identify risks and make improvements to our internal controls and we cannot assure you that additional material weaknesses in our internal control over financial reporting will not be identified in the future.

In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to add personnel, expend significant resources and provide significant management oversight, which involve substantial accounting-related costs. Any failure to maintain the adequacy of our internal controls, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating costs and could materially impair our ability to operate our business. In the event that we are not able to continue to demonstrate compliance with Section 404 of the Sarbanes-Oxley Act in a timely manner, that our internal controls are perceived as inadequate or that we are unable to produce timely or accurate financial statements, investors may lose confidence in our operating results and our stock price could decline. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the New York Stock Exchange.

We also have implemented elements of a disaster recovery/business continuity plan for our accounting and related information technology systems but we have not yet implemented a complete disaster recovery/business continuity plan that covers all of our operations. If the elements that we have developed and plan to develop in the future prove inadequate in the circumstances of a particular disaster or other business continuity event, our ability to maintain timely accounting and reporting may be materially impaired.

28


Market volatility may affect our stock price and the value of your investment

The trading prices of the securities of technology companies generally, and of our stock in particular, have been highly volatile. The market price of our common stock may fluctuate significantly in response to a number of factors, most of which we cannot predict or control, including:

 

·

announcements of new products, services or technologies, commercial relationships, acquisitions, strategic partnerships, joint ventures, capital commitments or other events by us or our competitors;

 

·

fluctuations in operating performance and in stock market prices and trading volumes of securities of other technology companies generally, or those in our industry in particular;

 

·

general market conditions and overall price and volume fluctuations in U.S. equity markets;

 

·

actual or anticipated variations in our operating results, or the operating results of our competitors;

 

·

the financial and other projections we may provide to the public, any changes in these projections or our failure to meet these projections or changes in our financial guidance or securities analysts’ estimates of our financial performance;

 

·

failure of securities analysts to maintain coverage of us, changes in financial or other estimates by any securities analysts who follow us, or our failure to meet these estimates or the expectations of our investors;

 

·

ratings or other changes by any securities analysts who follow our company or our industry;

 

·

sales of large blocks of our common stock, including sales by our executive officers, directors and significant stockholders;

 

·

rumors and market speculation involving Imperva or other companies in our industry; and

 

·

lawsuits threatened or filed against us and changing legal or regulatory developments in the United States and other countries.

In addition, the stock market in general, and the New York Stock Exchange in particular, have experienced substantial price and volume volatility that is often seemingly unrelated to the operating performance of particular companies. These broad market fluctuations or factors affecting us more specifically may cause the trading price of our common stock to decline. In the past, securities class action litigation has often been brought against a company after a period of volatility in the market price of its common stock.

We face risks related to securities litigation that could result in significant legal expenses and settlement or damage awards.

We are currently and may in the future become subject to claims and litigation alleging violations of the securities laws or similar claims, which could harm our business and require us to incur significant costs. For example, on April 11, 2014, a purported stockholder class action lawsuit was filed in the United States District Court for the Northern District of California against us and certain of our officers alleging that defendants made false and misleading statements and purporting to assert claims for violations of the federal securities laws, and seeking unspecified compensatory damages and other relief. In addition, on June 27, 2014, we (as a nominal defendant), along with certain of our directors and officers, were named in purported derivative litigation filed in the Court of Chancery in the State of Delaware. Regardless of the outcome, these matters or future litigation may require significant attention from management and could result in significant legal expenses, settlement costs or damage awards that could have a material impact on our financial position, results of operations and cash flows.

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our industry. If we do not establish and maintain adequate research coverage or if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price would likely decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which could cause our stock price and trading volume to decline.

We do not intend to pay dividends on our common stock so any returns will be limited to the value of our stock.

We have never declared or paid any cash dividend on our common stock. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any return to stockholders will therefore be limited to the value of their stock.

29


Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our sto ckholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.

Provisions in our restated certificate of incorporation and amended and restated bylaws may delay or prevent an acquisition of us or a change in our management. These provisions include:

 

·

authorizing “blank check” preferred stock, which could be issued by the board without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock, which would increase the number of outstanding shares and could thwart a takeover attempt;

 

·

a classified board of directors whose members can be dismissed only for cause;

 

·

the prohibition on actions by written consent of our stockholders;

 

·

the limitation on who may call a special meeting of stockholders;

 

·

the establishment of advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted upon at stockholder meetings; and

 

·

the requirement that at least 75% of our outstanding capital stock must approve any amendment of the foregoing second through fifth provisions.

In addition, because we are incorporated in Delaware, we are governed by the provisions of the anti-takeover provisions of the Delaware General Corporation Law, which may discourage, delay or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder, even if a change of control would be beneficial to our existing stockholders. Although we believe these provisions collectively provide for an opportunity to obtain greater value for stockholders by requiring potential acquirers to negotiate with our board of directors, they would apply even if an offer rejected by our board were considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management.

Our ability to use our net operating loss carryforwards may be subject to limitations and may result in increased future tax liability to us.

Generally, a change of more than 50% in the ownership of a corporation’s stock, by value, over a three-year period constitutes an ownership change for U.S. federal and applicable state income tax purposes. An ownership change may limit a company’s ability to use its net operating loss carryforwards attributable to the period prior to such change. We have not performed a detailed analysis to determine whether an ownership change under Section 382 of the Internal Revenue Code of 1986, as amended, has occurred after each of our previous private placements of preferred stock or after the issuance of shares of common stock in connection with our initial public offering and follow-on public offering. In the event we have undergone an ownership change under Section 382, if we earn net taxable income, our ability to use our pre-change net operating loss carryforwards to offset U.S. federal taxable income may become subject to limitations, which could potentially result in increased future tax liability to us.

Item 1B. Unresolved Staff Comments

Not applicable.

Item 2. Properties

Our corporate headquarters are located in Redwood Shores, California in an office consisting of approximately 81,979 square feet.  This includes 8404 sq. ft. that was added pursuant to the Fourth and Sixth amendments to the lease for this office and for which the lease period commences on March 1, 2016. The lease for this office expires in December 2020. Our offices in Texas, where we employ sales, support, research and development and professional services employees, consist of approximately 17,134 square feet and the leases for these offices expire in January 2018 and in April 2021. Our office in Tel Aviv, Israel, where we employ our SecureSphere research and development team, consists of approximately 8,417 square meters (approximately 90,600 square feet). The lease for 937 square meters (approximately 10,000 square feet) for this office expires in December 2016 and the lease for the remainder of the office expires in January 2027. The majority of our Incapsula team is in offices in Rehovot, Israel that consist of 2,900 square meters (approximately 31,200 square feet).  The lease for a portion of the office space expires in January 2022 and the lease for the remainder of the space expires in May 2025.  Our Skyfence research and development team is employed in an office in Ramat Gan, Israel that consists of 626 square meters (approximately 6,738 square feet) and the lease expires in 2019.  We also have a number of sales offices around the world.  We believe that our facilities are suitable to meet our needs for the foreseeable future; however, we will continue to seek additional space as needed to accommodate our growth.

30


Item 3. Legal Proceedings

From time to time, we may be subject to legal proceedings and claims in the ordinary course of business.

On April 11, 2014, a purported shareholder class action lawsuit was filed in the United States District Court for the Northern District of California against us and certain of our current and former officers. On August 7, 2014, the Court entered an order appointing lead plaintiff and counsel for the purported class. The lead plaintiff filed an amended complaint on October 10, 2014. The lawsuit named us and certain of our current and former officers and purported to bring suit on behalf of those investors who purchased our publicly traded securities between May 2, 2013 and April 9, 2014. The plaintiff alleged that defendants made false and misleading statements about our operations and business and financial results and purported to assert claims for violations of the federal securities laws. The amended complaint sought unspecified compensatory damages, interest thereon, costs incurred in the action and equitable/injunctive or other relief. On January 6, 2015, defendants filed a motion to dismiss the amended complaint. On September 17, 2015, the Court granted defendants’ motion to dismiss with leave to amend. The lead plaintiff filed an amended complaint on January 13, 2016, again naming the same current and former officers, alleging false and misleading statements about our operations and business and financial results, and seeking the same relief.  On February 10, 2016, defendants filed a motion to dismiss the amended complaint.

On June 27, 2014, a purported shareholder derivative lawsuit was filed in the Court of Chancery for the State of Delaware against us (as a nominal defendant), and naming certain of our officers and directors as individual defendants. The lawsuit relates to the acquisition of Skyfence Networks, Ltd. and the complaint asserts claims for breach of fiduciary duty and unjust enrichment, and seeks to recover unspecified compensatory damages allegedly sustained by us, corporate reforms, the recovery of plaintiffs’ attorney’s fees and other relief. On September 23, 2014, we and the individual defendants moved to dismiss the action. Plaintiffs filed an amended complaint on November 6, 2014. Defendants filed a motion to dismiss the amended complaint on January 14, 2015.  On September 2, 2015, the Court granted the motion to dismiss with prejudice. Plaintiffs filed a notice of appeal with the Supreme Court of Delaware on October 1, 2015. An oral argument before the Supreme Court of Delaware has been set for March 9, 2016.

In addition, we have received, and may in the future continue to receive, claims from third parties asserting, among other things, infringement of their intellectual property rights. Future litigation may be necessary to defend ourselves, our channel partners and our customers by determining the scope, enforceability and validity of third-party proprietary rights or to establish our proprietary rights.

Further, the ultimate outcome of any litigation is uncertain and, regardless of outcome, litigation can have an adverse impact on us because of defense costs, potential negative publicity, diversion of management resources and other factors. Accordingly, there can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, consolidated financial position, results of operations or cash flows.

Item 4. Mine Safety Disclosures

Not applicable.

 

 

31


PART  II

 

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information for Common Stock

Our common stock has been listed on the New York Stock Exchange under the symbol “IMPV” since our IPO in November 2011. The following table sets forth, for the periods indicated, the high and low intra-day prices for our common stock as reported on the New York Stock Exchange.

 

Fiscal 2014

 

High

 

 

Low

 

First Quarter

 

$

67.12

 

 

$

47.03

 

Second Quarter

 

$

57.45

 

 

$

18.40

 

Third Quarter

 

$

34.98

 

 

$

21.59

 

Fourth Quarter

 

$

53.35

 

 

$

24.91

 

 

 

 

 

 

 

 

 

 

Fiscal 2015

 

High

 

 

Low

 

First Quarter

 

$

51.19

 

 

$

38.20

 

Second Quarter

 

$

69.01

 

 

$

40.74

 

Third Quarter

 

$

74.00

 

 

$

53.54

 

Fourth Quarter

 

$

77.99

 

 

$

57.08

 

 

 

 

 

 

 

 

 

 

Fiscal 2016

 

High

 

 

Low

 

First Quarter (through February 17, 2016)

 

$

62.80

 

 

$

32.83

 

 

Stockholders

As of February 17, 2016, we had approximately 40 record holders of our common stock.

Dividend Policy

We have never declared or paid cash dividends on our common stock. We currently intend to retain any future earnings and do not expect to pay any dividends in the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our board of directors and will be dependent on a number of factors, including our earnings, capital requirements and overall financial conditions. The loan agreement for our credit facility contains a prohibition on the payment of cash dividends.

 

32


 

Stock Price Performance Graph

The following graph shows a comparison from November 9, 2011 (the date our common stock commenced trading on the New York Stock Exchange) through December 31, 2015 of the cumulative total return for an investment of $100 (and the reinvestment of dividends) in our common stock, the NYSE Composite Index and the S&P Information Technology Index. Such returns are based on historical results and are not intended to suggest future performance.

 

 

 

 

11/11

 

 

11/12

 

 

11/13

 

 

11/14

 

 

11/15

 

Imperva Inc.

 

$

100.00

 

 

$

170.89

 

 

$

249.89

 

 

$

236.33

 

 

$

414.61

 

NYSE Composite

 

$

100.00

 

 

$

112.47

 

 

$

142.18

 

 

$

156.66

 

 

$

152.56

 

S&P Information Technology

 

$

100.00

 

 

$

111.95

 

 

$

138.03

 

 

$

175.65

 

 

$

187.18

 

 

The above information under the heading “Stock Price Performance Graph” shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any registration statement or other document filed by us with the Securities and Exchange Commission, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

33


 

 

Use of Proceeds from Public Offering of Common Stock

The Form S-1 Registration Statement (Registration No. 333-175008) relating to our IPO was declared effective by the SEC on November 8, 2011, and the offering of our common stock commenced on November 9, 2011. J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. acted as joint book-running managers for the offering, and RBC Capital Markets, LLC, Lazard Capital Markets LLC and Pacific Crest Securities, Inc. acted as co-managers of the offering. The offering of 5,000,000 shares of our common stock has been completed.

The net proceeds to us of our IPO after deducting $6.9 million of underwriters’ discounts and $5.8 million of offering expenses were $86.2 million. In January 2012, we invested $3.5 million of the net proceeds to us resulting from our IPO in Incapsula, our majority owned subsidiary, and received in exchange an additional 4,375,000 shares of Incapsula’s Series A-1 Preferred Stock. In October 2013, we loaned $1.1 million of the net IPO proceeds to Incapsula at a rate of 2% per annum with a maturity date of December 31, 2014. In January 2014, we paid approximately $4.7 million in cash as part of the consideration in connection with our purchase of certain assets and liabilities of Tomium. In February 2014, we paid $8.6 million in cash, and in February 2016 released an additional $7.6 million, as part of the consideration in connection with the acquisition of Skyfence. We expect to use the remaining net IPO proceeds for working capital and general corporate purposes, including acquisitions. Although we may also use a portion of the net proceeds for acquisition of complementary businesses, technologies or other assets, we have no present understandings, commitments or agreements to enter into any acquisitions.

Our management will retain broad discretion in the allocation and use of the net proceeds of our IPO, and investors will be relying on the judgment of our management regarding the application of the net proceeds. Pending specific utilization of the net proceeds as described above, we have invested the net proceeds of the offering in short-term, interest-bearing obligations. The goal with respect to the investment of the net proceeds will be capital preservation and liquidity so that such funds are readily available to fund our operations.

 

 

34


 

Item 6. Selected Financial Data

The following selected consolidated financial data should be read in conjunction with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. The selected financial data in this section is not intended to replace the financial statements and is qualified in its entirety by the consolidated financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K. Our historical results of operations are not necessarily indicative of results to be expected for any future period.

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

2012

 

 

2011

 

 

 

(dollars in thousands, except per share amounts)

 

Consolidated Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

$

107,563

 

 

$

74,299

 

 

$

72,153

 

 

$

59,490

 

 

$

47,600

 

Services

 

 

126,735

 

 

 

89,711

 

 

 

65,606

 

 

 

44,745

 

 

 

30,702

 

Total net revenue

 

 

234,298

 

 

 

164,010

 

 

 

137,759

 

 

 

104,235

 

 

 

78,302

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

 

10,947

 

 

 

9,248

 

 

 

8,756

 

 

 

8,530

 

 

 

6,711

 

Services

 

 

36,633

 

 

 

27,335

 

 

 

20,940

 

 

 

13,374

 

 

 

9,510

 

Total cost of revenue 1

 

 

47,580

 

 

 

36,583

 

 

 

29,696

 

 

 

21,904

 

 

 

16,221

 

Gross profit

 

 

186,718

 

 

 

127,427

 

 

 

108,063

 

 

 

82,331

 

 

 

62,081

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development 1

 

 

53,376

 

 

 

43,052

 

 

 

27,556

 

 

 

20,555

 

 

 

17,598

 

Sales and marketing 1

 

 

136,292

 

 

 

106,382

 

 

 

81,500

 

 

 

53,509

 

 

 

42,682

 

General and administrative 1

 

 

43,440

 

 

 

34,499

 

 

 

24,436

 

 

 

15,371

 

 

 

11,807

 

Amortization of purchased intangibles

 

 

1,408

 

 

 

1,269

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

234,516

 

 

 

185,202

 

 

 

133,492

 

 

 

89,435

 

 

 

72,087

 

Loss from operations

 

 

(47,798

)

 

 

(57,775

)

 

 

(25,429

)

 

 

(7,104

)

 

 

(10,006

)

Other income (expense), net

 

 

(402

)

 

 

(220

)

 

 

(125

)

 

 

(243

)

 

 

(190

)

Loss before provision for income taxes

 

 

(48,200

)

 

 

(57,995

)

 

 

(25,554

)

 

 

(7,347

)

 

 

(10,196

)

Provision for income taxes

 

 

682

 

 

 

1,181

 

 

 

777

 

 

 

545

 

 

 

662

 

Net loss

 

 

(48,882

)

 

 

(59,176

)

 

 

(26,331

)

 

 

(7,892

)

 

 

(10,858

)

Loss attributable to non - controlling interest

 

 

 

 

 

213

 

 

 

1,153

 

 

 

505

 

 

 

589

 

Net loss attributable to Imperva, Inc. stockholders

 

$

(48,882

)

 

$

(58,963

)

 

$

(25,178

)

 

$

(7,387

)

 

$

(10,269

)

Net loss per share of common stock attributable to Imperva, Inc.

   stockholders, basic and diluted 2

 

$

(1.64

)

 

$

(2.28

)

 

$

(1.04

)

 

$

(0.32

)

 

$

(1.34

)

Shares used in computing net loss per share of common stock,

   basis and diluted 2

 

 

29,849

 

 

 

25,806

 

 

 

24,300

 

 

 

22,916

 

 

 

7,675

 

 

1

Includes stock-based compensation as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

2012

 

 

2011

 

Cost of revenue

 

$

3,862

 

 

$

2,058

 

 

$

1,440

 

 

$

469

 

 

$

118

 

Research and development

 

 

13,831

 

 

 

8,799

 

 

 

3,660

 

 

 

1,227

 

 

 

130

 

Sales and marketing

 

 

16,717

 

 

 

13,558

 

 

 

8,537

 

 

 

2,543

 

 

 

412

 

General and administrative

 

 

16,554

 

 

 

12,858

 

 

 

8,857

 

 

 

1,729

 

 

 

1,067

 

 

35


 

2

Please see Note 16 to our audited consolidated financial statements for an explanation of the calculations of our basic and diluted net loss per share of common sto ck.  

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

2012

 

 

2011

 

 

 

(in thousands)

 

Consolidated Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents and short-term investments

 

$

264,807

 

 

$

109,720

 

 

$

115,085

 

 

$

102,327

 

 

$

97,612

 

Working capital

 

$

214,173

 

 

$

78,244

 

 

$

103,214

 

 

$

92,796

 

 

$

88,660

 

Total assets

 

$

397,669

 

 

$

220,645

 

 

$

176,491

 

 

$

153,957

 

 

$

133,542

 

Deferred revenue, current and long-term

 

$

106,657

 

 

$

81,175

 

 

$

63,052

 

 

$

46,291

 

 

$

33,925

 

Non - controlling interest

 

$

-

 

 

$

-

 

 

$

(2,614

)

 

$

(1,104

)

 

$

(773

)

Total stockholders' equity

 

$

240,201

 

 

$

97,243

 

 

$

86,222

 

 

$

84,231

 

 

$

79,568

 

 

 

36


 

Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our “Selected Consolidated Financial Data” and consolidated financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K. This Annual Report on Form 10-K contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements are often identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue,” and similar expressions or variations. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified herein, and those discussed in the section titled “Risk Factors,” set forth in Item 1A of this Annual Report on Form 10-K and in our other SEC filings. You should review these risk factors for a more complete understanding of the risks associated with an investment in our securities. We disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

We are a leader in cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. Built to keep pace with the evolving threat landscape, our suite of cyber-security offerings are designed to enable organizations to discover data and application assets and vulnerabilities, to protect information wherever it lives and to comply with regulations. Our cyber-security solutions are also designed to fill the gaps left by existing endpoint and network or perimeter security solutions as organizations increasingly adopt “bring your own device” policies and move data and applications to the cloud.

Organizations are facing numerous challenges in providing the visibility and control required to protect business-critical applications and data from attack, theft and fraud from inside and outside the organization. Attacks, whether perpetrated by sophisticated hackers or malicious insiders, continue to increase in sophistication, scale and frequency. Additionally, organizations must comply with increasingly complex regulatory standards enacted to protect business-critical applications and data. Adoption of new technologies and architectures, such as mobile applications, web applications and big data, increases the complexity of, opens access to, and increases the vulnerability of business-critical data and applications. The increasing use of virtualization technologies and cloud delivery models, including unsanctioned, employee-adopted applications, known as “shadow IT,” is forcing organizations to operate outside of the traditional security model. We believe that these challenges are driving the need for cyber-security solutions that protect business-critical applications and data whether in the cloud or on premises.

Our Imperva SecureSphere product line provides database, file and web application security across various physical and virtual systems in data centers, including those in traditional on-premise data centers as well as in private, public and hybrid cloud computing environments. Our Imperva Incapsula product line provides cloud-based website security, denial of service protection and performance solutions that do not require software or hardware changes. Our Imperva Skyfence product line provides visibility into, and control over, cloud and Software-as-a-Service (“SaaS”) applications, including shadow IT, that are in growing use by enterprises of all sizes. In addition, all of our cloud offerings are designed to protect against the unique threats created as enterprises increasingly shift to deploying their applications and storing their data in the cloud to take advantage of the flexibility and cost-efficiency offered by cloud-based solutions.

We were incorporated as a Delaware corporation in 2002 with the vision of protecting high-value applications and data assets within the enterprise. Since that time we have been investing in our cyber-security solutions to meet the rapidly evolving demands of customers. We shipped our initial web application security and data security products in 2002; in 2006, we expanded our database security product to include compliance features. In 2010, we launched our file security offering. In addition, in 2010, we launched our cloud-based initiatives with ThreatRadar and, in 2011, we introduced our cloud-based offering for mid-market enterprises and small and medium-sized businesses (“SMB”) that we provide through Incapsula, Inc., which was majority owned by us until March 2014 when we acquired the remaining portion of Incapsula that we did not already own in order to more fully integrate their operations with ours. In January 2014, we acquired certain assets and liabilities of Tomium Software, LLC to accelerate our mainframe data security solutions. In February 2014, we acquired Skyfence Networks Ltd. to further our Software as a Service (“SaaS”) delivery models for securing cloud and SaaS applications.

37


 

Our research and development efforts are focused primarily on improving and enhancing our existing cyber-security solutions and services, as well as develop ing new products and services and conducting advanced security research. We conduct our research and development activities in Israel, and we believe this provides us with access to some of the best engineering talent in the security i ndustry. As of Decemb er 31, 2015, we had 288 employees dedicated to research and development, including our advanced security research group, the Application Defense Center (“ADC”). Our research and development expense was $ 53.4 million, $43.1 million and $27.6 million for the years ended December 31, 2015, 2014 and 2013, respectively.

We derive our revenue from sales and licenses of our products and sales of our services. Products and license revenue is generated primarily from sales of perpetual software licenses installed on hardware appliances or virtual appliances for our SecureSphere product line. Services revenue consists of maintenance and support, professional services and training and subscriptions. A majority of our revenue is derived from customers in the Americas region. In 2015, 64% of our total revenue was generated from the Americas, 24% from Europe, Middle East and Africa (“EMEA”) and 12% from Asia Pacific (“APAC”).

We market and sell our products through a hybrid sales model, which combines a direct touch sales organization and an overlay channel sales team that actively assist our extensive network of channel partners throughout the sales process. We also provide our channel partners with marketing assistance, technical training and support. We primarily sell our products and services through our channel partners, including distributors and resellers, which sell to end-user customers, who we refer to in this Annual Report on Form 10-K as our customers. We have a network of over 300 channel partners worldwide, including both resellers and distributors. In 2015, our channel partners originated over 45%, and fulfilled almost 89%, of our sales. We work with many of the world’s leading security value-added resellers, and our partners include some of the largest hosting companies for cloud-based deployments.

As of December 31, 2015, Imperva had over 4,500 customers in more than 90 countries. In addition, our solutions are used to protect thousands of organizations through cloud-based deployments with our Software-as-a-Service (“SaaS”) customers and our managed security service provider (“MSSP”) and hosting partners.

Our net revenue has increased in each of the last three years, growing from $137.8 million in 2013 to $164.0 million in 2014 to $234.3 million in 2015. We have incurred net losses attributable to our stockholders of $25.2 million, $59.0 million and $48.9 million in 2013, 2014 and 2015, respectively. As of December 31, 2015, we had an accumulated deficit of $206.5 million.

Opportunities, Challenges and Risks

We believe that the growth of our business and our future success are dependent upon many factors, including our ability to maintain our technology leadership, improve our sales and marketing, address the needs of smaller enterprises and compete effectively in the marketplace for cyber-security solutions. While each of these areas presents significant opportunities for us, they also pose important challenges and risks that we must successfully address in order to sustain the growth of our business and improve our results of operations.

Maintain Technology Leadership . As a result of the rise in sophisticated attacks by hackers and malicious insiders, the difficulty in complying with regulations governing business data and the growing complexity of, and open access to, data centers, we believe that enterprises are struggling to provide visibility and control over high-value business applications and data assets that they need to protect. In addition, organizations are increasingly taking advantage of cloud-based services and virtualization technologies, and these new technologies and architectures are increasing the complexity of, and accessibility to, the data center. We believe these challenges are driving the need for a new protection layer positioned closely around the applications and data assets in the data center. We expect that as enterprises recognize the growing risk to high-value business data and the need to comply with increasing regulatory compliance mandates, their spending will increase on solutions designed to control and protect such data. We believe that traditional security and compliance products do not address the evolving needs of enterprises or do not do so adequately, and that this presents us with a large market opportunity. To capitalize on this opportunity, we have introduced and expect that in the future we will need to continue to introduce innovations to our broad business security solutions, including solutions to address cyber-security opportunities that arise as enterprises pursue cloud computing initiatives. We cannot assure you that our products will achieve widespread market acceptance or that we will properly anticipate future customer needs. Moreover, if our products do not satisfy evolving customer requirements, we will not capture the increase in spending that we expect will result from enterprises seeking to secure data across various systems in the data center.

38


 

Invest in Sales and Marketing.  In order to capitalize on the anticipated increase in spending in the cyber-security market, we will need to continue to invest significant resources to further strengthen our existing relationships with channel partners, extend our global network by adding new channel partners and grow our sales and marketing team. A ny investments that we make in our sales and marketing will occur in advance of our experiencing any benefits from such investments, and so it may be difficult for us to determine if we are efficiently allocating our resources in this area. We cannot assur e you that the investments that we intend to make to strengthen our sales and marketing efforts will enable us to capitalize on the expected increase in spending in the cyber-security market or result in an increase in revenue or an improvement in our resu lts of operations.

Address Needs of Smaller Enterprises . As market awareness of the benefits of a comprehensive cyber-security solution increases, we believe there is a significant opportunity to provide cyber-security solutions to smaller enterprises as they confront increasing security threats and compliance mandates. To capitalize on this opportunity, we intend to increase our business with mid-market enterprises and SMBs by expanding our cloud-based service offerings and our distribution channel. We have made, and may in the future continue to make, significant investments in our cloud-based security products to address the business security needs of mid-market enterprises and SMBs. If our cloud-based security products, which are relatively new, fail to gain broad acceptance with mid-market enterprises and SMBs, our revenue growth, results of operations and competitive position in our industry could suffer.

Compete Effectively . We operate in an intensely competitive market that has witnessed significant consolidation in recent years with large companies acquiring many of our competitors. We track our success rate in competitive sales opportunities against certain competitors, some of which generate higher revenues and have greater market capitalizations than we do, and many of which are more established or have greater name recognition within our industry. Based upon our internal tracking of the results of such competitive sales opportunities, we believe that we have historically competed favorably against our larger competitors, and that we have a proven track record of successfully competing against such larger competitors. Nonetheless, some of our larger competitors have numerous advantages, including, but not limited to, greater financial resources, broader product offerings and more established relationships with channel partners and customers. If we are unable to compete effectively for a share of the business security market, our business, results of operations and financial condition could be materially and adversely affected.

To date, we have incurred, and continue to incur, losses from operations and net losses. However, we believe that our existing cash, cash equivalents and short-term investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Further, we expect that, if we successfully execute our business plan and strategy, our loss from operations and our net losses will decline, and that we will reach profitability. Should we need additional cash in the future, we may utilize existing lines of credit, enter into additional lines of credit or raise funds through the sale of equity securities.

Key Metrics of Our Business

We monitor the key financial metrics discussed below to help us evaluate growth trends, establish budgets, measure the effectiveness of our sales and marketing efforts and assess operational efficiencies.

Net Revenue . We measure our net revenue to assess the acceptance of our products from our customers, our growth in the markets we serve and to help us establish our strategic and operating plans for future periods. We discuss the components of our net revenue in “—Financial Overview— Net Revenue” below.

Gross Margin . We monitor our gross margin to assess the impact on our current and forecasted financial results from any changes to the pricing and mix of products we are selling to our customers.

Loss from Operations . We track our loss from operations to assess how effectively we are planning and monitoring our operations as well as controlling our operational costs, which are primarily driven by headcount.

Cash, Cash Equivalents and Short-term Investments . We evaluate the level of our cash, cash equivalents and short-term investments to ensure we have sufficient liquidity to fund our operations, including the development of future products and product enhancements and the expansion into new sales channels and territories.

Number of Customers . We believe our customer count is a key indicator of our market penetration, the productivity of our sales organization and the value that our products bring to our customer base. We also believe our existing customers represent significant future revenue opportunities for us.

We discuss for the periods presented revenue, gross margin, the components of loss from operations and number of customers further below under “—Segments” and “—Results of Operations”, as applicable, and we discuss our cash and cash equivalents under “—Liquidity and Capital Resources.”

39


 

We also believe that deferred revenue and cash flow from operations are key financial metrics for our business. The components of deferred revenue and cash flow from operations, as well as our rationale for monitoring these metrics, are discussed immediately below this table:

 

 

 

Years ended (or as of December 31)

 

 

 

2015

 

 

2014

 

 

2013

 

 

 

(in thousands, except number of

customers and percentages)

 

Net revenue

 

$

234,298

 

 

$

164,010

 

 

$

137,759

 

Gross margin

 

 

79.7

%

 

 

77.7

%

 

 

78.4

%

Loss from operations

 

$

(47,798

)

 

$

(57,775

)

 

$

(25,429

)

Total deferred revenue

 

$

106,657

 

 

$

81,175

 

 

$

63,052

 

Cash, cash equivalents and short-term investments

 

$

264,807

 

 

$

109,720

 

 

$

115,085

 

Net cash provided by operations

 

$

23,867

 

 

$

4,126

 

 

$

9,797

 

Number of customers

 

 

4,541

 

 

 

3,785

 

 

 

3,011

 

 

Deferred Revenue

Our deferred revenue consists of amounts that have been invoiced but that have not yet been recognized as revenue. The majority of our deferred revenue balance consists of the unrecognized portion of services revenue from maintenance and support, and subscription contracts. We monitor our deferred revenue balance because it represents a significant portion of revenue to be recognized in future periods. We also assess the increase in our deferred revenue balance plus revenue we recognized in a particular period as a measure of our sales activity for that period. While the change in our deferred revenue and revenue recognized in a given period comprise the majority of our sales activity during that period, they do not constitute the entire sales activity during the period. Our total sales activity also includes sales of products and services for which we have not yet met the criteria to recognize revenue or add such amounts to our deferred revenue balance. Revenue and deferred revenue from these transactions is recognized or recorded in future periods when we have met the required criteria. We discuss for the periods presented deferred revenue further below under “—Results of Operations.”

Net Cash Provided by Operations

We monitor cash flow from operations as a measure of our overall business performance. Our cash flow from operations is driven primarily by sales of our products and licenses and, to a lesser extent, from up-front payments from customers under maintenance and support contracts. Our primary uses of cash in operating activities are for personnel-related expenditures, costs of acquiring the hardware used for our appliances, marketing and promotional expenses and costs related to our facilities. Monitoring cash flow from operations enables us to analyze our financial performance without the non-cash effects of certain items such as depreciation and amortization and stock-based compensation expenses, thereby allowing us to better understand and manage the cash needs of our business.

Segments

Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by our chief operating decision maker in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is the Chief Executive Officer.

We operate our business in one operating segment, which is the development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

Financial Overview

Net Revenue

We derive our revenue from sales and licenses of our products and sales of our services. As discussed further in “—Critical Accounting Policies and Estimates—Revenue Recognition” below, revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed or determinable and collection is probable.

40


 

Our net revenue is comprised of the following:

 

·

Products and License Revenue—Product and license revenue is generated from sales of perpetual software licenses installed on hardware appliances or virtual appliances for our SecureSphere product line. Our SecureSphere product line consists of database security, file security and web application security. We offer multiple hardware appliance versions that accompany our software, each with different throughput capacities. Perpetual software license revenue is generated from sales of our appliances, licenses for additional users and add-on software modules. We also generate a small amount of hardware revenue from sales of spares or replacement appliances, demonstration units, third-party OEM units and accessories.

 

·

Services Revenue—Services revenue consists of maintenance and support, professional services and training and subscriptions. Maintenance and support revenue is generated from support services that are bundled with appliances and add-on software modules. There are three levels of maintenance and support—Standard, Enhanced and Premium—and these are usually offered through agreements for one to three-year terms. Maintenance and support includes major and minor when-and-if available software updates; customer care, which includes our designated support engineer and Imperva resident engineer programs; content updates from our advanced security research group, the ADC, and hardware replacement. Professional services revenue consists of fees we earn related to implementation and consulting services we provide our customers. Training services revenue consists of fees we earn related to training customers and partners on the use of our products. Subscription revenue is generated from sales of our cloud-based services. We expect that the services revenue from maintenance and support contracts will continue to grow along with the increase in the size of our installed base. We also expect subscription revenue will increase as our cloud-based services continue to increase.

A majority of our products and services are sold to customers in the Americas, primarily in the United States, however, a significant portion of our revenue is generated from international sales. See Note 15 of “Notes to Consolidated Financial Statements” for a discussion of our financial information by geographic region. Our revenue by geographic region is as follows (in thousands):

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Americas

 

$

149,766

 

 

$

94,266

 

 

$

83,736

 

EMEA

 

 

57,180

 

 

 

43,111

 

 

 

33,183

 

APAC

 

 

27,352

 

 

 

26,633

 

 

 

20,840

 

Total net revenue

 

$

234,298

 

 

$

164,010

 

 

$

137,759

 

 

Cost of Revenue

Our total cost of revenue is comprised of the following:

 

·

Cost of Products and License Revenue—Cost of products and license revenue is comprised primarily of third-party hardware costs and royalty fees. Our cost of products and license revenue also includes personnel costs related to our operations team, shipping costs and write-offs for excess and obsolete inventory.

 

·

Cost of Services Revenue—Cost of services revenue is primarily comprised of personnel costs of our technical support team, our professional consulting services and training teams and our Security Operations Center (“SOC”) team. Cost of services revenue also includes facilities costs, subscription fees and depreciation. We expect that our cost of services revenue will increase in absolute dollars as we increase our headcount.

Operating Expenses

Our operating expenses consist of research and development, sales and marketing, general and administrative expenses and amortization of acquired intangible assets. Personnel costs are the most significant component of our operating expenses and consist of wages, benefits and bonuses and, with regard to the sales and marketing expense, sales commissions. Personnel costs also include stock-based compensation. We expect personnel costs to continue to increase in absolute dollars as we hire new employees to continue to grow our business.

41


 

Research and Development

Our research and development is focused on maintaining and improving our existing products and on new product development. A majority of our research and development expenses are comprised of personnel costs and, to a lesser extent, facility costs, hardware prototype costs, laboratory expenses and depreciation. We expense research and development costs as incurred. We expect our research and development expenses to increase in absolute dollars as we continue to enhance our existing products and develop new products and services that address the emerging market for business security and regulatory compliance.

Sales and Marketing

Sales and marketing expense is the largest component of our operating expenses and consists primarily of personnel costs, including commissions and travel expenses. Sales and marketing expenses also include costs related to marketing and promotional activities, third-party referral fees and, to a lesser extent, facilities costs and depreciation. We expect our sales and marketing expenses to increase in absolute dollars as we expand our sales and marketing efforts worldwide.

General and Administrative

General and administrative expense consists primarily of personnel costs, including stock-based compensation, as well as professional fees, facilities costs and depreciation. General and administrative personnel costs include our executive, finance, purchasing, order entry, human resources, information technology and legal functions. Our professional fees consist primarily of accounting, external legal, information technology and other consulting costs.

Amortization of Acquired Intangible Assets

Amortization of acquired intangible assets consists of amortization of intangible assets from the acquisitions of Skyfence and Tomium that occurred in the first quarter of 2014.

Other Income (Expense), net

Other income (expense), net is comprised of the following items:

 

·

Interest Income—Interest income consists of interest earned on our cash, cash equivalents and short-term investments. We expect interest income will vary each reporting period depending on our average investment balances during the period and market interest rates.

 

·

Interest Expense—Interest expense consists of interest accrued or paid on debt obligations.

 

·

Foreign Currency Forward Contract Gains (Losses)—Foreign currency forward contract gains and losses pertain to the ineffective portion of derivative instruments designated as hedges that we have entered into primarily to manage our exposure to the variability in expected future expenses resulting from changes in foreign currency exchange rates. We do not use derivative financial instruments for speculative or trading purposes.

 

·

Foreign Currency Exchange Gains (Losses)—Foreign currency exchange gains and losses relate to transactions denominated in currencies other than the U.S. Dollar.

Provision for Income Taxes

We operate in several income tax jurisdictions and are subject to income taxes in each country or jurisdiction in which we conduct business including the United States and Israel. Earnings from our non-U.S. activities are subject to local country income tax and may be subject to U.S. income tax if such earnings are distributed to the U.S. To date, we have incurred net losses and have recorded insignificant U.S. federal income tax expense. Our income tax expense to date relates primarily to foreign income taxes, mainly from our Israeli and United Kingdom activities, and to a lesser extent, state income taxes.

42


 

Results of Operations

The following table is a summary of our consolidated statements of operations in dollars and as a percentage of our total net revenue. We have derived the data for the years ended December 31, 2015, 2014 and 2013 from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

% of Net

Revenue

 

 

 

(dollars in thousands)

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

$

107,563

 

 

 

46.0

 

 

$

74,299

 

 

 

45.3

 

 

$

72,153

 

 

 

52.4

 

Services:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance and support

 

 

66,380

 

 

 

28.3

 

 

 

54,795

 

 

 

33.4

 

 

 

44,353

 

 

 

32.2

 

Professional services and training

 

 

14,084

 

 

 

6.0

 

 

 

11,414

 

 

 

7.0

 

 

 

9,890

 

 

 

7.2

 

Subscriptions

 

 

46,271

 

 

 

19.7

 

 

 

23,502

 

 

 

14.3

 

 

 

11,363

 

 

 

8.2

 

Total services

 

 

126,735

 

 

 

54.0

 

 

 

89,711

 

 

 

54.7

 

 

 

65,606

 

 

 

47.6

 

Total net revenue

 

 

234,298

 

 

 

100.0

 

 

 

164,010

 

 

 

100.0

 

 

 

137,759

 

 

 

100.0

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

 

10,947

 

 

 

4.7

 

 

 

9,248

 

 

 

5.6

 

 

 

8,756

 

 

 

6.4

 

Services

 

 

36,633

 

 

 

15.6

 

 

 

27,335

 

 

 

16.7

 

 

 

20,940

 

 

 

15.2

 

Total cost of revenue

 

 

47,580

 

 

 

20.3

 

 

 

36,583

 

 

 

22.3

 

 

 

29,696

 

 

 

21.6

 

Gross profit

 

 

186,718

 

 

 

79.7

 

 

 

127,427

 

 

 

77.7

 

 

 

108,063

 

 

 

78.4

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

53,376

 

 

 

22.8

 

 

 

43,052

 

 

 

26.2

 

 

 

27,556

 

 

 

20.0

 

Sales and marketing

 

 

136,292

 

 

 

58.2

 

 

 

106,382

 

 

 

64.9

 

 

 

81,500

 

 

 

59.2

 

General and administrative

 

 

43,440

 

 

 

18.5

 

 

 

34,499

 

 

 

21.0

 

 

 

24,436

 

 

 

17.7

 

Amortization of purchased intangibles

 

 

1,408

 

 

 

0.6

 

 

 

1,269

 

 

 

0.8

 

 

 

 

 

 

0.0

 

Total operating expenses

 

 

234,516

 

 

 

100.1

 

 

 

185,202

 

 

 

112.9

 

 

 

133,492

 

 

 

96.9

 

Loss from operations

 

 

(47,798

)

 

 

(20.4

)

 

 

(57,775

)

 

 

(35.2

)

 

 

(25,429

)

 

 

(18.5

)

Other income (expense), net

 

 

(402

)

 

 

(0.2

)

 

 

(220

)

 

 

(0.1

)

 

 

(125

)

 

 

(0.1

)

Loss before provision for income taxes

 

 

(48,200

)

 

 

(20.6

)

 

 

(57,995

)

 

 

(35.3

)

 

 

(25,554

)

 

 

(18.6

)

Provision for income taxes

 

 

682

 

 

 

0.3

 

 

 

1,181

 

 

 

0.7

 

 

 

777

 

 

 

0.6

 

Net loss

 

 

(48,882

)

 

 

(20.9

)

 

 

(59,176

)

 

 

(36.0

)

 

 

(26,331

)

 

 

(19.2

)

Loss attributable to non - controlling interest

 

 

 

 

 

 

 

 

213

 

 

 

0.1

 

 

 

1,153

 

 

 

0.8

 

Net loss attributable to Imperva, Inc. stockholders

 

$

(48,882

)

 

 

(20.9

)

 

$

(58,963

)

 

 

(35.9

)

 

$

(25,178

)

 

 

(18.4

)

 

43


 

Comparison of the Years Ended December 31, 2015 and 2014

Net Revenue

 

 

 

Years ended December 31,

 

 

 

 

 

 

 

 

 

 

 

2015

 

 

2014

 

 

Change

 

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

$

107,563

 

 

 

46.0

 

 

$

74,299

 

 

 

45.3

 

 

$

33,264

 

 

 

44.8

%

Services:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance and Support

 

 

66,380

 

 

 

28.3

 

 

 

54,795

 

 

 

33.4

 

 

 

11,585

 

 

 

21.1

%

Professional Services and training

 

 

14,084

 

 

 

6.0

 

 

 

11,414

 

 

 

7.0

 

 

 

2,670

 

 

 

23.4

%

Subscriptions

 

 

46,271

 

 

 

19.7

 

 

 

23,502

 

 

 

14.3

 

 

 

22,769

 

 

 

96.9

%

Total Services

 

 

126,735

 

 

 

54.0

 

 

 

89,711

 

 

 

54.7

 

 

 

37,024

 

 

 

41.3

%

Total net revenue

 

$

234,298

 

 

 

100.0

 

 

$

164,010

 

 

 

100.0

 

 

$

70,288

 

 

 

42.9

%

Americas

 

$

149,766

 

 

 

63.9

 

 

$

94,266

 

 

 

57.5

 

 

$

55,500

 

 

 

58.9

%

EMEA

 

 

57,180

 

 

 

24.4

 

 

 

43,111

 

 

 

26.3

 

 

 

14,069

 

 

 

32.6

%

APAC

 

 

27,352

 

 

 

11.7

 

 

 

26,633

 

 

 

16.2

 

 

 

719

 

 

 

2.7

%

Total net revenue

 

$

234,298

 

 

 

100.0

 

 

$

164,010

 

 

 

100.0

 

 

$

70,288

 

 

 

42.9

%

 

Our net revenue increased by $70.3 million, or 42.9%, to $234.3 million during the year ended December 31, 2015 from $164.0 million during the year ended December 31, 2014 primarily due to growth in overall revenue, especially in the subscription service line. This revenue growth reflects the increasing demand for our subscription service offerings reflected in the addition of 756 customers in 2015 as well as a broader installed base of product and licenses which generate higher maintenance and support revenues. We had 501 orders exceeding $100,000 during the year ended December 31, 2015, from 404 orders for year ended December 31, 2014.

 

The Americas region contributed the largest portion of this increase in overall revenue with a $55.5 million increase, or approximately a 58.9% change over the same period in 2014. In addition, an increase in sales volume of our products, increase in our international sales personnel and improved sales execution contributed to increases in revenue in EMEA and to a much lesser extent in APAC of $14.1 million and $0.1 million, or approximately a 32.6% and 2.7% change, respectively, over the same period in 2014.

Products and license revenue increased by $33.3 million, or 44.8%, to $107.6 million during the year ended December 31, 2015 from $74.3 million during the year ended December 31, 2014. The change in product and license revenue was primarily due to an increase of $34.0 million in the Americas region and an increase of $0.5 million in the EMEA region offset by a decrease of $1.2 million in the APAC region during the year ended December 31, 2015 compared to year ended December 31, 2014. The increase in Americas and EMEA regions was primarily due to increased sales volume of our products, increased headcount and improved sales execution. The decrease in the APAC region product and license revenue was primarily due to sales execution challenges in the APAC region.

Services revenue increased by $37.0 million, or 41.3%, to $126.7 million during the year ended December 31, 2015 from $89.7 million during the year ended December 31, 2014. During the year ended December 31, 2015, our services revenue was comprised of $66.4 million of maintenance and support, $14.0 million of professional services and training and $46.3 million of subscriptions. The change in services revenue in the year ended December 31, 2015 from the year ended December 31, 2014 was primarily due to an increase of $22.8 million in subscriptions revenue resulting from our cloud-based security services and ThreatRadar, $11.6 million in maintenance and support revenue from our larger installed base as reflected in our product and license revenue, and $2.7 million in professional services and training revenues related to increases in headcount which allowed for completion of additional service engagements.

44


 

Gross Profit

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

Amount

 

 

Gross

Margin

 

 

Amount

 

 

Gross

Margin

 

 

% Change

 

 

 

(dollars in thousands)

 

 

 

 

 

Products and license gross profit

 

$

96,616

 

 

 

89.8

%

 

$

65,051

 

 

 

87.6

%

 

 

2.2

 

Services gross profit

 

 

90,102

 

 

 

71.1

%

 

 

62,376

 

 

 

69.5

%

 

 

1.6

 

Total gross profit

 

$

186,718

 

 

 

79.7

%

 

$

127,427

 

 

 

77.7

%

 

 

2.0

 

 

Total gross margin increased from 77.7% during the year ended December 31, 2014 to 79.7% during the year ended December 31, 2015 primarily due to an increased proportion of products and license revenue to total revenues. Products and license gross margin increased 2.2% to 89.8% for the year ended December 31, 2015 compared to 87.6% for the same period in 2014. The products and license gross margin increase was primarily attributable to increased sales of higher throughput appliances, which generally have higher gross margins. Services gross profit improved 1.6% to 71.1% for the year ended December 31, 2015 as compared to 69.5% for the same period in 2014, mostly due to higher maintenance and subscriptions revenue which better leveraged the internal cost structure to support these services.

Operating Expenses

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

 

 

 

 

2015

 

 

2014

 

 

Change

 

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

53,376

 

 

 

22.8

 

 

$

43,052

 

 

 

26.2

 

 

$

10,324

 

 

 

24.0

%

Sales and marketing

 

 

136,292

 

 

 

58.2

 

 

 

106,382

 

 

 

64.9

 

 

 

29,910

 

 

 

28.1

%

General and administrative

 

 

43,440

 

 

 

18.5

 

 

 

34,499

 

 

 

21.0

 

 

 

8,941

 

 

 

25.9

%

Amortization of acquired intangible assets

 

 

1,408

 

 

 

0.6

 

 

 

1,269

 

 

 

0.8

 

 

 

139

 

 

 

11.0

%

Total operating expenses

 

$

234,516

 

 

 

100.1

 

 

$

185,202

 

 

 

112.9

 

 

$

49,314

 

 

 

26.6

%

 

Results above include stock-based compensation expense of:

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

Change

 

 

 

(dollars in thousands)

 

Research and development

 

$

13,831

 

 

$

8,799

 

 

$

5,032

 

Sales and marketing

 

 

16,717

 

 

 

13,558

 

 

 

3,159

 

General and administrative

 

 

16,554

 

 

 

12,858

 

 

 

3,696

 

 

Research and development expenses increased by $10.3 million, or 24.0%, to $53.4 million during the year ended December 31, 2015 from $43.1 million during the year ended December 31, 2014. The change was primarily attributable to an increase of $8.6 million in personnel costs, including stock-based compensation, due to additional research and development personnel being hired to support our ongoing product development efforts. In addition, facility and travel expenses increased by $1.4 million expenses due to increased headcount.

Sales and marketing expenses increased by $29.9 million, or 28.1%, to $136.3 million during the year ended December 31, 2015 from $106.4 million during the year ended December 31, 2014. The change was due to an increase of $25.6 million in personnel costs, including stock-based compensation due to increased headcount worldwide in an effort to help drive our overall revenue growth, a $3.1 million increase in trade show, corporate marketing and seminar costs and a $1.2 million increase in travel expenses due to increased headcount.

General and administrative expenses increased by $8.9 million, or 25.9%, to $43.4 million during the year ended December 31, 2015 from $34.5 million during the year ended December 31, 2014. The change was primarily due to an increase of $7.5 million in personnel costs, including stock-based compensation, primarily related to increased headcount to support the growth and operations of our business and a $1.8 million increase in travel expenses and recruitment fees.

45


 

Amortization of purchased intangibles increased by $ 0.1 million or 11 %, to $ 1.4  million during the year ended December 31, 2015 from $1.3 million during the year ended December 3 1, 2014 due to the acquisitions of Skyfence and Tomium completed during the first quarter of 2014 .

Loss from Operations

 

Years ended December 31,

 

 

Change

 

2015

 

 

2014

 

 

Amount

 

 

%

 

(dollars in thousands)

 

$

(47,798

)

 

$

(57,775

)

 

$

9,977

 

 

 

17.3

%

 

 

 

Our loss from operations decreased by $10.0 million, or 17.3%, from $57.8 million during the year ended December 31, 2014 to $47.8 million during the year ended December 31, 2015. Our gross profit increased by $59.3 million during the year ended December 31, 2015 due to increased net revenues. This increase in gross profit is offset by an increase in operating expenses which increased by $49.3 million for the year ended December 31, 2015 when compared to the prior year principally due to increases in personnel costs, including stock-based compensation expense, to support the increased scope and global reach of our business. The increase in operating expenses was comprised of increased sales and marketing costs of $29.9 million to expand our global sales efforts, and increased general and administrative costs of $8.9 million primarily related to increased headcount to support the growth and operations of our business. In addition, we had increased research and development costs of $10.3 million primarily from hiring to support our ongoing product development efforts.

Other Income (Expense), Net

 

Years ended December 31,

 

 

Change

 

2015

 

 

2014

 

 

Amount

 

 

%

 

(dollars in thousands)

 

$

(402

)

 

$

(220

)

 

$

(182

)

 

 

-82.7

%

 

Other income (expense), net, increased by $0.2 million, or 82.7% during the year ended December 31, 2015 as compared to 2014. The change was primarily due to an increase of $0.7 million primarily due to bank charges offset by an increase of $0.6 million in other income primarily due to higher interest income with increased cash and cash equivalents.

Provision for Income Taxes

 

 

 

Years ended December 31,

 

 

Change

 

 

 

2015

 

 

2014

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

Provision for income taxes

 

$

682

 

 

$

1,181

 

 

$

(499

)

 

 

-42.3

%

Effective tax rate

 

 

(1.4

)%

 

 

(2.0

)%

 

 

 

 

 

 

 

 

 

The provision for income taxes for the years ended December 31, 2015 and 2014 was comprised primarily of foreign and state income taxes. The decrease in the provision for income taxes in the year ended December 31, 2015 compared with the year ended December 31, 2014 was primarily attributable to a decrease in foreign income tax.

Deferred Revenue

 

 

 

Year s  ended December 31,

 

 

Change

 

 

 

2015

 

 

2014

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

Total deferred revenue

 

$

106,657

 

 

$

81,175

 

 

$

25,482

 

 

 

31.4

%

 

Deferred revenue increased by $25.5 million, or 31.4%, to $106.7 million as of December 31, 2015 from $81.2 million as of December 31, 2014. The growth in our deferred revenue was primarily attributable to an increase in our installed base of products and licenses worldwide and resulting renewals of maintenance and support agreements, as well as new sales of subscription and maintenance and support agreements.

46


 

Number of Customers

 

 

 

As of December 31,

 

 

Change

 

 

 

2015

 

 

2014

 

 

Amount

 

 

%

 

Number of customers

 

 

4,541

 

 

 

3,785

 

 

 

756

 

 

 

20.0

%

 

Our number of customers increased by 756, or 20.0%, to 4,541as of December 31, 2015 from 3,785 as of December 31, 2014. Our growth in customer count was driven by increasing market acceptance of our products as well as an increase in our global sales and services and support organizations from 330 people as of December 31, 2014 to 397 as of December 31, 2015. The growth in our sales and service and support organizations was consistent with our plans to continue expanding our global sales and support coverage, in particular our channel partner sales and support teams. The increases in our sales and support organizations allowed us to target new customers while continuing to support existing customers across all of our geographies.

Comparison of the Years Ended December 31, 2014 and 2013

Net Revenue

 

 

 

Years ended December 31,

 

 

 

 

 

 

 

 

 

 

 

2014

 

 

2013

 

 

Change

 

 

 

Amount

 

 

%   of Net

Revenue

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

$

74,299

 

 

 

45.3

 

 

$

72,153

 

 

 

52.4

 

 

$

2,146

 

 

 

3.0

%

Services:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance and Support

 

 

54,795

 

 

 

33.4

 

 

 

44,353

 

 

 

32.2

 

 

 

10,442

 

 

 

23.5

%

Professional Services and training

 

 

11,414

 

 

 

7.0

 

 

 

9,890

 

 

 

7.2

 

 

 

1,524

 

 

 

15.4

%

Subscriptions

 

 

23,502

 

 

 

14.3

 

 

 

11,363

 

 

 

8.2

 

 

 

12,139

 

 

 

106.8

%

Total Services

 

 

89,711

 

 

 

54.7

 

 

 

65,606

 

 

 

47.6

 

 

 

24,105

 

 

 

36.7

%

Total net revenue

 

$

164,010

 

 

 

100.0

 

 

$

137,759

 

 

 

100.0

 

 

$

26,251

 

 

 

19.1

%

Americas

 

$

94,266

 

 

 

57.5

 

 

$

83,736

 

 

 

60.8

 

 

$

10,530

 

 

 

12.6

%

EMEA

 

 

43,111

 

 

 

26.3

 

 

 

33,183

 

 

 

24.1

 

 

 

9,928

 

 

 

29.9

%

APAC

 

 

26,633

 

 

 

16.2

 

 

 

20,840

 

 

 

15.1

 

 

 

5,793

 

 

 

27.8

%

Total net revenue

 

$

164,010

 

 

 

100.0

 

 

$

137,759

 

 

 

100.0

 

 

$

26,251

 

 

 

19.1

%

 

Our net revenue increased by $26.3 million, or 19.1%, to $164.0 million during the year ended December 31, 2014 from $137.8 million during the year ended December 31, 2013 primarily due to growth in services revenue. This revenue growth reflects the increasing demand for our subscription service offerings as well as a broader installed base of product and licenses which generate higher maintenance and support revenues. The Americas region contributed the largest portion with a $10.5 million increase, or approximately a 12.6% change over the same period in 2013. In addition, an increase in our international sales personnel resulted in increases in revenue in EMEA and APAC of $9.9 million and $5.8 million, or approximately a 29.9% and 27.8% change, respectively, over the same period in 2013.

Services revenue increased by $24.1 million, or 36.7%, to $89.7 million during the year ended December 31, 2014 from $65.6 million during the year ended December 31, 2013. During the year ended December 31, 2014, our services revenue was comprised of $54.8 million of maintenance and support, $11.4 million of professional services and training and $23.5 million of subscriptions. The change in services revenue in the year ended December 31, 2014 from the year ended December 31, 2013 was primarily due to an increase of $12.1 million in subscriptions revenue resulting from our cloud-based security services and ThreatRadar, $10.4 million in maintenance and support revenue from our larger installed base, and $1.5 million in professional services and training revenues related to increases in headcount which allowed for completion of more service engagements.

Products and license revenue increased by $2.1 million, or 3.0%, to $74.3 million during the year ended December 31, 2014 from $72.2 million during the year ended December 31, 2013. The change in product and license revenue was primarily due to an increase of $2.4 million in the APAC region and an increase of $0.8 million in the EMEA region offset by a decrease of $1.0 million in the Americas region during the year ended December 31, 2014 compared to year ended December 31, 2013. The decrease in the Americas region product and license revenue was primarily due to extended sales cycles for orders resulting from a combination of sales execution challenges in the United States and intensifying competition for orders exceeding $100,000.

47


 

Gross Profit

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2014

 

 

2013

 

 

 

 

 

 

 

Amount

 

 

Gross

Margin

 

 

Amount

 

 

Gross

Margin

 

 

% Change

 

 

 

(dollars in thousands)

 

 

 

 

 

Products and license gross profit

 

$

65,051

 

 

 

87.6

%

 

$

63,397

 

 

 

87.9

%

 

 

(0.3

)

Services gross profit

 

 

62,376

 

 

 

69.5

%

 

 

44,666

 

 

 

68.1

%

 

 

1.4

 

Total gross profit

 

$

127,427

 

 

 

77.7

%

 

$

108,063

 

 

 

78.4

%

 

 

(0.7

)

 

Total gross profit decreased 0.7 percentage points from 78.4% during the year ended December 31, 2013 to 77.7% during the year ended December 31, 2014 primarily due to an increased proportion of services revenue to total revenues. Products and license gross profit declined 0.3% to 87.6% for the year ended December 31, 2014 compared to 87.9% for the same period in 2013. Services gross profit improved 1.4% to 69.5% for the year ended December 31, 2014 as compared to 68.1% for the same period in 2013, mostly due to higher maintenance and subscriptions revenue which better leveraged the internal cost structure to support these services. The product and licenses gross profit decline was primarily attributable to a higher proportion of stand-alone hardware product revenues to total products and licenses revenues.

Operating Expenses

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

 

 

 

 

2014

 

 

2013

 

 

Change

 

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

% of Net

Revenue

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

43,052

 

 

 

26.2

 

 

$

27,556

 

 

 

20.0

 

 

$

15,496

 

 

 

56.2

%

Sales and marketing

 

 

106,382

 

 

 

64.9

 

 

 

81,500

 

 

 

59.2

 

 

 

24,882

 

 

 

30.5

%

General and administrative

 

 

34,499

 

 

 

21.0

 

 

 

24,436

 

 

 

17.7

 

 

 

10,063

 

 

 

41.2

%

Amortization of acquired intangible assets

 

 

1,269

 

 

 

0.8

 

 

 

 

 

 

 

 

 

1,269

 

 

n/a

 

Total operating expenses

 

$

185,202

 

 

 

112.9

 

 

$

133,492

 

 

 

96.9

 

 

$

51,710

 

 

 

38.7

%

 

Results above include stock-based compensation expense of:

 

 

 

Years ended December 31,

 

 

 

2014

 

 

2013

 

 

Change

 

 

 

(dollars in thousands)

 

Research and development

 

$

8,799

 

 

$

3,660

 

 

$

5,139

 

Sales and marketing

 

 

13,558

 

 

 

8,537

 

 

 

5,021

 

General and administrative

 

 

12,858

 

 

 

8,857

 

 

 

4,001

 

 

Research and development expenses increased by $15.5 million, or 56.2%, to $43.1 million during the year ended December 31, 2014 from $27.6 million during the year ended December 31, 2013. The change was primarily attributable to an increase of $13.6 million in personnel costs, including stock-based compensation, due to additional research and development personnel being hired to support our ongoing product development efforts. In addition, facility and depreciation expenses increased by $0.5 million.

Sales and marketing expenses increased by $24.9 million, or 30.5%, to $106.4 million during the year ended December 31, 2014 from $81.5 million during the year ended December 31, 2013. The change was due to an increase of $18.5 million in personnel costs, including stock-based compensation due to increased headcount worldwide in an effort to help drive our overall revenue growth, $1.3 million in travel expenses due to increased headcount, and a $2.9 million increase in trade show, corporate marketing and seminar costs.

General and administrative expenses increased by $10.1 million, or 41.2%, to $34.5 million during the year ended December 31, 2014 from $24.4 million during the year ended December 31, 2013. The change was primarily due to an increase of $6.8 million in personnel costs, including stock-based compensation, primarily related to increased headcount to support the growth and operations of our business and a $2.8 million increase in legal and accounting fees.

48


 

Amortization of purchased intangibles increased by $1.3 million during the year ended December 31, 2014 related to the acquisitions of Skyfence and Tomium completed during the first quarter of 2014. There was no such amortization in the prior ye ar.

Loss from Operations

 

Years ended December 31,

 

 

Change

 

2014

 

 

2013

 

 

Amount

 

 

%

 

(dollars in thousands)

 

$

(57,775

)

 

$

(25,429

)

 

$

(32,346

)

 

 

-127.2

%

 

Our loss from operations increased by $32.3 million, or 127.2%, from $25.4 million during the year ended December 31, 2013 to $57.8 million during the year ended December 31, 2014. Total operating expenses increased by $51.7 million for the year ended December 31, 2014 when compared to the prior year principally due to increases in personnel costs, including stock-based compensation expense, to support the increased scope and global reach of our business. The increase in operating expenses was comprised of increased sales and marketing costs of $24.9 million to expand our global sales efforts, and increased general and administrative costs of $10.1 million primarily related to increased headcount to support the growth and operations of our business. In addition, we had increased research and development costs of $15.5 million primarily from hiring to support our ongoing product development efforts. This increase in operating expenses was partially offset by an increase in our gross profit of $19.4 million during the year ended December 31, 2014 due to higher net revenues.

Other Income (Expense), Net

 

Years ended December 31,

 

 

Change

 

2014

 

 

2013

 

 

Amount

 

 

%

 

(dollars in thousands)

 

$

(220

)

 

$

(125

)

 

$

(95

)

 

 

-76.0

%

 

Other income (expense), net, decreased approximately $95,000, or 76.0% during the year ended December 31, 2014 as compared to 2013. The change was primarily due to a decrease of $227,000 in other income primarily due to lower interest income and a decrease of $132,000 in other expense primarily due to foreign currency exchange losses, net.

Provision for Income Taxes

 

 

 

Years ended December 31,

 

 

Change

 

 

 

2014

 

 

2013

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

Provision for income taxes

 

$

1,181

 

 

$

777

 

 

$

404

 

 

 

52.0

%

Effective tax rate

 

 

-2.0

%

 

 

-3.0

%

 

 

 

 

 

 

 

 

 

The provision for income taxes for the years ended December 31, 2014 and 2013 was comprised primarily of foreign and state income taxes. The increase in the provision for income taxes in the year ended December 31, 2014 compared with the year ended December 31, 2013 was primarily attributable to an increase in foreign income tax.

Deferred Revenue

 

 

 

Years ended December 31,

 

 

Change

 

 

 

2014

 

 

2013

 

 

Amount

 

 

%

 

 

 

(dollars in thousands)

 

Total deferred revenue

 

$

81,175

 

 

$

63,052

 

 

$

18,123

 

 

 

28.7

%

 

Deferred revenue increased by $18.1 million, or 28.7%, to $81.2 million as of December 31, 2014 from $63.1 million as of December 31, 2013. The growth in our deferred revenue was primarily attributable to an increase in our installed base of products and licenses worldwide and resulting renewals of maintenance and support agreements, as well as new sales of subscription and maintenance and support agreements.

49


 

Number of Customers

 

 

 

As of December 31,

 

 

Change

 

 

 

2014

 

 

2013

 

 

Amount

 

 

%

 

Number of customers

 

 

3,785

 

 

 

3,011

 

 

 

774

 

 

 

25.7

%

 

Our number of customers increased by 774, or 25.7%, to 3,785 as of December 31, 2014 from 3,011 as of December 31, 2013. Our growth in customer count was driven by increasing market acceptance of our products as well as an increase in our global sales and services and support organizations from 296 people as of December 31, 2013 to 330 as of December 31, 2014. The growth in our sales and service and support organizations was consistent with our plans to continue expanding our global sales and support coverage, in particular our channel partner sales and support teams. The increases in our sales and support organizations allowed us to target new customers while continuing to support existing customers across all of our geographies.

Liquidity and Capital Resources

To date, we have satisfied our capital and liquidity needs through sales of our products and services, our initial and follow-on public offering of common stock, and private placements of convertible preferred stock. We have incurred significant losses as we continue to expand our business. Our cash flow from operating activities will continue to be affected principally by the extent to which our revenue exceeds or does not exceed any increase in spending on personnel to support the growth of our business. Our largest source of operating cash flow is cash collections from our customers.

Capital Resources

As of December 31, 2015, we had $264.8 million of cash, cash equivalents and short-term investments, $9.0 million of which is held outside of the United States and not presently available to fund domestic operations and obligations. If we were to repatriate cash held outside of the United States, we could be subject to U.S. income taxes on such amounts, less any previously paid foreign income taxes. Our cash, cash equivalents and short-term investments have increased from $17.7 million as of December 31, 2010 to $264.8 million as of December 31, 2015. This increase is primarily the result of our initial public offering of common stock in November 2011 in which we raised $86.2 million, after deducting underwriters’ discounts and offering expenses and our follow-on public offering of common stock in March 2015 in which we raised $127.9 million after deducting underwriters’ discounts and offering expenses. This amount was partially offset by our losses from operations as we continued to fund our investments in growth, including the development of future products and product enhancements, and expanded into new sales channels and geographies. In addition, during the first quarter of 2014, we increased our use of cash through the acquisitions of Skyfence Networks, Ltd. and certain assets of Tomium which included cash consideration totaling approximately $20.9 million. We believe our existing cash, cash equivalents and short-term investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements may vary materially from those currently planned and will depend on many factors, including, among other things, market acceptance of our products, the cost of our research and development activities, the acquisition of other businesses and overall economic conditions.

As of December 31, 2015, we had no amounts outstanding under our credit facility agreement with a financial institution. The credit facility agreement, as amended, provides for borrowing capacity up to $7.5 million and contains a minimum cash and cash equivalents balance covenant of $3.0 million. The credit facility expires on April 1, 2019. As of December 31, 2015, we were compliant with the covenant under the credit facility.

Cash Flows

The following summary of our cash flows for the periods indicated has been derived from our consolidated financial statements which are included elsewhere in this Annual Report on Form 10-K:

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

 

(dollars in thousands)

 

Net cash provided by operating activities

 

$

23,867

 

 

$

4,126

 

 

$

9,797

 

Net cash provided by (used in) investing activities

 

$

(63,775

)

 

$

(21,591

)

 

$

1,597

 

Net cash provided by financing activities

 

$

140,078

 

 

$

8,857

 

 

$

6,316

 

 

50


 

Cash Flows from Operating Activities

Our largest uses of cash from operating activities are for employee related expenditures. Our primary source of cash flow from operating activities is cash receipts from customers. Our cash flow from operations will continue to be affected principally by the extent to which we grow our revenues and increase our headcount, primarily in our sales and marketing and research and development functions, in order to grow our business.

Net cash provided by operating activities of $23.9 million for the year ended December 31, 2015 reflected a net loss of $48.9 million, adjusted for non-cash charges of $58.5 million primarily due to stock-based compensation expense, as well as a net change of $14.3 million in our net operating assets and liabilities. The net change in our operating assets and liabilities was primarily the result of a $25.5 million increase in our deferred revenue, which represents unearned amounts billed to our customers, resulting from our larger installed base combined with strong maintenance and support renewal rates from our existing customers, in addition to an increase of $7.8 million in accrued compensation and benefits and accrued and other liabilities. This change was partially offset by an increase in accounts receivable of $14.8 million and prepaid expenses and other assets of $4.2 million.

Net cash provided by operating activities of $4.1 million for the year ended December 31, 2014 reflected a net loss of $59.2 million, adjusted for non-cash charges of $42.2 million primarily due to stock-based compensation expense, as well as a net change of $21.1 million in our net operating assets and liabilities. The net change in our operating assets and liabilities was primarily the result of a $18.1 million increase in our deferred revenue, which represents unearned amounts billed to our customers, resulting from our larger installed base combined with strong maintenance and support renewal rates from our existing customers, in addition to an increase of $4.5 million in accrued compensation and benefits and accrued and other liabilities. This change was partially offset by an increase in accounts receivable of $3.0 million.

Net cash provided by operating activities of $9.8 million for the year ended December 31, 2013 reflected a net loss of $26.3 million, adjusted for non-cash charges of $25.8 million, as well as a net change of $10.4 million in our net operating assets and liabilities. The net change in our operating assets and liabilities was primarily the result of a $16.8 million increase in our deferred revenue, which represents unearned amounts billed to our customers, resulting from our larger installed base combined with strong maintenance and support renewal rates from our existing customers, in addition to an increase of $3.7 million in accrued compensation and benefits. This change was partially offset by an increase in accounts receivable of $8.9 million and a decrease in prepaid expenses and other assets of $1.2 million.

Cash Flows from Investing Activities

Our investing activities consist primarily of cost of acquisitions, expenditures to purchase property and equipment and purchases and sales of short-term investments.

During the year ended December 31, 2015, cash used in investing activities was $63.8 million, primarily as a result of $89.6 million in purchases of short-term investments, and $8.1 million in net purchases of property and equipment partially offset by $33.9 million in proceeds from maturities of short-term investments.

During the year ended December 31, 2014, cash used in investing activities was $21.6 million, primarily as a result of $33.3 million in purchases of short-term investments, $12.1 million in acquisitions, and $5.6 million in net purchases of property and equipment partially offset by $29.8 million in proceeds from maturities of short-term investments.

During the year ended December 31, 2013, cash provided by investing activities was $1.6 million, primarily as a result of $42.2 million in proceeds from maturities of short-term investments partially offset by $2.6 million in net purchases of property and equipment and $38.0 million in purchases of short-term investments.

Cash Flows from Financing Activities

Net cash provided by financing activities was $140.1 million for the year ended December 31, 2015 primarily as a result of net proceeds from our follow-on public offering of $127.9 million and proceeds from the issuance of common stock under equity incentive plans, net of repurchases of $12.1 million.

Net cash provided by financing activities was $8.9 million for the year ended December 31, 2014 primarily as a result of proceeds from the issuance of common stock under equity incentive plans, net of repurchases

Net cash provided by financing activities was $6.3 million for the year ended December 31, 2013 as a result of proceeds from the issuance of common stock under equity incentive plans, net of repurchases.

51


 

Critical Accounting Policies and Estimates

Our consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and include our accounts and the accounts of our wholly-owned subsidiaries. The preparation of our consolidated financial statements requires our management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the applicable periods. Management bases its estimates, assumptions and judgments on historical experience and on various other factors that they believe to be reasonable under the circumstances. Different assumptions and judgments would change the estimates used in the preparation of our consolidated financial statements, which, in turn, could change the results from those reported. Our management evaluates its estimates, assumptions and judgments on an ongoing basis.

The critical accounting policies requiring estimates, assumptions, and judgments that we believe have the most significant impact on our consolidated financial statements are described below.

Revenue Recognition

Our management must make significant judgments and estimates to determine revenue to be recognized in any accounting period. Material differences may result in the amount and timing of our revenue for any period if our management makes different judgments or utilizes different estimates.

We derive revenue from two sources: (i) products and license revenue, which includes hardware and perpetual software license revenue and (ii) services revenue, which includes maintenance, professional services, training and subscription arrangements. Substantially all of product and license sales have been sold in combination with maintenance services. Revenue is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.

We define each of the four criteria above as follows:

 

·

Persuasive evidence of an arrangement exists: Evidence of an arrangement consists of a purchase order or acknowledgment issued pursuant to the terms and conditions of a direct customer end user or distributor or value-added reseller (VAR) agreement and, in limited cases with said distributor or VAR an end user agreement and/or purchase order.

 

·

Delivery or performance has occurred: We use shipping and related documents, or written evidence of customer acceptance, when applicable, to verify delivery or performance. We recognize product revenue upon transfer of title and risk of loss, which primarily is upon shipment to value-added resellers, distributors or end users. In most instances, we do not have significant obligations for future performance, such as customer acceptance provisions, rights of return or pricing credits, associated with our sales. In instances where final acceptance of the product or service is specified by the customer, revenue is deferred until all acceptance criteria have been met.

 

·

The sales price is fixed or determinable: We assess whether the sales price is fixed or determinable based on payment terms and whether the sales price is subject to refund or adjustment. Standard payment terms to customers range from 30 to 90 days. In the event payment terms are provided that differ from our standard business practices, the fees are deemed to not be fixed or determinable and revenue is recognized when the payments become due, provided the remaining criteria for revenue recognition have been met.

 

·

Collection is reasonably assured: We assess probability of collection on a customer-by-customer basis. Our customers are subjected to a credit review process that evaluates their financial condition and ability to pay for products and services. If we conclude that collection is not reasonably assured based upon an initial review, we do not recognize revenue until payment is received.

Maintenance and subscription revenue includes arrangements for software maintenance and technical support for our products and subscription services revenue primarily related to our cloud-based services. The terms of our subscription service arrangements do not provide customers the right to take possession of the related software. Maintenance is offered under renewable, fee-based contracts, which include technical support, hardware repair and replacement parts, bug fixes, patches and unspecified upgrades on a when-and-if-available basis. Maintenance and subscription revenue is initially deferred and recognized ratably over the life of the contract, with the related expenses recognized as incurred. Maintenance and subscription contracts usually have a term of one to three years. Unearned maintenance and subscription revenue is included in deferred revenue.

Professional service revenue primarily consists of the fees we earn related to installation and consulting services. We recognize revenue from professional services upon delivery or completion of performance. Professional service arrangements are typically short term in nature and are largely completed within 90 days from the start of service.

52


 

Training services are recognized upon delivery of the training.

Multiple Element Arrangements

Most of our products are hardware appliances containing software components that function together to provide the essential functionality of the product. Therefore, our hardware appliances are considered non-software deliverables and are not subject to industry-specific software revenue recognition guidance.

Our product revenue also includes revenue from the sale of stand-alone software products. Stand-alone software may operate on our hardware appliance, but is not considered essential to the functionality of the hardware and is, therefore, subject to the industry-specific software revenue recognition guidance. Additionally, we provide unspecified software upgrades for its products, on a when-and-if available basis, and hardware replacements through maintenance and support contracts. These support arrangements when sold on a stand-alone basis are subject to the industry-specific software revenue recognition guidance.

Under the software revenue recognition guidance, we use the residual method to recognize revenue when a product agreement includes one or more elements to be delivered at a future date and Vendor Specific Objective Evidence (“VSOE”) of the fair value of all undelivered elements exists. In the majority of our contracts, the only element that remains undelivered at the time of delivery of the product is maintenance and support services and subscriptions. Under the residual method, the VSOE of fair value of the undelivered elements is deferred and the remaining portion of the contract fee is recognized as product revenue. If evidence of the VSOE of fair value of one or more undelivered elements does not exist, all revenue is generally deferred and recognized when delivery of those elements occurs or when fair value can be established.

For certain arrangements with multiple deliverables, we allocate the arrangement fee to the non-software element based upon the relative selling price of such element and, if software and software-related elements (e.g., maintenance and support for the software element) are also included in the arrangement, we allocate the arrangement fee to each of those software and software-related elements as a group. After such allocations are made, the amount of the arrangement fee allocated to the software and software-related elements is accounted for using the residual method. When applying the relative selling price method, we determine the selling price for each element using VSOE of selling price, if it exists, or if not, Third-Party Evidence (“TPE”) of selling price, if it exists. If neither VSOE nor TPE of selling price exist for an element, we use its Best Estimate of Selling Price (“BESP”) for that element. The revenue allocated to each element is then recognized when the basic revenue recognition criteria are met for that element. We limit the amount of revenue recognized for delivered elements to the amount that is not contingent on the future delivery of products or services, or subject to our future performance obligation.

VSOE of fair value for elements of an arrangement is based upon the normal pricing and discounting practices for those services when sold separately. In determining VSOE, we require that a substantial majority of the selling prices for a service fall within a reasonably narrow pricing range, evidenced by a substantial majority of such historical stand-alone transactions falling within a reasonably narrow range. In addition, we consider major service groups and geographies in determining VSOE.

We are not able to determine TPE for our products or services. TPE is determined based on competitor prices for similar deliverables when sold separately. Generally, our go-to-market strategy differs from that of our peers and our offerings contain a significant level of differentiation such that the comparable pricing of products with similar functionality cannot be obtained. Furthermore, we are unable to reliably determine what similar competitor products’ selling prices are on a stand-alone basis.

When we are unable to establish the selling price of our non-software deliverables using VSOE or TPE, we use BESP in our allocation of arrangement consideration. The objective of BESP is to determine the price at which we would transact a sale if the product or service were sold on a stand-alone basis. We determine BESP for the purposes of allocating the arrangement by reviewing external and internal market factors including, but not limited to, pricing practices including discounting, the geographies in which we offer our products and services, the type of customer (i.e., distributor, value added reseller or direct end user) and competition. Additionally, we consider historical transactions, including transactions whereby the deliverable was sold on a stand-alone basis. The determination of BESP is made through consultation with and approval by our management. Selling prices are analyzed on a quarterly basis to identify if we have experienced significant changes in our selling prices.

For our non-software deliverables we allocate the arrangement consideration based on the relative selling price of the deliverables. For our hardware appliances we use BESP as our selling price. For our maintenance and support services, subscriptions and professional services and training, we primarily use VSOE as the selling price and when we are unable to establish a selling price using VSOE, we use BESP.

53


 

Stock-Based Compensation

We recognize compensation costs related to stock option, employee stock purchase plan, restricted stock unit, or RSU, and shares of restricted stock grants to employees based on the estimated fair value of the awards on the date of grant, net of estimated forfeitures. For stock option and employee stock purchase plan grants, we estimate the grant date fair value, and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model. The fair value of RSUs is determined using the closing price of our stock on the date of grant. The grant date fair value of the stock-based awards is generally recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the respective awards.

For performance based RSUs granted to employees which have multiple performance and a market condition we used a Monte Carlo simulation model to determine fair value of such awards. The key inputs used to determine the fair value of the awards were our stock price on the date of grant, the expected volatility, the risk free interest rate and revenues achieved. We update the estimated expense, net of forfeitures, at the end of each reporting period. The expense is recognized on an accelerated basis over the requisite service period, generally the vesting period of the respective awards.

The fair value of the options and employee stock purchase plan awards during 2015, 2014 and 2013 were calculated using the Black-Scholes option pricing model with the following weighted-average assumptions:

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Option grants:

 

 

 

 

 

 

 

 

 

 

 

 

Expected dividend rate

 

 

0

%

 

 

0

%

 

 

0

%

Risk-free interest rate

 

 

1.8

%

 

 

1.8

%

 

 

1.2

%

Expected term (in years)

 

 

6.1

 

 

 

6.1

 

 

 

6.1

 

Expected volatility

 

 

49

%

 

 

46

%

 

 

46

%

ESPP grants:

 

 

 

 

 

 

 

 

 

 

 

 

Dividend rate

 

 

0

%

 

 

0

%

 

 

0

%

Risk-free interest rate

 

 

0.4

%

 

 

0.1

%

 

 

0.1

%

Expected term (in years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Expected volatility

 

 

65

%

 

 

45

%

 

 

27

%

 

The Black-Scholes options pricing model requires the use of highly subjective and complex assumptions which determine the fair value of share-based awards, including the grant’s expected term and the price volatility of the underlying stock. These assumptions include:

Expected Term . The expected term represents the period over which the stock-based awards are expected to be outstanding. For option grants that are considered to be “plain vanilla,” we used the simplified method to determine the expected term as set forth in the guidance provided by the U.S. Securities and Exchange Commission. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options. For option grants that are not considered “plain vanilla,” the expected term is based on historical option exercise behavior and post-vesting cancellations of options by employees. For ESPP grants, the expected term is based on the length of the offering period, which is six months.

Risk-Free Interest Rate . The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to each award’s expected term.

Expected Volatility . The expected volatility was based on a combination of our historical volatilities and the Company’s publicly listed peers because we do not have sufficient trading history for our common stocks. The volatility is over a period equal to the expected terms of the stock option grants and the offering period for employee stock purchase plan.

Expected Dividend . The expected dividend was assumed to be zero as we have never paid dividends and have no current plans to do so.

54


 

In addition to assumptions used in the Black-Scholes option pricing model, we must also estimate a forfeiture rate to calculate the stock-based compensation for expense related to our awards. Our forfeiture rate is based on an analysis of our actual forfeitures. We will continue to evaluate the appropriateness of t he forfeiture rate based on actual forfeiture experience, analysis of employee turnover and other factors. Quarterly changes in the estimated forfeiture rate can have a significant impact on our stock-based compensation expense as the cumulative effect of adjusting the rate is recognized in the period the forfeiture estimate is changed. If a revised forfeiture rate is higher than the previously estimated forfeiture rate, an adjustment is made that will result in a decrease to the stock-based compensation ex pense recognized in the financial statements. If a revised forfeiture rate is lower than the previously estimated forfeiture rate, an adjustment is made that will result in an increase to the stock-based compensation expense recognized in the financial sta tements.

We will continue to use judgment in evaluating the expected term, expected volatility and forfeiture rate related to our own stock-based compensation on a prospective basis. As we continue to accumulate additional data related to our common stock, we may have refinements to the estimates of our expected volatility, expected terms and forfeiture rates, which could materially impact our future stock-based compensation expense.

Business Combination

We account for our business acquisitions in accordance with Accounting Standards Codification (ASC) No. 805, Business Combinations. We use our best estimates and assumptions as part of the purchase price allocation process to value assets acquired and liabilities assumed at the business combination date. However, our estimates and assumptions are subject to refinement. We record adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in our operating results in the period in which the adjustments were determined.

The total purchase price allocated to the tangible assets acquired is assigned based on the fair values as of the date of the acquisition. The fair value assigned to identifiable intangible assets acquired is determined using the income approach which discounts expected future cash flows to present value using estimated assumptions determined by management. The identifiable intangible assets are subject to amortization on a straight-line basis as this best approximates the benefit period related to these assets.

Property and Equipment

Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, generally two to seven years.

Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the assets. Upon the retirement or disposition of property and equipment, the related costs and accumulated depreciation is removed and any related gain or loss is recorded in the consolidated statements of operations. Repairs and maintenance that do not extend the life or improve an asset are expensed in the periods incurred.

Goodwill and Acquired Intangibles

Goodwill is not amortized and is reviewed at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In reviewing goodwill, we bypass the qualitative assessment and proceeds directly to performing the quantitative two step impairment test to test the reporting unit’s goodwill for impairment. The first step of the impairment test involves comparing the fair value of the reporting unit to its net book value, including goodwill and is used as a screening process for identifying a potential goodwill impairment loss. If the net book value exceeds its fair value, then we would perform the second step of the goodwill impairment test to determine the amount of the impairment loss. The impairment loss would be calculated by comparing the implied fair value of our goodwill to our net book value. In calculating the implied fair value of our goodwill, the fair value would be allocated to all of the other assets and liabilities based on their fair values. The excess of the fair value of the Company over the amount assigned to its other assets and liabilities is the implied fair value of goodwill. An impairment loss would be recognized when the carrying amount of goodwill exceeds its implied fair value.

We complete our annual impairment test during the fourth quarter of each fiscal year. There was no impairment of goodwill recorded for the fiscal year ended December 31, 2015.

Intangible assets consist of purchased technology which are amortized over the period of estimated benefit using the straight-line method, as the consumption pattern of the asset is not apparent, and estimated useful lives ranging from seven to ten years. The weighted average remaining useful life of our acquired technology intangible assets is six years as of December 31, 2015. No significant residual value is estimated for intangible assets.

55


 

Impairment of Long-Lived Assets

We evaluate our long-lived assets, which consist of property and equipment and acquired intangible assets, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Impairment exists if the carrying amounts of such assets exceed the estimates of future net undiscounted cash flows expected to be generated by such assets. Should impairment exist, the impairment loss would be measured based on the excess carrying value of the asset over the asset’s estimated fair value. As of December 31, 2015 and 2014, we have not incurred impairment losses on our long-lived assets.

Income Taxes

We make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, tax benefits and deductions and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Significant changes to these estimates may result in an increase or decrease to our tax provision in the subsequent period when such a change in estimate occurs.

We use the liability method for accounting of deferred income taxes, which requires recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been recognized in our financial statements, but have not been reflected in our taxable income. Estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred income tax assets, which arise from temporary differences and carry-forwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We regularly assess the likelihood that our deferred income tax assets will be realized. To the extent that we believe any amounts are not more likely than not to be realized, we record a valuation allowance to reduce our deferred income tax assets. In the event we determine that all or part of the net deferred tax assets are not realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period such determination is made. Similarly, if we subsequently realize deferred income tax assets that were previously determined to be unrealizable, the respective valuation allowance would be reversed, resulting in an adjustment to earnings in the period such determination is made. In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize and measure potential liabilities based upon a more likely than not criteria. Based upon these criteria, we estimate whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities may result in tax benefits being recognized in the period when we determine the liabilities are no longer necessary. If our estimate of tax liabilities is less than the amount ultimately assessed, a further charge to expense would result.

Significant judgment is required in determining any valuation allowance recorded against deferred income tax assets. In assessing the need for a valuation allowance, we consider all available evidence, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that we change our determination as to the amount of deferred income tax assets that could be realized, we will adjust our valuation allowance with a corresponding effect to the provision for income taxes in the period in which such determination is made.

Significant judgment is also required in evaluating our uncertain tax positions and determining our provision for income taxes. Although we believe our reserves for uncertain tax positions are reasonable, no assurance can be given that the final tax outcome of these matters will not be different from that which is reflected in our historical income tax provisions and accruals. We adjust these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the effect of reserves for uncertain tax positions and any changes to the reserves that are considered appropriate, as well as the related net interest and penalties, if applicable.

56


 

Contractual Obligations

The following summarizes our contractual obligations as of December 31, 2015:

 

 

 

Payments Due by Period

 

Contractual Obligations:

 

2016

 

 

2017

 

 

2018

 

 

2019

 

 

2020

 

 

Thereafter

 

 

Total

 

 

 

(in thousands)

 

Operating lease obligations (1)

 

$

7,295

 

 

$

7,107

 

 

$

7,412

 

 

$

4,578

 

 

$

4,210

 

 

$

120

 

 

$

30,722

 

Severance Pay Fund (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,884

 

Purchase commitments (3)

 

 

5,809

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,809

 

Total

 

$

13,104

 

 

$

7,107

 

 

$

7,412

 

 

$

4,578

 

 

$

4,210

 

 

$

120

 

 

$

41,415

 

  

1  

Operating lease agreements represent our obligations to make payments under our non-cancelable lease agreements for our facilities. During the year ended December 31, 2015, we made regular lease payments of $5.0 million under the operating lease agreements.

2  

Our consolidated balance sheet as of December 31, 2015 includes $4.9 million of non-current liabilities for our Israeli severance pay fund. The specific timing of any cash payments relating to this obligation cannot be projected with reasonable certainty and, therefore, no amounts for this obligation are included in the annual columns of the table set forth above.

3  

Purchase commitments are contractual obligations to purchase hardware appliances and related component parts from our vendors in advance of anticipated sales.

Off-Balance Sheet Arrangements

Through December 31, 2015, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Recent Accounting Pronouncements

See "Note 1 - The Company and Summary of Significant Accounting Policies" to the consolidated financial statements included in this report, regarding the impact of certain recent accounting pronouncements on our consolidated financial statements.

 

 

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in interest rates and foreign currency exchange rates. We do not hold or issue financial instruments for trading purposes.

Interest Rate Sensitivity

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and outstanding debt obligations. Our cash, cash equivalents and short-term investment accounts as of December 31, 2015 and 2014 totaled $264.8 million and $109.7 million, respectively, and consist primarily of cash, cash equivalents and short-term investments with maturities of less than two years from the date of purchase. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of the interest rates in the United States. However, because of the short-term nature of the instruments in our portfolio, a sudden change in market interest rates would not be expected to have a material impact on our financial condition or our results of operation.

As of December 31, 2015, we have no amounts outstanding under our credit facility agreement. To the extent in the future we enter into other long-term debt arrangements, we would be subject to fluctuations in interest rates which could have a material impact on our future financial condition and results of operation.

Foreign Currency Exchange Risk

Our consolidated results of operations and cash flow are subject to fluctuations due to changes in foreign currency exchange rates. Substantially all of our revenue is generated in U.S. dollars. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the U.S. and Israel and to a lesser extent in EMEA and APAC. Our consolidated results of operations and cash flow are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be

57


 

adversely affected in the future due to changes in foreign exchange rates. The effect of a hypothetical 10% change in foreign currency exchanges rates app licable to our business would not have a material impact on our historical consolidated financial statements.

To date, we have used derivative financial instruments, specifically foreign currency forward contracts, to manage exposure to foreign currency risks, by hedging a portion of our forecasted expenses denominated in Israeli shekels expected to occur within a year. The effect of exchange rate changes on foreign currency forward contracts is expected to offset the effect of exchange rate changes on the underlying hedged item. We do not use derivative financial instruments for speculative or trading purposes.

 

 

Item 8. Financial Statements and Supplementary Data

Quarterly Results of Operations

The following table sets forth unaudited quarterly consolidated statements of operations data for each of the years in the two-year period ended December 31, 2015 (in thousands, except per share data). We derived this information from our unaudited consolidated financial statements, which we prepared on the same basis as our audited consolidated financial statements contained in this Annual Report on Form 10-K. In our opinion, these unaudited statements include all adjustments, consisting only of normal recurring adjustments that we consider necessary for a fair statement of that information when read in conjunction with the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. The operating results for any quarter should not be considered indicative of results for any future period.

 

 

 

Three Months Ended

 

 

 

Dec. 31,

2015

 

 

Sept.30,

2015

 

 

June 30,

2015

 

 

March 31,

2015

 

 

Dec. 31,

2014

 

 

Sept.30,

2014

 

 

June 30,

2014

 

 

March 31,

2014

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

$

36,113

 

 

$

30,451

 

 

$

23,895

 

 

$

17,104

 

 

$

26,100

 

 

$

19,642

 

 

$

16,586

 

 

$

11,971

 

Services:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance and support

 

 

18,217

 

 

 

17,110

 

 

 

16,005

 

 

 

15,048

 

 

 

14,731

 

 

 

13,879

 

 

 

13,522

 

 

 

12,663

 

Professional services and training

 

 

3,476

 

 

 

3,500

 

 

 

3,176

 

 

 

3,932

 

 

 

3,260

 

 

 

2,774

 

 

 

3,081

 

 

 

2,299

 

Subscriptions

 

 

14,908

 

 

 

12,288

 

 

 

10,402

 

 

 

8,673

 

 

 

7,286

 

 

 

6,380

 

 

 

5,253

 

 

 

4,583

 

Total services

 

 

36,601

 

 

 

32,898

 

 

 

29,583

 

 

 

27,653

 

 

 

25,277

 

 

 

23,033

 

 

 

21,856

 

 

 

19,545

 

Total net revenue

 

 

72,714

 

 

 

63,349

 

 

 

53,478

 

 

 

44,757

 

 

 

51,377

 

 

 

42,675

 

 

 

38,442

 

 

 

31,516

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

 

3,412

 

 

 

2,741

 

 

 

2,796

 

 

 

1,998

 

 

 

3,142

 

 

 

2,299

 

 

 

2,075

 

 

 

1,732

 

Services

 

 

10,383

 

 

 

9,148

 

 

 

8,770

 

 

 

8,332

 

 

 

7,154

 

 

 

7,202

 

 

 

6,959

 

 

 

6,020

 

Total cost of revenue

 

 

13,795

 

 

 

11,889

 

 

 

11,566

 

 

 

10,330

 

 

 

10,296

 

 

 

9,501

 

 

 

9,034

 

 

 

7,752

 

Gross profit

 

 

58,919

 

 

 

51,460

 

 

 

41,912

 

 

 

34,427

 

 

 

41,081

 

 

 

33,174

 

 

 

29,408

 

 

 

23,764

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

14,403

 

 

 

13,183

 

 

 

13,112

 

 

 

12,678

 

 

 

11,014

 

 

 

10,459

 

 

 

11,618

 

 

 

9,961

 

Sales and marketing

 

 

39,162

 

 

 

31,806

 

 

 

34,071

 

 

 

31,253

 

 

 

31,429

 

 

 

26,853

 

 

 

25,065

 

 

 

23,035

 

General and administrative

 

 

10,659

 

 

 

11,401

 

 

 

11,637

 

 

 

9,743

 

 

 

9,486

 

 

 

8,987

 

 

 

7,621

 

 

 

8,405

 

Amortization of acquired intangible assets

 

 

352

 

 

 

352

 

 

 

352

 

 

 

352

 

 

 

352

 

 

 

351

 

 

 

362

 

 

 

204

 

Total operating expenses

 

 

64,576

 

 

 

56,742

 

 

 

59,172

 

 

 

54,026

 

 

 

52,281

 

 

 

46,650

 

 

 

44,666

 

 

 

41,605

 

Loss from operations

 

 

(5,657

)

 

 

(5,282

)

 

 

(17,260

)

 

 

(19,599

)

 

 

(11,200

)

 

 

(13,476

)

 

 

(15,258

)

 

 

(17,841

)

Other income (expense), net

 

 

(189

)

 

 

91

 

 

 

(224

)

 

 

(80

)

 

 

101

 

 

 

48

 

 

 

(215

)

 

 

(154

)

Loss before provision for income taxes

 

 

(5,846

)

 

 

(5,191

)

 

 

(17,484

)

 

 

(19,679

)

 

 

(11,099

)

 

 

(13,428

)

 

 

(15,473

)

 

 

(17,995

)

Provision (benefit) for income taxes

 

 

(65

)

 

 

556

 

 

 

(160

)

 

 

351

 

 

 

1,397

 

 

 

190

 

 

 

(35

)

 

 

(371

)

Net loss

 

 

(5,781

)

 

 

(5,747

)

 

 

(17,324

)

 

 

(20,030

)

 

 

(12,496

)

 

 

(13,618

)

 

 

(15,438

)

 

 

(17,624

)

Loss attributable to non - controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

213

 

Net loss attributable to Imperva, Inc. stockholders

 

$

(5,781

)

 

$

(5,747

)

 

$

(17,324

)

 

$

(20,030

)

 

$

(12,496

)

 

$

(13,618

)

 

$

(15,438

)

 

$

(17,411

)

Net loss per share attributable to Imperva, Inc.

   stockholders, basic and diluted

 

$

(0.18

)

 

$

(0.19

)

 

$

(0.57

)

 

$

(0.74

)

 

$

(0.48

)

 

$

(0.52

)

 

$

(0.60

)

 

$

(0.69

)

Weighted-average shares used to compute

   net loss per share attributable to Imperva, Inc.

   stockholders, basic and diluted

 

 

31,393

 

 

 

30,797

 

 

 

30,287

 

 

 

26,973

 

 

 

26,177

 

 

 

25,967

 

 

 

25,782

 

 

 

25,255

 

 

 

 

58


 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

IMPERVA, INC. AND SUBSIDIARIES

 

 

Page

Reports of Independent Registered Public Accounting Firm

60

Consolidated Balance Sheets

62

Consolidated Statements of Operations

63

Consolidated Statements of Comprehensive Loss

64

Consolidated Statements of Stockholders’ Equity

65

Consolidated Statements of Cash Flows

66

Notes to Consolidated Financial Statements

67

 

 

59


 

REPORT OF INDEPENDENT REGIST ERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of

Imperva, Inc.

We have audited Imperva, Inc.’s internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the COSO criteria). Imperva, Inc.’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Imperva, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2015, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Imperva, Inc. and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2015 and our report dated February 26, 2016 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

San Jose, California

February 26, 2016

 

 

60


 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of

Imperva, Inc.

We have audited the accompanying consolidated balance sheets of Imperva, Inc. and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2015. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Imperva, Inc. and subsidiaries at December 31, 2015 and 2014, and the consolidated results of their operations and their cash flows for each of the three years in the period ended December 31, 2015, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Imperva, Inc.’s internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 26, 2016 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

San Jose, California

February 26, 2016

 

 

61


 

IMPERVA, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except share and per share data)

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

ASSETS

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

168,252

 

 

$

68,096

 

Short-term investments

 

 

96,555

 

 

 

41,624

 

Restricted cash

 

 

79

 

 

 

62

 

Accounts receivable, net of allowance of $1,438 and $ 215 as of

   December 31, 2015 and 2014, respectively

 

 

61,051

 

 

 

47,446

 

Inventory

 

 

815

 

 

 

259

 

Deferred tax assets

 

 

 

 

 

408

 

Prepaid expenses and other current assets

 

 

7,965

 

 

 

3,927

 

Total current assets

 

 

334,717

 

 

 

161,822

 

Property and equipment, net

 

 

12,164

 

 

 

7,618

 

Goodwill

 

 

34,972

 

 

 

34,972

 

Acquired intangible assets, net

 

 

7,991

 

 

 

9,399

 

Severance pay fund

 

 

4,530

 

 

 

3,980

 

Restricted cash

 

 

1,665

 

 

 

1,665

 

Deferred tax assets

 

 

588

 

 

 

329

 

Other assets

 

 

1,042

 

 

 

860

 

TOTAL ASSETS

 

$

397,669

 

 

$

220,645

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Accounts payable

 

$

6,870

 

 

$

5,376

 

Accrued compensation and benefits

 

 

20,259

 

 

 

15,749

 

Accrued and other current liabilities

 

 

14,283

 

 

 

6,376

 

Deferred revenue

 

 

79,132

 

 

 

56,077

 

Total current liabilities

 

 

120,544

 

 

 

83,578

 

Other liabilities

 

 

4,515

 

 

 

10,408

 

Deferred revenue

 

 

27,525

 

 

 

25,098

 

Accrued severance pay

 

 

4,884

 

 

 

4,318

 

TOTAL LIABILITIES

 

 

157,468

 

 

 

123,402

 

Commitments and Contingencies (Note 11)

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY:

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value - 5,000,000 shares authorized, no shares

     issued and outstanding as of December 31, 2015 and 2014, respectively

 

 

 

 

 

 

Common stock, $0.0001 par value - 145,000,000 shares authorized, 31,837,144

    and 26,895,480 shares issued and outstanding as of December 31, 2015 and

    2014, respectively

 

 

3

 

 

 

2

 

Additional paid-in capital

 

 

448,069

 

 

 

256,388

 

Accumulated deficit

 

 

(206,540

)

 

 

(157,658

)

Accumulated other comprehensive loss

 

 

(1,331

)

 

 

(1,489

)

TOTAL STOCKHOLDERS' EQUITY

 

 

240,201

 

 

 

97,243

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

 

$

397,669

 

 

$

220,645

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 

62


 

IMPERVA, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

(In thousands, except per share data)

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

$

107,563

 

 

$

74,299

 

 

$

72,153

 

Services

 

 

126,735

 

 

 

89,711

 

 

 

65,606

 

Total net revenue

 

 

234,298

 

 

 

164,010

 

 

 

137,759

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Products and license

 

 

10,947

 

 

 

9,248

 

 

 

8,756

 

Services

 

 

36,633

 

 

 

27,335

 

 

 

20,940

 

Total cost of revenue

 

 

47,580

 

 

 

36,583

 

 

 

29,696

 

Gross profit

 

 

186,718

 

 

 

127,427

 

 

 

108,063

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

53,376

 

 

 

43,052

 

 

 

27,556

 

Sales and marketing

 

 

136,292

 

 

 

106,382

 

 

 

81,500

 

General and administrative

 

 

43,440

 

 

 

34,499

 

 

 

24,436

 

Amortization of acquired intangible assets

 

 

1,408

 

 

 

1,269

 

 

 

 

Total operating expenses

 

 

234,516

 

 

 

185,202

 

 

 

133,492

 

Loss from operations

 

 

(47,798

)

 

 

(57,775

)

 

 

(25,429

)

Other income (expense), net

 

 

(402

)

 

 

(220

)

 

 

(125

)

Loss before provision for income taxes

 

 

(48,200

)

 

 

(57,995

)

 

 

(25,554

)

Provision for income taxes

 

 

682

 

 

 

1,181

 

 

 

777

 

Net loss

 

 

(48,882

)

 

 

(59,176

)

 

 

(26,331

)

Loss attributable to non - controlling interest

 

 

 

 

 

213

 

 

 

1,153

 

Net loss attributable to Imperva, Inc. stockholders

 

$

(48,882

)

 

$

(58,963

)

 

$

(25,178

)

Net loss per share of common stock attributable to Imperva, Inc.

    stockholders, basic and diluted

 

$

(1.64

)

 

$

(2.28

)

 

$

(1.04

)

Shares used in computing net loss per share of common stock, basic

    and diluted

 

 

29,849

 

 

 

25,806

 

 

 

24,300

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

63


 

IMPERVA, INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Loss

(In thousands)

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Net loss

 

$

(48,882

)

 

$

(59,176

)

 

$

(26,331

)

Other comprehensive loss (net of tax):

 

 

 

 

 

 

 

 

 

 

 

 

Net change in net unrealized loss on investments

 

 

(249

)

 

 

(59

)

 

 

(172

)

Net change in unrealized gain (loss) on hedging instruments

 

 

407

 

 

 

(1,002

)

 

 

(1,117

)

 

 

 

158

 

 

 

(1,061

)

 

 

(1,289

)

Comprehensive loss

 

 

(48,724

)

 

 

(60,237

)

 

 

(27,620

)

Comprehensive loss attributable to non - controlling interest

 

 

 

 

 

213

 

 

 

1,153

 

Comprehensive loss attributable to Imperva, Inc. stockholders

 

$

(48,724

)

 

$

(60,024

)

 

$

(26,467

)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

64


 

IMPERVA, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’ Equity

(In thousands except share data)

 

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Non - controlling

 

 

Total

Shareholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income   (Loss)

 

 

Interest

 

 

Equity

 

Balance as at December 31, 2012

 

 

24,296,076

 

 

$

2

 

 

$

157,989

 

 

$

(73,517

)

 

$

861

 

 

$

(1,104

)

 

$

84,231

 

Issuance of common stock, net of repurchases

 

 

806,226

 

 

 

 

 

 

4,796

 

 

 

 

 

 

 

 

 

 

 

 

4,796

 

Vesting of restricted stock

 

 

 

 

 

 

 

 

801

 

 

 

 

 

 

 

 

 

 

 

 

801

 

Stock-based compensation

 

 

 

 

 

 

 

 

22,494

 

 

 

 

 

 

 

 

 

 

 

 

22,494

 

Issuance of common stock in connection with employee stock

   purchase plan

 

 

96,502

 

 

 

 

 

 

2,772

 

 

 

 

 

 

 

 

 

 

 

 

2,772

 

Exercise of warrant

 

 

7,694

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares withheld for tax withholding on

      vesting of restricted stock units

 

 

 

 

 

 

 

 

 

 

(1,252

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,252

)

Sale of additional ownership interest in Incapsula, Inc.

 

 

 

 

 

 

 

 

357

 

 

 

 

 

 

 

 

 

(357

)

 

 

 

Components of other comprehensive income (loss), net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(172

)

 

 

 

 

 

(172

)

Change in unrealized loss on derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,117

)

 

 

 

 

 

(1,117

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(25,178

)

 

 

 

 

 

(1,153

)

 

 

(26,331

)

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(27,620

)

Balance as at December 31, 2013

 

 

25,206,498

 

 

 

2

 

 

 

187,957

 

 

 

(98,695

)

 

 

(428

)

 

 

(2,614

)

 

 

86,222

 

Issuance of common stock related to acquisitions

 

 

738,479

 

 

 

 

 

 

24,163

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24,163

 

Issuance of common stock, net of repurchases

 

 

672,832

 

 

 

 

 

 

7,371

 

 

 

 

 

 

 

 

 

 

 

 

7,371

 

Vesting of restricted stock

 

 

 

 

 

 

 

 

454

 

 

 

 

 

 

 

 

 

 

 

 

454

 

Stock-based compensation

 

 

 

 

 

 

 

 

37,273

 

 

 

 

 

 

 

 

 

 

 

 

37,273

 

Issuance of common stock in connection with employee stock

   purchase plan

 

 

188,068

 

 

 

 

 

 

3,332

 

 

 

 

 

 

 

 

 

 

 

 

3,332

 

Income tax benefit from employee stock option exercises

 

 

 

 

 

 

 

 

385

 

 

 

 

 

 

 

 

 

 

 

 

385

 

Shares withheld for tax withholding on

      vesting of restricted stock units

 

 

 

 

 

 

 

 

 

 

(2,074

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,074

)

Pre-combination service relating to acquired Skyfence

   option plan

 

 

 

 

 

 

 

 

354

 

 

 

 

 

 

 

 

 

 

 

 

354

 

Purchase of additional ownership interest in Incapsula, Inc.

 

 

89,603

 

 

 

 

 

 

(2,827

)

 

 

 

 

 

 

 

 

2,827

 

 

 

-

 

Components of other comprehensive income (loss), net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(59

)

 

 

 

 

 

(59

)

Change in unrealized loss on derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,002

)

 

 

 

 

 

(1,002

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(58,963

)

 

 

 

 

 

(213

)

 

 

(59,176

)

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(60,237

)

Balance as at December 31, 2014

 

 

26,895,480

 

 

 

2

 

 

 

256,388

 

 

 

(157,658

)

 

 

(1,489

)

 

 

 

 

 

97,243

 

Proceeds from follow-on public offering, net of offering costs

 

 

3,450,000

 

 

 

1

 

 

 

127,740

 

 

 

 

 

 

 

 

 

 

 

 

127,741

 

Issuance of common stock, net of repurchases

 

 

670,844

 

 

 

 

 

 

18,724

 

 

 

 

 

 

 

 

 

 

 

 

18,724

 

Vesting of restricted stock

 

 

706,121

 

 

 

 

 

 

767

 

 

 

 

 

 

 

 

 

 

 

 

767

 

Stock-based compensation

 

 

 

 

 

 

 

 

50,964

 

 

 

 

 

 

 

 

 

 

 

 

50,964

 

Issuance of common stock in connection with employee stock

   purchase plan

 

 

114,699

 

 

 

 

 

 

4,785

 

 

 

 

 

 

 

 

 

 

 

 

4,785

 

Income tax benefit from employee stock option exercises

 

 

 

 

 

 

 

 

165

 

 

 

 

 

 

 

 

 

 

 

 

165

 

Shares withheld for tax withholding on

      vesting of restricted stock units

 

 

 

 

 

 

 

 

 

 

(11,464

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11,464

)

Components of other comprehensive income (loss), net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(249

)

 

 

 

 

 

(249

)

Change in unrealized loss on derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

407

 

 

 

 

 

 

407

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(48,882

)

 

 

 

 

 

 

 

 

(48,882

)

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(48,724

)

Balance as at December 31, 2015

 

 

31,837,144

 

 

$

3

 

 

$

448,069

 

 

$

(206,540

)

 

$

(1,331

)

 

$

 

 

$

240,201

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

65


 

IMPERVA, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands)

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(48,882

)

 

$

(59,176

)

 

$

(26,331

)

Adjustments to reconcile net loss to net cash provided by

   operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

4,551

 

 

 

3,578

 

 

 

2,642

 

Stock-based compensation

 

 

50,964

 

 

 

37,273

 

 

 

22,494

 

Amortization of acquired intangibles

 

 

1,408

 

 

 

1,269

 

 

 

 

Amortization of premiums/accretion of discounts on short-term investments

 

 

496

 

 

 

416

 

 

 

639

 

Allowance for doubtful debts

 

 

1,223

 

 

 

(195

)

 

 

(2

)

Excess tax benefits from share-based compensation

 

 

(165

)

 

 

(385

)

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(14,828

)

 

 

(2,805

)

 

 

(8,868

)

Inventory

 

 

(1,056

)

 

 

253

 

 

 

(184

)

Prepaid expenses and other assets

 

 

(4,220

)

 

 

409

 

 

 

(1,161

)

Accounts payable

 

 

977

 

 

 

1,150

 

 

 

159

 

Accrued compensation and benefits

 

 

4,510

 

 

 

2,630

 

 

 

3,672

 

Accrued and other liabilities

 

 

3,242

 

 

 

1,847

 

 

 

(206

)

Severance pay (net)

 

 

16

 

 

 

93

 

 

 

(32

)

Deferred revenue

 

 

25,482

 

 

 

18,123

 

 

 

16,761

 

Deferred tax assets

 

 

149

 

 

 

(354

)

 

 

214

 

Net cash provided by operating activities

 

 

23,867

 

 

 

4,126

 

 

 

9,797

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from sales/maturities of short-term investments

 

 

(89,626

)

 

 

29,821

 

 

 

42,162

 

Purchase of short-term investments

 

 

33,948

 

 

 

(33,267

)

 

 

(38,021

)

Acquisitions, net of cash acquired

 

 

 

 

 

(12,083

)

 

 

 

Net purchases of property and equipment

 

 

(8,080

)

 

 

(5,621

)

 

 

(2,602

)

Change in restricted cash

 

 

(17

)

 

 

(441

)

 

 

58

 

Net cash (used in) provided by investing activities

 

 

(63,775

)

 

 

(21,591

)

 

 

1,597

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from follow-on public offering, net of offering costs

 

 

127,853

 

 

 

 

 

 

 

Proceeds from issuance of common stock, net of repurchases

 

 

23,524

 

 

 

10,546

 

 

 

7,568

 

Shares withheld for tax withholding on vesting of restricted stock units

 

 

(11,464

)

 

 

(2,074

)

 

 

(1,252

)

Excess tax benefits from share-based compensation

 

 

165

 

 

 

385

 

 

 

 

Net cash provided by financing activities

 

 

140,078

 

 

 

8,857

 

 

 

6,316

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(14

)

 

 

 

 

 

(207

)

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

 

100,156

 

 

 

(8,608

)

 

 

17,503

 

CASH AND CASH EQUIVALENTS - Beginning of period

 

 

68,096

 

 

 

76,704

 

 

 

59,201

 

CASH AND CASH EQUIVALENTS - End of period

 

$

168,252

 

 

$

68,096

 

 

$

76,704

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for income taxes

 

$

652

 

 

$

287

 

 

$

835

 

NONCASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued related to acquisitions of businesses

 

$

 

 

$

24,163

 

 

$

 

Property and equipment incurred but not yet paid

 

$

517

 

 

$

820

 

 

$

 

Vesting of restricted and early exercised stock options

 

$

767

 

 

$

454

 

 

$

801

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

 

66


 

IMPERVA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

1. The Company and Summary of Significant Accounting Policies

Business

Imperva, Inc. (together with its subsidiaries, the “Company”) was incorporated in April 2002 in Delaware. The Company is headquartered in Redwood Shores, California and has subsidiaries located throughout the world including Israel, Asia and Europe. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises.

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and include all adjustments necessary for the fair presentation of the Company’s consolidated financial position, results of operations and cash flows for the periods presented. The consolidated financial statements include the accounts of Imperva Inc., and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Non-controlling Interest

On March 20, 2014, the Company acquired the remaining interest it did not previously own in its majority-owned subsidiary, Incapsula, Inc. (“Incapsula”) (Refer to Note 2). The Company separately presented the non-controlling interest on its Consolidated Balance Sheets in Total Stockholders’ Equity, Consolidated Statements of Operations, Consolidated Statements of Comprehensive Loss and Consolidated Statements of Stockholders’ Equity for periods prior to such date. The Company had recorded a non - controlling interest in these consolidated financial statements for the 19% ownership interest of the minority owners of Incapsula as of December 31, 2013. Changes to the ownership interest in Incapsula held by the minority owners were accounted for as equity transactions in the consolidated statements of stockholders’ equity as the Company obtained control of Incapsula on November 5, 2009.

Segment Information

Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is the Chief Executive Officer.

The Company has one operating segment, which is the development, marketing, sales, service and support of cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises.

Use of Estimates

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such management estimates include the fair value of accounts receivable, inventory intangible assets and goodwill, useful lives of intangible assets and property and equipment, and assumptions used in the calculation of revenue, income taxes and stock-based compensation, among others. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.

Concentration of Supply Risk

The Company relies on a single third party to manufacture its hardware appliances, and purchases its hardware appliances through such third party’s value-added resellers. Quality or performance failures of the Company’s products or changes in the Company’s suppliers’ financial or business condition could disrupt the Company’s ability to supply quality products to its customers and thereby have a material adverse effect on its business and consolidated financial statements.

67


 

Concentration of Credit Risk

Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash, cash equivalents, short-term investments, restricted cash and derivative financial instruments. The Company’s cash, cash equivalents, short-term investments and restricted cash are invested in high-quality instruments with banks and financial institutions located in the United States and Israel. Such deposits may be in excess of insured limits provided on such deposits.

The Company uses derivative financial instruments to manage exposures to foreign currency risks. The Company’s derivatives expose it to credit risk to the extent that the counterparty may be unable to meet the terms of the agreement. The Company seeks to mitigate such risk by limiting its counterparties to those with high or investment-grade credit ratings. The Company does not require collateral under these agreements and has not historically experienced any losses due to credit risk or lack of performance by counterparties.

Derivative Financial Instruments

The Company uses forward foreign currency exchange contracts to reduce its exposure to foreign currency rate changes for operating expenses that are forecasted to be incurred in currencies other than U.S. dollars. The Company records all of its derivative instruments at their gross fair value on the consolidated balance sheets. The Company classifies its cash flows from derivative financial instruments as operating activities.

The accounting for changes in the fair value of a derivative instrument depends on whether the instrument has been designated and qualifies as a cash flow hedge for accounting purposes. For forward foreign currency exchange contracts that are designated and qualify as cash flow hedges, the effective portion of the gain or loss resulting from changes in the fair value of the derivative instruments is accounted for in accumulated other comprehensive income (loss) (“AOCI”) in the consolidated statements of stockholders’ equity and reclassified into operating expenses in the consolidated statements of operations in the period or periods during which the hedged transaction affects earnings. As of December 31, 2015, the Company estimated that $0.6 million of net derivative loss included in accumulated other comprehensive income (loss) will be reclassified into earnings within the next 12 months. The ineffective portion of the gain or loss resulting from the change in fair value is recognized in other income (expense), net in the consolidated statements of operations.

Cash, Cash Equivalents and Short-Term Investments

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents consist of cash on hand, highly liquid investments in money market funds and various deposit accounts.

The Company considers all high quality investments purchased with original maturities at the date of purchase greater than three months to be short-term investments. Investments are available to be used in current operations and are, therefore, classified as current assets even though maturities may extend beyond one year. Cash equivalents and short-term investments are classified as available-for-sale and are, therefore, recorded at fair value on the consolidated balance sheets, with any unrealized gains and losses reported in the consolidated statements of stockholders’ equity as a component of accumulated other comprehensive income (loss) until realized. The Company uses the specific-identification method to compute gains and losses on the investments. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion is included as a component of other income (expense), net in the consolidated statements of operations.

Restricted Cash

The Company has restricted cash pledged as collateral representing a security deposit required for facility leases. As of December 31, 2015 and 2014, the Company has classified $1.7 million and $1.7 million, respectively, of security deposit as non-current assets relating to its facility lease arrangements.

Inventory

Inventory consists of finished goods hardware appliances and related component parts and is stated at the lower of cost or market value where the cost is determined as the lower of an average cost basis or last invoice. Inventory that is obsolete or in excess of forecasted demand is written down to its estimated realizable value. Inventory write-downs, once established, are not reversed as they establish a new cost basis for the inventory. For the years ended December 31, 2015, 2014 and 2013, the amount of inventory write-downs incurred by the Company were insignificant.

68


 

Business Combination

The Company accounts for its business acquisitions in accordance with Accounting Standards Codification (ASC) No. 805, Business Combinations. The Company uses its best estimates and assumptions as part of the purchase price allocation process to value assets acquired and liabilities assumed at the business combination date. However, the Company’s estimates and assumptions are subject to refinement. The Company records adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in our operating results in the period in which the adjustments were determined.

The total purchase price allocated to the tangible assets acquired is assigned based on the fair values as of the date of the acquisition. The fair value assigned to identifiable intangible assets acquired is determined using the income approach which discounts expected future cash flows to present value using estimated assumptions determined by management. The identifiable intangible assets are subject to amortization on a straight-line basis as this best approximates the benefit period related to these assets

Property and Equipment

Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, generally two to seven years.

Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the assets. Upon the retirement or disposition of property and equipment, the related costs and accumulated depreciation is removed and any related gain or loss is recorded in the consolidated statements of operations. Repairs and maintenance that do not extend the life or improve an asset are expensed in the periods incurred.

Goodwill and Acquired Intangibles

Goodwill is not amortized and is reviewed at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In reviewing goodwill, the Company bypasses the qualitative assessment and proceeds directly to performing the quantitative two step impairment test to test the reporting unit’s goodwill for impairment. The first step of the impairment test involves comparing the fair value of the reporting unit to its net book value, including goodwill and is used as a screening process for identifying a potential goodwill impairment loss. If the net book value exceeds its fair value, then the Company would perform the second step of the goodwill impairment test to determine the amount of the impairment loss. The impairment loss would be calculated by comparing the implied fair value of goodwill of the Company to its net book value. In calculating the implied fair value of the Company’s goodwill, the fair value of the Company would be allocated to all of the other assets and liabilities based on their fair values. The excess of the fair value of the Company over the amount assigned to its other assets and liabilities is the implied fair value of goodwill. An impairment loss would be recognized when the carrying amount of goodwill exceeds its implied fair value.

The Company completes its annual impairment test during the fourth quarter of each fiscal year. There was no impairment of goodwill recorded for the fiscal year ended December 31, 2015.

Intangible assets consist of purchased technology which are amortized over the period of estimated benefit using the straight-line method, as the consumption pattern of the asset is not apparent, and estimated useful lives ranging from seven to ten years. The weighted average remaining useful life of the Company’s acquired technology intangible assets is six years as of December 31, 2015. No significant residual value is estimated for intangible assets.

Impairment of Long-Lived Assets

The Company evaluates its long-lived assets, which consist of property and equipment and acquired intangible assets, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Impairment exists if the carrying amounts of such assets exceed the estimates of future net undiscounted cash flows expected to be generated by such assets. Should impairment exist, the impairment loss would be measured based on the excess carrying value of the asset over the asset’s estimated fair value. As of December 31, 2015 and 2014, the Company has not written down any of its long-lived assets as a result of impairment.

69


 

Revenue Recognition

The Company derives revenue from two sources: (i) products and license revenue, which includes hardware and perpetual software license revenue and (ii) services revenue, which includes maintenance and support, professional services, training and subscription arrangements. Substantially all of product and license sales have been sold in combination with maintenance and support services. Revenue is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery or performance has occurred; the sales price is fixed or determinable; and collection is reasonably assured.

The Company defines each of the four criteria above as follows:

 

·

Persuasive evidence of an arrangement exists:  Evidence of an arrangement consists of a purchase order or acknowledgment issued pursuant to the terms and conditions of a direct customer end user or distributor or value-added reseller (VAR) agreement and, in limited cases with said distributor or VAR, an end user agreement and/or purchase order

 

·

Delivery or performance has occurred:  The Company uses shipping and related documents, or written evidence of customer acceptance, when applicable, to verify delivery or performance. The Company recognizes product revenue upon transfer of title and risk of loss, which primarily is upon shipment to value-added resellers, distributors or end users. In most instances, the Company does not have significant obligations for future performance, such as customer acceptance provisions, rights of return or pricing credits, associated with the Company’s sales. In instances where final acceptance of the product or service is specified by the customer, revenue is deferred until all acceptance criteria have been met.

 

·

The sales price is fixed or determinable:  The Company assesses whether the sales price is fixed or determinable based on payment terms and whether the sales price is subject to refund or adjustment. Standard payment terms to customers range from 30 to 90 days. In the event payment terms are provided that differ from the Company’s standard business practices, the fees are deemed to not be fixed or determinable and revenue is recognized when the payments become due, provided the remaining criteria for revenue recognition have been met.

 

·

Collection is reasonably assured:  The Company assesses probability of collection on a customer-by-customer basis. The Company’s customers are subjected to a credit review process that evaluates their financial condition and ability to pay for products and services. If the Company concludes that collection is not reasonably assured based upon an initial review, the Company does not recognize revenue until payment is received.

Maintenance and support and subscription revenue includes arrangements for software maintenance and technical support for the Company’s products and subscription services revenue primarily related to the Company’s cloud-based services. The terms of the Company’s subscription service arrangements do not provide customers the right to take possession of the related software. Maintenance and support is offered under renewable, fee-based contracts, which include technical support, hardware repair and replacement parts, bug fixes, patches and unspecified upgrades on a when-and-if-available basis. Maintenance and support and subscription revenue is initially deferred and recognized ratably over the life of the contract, with the related expenses recognized as incurred. Maintenance and support and subscription contracts usually have a term of one to three years. Unearned maintenance and support and subscription revenue is included in deferred revenue.

Professional service revenue primarily consists of the fees the Company earns related to installation and consulting services. The Company recognizes revenue from professional services upon delivery or completion of performance. Professional service arrangements are typically short term in nature and are largely completed within 90 days from the start of service.

Training services are recognized upon delivery of the training.

Multiple Element Arrangements

Most of the Company’s products are hardware appliances containing software components that function together to provide the essential functionality of the product. Therefore, the Company’s hardware appliances are considered non-software deliverables and are not subject to industry-specific software revenue recognition guidance.

The Company’s product revenue also includes revenue from the sale of stand-alone software products. Stand-alone software may operate on the Company’s hardware appliance, but is not considered essential to the functionality of the hardware and is, therefore, subject to the industry-specific software revenue recognition guidance. Additionally, the Company provides unspecified software upgrades for its products, on a when-and-if available basis, and hardware replacements through maintenance and support contracts. These support arrangements when sold on a stand-alone basis are subject to the industry-specific software revenue recognition guidance.

70


 

Under the software revenue recognition guidance, the Company uses the residual method to recognize revenue when a product agreement includes one or more elements to be delivered at a future date and Vendor Specific Objective Evidence (“ VSOE ”) of the fair value of all undelivered elements exists. In the majority of the Company’s contracts, the only element that remains undelivered at th e time of delivery of the product is maintenance and support services and subscriptions. Under the residual method, the VSOE of fair value of the undelivered elements is deferred and the remaining portion of the contract fee is recognized as product revenu e. If evidence of the VSOE of fair value of one or more undelivered elements does not exist, all revenue is generally deferred and recognized when delivery of those elements occurs or when fair value can be established.

For certain arrangements with multiple deliverables, the Company allocates the arrangement fee to the non-software element based upon the relative selling price of such element and, if software and software-related elements (e.g., maintenance and support for the software element) are also included in the arrangement, the Company allocates the arrangement fee to each of those software and software-related elements as a group. After such allocations are made, the amount of the arrangement fee allocated to the software and software-related elements is accounted for using the residual method. When applying the relative selling price method, the Company determines the selling price for each element using VSOE of selling price, if it exists, or if not, Third-Party Evidence (“TPE”) of selling price, if it exists. If neither VSOE nor TPE of selling price exist for an element, the Company uses its Best Estimate of Selling Price (“BESP”) for that element. The revenue allocated to each element is then recognized when the basic revenue recognition criteria are met for that element. The Company limits the amount of revenue recognized for delivered elements to the amount that is not contingent on the future delivery of products or services, or subject to the Company’s future performance obligation.

VSOE of fair value for elements of an arrangement is based upon the normal pricing and discounting practices for those services when sold separately. In determining VSOE, the Company requires that a substantial majority of the selling prices for a service fall within a reasonably narrow pricing range, evidenced by a substantial majority of such historical stand-alone transactions falling within a reasonably narrow range. In addition, the Company considers major service groups and geographies in determining VSOE.

The Company is not able to determine TPE for its products or services. TPE is determined based on competitor prices for similar deliverables when sold separately. Generally, the Company’s go-to-market strategy differs from that of its peers and its offerings contain a significant level of differentiation such that the comparable pricing of products with similar functionality cannot be obtained. Furthermore, the Company is unable to reliably determine what similar competitor products’ selling prices are on a stand-alone basis.

When the Company is unable to establish the selling price of its non-software deliverables using VSOE or TPE, the Company uses BESP in its allocation of arrangement consideration. The objective of BESP is to determine the price at which the Company would transact a sale if the product or service were sold on a stand-alone basis. The Company determines BESP for the purposes of allocating the arrangement by reviewing external and internal market factors including, but not limited to, pricing practices including discounting, the geographies in which the Company offers its products and services, the type of customer (i.e., distributor, value added reseller or direct end user) and competition. Additionally, the Company considers historical transactions, including transactions whereby the deliverable was sold on a stand-alone basis. The determination of BESP is made through consultation with and approval by the Company’s management. Selling prices are analyzed on a quarterly basis to identify if the Company has experienced significant changes in its selling prices.

For its non-software deliverables the Company allocates the arrangement consideration based on the relative selling price of the deliverables. For its hardware appliances the Company uses BESP as its selling price. For its maintenance and support services, subscriptions and professional services and training, the Company primarily uses VSOE as the selling price and when the Company is unable to establish a selling price using VSOE, it uses BESP.

Deferred Revenue

Deferred revenue represents amounts invoiced to customers for which the related revenue has not been recognized because one or more of the revenue recognition criteria have not been met. The current portion of the deferred revenues represents the amount that is expected to be recognized as revenue within one year of the consolidated balance sheet date.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at invoiced amounts, net of allowances for doubtful accounts if applicable, and do not bear interest.

71


 

The Company generally does not require collateral from its customers; however, in certain circumstances, may require letters of credit, other collateral, additional guarantees or advance payments. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of its customer accounts. The Company regularly reviews its accounts receivable that remain outstanding past their applicable payment terms and establishes allow ance and potential write-offs by considering certain factors such as historical experience, industry data, credit quality, age of balances and current economic conditions that may affect a customers’ ability to pay.

Concentration of Revenue and Accounts Receivable

Significant customers are those which represent 10% or more of the Company’s total revenue or gross accounts receivable balance at each respective balance sheet date. For the year ended December 31, 2015, we had one customer that represented 18% of our total revenue, and for the year ended December 31, 2013, a different customer represented 10% of our total revenue. For the year ended December 31, 2014, the Company did not have any customers that represented 10% or more of the Company’s total revenue. One customer represented 21% of gross accounts receivable as of December 31, 2015. There were no customers who represented 10% or more of gross accounts receivable as of December 31, 2014.

Shipping and Handling Costs

Costs related to shipping and handling are included in cost of revenue.

Research and Development Costs

Research and development costs, including direct and allocated expenses, are expensed as incurred.

Software Development Costs

The costs to develop software for sale have not been capitalized as the Company believes that the technological feasibility of the related software is not established until substantially all product development is complete.

Warranty Costs

The Company generally provides a 60-day warranty on hardware appliance products and software from the date of shipment to customers. To date, cost to repair or replace items sold to customers has been insignificant.

Advertising Costs

The Company expenses advertising costs as incurred. Advertising expense is included within sales and marketing expense in the consolidated statements of operations. For the years ended December 31, 2015, 2014 and 2013, advertising expenses were not material.

Retirement Savings Plan

The Company maintains a defined contribution 401(k) retirement savings plan for its U.S. employees. Each participant in the 401(k) retirement savings plan may elect to contribute a percentage of his or her annual compensation up to a specified maximum amount allowed under U.S. Internal Revenue Service regulations. There were no employer contributions to the 401(k) retirement savings plan for the years ended December 31, 2015, 2014 and 2013.

Severance Pay Asset and Liability

The Company has recorded a severance pay asset and liability on its consolidated balance sheets related to its employees located in Israel. The Company’s liability for severance pay is calculated pursuant to Israeli severance pay law based on the most recent salary for the employees multiplied by the number of years of employment, as of the respective balance sheet date. Employees are entitled to one month salary for each year of employment or a portion thereof. The Company’s liability at each respective balance sheet date for all of its Israeli employees is fully accrued in the accompanying consolidated financial statements and is mainly funded through monthly deposits to the employee’s pension and management insurance policies. The carrying value of these policies is recorded as a severance fund asset in the Company’s consolidated balance sheets.

72


 

The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law. The carrying value of the deposited funds is based on the cash surrender value of these policies and includes profits accumulated through the respecti ve balance sheet date. The Company recognized severance expense related to the Israeli severance pay law during the years ended December 31, 2015, 2014 and 2013 of $ 1.3 million, $1.4 million, and $1.2 million, respectively.

Income Taxes

The Company accounts for income taxes in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification No. 740 (“ASC 740”), Accounting for Income Taxes. The Company makes certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, tax benefits and deductions and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Significant changes to these estimates may result in an increase or decrease to the Company’s tax provision in the subsequent period when such a change in estimate occurs.

The Company uses the liability method for accounting for deferred income taxes, which requires recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements, but have not been reflected in its taxable income. Estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred income tax assets, which arise from temporary differences and carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets and liabilities are expected to be realized or settled. The Company regularly assesses the likelihood that its deferred income tax assets will be realized from recoverable income taxes or recovered from future taxable income based on the realization criteria set forth in ASC 740. To the extent that the Company believes any amounts are more likely not to be realized, the Company records a valuation allowance to reduce the deferred income tax assets. In the event the Company determines that all or part of the net deferred tax assets are not realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period such determination is made. Similarly, if the Company subsequently realizes deferred income tax assets that were previously determined to be unrealizable, the respective valuation allowance would be reversed, resulting in an adjustment to earnings in the period such determination is made.

In addition, the calculation of the Company’s tax liabilities involves addressing uncertainties in the application of complex tax regulations. The Company recognizes and measures potential liabilities based upon criteria set forth in ASC 740. Based upon these criteria, the Company estimates whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities may result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary. If the Company’s estimate of tax liabilities is less than the amount ultimately assessed, a further charge to expense would result.

Significant judgment is required in determining any valuation allowance recorded against deferred income tax assets. In assessing the need for a valuation allowance, the Company considers all available evidence, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that the Company changes its determination as to the amount of deferred income tax assets that could be realized, it will adjust its valuation allowance with a corresponding effect to the provision for income taxes in the period in which such determination is made.

Significant judgment is also required in evaluating the Company’s uncertain tax positions under ASC 740 and determining its provision for income taxes. Although the Company believes its reserves for uncertain tax positions are reasonable, no assurance can be given that the final tax outcome of these matters will not be different from that which is reflected in the Company’s historical income tax provisions and accruals. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the effect of reserves for uncertain tax positions and any changes to the reserves that are considered appropriate, as well as the related net interest and penalties, if applicable.

Stock-Based Compensation

Compensation costs related to employee stock option grants are based on the fair value of the options on the date of grant, net of estimated forfeitures. The Company determines the grant date fair value of the options using the Black-Scholes option-pricing model and the related stock-based compensation expense is generally recognized on a straight-line basis over the period in which an employee is required to provide service in exchange for the options, or the vesting period of the respective options.

73


 

For performance based RSUs granted to employees which have multiple performance conditions and a market condition the Comp any used a Monte Carlo simulation model to determine the fair value of such awards. The key inputs used were the Company’s stock price on the date of grant, the expected volatility, the risk free interest rate and revenues achieved. The Company updates the estimated expense, net of forfeitures, at the end of each reporting period. The expense is recognized on an accelerated basis over the requisite service period, which is generally the vesting period of the respective awards.

Foreign Currency

The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are re-measured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are re-measured at historical exchange rates. Gains and losses related to remeasurement are recorded in other income (expense) in the consolidated statements of operations.

Fair Value of Financial Instruments

The Company measures and reports its cash equivalents, short-term investments, derivative instruments, and the Israeli severance pay fund assets at fair value. Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:

Level I—Unadjusted quoted prices in active markets for identical assets or liabilities;

Level II—Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

Level III—Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.

The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The Company’s financial instruments consist of Level I and Level II assets. Level I securities include highly liquid money market funds and mutual funds. Level II instruments include deposits maintained with financial institutions and derivative instruments.

Net Loss per Share of Common Stock

The Company’s basic net loss per share of common stock is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. The weighted-average number of shares of common stock used to calculate the Company’s basic net loss per share of common stock excludes those shares subject to repurchase as these shares are not deemed to be issued for accounting purposes until they vest. The diluted net loss per share of common stock is computed by giving effect to all potential common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options to purchase common stock, common stock subject to repurchase, and warrants to purchase common stock are considered to be common stock equivalents. Basic and diluted net loss per share of common stock was the same for each period presented as the inclusion of all potential common shares outstanding was anti-dilutive.

Reclassifications

From time to time the Company reclassifies certain prior period balances to conform to the current year presentation. Starting first quarter 2015, we present tax withholdings on vesting of restricted stock units separately from proceeds from issuance of common stock in connection with employee stock purchase plan, in the Consolidated Statements of Stockholders’ Equity and Consolidated Statements of Cash Flows. The change was made to better reflect nature of the transactions, and prior period balances were reclassified accordingly. These reclassifications have no material impact on previously reported total assets, total liabilities, stockholders’ equity, results of operations or cash flows.

 

74


 

Recent Accounting Pronouncements

In January 2016, the FASB issued ASU 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. This guidance relates accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the FASB clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. This guidance will be effective for the Company beginning January 1, 2018, early adoption is permitted only for certain provisions. Adoption of the guidance is retrospective with a cumulative adjustment to retained earnings or accumulated deficit as of the adoption date. The Company is evaluating the impact of adopting this new accounting standard on its consolidated financial statements.

In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. This guidance requires that deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. This guidance is effective beginning January 1, 2017, with early adoption permitted. Adoption of the ASU is either retrospective to each prior period presented or prospective. In the fourth quarter of 2015, the Company early adopted this guidance prospectively. As a result, the Company no longer presents any current deferred income tax assets or liabilities but did not reclassify prior period deferred income tax assets or liabilities, as permitted by the guidance. See "Note 14 - Income Taxes" for additional information.

In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination account for measurement-period adjustments retrospectively. Instead, an acquirer will recognize a measurement-period adjustment during the period in which it determines the amount of the adjustment. This guidance will be effective for the Company beginning January 1, 2016, with early adoption permitted. The Company does not believe the implementation of this standard will result in a material impact to its consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory, which changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. ASU No. 2015-11 defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. This guidance will be effective for the Company beginning January 1, 2017, with early adoption permitted. The Company does not believe the implementation of this standard will result in a material impact to its consolidated financial statements.

In May 2014, the FASB issued ASU No. 2014-09—Revenue (Topic 606): Revenue from Contracts with Customers. ASU No. 2014-09 will replace most existing U.S. GAAP guidance on this topic. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB approved a one-year deferral of the effective date for the new revenue reporting standard for entities reporting under U.S. GAAP. In accordance with the deferral, this guidance will be effective for the Company beginning January 1, 2018 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. Early adoption is permitted beginning January 1, 2017. The Company is evaluating the impact of adopting this new accounting standard on its consolidated financial statements and has not selected a transition method.

 

 

2. Incapsula

On November 5, 2009, the Company entered into a license agreement for Incapsula to use certain developed technology of the Company. In lieu of any other fee or royalty under the license agreement, Incapsula issued to the Company 5,000,000 shares of its Series A Convertible Preferred Stock representing a 58% ownership interest at the date of issuance. The transaction was accounted for as a business combination.

In March 2010, the Company entered into a Series A and Series A-1 Purchase Agreement whereby Incapsula issued 6,666,666 shares of its Series A Convertible Preferred Stock to the Company in exchange for cash consideration of $3.0 million. As a result of this transaction, the Company increased its ownership interest in Incapsula to 76% at the date of issuance. The purchase of the additional ownership interest in Incapsula was treated as an equity transaction.

In July 2011, the Company purchased 4,375,000 shares of Incapsula’s Series A-1 Preferred Stock for $3.5 million thereby increasing its ownership interest to 82%. In January 2012, the Company purchased the remaining 4,375,000 shares of Incapsula’s Series A-1 Preferred Stock for $3.5 million thereby increasing its ownership interest in Incapsula to 85%.

75


 

Under the terms of the agreements between the Comp any and Incapsula, the Company had the right, but not the obligation, to purchase the remaining ownership interest in Incapsula commencing on November 5, 2013 and ending on November 5, 2018 (the “Purchase Right”). In March 2014, the Company acquired the re maining outstanding capital stock in exchange for approximately 124,088 shares of Company common stock with an aggregate fair value of $7.7 million.

As of the date of the acquisition, the remaining non-controlling interest on the Company’s balance sheet of $2.8 million was reclassified to additional paid-in capital given the Company’s complete ownership of Incapsula.

 

 

3. Acquisitions

Acquisitions during 2014 were accounted for in accordance with Accounting Standards Codification (ASC) No. 805, Business Combinations, and the results of operations of each acquisition have been included in the Company’s consolidated results of operations from the respective date of the acquisition. Each of the acquisitions was not material, either individually or in the aggregate to the Company’s results of operations in the period of acquisition.

While management uses its best estimates and assumptions as part of the purchase price allocation process to value assets acquired and liabilities assumed at the business combination date, its estimates and assumptions are subject to refinement. As a result, during the preliminary purchase price allocation period, which may be up to one year from the business combination date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The Company record adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in its operating results in the period in which the adjustments were determined.

The total purchase price allocated to the tangible assets acquired is assigned based on the fair values as of the date of the acquisition. The fair value assigned to identifiable intangible assets acquired is determined using the income approach which discounts expected future cash flows to present value using estimated assumptions determined by management. The Company believes that these identified intangible assets will have no residual value after their estimated economic useful lives. The identifiable intangible assets are subject to amortization on a straight-line basis as this best approximates the benefit period related to these assets.

The excess of the purchase price over the identified tangible and intangible assets, less liabilities assumed, is recorded as goodwill and primarily reflects the value of the synergies expected to be generated from combining the Company’s and the acquired entities’ technology and operations.

Acquisition of Skyfence Networks Ltd.

On February 7, 2014, the Company acquired Skyfence, a private company based and incorporated in Israel. Skyfence is a developer of a solution which allows real time visibility and control over corporate use of Software-as-a-Service (“SaaS”) applications, which enforces security policy, protects sensitive data from external and inside threats, as well as ensures compliance with standards.

Per the terms of the acquisition agreement (as amended) with Skyfence and its security holders, the Company purchased all of the outstanding shares of capital stock of Skyfence in exchange for (a) approximately $8.6 million in cash, in addition to a holdback payment commitment due 24 months from the date the acquisition closes valued at approximately $7.2 million, and (b) 884,422 shares of Company common stock, of which 532,262 shares are subject to forfeiture based upon time-based vesting and continuing employment, and were therefore excluded from purchase consideration as such amounts will be recorded as compensation expense over the term of the corresponding four-year service period. In addition, 29,871 of the shares are subject to a holdback period of up to 24 months from the date of acquisition. The Company also assumed stock options outstanding in accordance with the terms of the applicable Skyfence stock option plan and Skyfence stock option agreement relating to that Skyfence stock option. Based on Skyfence’s stock options outstanding at February 7, 2014, Imperva converted options to purchase 164,000 shares of Skyfence stock into options to purchase 24,248 shares of Imperva common stock.

The fair value of Imperva’s shares issued is based on Imperva’s closing price per share of $59.08 as reported on the New York Stock Exchange at the closing of the Acquisition on February 7, 2014.

76


 

The fair values of the stock option awards assumed were estimated using a Black-Scholes option-pricing model. The estimated fair values of unvested equity awards of $1.1 million will be recorded as operating expense over the remaining requisite service periods as they re late to post-combination services, while the fair values of vested equity based awards of $0.3 million were included in total purchase price as they relate to pre-combination services. The total purchase consideration is as follows (in thousands):

 

 

Cash

 

$

8,558

 

Cash holdback liability

 

 

7,157

 

Fair value of common stock

 

 

20,855

 

Estimated fair value of equity awards assumed and replaced

 

 

354

 

Total purchase price

 

$

36,924

 

 

The acquisition of Skyfence was accounted for in accordance with the acquisition method of accounting for business combinations with Imperva as the accounting acquirer. The Company expensed the related acquisition costs in the amount of $0.9 million in general and administrative expenses. In addition, stock-based compensation expense totaling $7.3 million was recognized from the date of acquisition through December 31, 2014.

The excess of the consideration for Skyfence over the fair values assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisition. The Company’s management believes that the goodwill represents the synergies expected from combining the products and technologies of Imperva with those of Skyfence, which will enhance the Company’s overall product portfolio. The purchased technology will be amortized straight-line over a seven-year estimated useful life. Also as part of the acquisition, the Company assumed deferred tax liabilities related to the fair value of the developed technology the Company obtained in the acquisition. Goodwill recorded in connection with the acquisition is not deductible for income tax purposes. The total purchase price was allocated using the information available at the business combination date. The following table summarizes the allocation of the consideration to the fair value of the tangible and intangible assets acquired and liabilities assumed as of the acquisition date (in thousands):

 

 

Net tangible assets

 

$

1,014

 

Existing technology

 

 

7,965

 

Deferred tax liability assumed

 

 

(1,528

)

Goodwill

 

 

29,473

 

Total purchase price

 

$

36,924

 

 

The results of operations of Skyfence described above have been included in Imperva’s consolidated financial statements from the date of acquisition. The following table presents pro forma results of operations of the Company and Skyfence as if the companies had been combined as of January 1, 2013, and includes pro forma adjustments related to the amortization of acquired intangible assets and share-based compensation expense and the related income tax effects. Direct transaction costs are excluded from the December 31, 2014 pro forma condensed combined financial information presented below. The pro forma condensed combined financial information is presented for informational purposes only. The unaudited pro forma results of operations are not necessarily indicative of results that would have occurred had the acquisition taken place at the beginning of the earliest period presented, or of future results. Included in the pro forma results are fair value adjustments based on the fair values of assets acquired and liabilities assumed as of the acquisition date. Supplemental information on an unaudited pro forma basis, as if the Skyfence acquisition had been consummated on January 1, 2013 is presented as follows (in thousands):

 

 

 

Year Ended December

 

 

 

2014

 

 

2013

 

Pro forma revenue

 

$

164,010

 

 

$

137,759

 

Pro forma loss from operations

 

$

(58,491

)

 

$

(36,629

)

Pro forma net loss

 

$

(59,740

)

 

$

(37,414

)

 

Acquisition of Certain Assets and Liabilities of Tomium Software, LLC.

On January 30, 2014, the Company acquired certain assets and liabilities of Tomium, a private company based in Texas. Tomium is a provider of real-time mainframe security auditing agents. The purchase price of approximately $8.3 million includes approximately $4.6 million in cash and assumption of a liability to pay cash of $0.3 million, and also the issuance of 60,556 shares of

77


 

Company common stock valued at approximately $3.4 million based upon the closing price of the Company’s stock on the acquisition date of $55.45 per share. Imperva acquired certain tangible assets and also assumed a facility lease of Tomium.

The following table summarizes the preliminary allocation of the consideration to the fair value of the tangible and intangible assets acquired and liabilities assumed as of the acquisition date based on information available at the business combination date (in thousands):

 

Intangible assets

 

$

2,704

 

Goodwill

 

 

5,499

 

Total intangible assets acquired

 

 

8,203

 

Other acquired tangible assets

 

 

60

 

Fair value of assets acquired

 

$

8,263

 

 

The total purchase price was allocated using the information available at the business combination date. Goodwill recorded in connection with the acquisition is deductible for U.S. income tax purposes.

The acquisition of Tomium was accounted for in accordance with the acquisition method of accounting for business combinations with Imperva as the accounting acquirer. The Company expensed the related acquisition costs, consisting primarily of legal costs in the amount of $0.3 million in general and administrative expenses. The Company’s management believes that the goodwill represents the synergies expected from combining the acquired technology and operations with those of Imperva. The intangible assets acquired by Imperva in conjunction with the acquisition of Tomium are being amortized straight-line over a ten-year estimated useful life.

The results of operations related to the Tomium assets and liabilities have been included in the Company’s consolidated statements of operations from the acquisition date. Pro forma results of operations have not been presented because the acquisition was not material to the Company’s results of operations.

 

 

4. Cash, Cash Equivalents and Short-Term Investments

Cash, cash equivalents and short-term investments consist of the following (in thousands):

 

 

 

As of December 31, 2015

 

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

57,906

 

 

$

 

 

$

 

 

$

57,906

 

Bank deposits

 

 

10,253

 

 

 

 

 

 

 

 

 

10,253

 

Commercial paper

 

 

13,896

 

 

 

 

 

 

3

 

 

 

13,893

 

Money market funds

 

 

86,200

 

 

 

 

 

 

 

 

 

86,200

 

Total

 

$

168,255

 

 

$

 

 

$

3

 

 

$

168,252

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt obligations

 

$

86,590

 

 

$

2

 

 

$

300

 

 

$

86,292

 

Bank deposits

 

 

10,263

 

 

 

 

 

 

 

 

 

10,263

 

Total

 

$

96,853

 

 

$

2

 

 

$

300

 

 

$

96,555

 

78


 

 

 

 

As of December 31, 2014

 

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

26,284

 

 

$

 

 

$

 

 

$

26,284

 

Bank deposits

 

 

11,877

 

 

 

 

 

 

 

 

 

11,877

 

Commercial paper

 

 

18,341

 

 

 

 

 

 

2

 

 

 

18,339

 

Money market funds

 

 

11,596

 

 

 

 

 

 

 

 

 

11,596

 

Total

 

$

68,098

 

 

$

 

 

$

2

 

 

$

68,096

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt obligations

 

$

31,404

 

 

$

3

 

 

$

53

 

 

 

31,354

 

Bank deposits

 

 

10,270

 

 

 

 

 

 

 

 

 

10,270

 

Total

 

$

41,674

 

 

$

3

 

 

$

53

 

 

$

41,624

 

 

The following table sets forth the cost and estimated fair value of short-term investments based on stated effective maturities as of December 31, 2015 (in thousands):

 

 

 

As of December 31, 2015

 

 

 

 

 

 

 

Estimated

 

 

 

Amortized

 

 

Fair

 

 

 

Cost

 

 

Value

 

Short-term investments:

 

 

 

 

 

 

 

 

Due in 2016

 

$

53,086

 

 

$

53,003

 

Due in 2017

 

 

43,767

 

 

 

43,552

 

Total

 

$

96,853

 

 

$

96,555

 

 

The Company reviews its short-term investments on a regular basis to evaluate whether or not any security has experienced an other-than-temporary decline in fair value. The Company considers factors such as the length of time and extent to which the market value has been less than the cost, the financial condition and near-term prospects of the issuer and its intent to sell, or whether it is more likely than not the Company will be required to sell, the investment before recovery of the investment’s amortized cost basis. If the Company believes that an other-than-temporary decline exists in one of these securities, the Company writes down these investments to fair value. For debt securities, the portion of the write-down related to credit loss would be recorded to other income (expense), net, in the Company’s condensed consolidated statements of operations. Any portion not related to credit loss would be recorded to accumulated other comprehensive income (loss), which is reflected as a separate component of stockholders’ equity in the Company’s condensed consolidated balance sheets. During the years ended December 31, 2015 and 2014, the Company did not consider any of its investments to be other-than-temporarily impaired.

The following tables show the short-term investments in an unrealized loss position and the related gross unrealized losses and fair value and length of time that the short-term investments have been in a continuous unrealized loss position (in thousands):

 

 

 

As of December 31, 2015

 

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

 

Fair Value

 

 

Unrealized

Losses

 

 

Fair Value

 

 

Unrealized

Losses

 

 

Fair Value

 

 

Unrealized

Losses

 

Corporate debt obligations

 

$

73,673

 

 

$

286

 

 

$

10,609

 

 

$

14

 

 

$

84,282

 

 

$

300

 

 

 

 

As of December 31, 2014

 

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

 

Fair Value

 

 

Unrealized

Losses

 

 

Fair Value

 

 

Unrealized

Losses

 

 

Fair Value

 

 

Unrealized

Losses

 

Corporate debt obligations

 

$

12,735

 

 

$

47

 

 

$

12,088

 

 

$

6

 

 

$

24,823

 

 

$

53

 

 

 

79


 

5. Fair Value of Financial Instruments

The Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. The following table sets forth the Company’s assets and liabilities that were measured at fair value as of December 31, 2015 and 2014, by level within the fair value hierarchy (in thousands):

 

 

 

As of December 31, 2015

 

 

 

Level I

 

 

Level II

 

 

Level III

 

 

Fair   Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bank deposits

 

$

 

 

$

10,253

 

 

$

 

 

$

10,253

 

Commercial paper

 

 

 

 

 

13,893

 

 

 

 

 

 

13,893

 

Money market funds

 

 

86,200

 

 

 

 

 

 

 

 

 

86,200

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt obligations

 

 

 

 

 

86,292

 

 

 

 

 

 

86,292

 

Bank deposits

 

 

 

 

 

10,263

 

 

 

 

 

 

10,263

 

Total financial assets

 

$

86,200

 

 

$

120,701

 

 

$

 

 

$

206,901

 

Financial Liability:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrued and other current liabilities - Forward foreign

    exchange contracts

 

$

 

 

$

595

 

 

$

 

 

$

595

 

 

 

 

As of December 31, 2014

 

 

 

Level I

 

 

Level II

 

 

Level III

 

 

Fair Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bank deposits

 

$

 

 

$

11,877

 

 

$

 

 

$

11,877

 

Commercial paper

 

 

 

 

 

18,339

 

 

 

 

 

 

18,339

 

Money market funds

 

 

11,596

 

 

 

 

 

 

 

 

 

11,596

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt obligations

 

 

 

 

 

31,354

 

 

 

 

 

 

31,354

 

Bank deposits

 

 

 

 

 

10,270

 

 

 

 

 

 

10,270

 

Total financial assets

 

$

11,596

 

 

$

71,840

 

 

$

 

 

$

83,436

 

Financial Liability:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrued and other current liabilities - Forward foreign

    exchange contracts

 

$

 

 

$

1,002

 

 

$

 

 

$

1,002

 

 

In addition to the amounts disclosed in the above table, the fair value of the Company’s Israeli severance pay assets, which were comprised of Level II assets, was $4.5 million and $4.0 million as of December 31, 2015 and 2014, respectively.

The Company’s cash equivalents and short-term investments are classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. The types of instruments valued based on quoted market prices in active markets include mutual funds and money market securities. Such instruments are generally classified within Level 1 of the fair value hierarchy. The types of instruments valued based on quoted prices in less active markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability, include U.S. agency securities, investment-grade corporate bonds, term deposits and commercial paper. Such instruments are generally classified within Level 2 of the fair value hierarchy. There was no transfer between Level 1, Level 2 and Level 3 during the years ended December 31, 2015 and 2014.

 

 

6. Derivative Instruments

The Company’s primary objective for holding derivative instruments is to reduce its exposure to foreign currency rate changes. The Company reduces its exposure by entering into forward foreign exchange contracts with respect to operating expenses that are forecast to be incurred in currencies other than U.S. dollars. Substantially all of the Company’s revenue and capital purchasing activities and a majority of its operating expenditures are transacted in U.S. dollars. However, certain operating expenditures are incurred in or exposed to other currencies, primarily the Israeli shekel and the Euro.

The Company has established forecasted transaction currency risk management programs to protect against fluctuations in fair value and the volatility of future cash flows caused by changes in exchange rates. The Company’s currency risk management program

80


 

includes forward foreign exchange contracts designated as cash flow hedges. These forw ard foreign exchange contracts generally mature within 12 months. The Company does not enter into derivative financial instruments for trading purposes.

Derivative instruments measured at fair value and their classification on the consolidated balance sheets are presented in the following tables (in thousands):

 

 

 

Liability as of December 31,

 

 

 

2015

 

 

2014

 

 

 

Notional

Amount

 

 

Fair Value

 

 

Notional

Amount

 

 

Fair Value

 

Foreign exchange forward contract derivatives in cash flow hedging

   relationships -  included in accrued and other current liabilities

 

$

47,231

 

 

$

595

 

 

$

25,990

 

 

$

1,002

 

 

Gains (losses) on derivative instruments accounted for as hedges and their classification on the consolidated statement of operations, are presented in the following tables (in thousands):

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Foreign Exchange Forward Contract Derivatives in cash flow

    hedging relationships:

 

 

 

 

 

 

 

 

 

 

 

 

Gains recognized in OCI (a)

 

$

834

 

 

$

191

 

 

$

730

 

Losses recognized in OCI (a)

 

$

(1,399

)

 

$

(1,846

)

 

$

(18

)

Gains recognized from accumulated OCI into net loss (b)

 

$

 

 

$

55

 

 

$

1,829

 

Losses recognized from accumulated OCI into net loss (b)

 

$

(972

)

 

$

(708

)

 

$

 

Foreign Exchange Forward Contract Derivatives not designated as

    hedging relationships:

 

 

 

 

 

 

 

 

 

 

 

 

Gains recognized in net loss (c)

 

$

 

 

$

 

 

$

71

 

Losses recognized in net loss (c)

 

$

 

 

$

 

 

$

(60

)

 

(a)

Net change in the fair value of the effective portion classified in other comprehensive income (loss) (“OCI”).

(b)

Effective portion of cash flow hedges reclassified from accumulated other income (loss), into net loss, of which $(107), $(72) and $117 were recognized within cost of sales for the years ended December 31, 2015, 2014 and 2013, respectively, and $(865), $(581), and $1,712 were recognized within operating expenses for the year ended December 31, 2015, 2014 and 2013, respectively. All amounts are reflected with the respective consolidated statement of operations.

(c )

Classified in other income (expense), net.

 

 

7. Consolidated Balance Sheet Components

Allowance for Doubtful Accounts

The allowance for doubtful accounts is comprised of the following activity (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Allowance for doubtful accounts and sales returns reserve, beginning balance

 

$

215

 

 

$

410

 

 

$

412

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts, beginning balance

 

$

215

 

 

$

410

 

 

$

412

 

Charged to costs and expenses

 

 

1,044

 

 

 

418

 

 

 

46

 

Deductions (write-offs)

 

 

(144

)

 

 

(613

)

 

 

(48

)

Allowance for doubtful accounts, ending balance

 

 

1,115

 

 

 

215

 

 

 

410

 

Sales returns reserve, beginning balance

 

 

 

 

 

 

 

 

 

 

 

 

Charged to revenue

 

 

677

 

 

 

-

 

 

 

-

 

Deductions (write-offs)

 

 

(354

)

 

 

-

 

 

 

-

 

Sales returns reserve, ending balance

 

 

323

 

 

 

-

 

 

 

-

 

Total allowance for doubtful accounts and sales returns reserve, ending balance

 

$

1,438

 

 

$

215

 

 

$

410

 

 

81


 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Prepaid expenses

 

$

5,111

 

 

$

3,263

 

Prepaid income taxes

 

 

585

 

 

 

45

 

Interest receivable

 

 

467

 

 

 

230

 

Other

 

 

1,802

 

 

 

389

 

Total prepaid expenses and other current assets

 

$

7,965

 

 

$

3,927

 

 

Property and Equipment, net

Property and equipment, net consist of the following (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Computers and related equipment

 

$

15,953

 

 

$

11,591

 

Office furniture and equipment

 

 

1,632

 

 

 

1,510

 

Leasehold improvements

 

 

7,791

 

 

 

3,751

 

Total property and equipment

 

 

25,376

 

 

 

16,852

 

Less: accumulated depreciation and amortization

 

 

(13,212

)

 

 

(9,234

)

Total property and equipment, net

 

$

12,164

 

 

$

7,618

 

 

Depreciation and amortization expense totaled $4.5 million, $3.6 million and $2.6 million, for the years ended December 31, 2015, 2014 and 2013, respectively.

Accrued Compensation and Benefits

Accrued compensation and benefits consist of the following (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Salary and related benefits

 

$

7,215

 

 

$

5,291

 

Accrued vacation

 

 

3,774

 

 

 

3,849

 

Accrued incentive payments

 

 

9,270

 

 

 

6,609

 

Total accrued compensation and benefits

 

$

20,259

 

 

$

15,749

 

 

Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Accrued expenses

 

$

4,633

 

 

$

3,352

 

Derivative liability

 

 

595

 

 

 

1,002

 

Income tax payable

 

 

323

 

 

 

317

 

Short-term deferred rent

 

 

283

 

 

 

297

 

Short-term stock repurchase liability

 

 

 

 

 

767

 

Skyfence holdback liability

 

 

7,556

 

 

 

-

 

Other

 

 

893

 

 

 

641

 

Total accrued and other current liabilities

 

$

14,283

 

 

$

6,376

 

 

82


 

Other Liabilities

Other long-term liabilities consist of the following (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Skyfence holdback liability

 

$

 

 

$

7,343

 

Long-term deferred rent

 

 

1,926

 

 

 

841

 

Deferred tax liability

 

 

1,145

 

 

 

1,503

 

Other

 

 

1,444

 

 

 

721

 

Total other liabilities

 

$

4,515

 

 

$

10,408

 

 

 

8. Goodwill and Acquired Intangible Assets

During 2014, the Company completed two acquisitions of which $35.0 million was allocated to goodwill and $10.7 million to acquired intangible assets. The Company’s gross carrying amount of goodwill was $35.0 million as of December 31, 2015 and 2014, respectively. The Company did not have any goodwill impairments during 2015, 2014 or 2013. Acquired technology intangible assets subject to amortization as of December 31, 2015 were as follows (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Acquired Technology

 

$

10,668

 

 

$

10,668

 

Less: accumulated amortization

 

 

(2,677

)

 

 

(1,269

)

Total acquired technology, net

 

$

7,991

 

 

$

9,399

 

 

 

 

 

Amortization expense related to acquired intangible assets was $1.4 million for the year ended December 31, 2015. Acquired intangible assets are amortized over their estimated useful lives of seven to 10 years. As of December 31, 2015, the Company expects amortization expense in future periods to be as follows (in thousands):

 

 

 

Acquired

 

Fiscal Year

 

Technology

 

2016

 

$

1,408

 

2017

 

 

1,408

 

2018

 

 

1,408

 

2019

 

 

1,408

 

2020

 

 

1,408

 

Thereafter

 

 

951

 

Total expected amortization expense

 

$

7,991

 

 

 

83


 

9. Other Income (Expense), net

Other income (expense), net is comprised of the following (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Other Income:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

701

 

 

$

163

 

 

$

386

 

Foreign currency forward contract gains, net

 

 

-

 

 

 

-

 

 

 

12

 

Foreign currency exchange gains, net

 

 

5

 

 

 

8

 

 

 

 

Total other income

 

 

706

 

 

 

171

 

 

 

398

 

Other Expense:

 

 

 

 

 

 

 

 

 

 

 

 

Skyfence holdback liability accretion

 

 

(212

)

 

 

(186

)

 

 

 

Foreign currency exchange losses, net

 

 

(322

)

 

 

 

 

 

(373

)

Other

 

 

(574

)

 

 

(205

)

 

 

(150

)

Total other expense

 

 

(1,108

)

 

 

(391

)

 

 

(523

)

Total other income (expense), net

 

$

(402

)

 

$

(220

)

 

$

(125

)

 

 

10. Revolving Credit Facility

In September 2010, the Company entered into a revolving credit facility with a financial institution. The agreement, as amended, provides for maximum borrowing capacity of up to $7.5 million as of December 31, 2015. As of December 31, 2015 and 2014, there was no balance outstanding on the credit facility.

The credit facility expires on April 1, 2019, is secured by the assets of the Company, and contains a restrictive covenant that requires the Company to maintain a minimum cash and cash equivalents balance of $3.0 million. The terms of this agreement requires payment of an unused line fee of 0.25% per quarter of the unused portion, standby letter of credit fees of 1% per annum of the stated amount of each letter of credit and bears interest at LIBOR plus 2.75%. As of December 31, 2015, the Company was compliant with the amended covenant of the credit facility.

 

 

11. Commitments and Contingencies

(a) Operating Leases

The Company rents its facilities under operating leases with lease periods expiring from 2015 through 2022. Future minimum payments under these facility operating leases are as follows as of December 31, 2015 (in thousands):

 

 

 

Operating

Leases

 

 

Estimated

Sublease

Income

 

Year Ending December 31:

 

 

 

 

 

 

 

 

2016

 

$

7,295

 

 

$

436

 

2017

 

 

7,107

 

 

 

 

2018

 

 

7,412

 

 

 

 

2019

 

4,578

 

 

 

 

2020

 

4,210

 

 

 

 

Thereafter

 

 

120

 

 

 

 

Total

 

$

30,722

 

 

$

436

 

 

Rent expense for the Company’s operating leases is recognized on a straight-line basis over the lease term. Rent expense for the years ended December 31, 2015, 2014 and 2013 was $4.6 million, $3.9 million, and $3.3 million, respectively.

In connection with leases for office space, the Company received tenant improvement allowances of $336,000 and $639,000 during the years ended December 31, 2012 and 2010, respectively, and is entitled to receive additional $791,000 under the lease amendments executed during the year ended December 31, 2015 from the lessor for certain improvements made to the leased property. The Company has recorded the tenant improvement allowances as a leasehold improvement within property and equipment, net and as deferred rent within other liabilities on the consolidated balance sheets. The deferred rent liability is amortized to rent

84


 

expense over the term of the lease on a straight-line basis. The leasehold improvements are being amortized to expense over the period from when the improvements were placed into service until the end of their useful life, which is the end of the respective lease term.

In addition, certain of the Company’s operating lease agreements for office space also include rent holidays and scheduled rent escalations during the initial lease term. The Company has recorded the rent holidays as a deferred rent within other liabilities on the consolidated balance sheets. The Company recognizes the deferred rent liability and scheduled rent increase on a straight-line basis into rent expense over the lease term commencing on the date the Company takes possession of the lease space.

As of December 31, 2015 and 2014 the Company has $1.7 million and $1.7 million, respectively, in restricted deposits to secure bank guarantees provided to the lessor.

(b) Cancelable Lease Agreement

The Company leases motor vehicles under a cancelable operating lease agreement. The Company has an option to cancel the lease agreement, which may result in penalties in a maximum amount of $115,000 as of December 31, 2015. Motor vehicle lease expenses for the years ended December 31, 2015, 2014 and 2013 were $2.4 million, $2.6 million and $2.4 million, respectively.

(c) Purchase Commitments

As of both December 31, 2015 and 2014, the Company had purchase commitments of $5.8 million and $4.8 million, respectively, to purchase inventory, trial units, and research and development equipment from its vendors. The purchase commitments result from the Company’s contractual obligation to order or build inventory in advance of anticipated sales. According to the Company’s agreements with its vendors, the Company committed to purchase inventory within six months from the date the inventory arrived at the vendor’s warehouse.

(d) Litigation

From time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business.

On April 11, 2014, a purported shareholder class action lawsuit was filed in the United States District Court for the Northern District of California against the Company and certain of its current and former officers. On August 7, 2014, the Court entered an order appointing lead plaintiff and counsel for the purported class. The lead plaintiff filed an amended complaint on October 10, 2014. The lawsuit named the Company and certain of its current and former officers and purported to bring suit on behalf of those investors who purchased the Company’s publicly traded securities between May 2, 2013 and April 9, 2014. The plaintiff alleged that defendants made false and misleading statements about the Company’s operations and business and financial results and purported to assert claims for violations of the federal securities laws. The amended complaint sought unspecified compensatory damages, interest thereon, costs incurred in the action and equitable/injunctive or other relief. On January 6, 2015, defendants filed a motion to dismiss the amended complaint. On September 17, 2015, the Court granted defendants’ motion to dismiss with leave to amend. The lead plaintiff filed an amended complaint on January 13, 2016, again naming the same current and former officers, alleging false and misleading statements about the Company’s operations and business and financial results, and seeking the same relief.  On February 10, 2016, defendants filed a motion to dismiss the amended complaint.

On June 27, 2014, a purported shareholder derivative lawsuit was filed in the Court of Chancery for the State of Delaware against the Company (as a nominal defendant), and naming certain of the Company’s officers and directors as individual defendants. The lawsuit relates to the acquisition of Skyfence Networks, Ltd. and the complaint asserts claims for breach of fiduciary duty and unjust enrichment, and seeks to recover unspecified compensatory damages allegedly sustained by the Company, corporate reforms, the recovery of plaintiffs’ attorney’s fees and other relief. On September 23, 2014, the Company and the individual defendants moved to dismiss the action. Plaintiffs filed an amended complaint on November 6, 2014. Defendants filed a motion to dismiss the amended complaint on January 14, 2015. On September 2, 2015, the Court granted the motion to dismiss with prejudice. Plaintiffs filed a notice of appeal with the Supreme Court of Delaware on October 1, 2015. An oral argument before the Supreme Court of Delaware has been set for March 9, 2016.

In addition, the Company has received, and may in the future continue to receive, claims from third parties asserting, among other things, infringement of their intellectual property rights. Future litigation may be necessary to defend the Company, its channel partners and its customers by determining the scope, enforceability and validity of third-party proprietary rights or to establish its proprietary rights.

In the opinion of management, liabilities associated with these claims, while possible, are not probable at this time, and therefore the Company has not recorded any accrual for them as of December 31, 2015 and 2014. Further, any possible range of loss cannot be reasonably estimated at this time. The ultimate outcome of any litigation is uncertain and, regardless of outcome, litigation

85


 

can have an adverse impact on the Company because of defense costs, potential negative publicity, diversion of management resources and other factors. Accordingly, there can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on the Company’s business, consolidated financial position, results of operations or cash flows.

(e) Indemnification

Under the indemnification provisions of its standard sales contracts, the Company agrees to defend its channel partners and end customers against third-party claims asserting infringement of certain intellectual property rights, which may include patents, copyrights, trademarks, or trade secrets, and to pay judgments and settlements entered on such claims. The Company’s exposure under these indemnifications provisions is generally limited to the total amount paid under the agreement. However, certain agreements included indemnification provisions that could potentially expose the Company to losses in excess of the amount received under the agreement. To date, there have been no claims under such indemnification provisions. Accordingly, the Company has not recorded a liability on its consolidated balance sheets for these indemnification provisions.

In addition to the foregoing, the Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and officers.

 

 

12. Capital Stock

Common Stock Reserved for Issuance

The Company had reserved shares of common stock, on an as if converted basis, for issuance as follows:

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Issuance in connection with outstanding stock options

 

 

1,949,089

 

 

 

2,244,363

 

Issuance in connection with restricted stock units outstanding

 

 

1,898,025

 

 

 

2,279,081

 

Reserved for future stock option and restricted stock unit grants

 

 

650,527

 

 

 

1,166,742

 

Reserved for future issuance under the employee stock

   purchase plan

 

 

1,049,524

 

 

 

895,268

 

 

 

 

5,547,165

 

 

 

6,585,454

 

 

Preferred Stock

Our board of directors is authorized, subject to any limitations prescribed by law, without stockholder approval, to issue from time to time up to an aggregate of 5,000,000 shares of preferred stock, in one or more series, each series to have such rights and preferences, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences as the Company’s board of directors determines. The rights of the holders of common stock will be subject to, and may be adversely affected by, the rights of holders of any preferred stock that may be issued in the future. The Company currently has no shares of preferred stock outstanding and the Company has no present plans to issue any shares of preferred stock.

Stock Plans

(a) 2003 Stock Plan

During 2003, the Board of Directors adopted the 2003 Stock Plan (the “2003 Plan”), which allows for the granting of both incentive stock options and non-qualified stock options and the direct award or sale of shares of the Company’s common stock (including restricted common stock) to officers, employees, directors, consultants and other key persons. Incentive stock options may be granted to employees with exercise prices of no less than the fair value of the common stock on the grant date, and non-qualified options may be granted to employees, directors, or consultants at exercise prices of no less than 85% of the fair value of the common stock on the grant date, as determined by the Board of Directors. If, at the time the Company grants an option, the optionee directly or by attribution owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, the option price shall be at least 110% of the fair value. Options granted under the Plan generally expire no later than ten years and in general vest four years from the date of grant.

86


 

(b) 2011 Stock Option and Incentive Plan

In September 2011, the Board of Directors adopted the 2011 Stock Option and Incentive Plan (the “2011 Plan”) which was subsequently approved by the Company’s stockholders. The 2011 Plan replaces the 2003 Plan as the Board has decided not to grant any additional awards under that plan. The Company has reserved a total of 1,000,000 shares of common stock for issuance under the 2011 Plan. In addition, any reserved but unissued shares under the 2003 Stock Plan will be added to the number of shares reserved for issuance under the 2011 Plan. The 2011 Plan also provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning in 2012 and ending in 2015, by 4% of the outstanding number of shares of common stock on the immediately preceding December 31. The Board of Directors or compensation committee may reduce the amount of the increase in any particular year. On January 1, 2015, the share reserve under the 2011 Plan was automatically increased by 1,075,819 shares. As of December 31, 2014, there were 1,166,742 shares available for grant under the 2011 Plan.

The 2011 Plan permits the granting of incentive stock options, non-qualified stock options, RSUs, stock appreciation rights, restricted shares of common stock and performance share awards. The exercise price of stock options may not be less than 100% of the fair market value of the common stock on the date of grant. Options granted pursuant to the 2011 Plan generally expire no later than ten years. The Company began granting RSUs in February 2012, which generally vest either over a four-year period with 25% vesting at the end of one year and the remainder vesting quarterly thereafter or they completely vest at the end of a three-year period. Additionally, in conjunction with the Incapsula Acquisition, the Company granted performance-based RSUs to an employee of Incapsula for approximately 264,878 shares of Company common stock (Refer to Note 2).

(c) 2011 Employee Stock Purchase Plan

In September 2011, the Board of Directors adopted the 2011 Employee Stock Purchase Plan (the “ESPP”) which was subsequently approved by the Company’s stockholders. The ESPP took effect on the effective date of the registration statement for the Company’s IPO. The ESPP permits eligible employees to acquire shares of the Company’s common stock by accumulating funds through periodic payroll deductions of up to 15% of base salary. Each offering period may run for no more than 24 months and consist of no more than five purchase periods. The purchase price for shares of the Company’s common stock purchased under the ESPP will be 85% of the lesser of the fair market value of the Company’s common stock on the first day of the offering period or the last trading day of the applicable purchase period within that offering period.

The Company has initially reserved a total of 500,000 shares of common stock for future issuance under the ESPP. The number of shares reserved for issuance under the ESPP will increase automatically on January 1 of each of the first eight years commencing in 2012 by the number of shares equal to 1% of the Company’s total outstanding shares as of the immediately preceding December 31. The Board of Directors or compensation committee may reduce the amount of the increase in any particular year. No more than 20,000,000 shares of common stock may be issued under the ESPP and no other shares may be added to the ESPP without the approval of the Company’s stockholders. On January 1, 2015, the share reserve under the 2011 Employee Stock Purchase Plan was automatically increased by 268,955 shares.

(d) Inducement Stock Option Plans and Agreement and Inducement Restricted Stock Unit Plans and Agreement

In August 2014 and August 2015, the Compensation Committee of the Board of Directors adopted Inducement Stock Option Plans and Agreements (the “Inducement Option Plans”) and Inducement Restricted Stock Unit Plans and Agreements (the “Inducement RSU Plans”), in each case created as employment inducement awards. In accordance with the terms of the Inducement Option Plans, the Company issued options to purchase up to 290,000 shares of the Company’s common stock at an exercise price equal to the fair market value of a share of the Company’s common stock on the dates of grant of the options. The options, which will have a ten-year term, will vest at the rate of 25% of the shares on each of the first anniversary of the vesting commencement date with an additional 6.25% of the shares subject to the option vesting each quarter thereafter so long as the participant has not been terminated. In accordance with the terms of the Inducement RSU Plans, the Company issued RSUs representing a total of 290,000 shares of the Company’s common stock. The RSUs, which will expire following settlement, will vest at the rate of 25% of the shares on each of the first anniversary of the vesting commencement date with an additional 6.25% of the shares subject to the RSU vesting each quarter thereafter so long as the participant has not been terminated.

(e) 2015 Equity Inducement Plan

In October 2015, the Board of Directors adopted the 2015 Equity Inducement Plan, a non-stockholder approved plan that provides for the granting of stock options and RSUs as employment inducement awards and in connection with acquisitions, subject to compliance with applicable securities laws and stock exchange requirements for such plans.  The Company has reserved 100,000 shares of common stock for issuance under the 2015 Equity Inducement Plan.  No awards have been made under the 2015 Equity Inducement Plan and the entire reserve remains available for grant.  Under the terms of the 2015 Equity Inducement Plan, the exercise

87


 

price of stock options may not be less than 100% of the fair market value of common stock on the date of grant and generally expire no later than t en years.  The Company will issue a press release in connection with any stock options or RSUs awarded under the plan .

(f) Incapsula 2010 Share Incentive Plan

In March 2010, Incapsula’s board of directors adopted the Incapsula 2010 Share Incentive Plan (the “Incapsula Plan”), pursuant to which Incapsula may grant to its employees and service providers options to purchase shares of its common stock, restricted shares, or RSUs. The total number of shares of common stock that may be granted under the Incapsula Plan shall not exceed 4,733,333 in the aggregate, subject to certain adjustments.

In November 2013, the board of directors of Incapsula approved the grant of RSUs for 7,095,461 shares of Incapsula’s common stock (“Incapsula RSUs”). As part of the Incapsula Acquisition, the Incapsula RSUs were assumed and replaced by RSUs for Company Common Stock issued to continuing employees of Incapsula . The Incapsula RSU’s vest according to performance-based vesting terms tied to 2014 revenue for Incapsula and Incapsula-related products and services, which were converted into approximately 198,825 shares of Company Common Stock at the same exchange ratio applicable to the Incapsula Acquisition. In addition to performance conditions, the awards are dependent on future market price of Imperva’s common stock, which is deemed a market condition under ASC 718.

The following table summarizes option activity under the Incapsula Plan and related:

 

 

 

Shares

Available

for Grant

 

 

Number of

Performance-

base d  Restricted

Stock Units

Outstanding

 

 

Number of

Stock Options

Outstanding

 

 

Weighted

Average Exercise

Price of Stock

Options

Outstanding

 

Outstanding - December 31, 2012

 

 

2,753,708

 

 

 

 

 

 

1,836,500

 

 

$

0.10

 

Additional shares authorized

 

 

5,529,878

 

 

 

 

 

 

 

 

 

 

$

 

Granted, performance RSUs

 

 

(7,095,461

)

 

 

7,095,461

 

 

 

 

 

$

 

Granted, stock options

 

 

(1,240,000

)

 

 

 

 

 

1,240,000

 

 

$

0.58

 

Exercised/Released

 

 

 

 

 

 

 

 

(1,128,438

)

 

$

0.02

 

Forfeited

 

 

141,562

 

 

 

 

 

 

(141,562

)

 

$

0.22

 

Outstanding - December 31, 2013

 

 

89,687

 

 

 

7,095,461

 

 

 

1,806,500

 

 

$

0.47

 

Granted

 

 

(95,000

)

 

 

 

 

 

95,000

 

 

$

1.25

 

Forfeited

 

 

15,213

 

 

 

(12,713

)

 

 

(2,500

)

 

$

1.25

 

Transferred to Imperva 2011 stock option plan

 

 

(9,900

)

 

 

(7,082,748

)

 

 

(1,899,000

)

 

$

0.16

 

Outstanding - December 31, 2014

 

 

 

 

 

 

 

 

 

 

$

 

 

The options outstanding and performance restricted share units under the Incapsula 2010 Share Incentive Plan were assumed as part of the Incapsula Acquisition and are equivalent to 247,184 shares of Company common stock on an as-converted basis. The Company does not intend to grant any additional shares under the Incapsula 2010 Share Incentive Plan.

88


 

The following table summarizes option activity under the Plans and related info rmation:

 

 

 

Options Outstanding

 

 

Weighted-

Average

Remaining

 

 

 

 

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercis e  Price

 

 

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic Value

(i n  thousands) (1)

 

Outstanding - December 31, 2012

 

 

1,989,237

 

 

$

14.08

 

 

 

8.09

 

 

$

35,513

 

Granted

 

 

631,775

 

 

$

36.55

 

 

 

 

 

 

 

 

 

Exercised or released

 

 

(687,719

)

 

$

6.94

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(257,787

)

 

$

25.11

 

 

 

 

 

 

 

 

 

Outstanding - December 31, 2013

 

 

1,675,506

 

 

$

23.78

 

 

 

8.01

 

 

$

40,813

 

Granted

 

 

1,256,559

 

 

$

41.39

 

 

 

 

 

 

 

 

 

Options assumed in acquisitions

 

 

72,607

 

 

$

13.30

 

 

 

 

 

 

 

 

 

Exercised or released

 

 

(496,297

)

 

$

14.85

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(264,012

)

 

$

35.85

 

 

 

 

 

 

 

 

 

Balances - December 31, 2014

 

 

2,244,363

 

 

$

33.83

 

 

 

8.27

 

 

$

38,457

 

Granted

 

 

696,971

 

 

$

49.20

 

 

 

 

 

 

 

 

 

Exercised or released

 

 

(636,424

)

 

$

29.44

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(355,821

)

 

$

42.00

 

 

 

 

 

 

 

 

 

Balances - December 31, 2015

 

 

1,949,089

 

 

$

39.27

 

 

 

8.09

 

 

$

47,480

 

Vested and expected to vest - December 31, 2015

 

 

1,700,981

 

 

$

38.26

 

 

 

8.01

 

 

$

43,108

 

Exercisable - December 31, 2015

 

 

609,137

 

 

$

29.57

 

 

 

6.91

 

 

$

20,557

 

 

(1)

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $63.31 of the Company’s common stock on December 31, 2015

Additional information regarding the Company’s stock options outstanding and exercisable as of December 31, 2015 is summarized below:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Prices

 

Number of

Stock Options

Outstanding

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Weighted

Average

Exercise Price

per Share

 

 

Shares Subject

to Stock Options

 

 

Weighted

Average

Exercise Price

per Share

 

$0.02 to $10.70

 

 

157,918

 

 

 

4.86

 

 

$

6.66

 

 

 

148,074

 

 

$

7.07

 

$10.71 to $29.10

 

 

242,340

 

 

 

7.66

 

 

$

25.34

 

 

 

118,092

 

 

$

24.95

 

$29.11 to $32.54

 

 

269,777

 

 

 

8.51

 

 

$

29.43

 

 

 

72,161

 

 

$

29.66

 

$32.55 to $34.55

 

 

206,863

 

 

 

7.26

 

 

$

33.72

 

 

 

99,746

 

 

$

33.62

 

$34.56 to $54.48

 

 

581,938

 

 

 

8.79

 

 

$

43.19

 

 

 

74,298

 

 

$

41.88

 

$54.49 to $61.55

 

 

275,131

 

 

 

8.14

 

 

$

54.98

 

 

 

82,179

 

 

$

54.76

 

$61.56 to $69.55

 

 

184,232

 

 

 

9.21

 

 

$

64.87

 

 

 

14,587

 

 

$

62.81

 

$69.56 to $77.00

 

 

30,890

 

 

 

9.79

 

 

$

71.72

 

 

 

-

 

 

$

-

 

 

 

 

1,949,089

 

 

 

8.09

 

 

$

39.27

 

 

 

609,137

 

 

$

29.57

 

 

89


 

(g ) RSU Activity

A summary of RSU activity for the year ended December 31, 2015, is as follows:

 

 

 

Number of

Restricted

Stock Units

Outstanding

 

 

Weighted-

Average Grant

Date Fair Value

 

Unvested - December 31, 2013

 

 

1,044,651

 

 

$

31.64

 

Granted

 

 

1,368,761

 

 

$

41.66

 

Granted, performance RSUs

 

 

131,143

 

 

$

31.42

 

PRSUs assumed in acquisitions

 

 

198,825

 

 

$

61.14

 

Released

 

 

(238,446

)

 

$

34.84

 

Cancelled or expired

 

 

(225,853

)

 

$

39.83

 

Unvested - December 31, 2014

 

 

2,279,081

 

 

$

39.07

 

Granted

 

 

911,734

 

 

$

53.02

 

Granted, performance RSUs

 

 

249,220

 

 

$

42.58

 

Released

 

 

(898,205

)

 

$

34.97

 

Cancelled or expired

 

 

(643,805

)

 

$

35.09

 

Unvested - December 31, 2015

 

 

1,898,025

 

 

$

49.53

 

 

(h) Stock-Based Compensation Expense

The Company recognized stock-based compensation expense under the 2011 Stock Option and Incentive Plan, 2003 Stock Plan, Inducement Plans, 2011 Employee Stock Purchase Plan, and the Incapsula 2010 Share Incentive Plan in the consolidated statements of operations as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Cost of revenue

 

$

3,862

 

 

$

2,058

 

 

$

1,440

 

Research and development

 

 

13,831

 

 

 

8,799

 

 

 

3,660

 

Sales and marketing

 

 

16,717

 

 

 

13,558

 

 

 

8,537

 

General and administrative

 

 

16,554

 

 

 

12,858

 

 

 

8,857

 

Total stock-based compensation expense

 

$

50,964

 

 

$

37,273

 

 

$

22,494

 

 

(i) Determining the Fair Value of RSUs, Performance RSUs, Stock Options, and ESPP

The fair value of RSUs is determined using the closing price of the Company’s stock on the date of grant. Compensation is recognized on a straight-line basis over the requisite service period of each grant adjusted for estimated forfeitures.

The fair value of RSUs granted to employees which have multiple performance conditions and a market condition is determined by the Company using a Monte Carlo simulation model. The key inputs used were the Company’s stock price on the date of grant, the expected volatility, the risk free interest rate and a revenue forecast. The Company updates the estimated expense, net of forfeitures, at the end of each reporting period. The expense is recognized on an accelerated basis over the requisite service period, which is generally the vesting period of the respective awards.

The fair value of each stock option and ESPP grant to employees was determined by the Company and its board of directors using the Black-Scholes option-pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment to determine.

Expected Term — The expected term represents the period that the Company’s stock-based awards are expected to be outstanding. For option grants that are considered to be “plain vanilla,” the Company used the simplified method to determine the expected term as provided by the Securities and Exchange Commission. The simplified method is calculated as the average of the time-to-vesting and the contractual life of the options. For option grants that are not considered “plain vanilla”, the expected term is derived from historical data on employee exercises and post-vesting employment termination behavior taking into account the contractual life of the award. For ESPP grants, the expected term is based on the length of the offering period, which is six months.

90


 

Expected Volatility —The expected volatility was based on a com bination of our historical volatilities and the Company’s publicly listed peers because we do not have sufficient trading history for our common stock s. The volatility is over a period equal to the expected terms of the stock option grants and the offering period for employee stock purchase plan.

Risk-Free Interest Rate —The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to the grant’s expected term.

Expected Dividend — The Company has never paid dividends and does not expect to pay dividends.

Forfeiture Rate —The Company estimates its forfeiture rate based on an analysis of its actual forfeitures and will continue to evaluate the adequacy of the forfeiture rate based on actual forfeiture experience, analysis of employee turnover behavior, and other factors. The impact from a forfeiture rate adjustment will be recognized in full in the period of adjustment, and if the actual number of future forfeitures differs from that estimated by the Company, the Company may be required to record adjustments to stock-based compensation expense in future periods.

A summary of the weighted-average assumptions is as follows:

 

 

 

Years Ended December 31

 

 

 

2015

 

 

2014

 

 

2013

 

Stock option grants:

 

 

 

 

 

 

 

 

 

 

 

 

Dividend rate

 

 

0

%

 

 

0

%

 

 

0

%

Risk-free interest rate

 

 

1.8

%

 

 

1.8

%

 

 

1.2

%

Expected term (in years)

 

 

6.1

 

 

 

6.1

 

 

 

6.1

 

Expected volatility

 

 

49

%

 

 

46

%

 

 

46

%

ESPP grants:

 

 

 

 

 

 

 

 

 

 

 

 

Dividend rate

 

 

0

%

 

 

0

%

 

 

0

%

Risk-free interest rate

 

 

0.4

%

 

 

0.1

%

 

 

0.1

%

Expected term (in years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Expected volatility

 

 

65

%

 

 

45

%

 

 

27

%

 

The weighted-average grant date fair value of the Company’s stock options granted during the years ended December 31, 2015, 2014 and 2013 was $23.75, $19.36, and $16.48 per share, respectively. The aggregate grant date fair value of the Company’s stock options granted to employees during the years ended December 31, 2015, 2014 and 2013 was $16.6 million, $24.3 million, and $7.3 million, respectively. The aggregate grant date fair value of the Company’s stock options vested during the years ended December 31, 2015, 2014, and 2013 was $11.7 million, $7.2 million, and $4.6 million, respectively. The fair value of the Company’s RSUs vested during the year ended December 31, 2015, 2014 and 2013 was $31.4 million, $8.3 million and $6.0 million, respectively.

The aggregate intrinsic value of options exercised under the Plans was $21.6 million, $14.7 million, and $23.2 million for the years ended December 31, 2015, 2014 and 2013, respectively. The aggregate intrinsic value of options exercised is calculated as the difference between the fair market value of the Company’s common stock on the date of the exercise and the exercise price of each option.

As of December 31, 2015, total compensation cost related to unvested stock-based awards granted to employees under the Plans, but not yet recognized, was $92.6 million, net of estimated forfeitures. As of December 31, 2015, this cost will be amortized to expense over a weighted-average remaining period of 2.6 years, and will be adjusted for subsequent changes in estimated forfeitures. Future option grants will increase the amount of compensation expense to be recorded in these periods.

Net cash proceeds from the exercise of stock options and the issuance of common stock in connection with the employee stock purchase plan were $12.1 million, $8.5 million, and $6.3 million for the years ended December 31, 2015, 2014 and 2013, respectively. There was no capitalized stock-based compensation cost during the years ended December 31, 2015, 2014 and 2013. Recognized stock-based compensation tax benefits during the year ended December 31, 2015 and 2014 was $165,000 and $385,000, respectively. There was no recognized stock-based compensation tax benefit during the year ended December 31, 2013.

(j) Common Stock Subject to Repurchase

Pursuant to restricted stock agreements with the Company’s former CEO, the Company had the right, but not the obligation, to repurchase the unvested shares of common stock upon termination of employment at the original purchase price per share. The repurchase rights with respect to the common stock lapse over the vesting period, which ranges from 48 months to 60 months. The amounts received in exchange for these shares have been included in other liabilities in the accompanying condensed consolidated balance sheet and are reclassified to equity as the shares vest. The Company granted 843,819 shares of restricted common stock with a

91


 

weighted-average grant date fair value per s hare of $1.94 during the year ended December 31, 2010. There were no grants of shares of restricted common stock during years ended December 31, 2015, 2014 and 2013. All these shares were fully vested as of December 31, 2015. As of December 31, 2014, 210,9 54 shares of restricted common stock held by the Company’s former CEO were unvested and subject to repurchase by the Company.

In connection with the acquisition of Skyfence in the first quarter of 2014, the Company issued 532,262 shares of the Company’s common stock with a fair value per share of $59.08 which are subject to forfeiture based upon time-based vesting and continuing employment over the term of the corresponding four-year service period. 236,537 shares were fully vested as of December 31, 2015. None of these shares were vested as of December 31, 2014.

(k) Early Exercise of Stock Options

In 2010 and 2011, the Company’s board of directors allowed for the early exercise of stock options granted to certain members of the Company’s board of directors. The amounts received in exchange for these shares have been included in accrued and other current liabilities and other liabilities in the accompanying condensed consolidated balance sheet and are reclassified to equity as the shares vest. As of December 31, 2015 there were no unvested shares. As of December 31, 2014 and 2013, 6,667 shares and 45,000 shares were unvested amounting to $71,000 and $0.4 million, respectively.

(l) Equity Awards Issued in Acquisitions

In connection with the Skyfence and Incapsula acquisitions, the Company assumed stock options covering an aggregate of 72,607 shares of its common stock (in addition to the Incapsula RSUs discussed above). At the date of the acquisition, vested stock options and the associated fair value was recorded as part of the purchase consideration. The fair value related to the assumed unvested stock options are recognized as post-combination compensation costs and is being recorded as post-combination compensation expense ratably over the respective remaining service periods.

(m) Follow-On Public Offering

In March 2015, the Company completed a follow-on public offering whereby the Company sold 3,450,000 shares of common stock at a price of $39.00 per share, for aggregate net proceeds of $127.9 million, after deducting underwriting discounts, commissions and other offering costs of approximately $6.7 million.

 

 

13. Accumulated Other Comprehensive Income (Loss)

The changes in the balances of accumulated other comprehensive income (loss) by component are as follows (in thousands):

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

 

Unrealized

gain (loss)

on cash flow

hedges

 

 

Unrealized

gain (loss) on

investments

 

 

Total

 

 

Unrealized

gain (loss) on

cash flow

hedges

 

 

Unrealized

gain (loss) on

investments

 

 

Total

 

 

Unrealized

gain (loss) on

cash flow

hedges

 

 

Unrealized

gain (loss) on

investments

 

 

Total

 

Balance at January 1

 

$

(1,428

)

 

$

(61

)

 

$

(1,489

)

 

$

(426

)

 

$

(2

)

 

$

(428

)

 

$

691

 

 

$

170

 

 

$

861

 

Other comprehensive income (loss)

   before reclassifications

 

 

(565

)

 

 

(249

)

 

 

(814

)

 

 

(1,655

)

 

 

(59

)

 

 

(1,714

)

 

 

712

 

 

 

34

 

 

 

746

 

Amounts reclassified to net loss

 

 

972

 

 

 

 

 

 

972

 

 

 

653

 

 

 

 

 

 

653

 

 

 

(1,829

)

 

 

(206

)

 

 

(2,035

)

Change in other comprehensive

   income (loss)

 

 

407

 

 

 

(249

)

 

 

158

 

 

 

(1,002

)

 

 

(59

)

 

 

(1,061

)

 

 

(1,117

)

 

 

(172

)

 

 

(1,289

)

Balance at December 31

 

$

(1,021

)

 

$

(310

)

 

$

(1,331

)

 

$

(1,428

)

 

$

(61

)

 

$

(1,489

)

 

$

(426

)

 

$

(2

)

 

$

(428

)

 

92


 

The following is a summary of reclassifications out of accumulated other comprehensive inc ome (loss) for the years 2015, 2014 , and 201 3 (in thousands):

 

 

 

Year ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

 

 

Pre-Tax

Amount

 

 

Tax

Expense

(Benefit)

 

 

After-Tax

Amount

 

 

Pre-Tax

Amount

 

 

Tax

Expense

(Benefit)

 

 

After-Tax

Amount

 

 

Pre-Tax

Amount

 

 

Tax

Expense

(Benefit)

 

 

After-Tax

Amount

 

Unrealized gains (losses) on cash flow

   hedges:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current period unrealized gain (loss)

 

$

(565

)

 

 

-

 

 

$

(565

)

 

$

(1,655

)

 

$

 

 

$

(1,655

)

 

$

712

 

 

$

 

 

$

712

 

Reclassification adjustments 1

 

 

972

 

 

 

-

 

 

 

972

 

 

 

653

 

 

 

 

 

 

653

 

 

 

(1,829

)

 

 

 

 

$

(1,829

)

Unrealized gains (losses) on cash flow

   hedges, net

 

 

407

 

 

 

-

 

 

 

407

 

 

 

(1,002

)

 

 

 

 

 

(1,002

)

 

 

(1,117

)

 

 

 

 

 

(1,117

)

Unrealized gains (losses) on investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current period unrealized gain (loss)

 

$

(249

)

 

 

-

 

 

 

(249

)

 

 

(59

)

 

 

 

 

 

(59

)

 

 

34

 

 

 

 

 

 

34

 

Reclassification adjustments 2

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(206

)

 

 

 

 

 

(206

)

Unrealized gains (losses) on investments:

 

 

(249

)

 

 

 

 

 

(249

)

 

 

(59

)

 

 

 

 

 

(59

)

 

 

(172

)

 

 

 

 

 

(172

)

Other comprehensive income (loss)

 

$

158

 

 

$

 

 

$

158

 

 

$

(1,061

)

 

$

 

 

$

(1,061

)

 

$

(1,289

)

 

$

 

 

$

(1,289

)

 

1

Refer to Note 6 for the affected line items in the consolidated statement of operations

2

Amount included in other income (expense), net, in the consolidated statement of operations

 

 

14. Income Taxes

The Company’s geographical breakdown of its loss before provision for income taxes is as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Domestic

 

$

(50,892

)

 

$

(55,330

)

 

$

(28,831

)

Foreign

 

 

2,692

 

 

 

(2,665

)

 

 

3,277

 

Loss before provision for taxes

 

$

(48,200

)

 

$

(57,995

)

 

$

(25,554

)

 

The components of the provision for income taxes are as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Current

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

$

 

 

$

 

State

 

 

34

 

 

 

66

 

 

 

127

 

Foreign

 

 

857

 

 

 

1,523

 

 

 

700

 

Total current provision

 

 

891

 

 

 

1,589

 

 

 

827

 

Deferred

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

63

 

 

 

109

 

 

 

 

State

 

 

(1

)

 

 

6

 

 

 

 

Foreign

 

 

(271

)

 

 

(523

)

 

 

(50

)

Total deferred provision

 

 

(209

)

 

 

(408

)

 

 

(50

)

Total

 

$

682

 

 

$

1,181

 

 

$

777

 

 

93


 

Reconciliation of the provision for income taxes at the statutory rate to the Company’s provision for income tax is as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Tax benefit at federal statutory tax rate

 

$

(16,388

)

 

$

(19,718

)

 

$

(8,688

)

Tax benefit at state statutory tax rate

 

 

(499

)

 

 

(1,169

)

 

 

(829

)

Foreign tax rate differential

 

 

(826

)

 

 

(526

)

 

 

(705

)

Unbenefitted loss of consolidated investment

 

 

-

 

 

 

2,366

 

 

 

2,402

 

Change in valuation allowance

 

 

9,738

 

 

 

12,407

 

 

 

7,400

 

Meals and entertainment

 

 

44

 

 

 

34

 

 

 

197

 

Stock compensation

 

 

8,492

 

 

 

7,160

 

 

 

810

 

Nondeductible expenses and other

 

 

121

 

 

 

627

 

 

 

190

 

Provision for income taxes

 

$

682

 

 

$

1,181

 

 

$

777

 

 

Significant components of the Company’s net deferred tax assets are as follows (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Reserves and accruals

 

$

2,662

 

 

$

1,387

 

Deferred revenue

 

 

8,724

 

 

 

8,429

 

Stock-based compensation

 

 

4,772

 

 

 

5,776

 

Net operating loss carryforwards

 

 

37,793

 

 

 

25,519

 

Loss on OCI

 

 

374

 

 

 

380

 

Other

 

 

32

 

 

 

41

 

Gross deferred tax assets

 

 

54,357

 

 

 

41,532

 

Valuation allowance

 

 

(53,468

)

 

 

(40,488

)

Total deferred tax assets

 

 

889

 

 

 

1,044

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

(21

)

 

 

(53

)

Depreciation and amortization

 

 

(1,425

)

 

 

(1,757

)

Total deferred tax liabilities

 

 

(1,446

)

 

 

(1,810

)

Net deferred tax assets

 

$

(557

)

 

$

(766

)

 

Recognition of deferred tax assets is appropriate when realization of these assets is more likely than not. Based upon the weight of available evidence, which includes the Company’s historical operating performance and the recorded cumulative net losses in all prior fiscal periods, the Company has provided a full valuation allowance against its U.S. deferred tax assets. The Company’s valuation allowance increased by $13.0 million, $7.8 million, and $8.4 million in the years ended December 31, 2015, 2014 and 2013, respectively.

In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes, related to balance sheet classification of deferred taxes. The ASU requires that deferred tax assets and liabilities be classified as noncurrent in the statement of financial position, thereby simplifying the current guidance that requires an entity to separate deferred assets and liabilities into current and noncurrent amounts. In the fourth quarter of 2015, the Company early adopted this guidance prospectively and our statement of financial position as of this date reflects the revised classification of current deferred tax assets and liabilities as noncurrent. There is no other impact on our financial statements of early-adopting the ASU.

As of December 31, 2015, the Company had U.S. federal and state net operating loss carryforwards of approximately $153.0 million and $73.7 million, respectively. The U.S. federal net operating loss carryforwards will expire at various dates beginning in 2023 through 2035 if not utilized. Most state net operating loss carryforwards will expire at various dates beginning in 2018 through 2035.

The Company uses the “with-and-without” approach to determine the recognition and measurement of excess tax benefits. Accordingly, the Company has elected to recognize excess income tax benefits from stock option exercises in additional paid in capital only if an incremental income tax benefit would be realized after considering all other tax attributes presently available to the Company. As of December 31, 2015, the amount of such excess tax benefits from stock options included in deferred tax assets for

94


 

federal and state net operating losses were $ 49.9 million and $ 13.5 million, respectively. In addition, the Company has e lected to account for the indirect effects of stock-based awards on other tax attributes, such as the research and alternative minimum tax credits, through the statement of operations.

Net operating loss carryforwards reflected above may be subject to limitations due to ownership changes as provided in the Internal Revenue Code and similar state provisions.

The Company has not provided U.S. income tax on certain foreign earnings that are deemed to be indefinitely invested outside the U.S. For fiscal years 2015, 2014, and 2013 the amount of accumulated unremitted earnings from the Company’s foreign subsidiaries is approximately $13.6 million, $12.9 million and $9.8 million, respectively. Determination of the amount of unrecognized deferred U.S. income tax liability is not practical due to the complexities associated with the hypothetical calculation.

As of December 31, 2015 and 2014, the Company had gross unrecognized tax benefits of approximately $1.2 million and $672,000, respectively, all of which would impact the effective tax rate if recognized. While it is often difficult to predict the final outcome of any particular uncertain tax position, the Company does not believe that the amount of unrecognized tax benefits will change significantly in the next twelve months.

The Company recognizes interest accrued and penalties related to unrecognized tax benefits in its income tax provision. For the years ended December 31, 2015 and 2014, the Company accrued interest of $83,000 and $43,000 in income tax expense, respectively.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):

 

 

 

2015

 

 

2014

 

 

2013

 

Balance at January 1

 

$

672

 

 

$

353

 

 

$

239

 

Additions based on tax positions taken during the current period

 

 

401

 

 

 

222

 

 

 

134

 

Reductions based on tax positions taken during the prior period

 

 

(50

)

 

 

(47

)

 

 

(20

)

Additions based on tax positions taken during a prior period

 

 

131

 

 

 

144

 

 

 

 

Balance at December 31

 

$

1,154

 

 

$

672

 

 

$

353

 

 

The Company’s material income tax jurisdictions are the United States (federal), California and Israel. The Israeli Tax Authorities have now settled the audit of income tax returns of the Israeli subsidiary for the tax years 2006 through 2010. As a result of net operating loss carryforwards, the Company is subject to audit for tax years 2003 and forward for federal purposes and 2005 and forward for California purposes. There are tax years which remain subject to examination in various other jurisdictions that are not material to the Company’s financial statements.

The Company’s Israeli subsidiaries (“Israeli subsidiaries”) research and development intercompany services activity (“R&D activity”) have a “Beneficiary Enterprise” status for a separate investment program that was elected by the Israel subsidiaries starting 2012 under the Law for Encouragement of Capital Investments, 1959 (the “Investments Law”), amended from time to time.

The entitlement to the above benefits is conditional upon the Israeli subsidiaries fulfilling the conditions stipulated by the Investments Law and regulations published there under.

 

In December 2010 the “Knesset” (Israeli Parliament) passed the Law for Economic Policy for 2011 and 2012 (Amended Legislation), which prescribes, among others, amendments in the Investment Law (the “Amendment”). The Amendment became effective as of January 1, 2011. According to the Amendment, a flat tax rate applies to the Israeli subsidiary’s R&D activities as follows: 2011 and 2012—15%, 2013 and 2014—12.5% and in 2015 and thereafter—12%. The Israeli subsidiaries fully adopted the provisions of the Amendment in 2012.

On July 30, 2013, the Knesset approved an amended Economic Plan for 2013-2014 (“Amended Budget Law”) to raise the Israeli corporate tax rate from 25% to 26.5%, in addition to increasing the flat tax rate applicable to the Israeli subsidiaries R&D activities starting in 2014 to 16%. Activities other than R&D will be taxed at the rate of 26.5%.

 

 

15. Segment Information

The Company operates its business in one operating segment, which is the development, marketing, sales, service and support of cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. Operating segments are defined as components of an enterprise that engage in business activities for which separate financial information is available and

95


 

evaluated by the chief operating decision maker in deciding how to allocate resources and assessing pe rformance. The chief operating decision maker is the Company’s Chief Executive Officer.

The Company’s services revenue was comprised of the following (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Maintenance and support

 

$

66,380

 

 

$

54,795

 

 

$

44,353

 

Professional services and training

 

 

14,084

 

 

 

11,414

 

 

 

9,890

 

Subscriptions

 

 

46,271

 

 

 

23,502

 

 

 

11,363

 

Total net services revenue

 

$

126,735

 

 

$

89,711

 

 

$

65,606

 

 

The Company’s revenue by geographic region, based on the customer’s location, is summarized as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Americas

 

$

149,766

 

 

$

94,266

 

 

$

83,736

 

EMEA

 

 

57,180

 

 

 

43,111

 

 

 

33,183

 

APAC

 

 

27,352

 

 

 

26,633

 

 

 

20,840

 

Total net revenue

 

$

234,298

 

 

$

164,010

 

 

$

137,759

 

 

The following table presents long-lived assets by location (in thousands):

 

 

 

As of December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

United States

 

$

9,913

 

 

$

6,761

 

 

$

3,039

 

Israel

 

 

10,224

 

 

 

10,221

 

 

 

2,422

 

Other

 

 

18

 

 

 

35

 

 

 

14

 

Total long-lived assets

 

$

20,155

 

 

$

17,017

 

 

$

5,475

 

 

 

16. Net Loss per Share

The following table sets forth the computation of the Company’s basic and diluted net loss per share of common stock (in thousands, except per share amounts):

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Net loss attributable to Imperva, Inc. stockholders

 

$

(48,882

)

 

$

(58,963

)

 

$

(25,178

)

Shares used in computing net loss per share of common stock,

   basic and diluted

 

 

29,849

 

 

 

25,806

 

 

 

24,300

 

Net loss per share of common stock, basic and diluted

 

$

(1.64

)

 

$

(2.28

)

 

$

(1.04

)

 

The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been antidilutive:

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Stock options to purchase common stock

 

 

1,949,089

 

 

 

2,244,363

 

 

 

1,675,506

 

Restricted stock units for common stock

 

 

1,898,025

 

 

 

2,279,081

 

 

 

1,044,651

 

Restricted shares of common stock subject to repurchase

 

 

-

 

 

 

217,621

 

 

 

335,062

 

Restricted stock issued in connection with Skyfence acquisition

 

 

118,961

 

 

 

355,499

 

 

 

 

 

 

 

 

 

 

96


 

Item 9. Changes in and Disagreements with Acco untants on Accounting and Financial Disclosure

None.

 

 

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation and supervision of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on the aforementioned evaluation, our chief executive officer and chief financial officer have concluded that as of December 31, 2015, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2015 based on the guidelines established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (COSO). Based on the results of this evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2015 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with accounting principles generally accepted in the United States. We reviewed the results of management’s assessment with the Audit Committee of our Board of Directors. The effectiveness of our internal control over financial reporting as of December 31, 2015 has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report which is included in Part II, Item 8 of this Annual Report on Form 10-K.

Changes in Internal Control over Financial Reporting

 

Regulations under the Exchange Act require public companies, including our company, to evaluate any change in our “internal control over financial reporting” as such term is defined in Rule 13a-15(f) and Rule 15d-15(f) of the Exchange Act. In connection with their evaluation of our disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K, our chief executive officer and chief financial officer did not identify any changes in our internal control over financial reporting during our fourth quarter ended December 31, 2015 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information

None.

 

 

97


 

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Except as set forth below, the information required by this item is incorporated by reference to our Proxy Statement for our 2016 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2015.

We maintain a Code of Business Conduct and Ethics that incorporates our code of ethics applicable to all employees, including all officers. Our Code of Business Conduct and Ethics is published on the Investor Relations section of our website at www.imperva.com. We intend to disclose future amendments to certain provisions of our Code of Business Conduct and Ethics, or waivers of such provisions granted to the principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions on this website within four business days following the date of such amendment or waiver.

Item 11. Executive Compensation

The information required by this item is incorporated by reference to our Proxy Statement for our 2016 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the year ended December 31, 2015.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item is incorporated by reference to our Proxy Statement for our 2016 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the year ended December 31, 2015.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by this item is incorporated by reference to our Proxy Statement for our 2016 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the year ended December 31, 2015.

Item 14. Principal Accountant Fees and Services

The information required by this item is incorporated by reference to our Proxy Statement for our 2016 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the year ended December 31, 2015.

 

 

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)(1)  Financial Statements:  The financial statements filed as part of this Annual Report on Form 10-K are listed on the index to financial statements on page 59.

(2) No Financial Statement Schedules were required to be filed as part of this report because the required information is not present or is not present in amounts sufficient to require submission of the schedules or because the information required is included in the Consolidated Financial Statements or Notes thereto.

(b) Exhibits. The exhibits listed on the Exhibit Index (following the Signatures section of this report) are included, or incorporated by reference, in this Annual Report on Form 10-K.

 

98


 

SIGNAT URES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, on February 26, 2016, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

 

IMPERVA, INC.

 

 

 

 

 

 

 

By:

/s/ Anthony Bettencourt

 

By:

/s/ Terrence J. Schmid

 

Anthony Bettencourt

 

 

Terrence J. Schmid

 

President and Chief Executive Officer

 

 

Chief Financial Officer

 

99


 

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Anthony Bettencourt and Terrence J. Schmid as his or her attorneys-in-fact, with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that each said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

Title

Date

 

 

 

/s/ Anthony Bettencourt

President, Chief Executive Officer and

February 26, 2016

Anthony Bettencourt

Chairman of the Board

 

 

(Principal Executive Officer)

 

 

 

 

/s/ Terrence J. Schmid

Chief Financial Officer

February 26, 2016

Terrence J. Schmid

(Principal Accounting and

 

 

Financial Officer)

 

 

 

 

/s/ Geraldine Elliott

Director

February 26, 2016

Geraldine Elliott

 

 

 

 

 

/s/ Charles Giancarlo

Director

February 26, 2016

Charles Giancarlo

 

 

 

 

 

/s/ Theresia Gouw

Director

February 26, 2016

Theresia Gouw

 

 

 

 

 

/s/ Albert A. Pimentel

Director

February 26, 2016

Albert A. Pimentel

 

 

 

 

 

/s/ Frank Slootman

Director

February 26, 2016

Frank Slootman

 

 

 

 

 

/s/ Allan Tessler

Director

February 26, 2016

Allan Tessler

 

 

 

 

 

/s/ James Tolonen

Director

February 26, 2016

James Tolonen

 

 

 

100


 

EXHIBIT INDEX

 

 

 

 

 

Incorporated by Reference

Exhibit

Number

 

Exhibit Description

 

Form

 

File No.

 

Exhibit

 

Filing
Date

 

Provided
Herewith

3.1

 

Restated Certificate of Incorporation of Imperva, Inc., as currently in effect.

 

S-1/A

 

333-175008

 

3.3

 

10/28/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.2

 

Amended and Restated Bylaws of Imperva, Inc., as currently in effect.

 

8-K

 

001-35338

 

3.1

 

2/11/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Specimen Certificate Evidencing Shares of Imperva, Inc. common stock.

 

S-1/A

 

333-175008

 

4.1

 

10/28/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.2

 

Amended and Restated Investor Rights Agreement, dated November 1, 2011, by and among Imperva, Inc. and the investors party thereto.

 

S-1/A

 

333-175008

 

4.4

 

11/7/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.1#

 

2003 Stock Plan, as amended, including addendums and sub-plans.

 

S-1

 

333-175008

 

10.1

 

6/17/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.2#

 

Forms of agreements under the 2003 Stock Plan, as amended.

 

S-1

 

333-175008

 

10.2

 

6/17/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.3#

 

2011 Stock Option and Incentive Plan and subplan and form agreements thereunder.

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

10.4#

 

2011 Employee Stock Purchase Plan.

 

S-1/A

 

333-175008

 

10.19

 

10/28/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.5#

 

Incapsula, Inc. 2010 Stock Incentive Plan and form agreements thereunder.

 

S-8

 

333-194955

 

99.1

 

4/1/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.6#

 

Form of Imperva, Inc. Stock Option Assumption Agreement for Incapsula, Inc. 2010 Stock Incentive Plan.

 

S-8

 

333-194955

 

99.2

 

4/1/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.6#

 

Skyfence Networks Ltd. 2013 Share Incentive Plan and form agreements thereunder.

 

S-8

 

333-194955

 

99.3

 

4/1/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.7#

 

2015 Equity Inducement Plan and forms of agreements thereunder.

 

S-8

 

222-207825

 

99.1

 

11/5/15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.8#

 

Form of Inducement Stock Option Plan and Agreement between Imperva, Inc. and Anthony Bettencourt.

 

8-K

 

001-35338

 

10.5

 

8/18/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.9#

 

Form of Inducement Restricted Stock Unit Plan and Agreement between Imperva, Inc. and Anthony J. Bettencourt.

 

8-K

 

001-35338

 

10.6

 

8/18/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.10#

 

Form of Amended and Restated Indemnification Agreement.

 

S-1/A

 

333-175008

 

10.4

 

10/28/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.11#

 

Offer Letter, dated September 29, 2010, between Imperva, Inc. and Terrence J. Schmid.

 

S-1/A

 

333-175008

 

10.6

 

9/6/11

 

 

10.12#

 

Employment and Non-Competition Agreement, dated May 7, 2002, between Imperva, Ltd. and Amichai Shulman, and Car Leasing Agreement, dated February 6, 2013, between Imperva, Ltd. and Amichai Shulman.

 

10-Q

 

001-35338

 

10.02

 

5/9/13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.13#

 

Offer Letter, dated May 5, 2004, between Imperva, Inc. and Mark Kraynak.

 

10-Q

 

001-35338

 

10.01

 

5/9/13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101


 

10.14#

 

Offer Letter, dated August 13, 2014, between

Imperva, Inc. and Anthony Bettencourt.

 

8-K

 

001-35338

 

10.1

 

8/18/14

 

 

10.15#

 

Offer Letter, dated December 12, 2014, between Imperva, Inc. and Sunil D. Nagdev

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

10.16#

 

Imperva, Inc. Change in Control Plan and Form Notice of Participation.

 

10-K

 

001-35338

 

10.26

 

3/28/12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.17#

 

Imperva, Inc. 2016 Senior Management Bonus Plan.

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

10.18†

 

OEM Agreement, dated September 9, 2009, between Imperva, Inc., Imperva, Ltd. and American Portwell Technology Inc.

 

S-1

 

333-175008

 

10.11

 

6/17/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.19†

 

First Amendment to OEM Agreement dated as of June 14, 2012 among Imperva, Inc., Imperva, Ltd. and American Portwell Technology.

 

10-Q

 

001-35338

 

10.1

 

8/13/12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.20†

 

Second Amendment to OEM Agreement dated as of January 23, 2013 among Imperva, Inc., Imperva, Ltd. and American Portwell Technology.

 

10-K

 

001-35338

 

10.17

 

3/15/13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.21†

 

Third Amendment to OEM Agreement dated as of May 22, 2014 among Imperva, Inc., Imperva, Ltd. and American Portwell Technology.

 

10-Q

 

001-35338

 

10.1

 

8/8/14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.22

 

Lease Agreement, dated February 6, 2008, between Westport Office Park, LLC and Imperva, Inc.

 

S-1

 

333-175008

 

10.13

 

6/17/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.23

 

First Amendment to Lease (Relocation), dated February 12, 2010, between Westport Office Park, LLC and Imperva, Inc.

 

S-1

 

333-175008

 

10.14

 

6/17/11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.24

 

Second Amendment to Lease (Expansion) effective as of May 16, 2012 between Westport Office Park, LLC and Imperva, Inc.

 

8-K

 

001-35338

 

10.2

 

5/30/12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.25

 

Third Amendment to Lease effective as of August 22, 2012 between Westport Office Park, LLC and Imperva, Inc.

 

10-Q

 

001-35338

 

10.1

 

11/13/12

 

 

10.26

 

Fourth Amendment to Lease (Expansion) effective as of May 6, 2015 between Westport Office Park, LLC and Imperva, Inc.

 

8-K

 

001-35338

 

10.1

 

5/12/15

 

 

10.27

 

Fifth Amendment to Lease (Expansion) effective as of October 28, 2015 between Westport Office Park, LLC and Imperva, Inc.

 

8-K

 

001-35338

 

10.1

 

10/29/15

 

 

10.28

 

Sixth Amendment to Lease effective as of October 28, 2015 between Westport Office Park, LLC and Imperva. Inc.

 

8-K

 

001-35338

 

10.1

 

10/29/15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21.1

 

Subsidiaries of Imperva, Inc.

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

23.1

 

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

24.1

 

Power of Attorney (included on the signature page).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

102


 

31.1

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act

Rule 13a-14(a).

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

31.2

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

32.1*

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

32.2*

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

101.INS

 

XBRL Instance Document

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Label Linkbase Document

 

 

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

X

 

Certain portions of this exhibit have been omitted and filed separately with the SEC pursuant to an order granting confidential treatment under Rule 406 of the Securities Act and Rule 24b-2 of the Securities Exchange Act.

#

Indicates management contract or compensatory plan or arrangement.

*

This certification is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Imperva, Inc. specifically incorporates it by reference.

 

 

103

EXHIBIT 10.3

IMPERVA, INC.

2011 Stock Option and Incentive Plan

1. PURPOSE .  The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to the success of the Company, and any Parents and Subsidiaries that exist now or in the future, by offering them an opportunity to participate in the Company’s future performance through the grant of Awards.  Capitalized terms not defined elsewhere in the text are defined in Sectio n 27 .

2. SHARES SUBJECT TO THE PLAN .

2.1 Number of Shares Available .   Subject to Section 2.5 and any other applicable provisions hereof, the total number of Shares reserved and available for grant and issuance pursuant to this Plan as of the date of adoption of this Plan by the Board, is 1,000,000 Shares plus (a) any reserved shares not issued or subject to outstanding grants under the Company’s 2003 Stock Plan (together with any subplans and addenda adopted thereunder, the “ Prior Plan ”) on the Effective Date, (b) shares that are subject to stock options granted under the Prior Plan that cease to be subject to such stock options after the Effective Date (other than by exercise), (c) shares issued under the Prior Plan before or after the Effective Date pursuant to the exercise of stock options that are, after the Effective Date, forfeited, and (d) shares issued under the Prior Plan that are repurchased by the Company at the original issue price.

2.2 Lapsed, Returned Awards .  Shares subject to Awards, and Shares issued under this Plan under any Award, will again be available for grant and issuance in connection with subsequent Awards under this Plan to the extent such Shares:  (a) are subject to issuance upon exercise of an Option or SAR granted under this Plan but which cease to be subject to the Option or SAR for any reason other than exercise of the Option or SAR; (b) are subject to Awards granted under this Plan that are forfeited or are repurchased by the Company at the original issue price; (c) are subject to Awards granted under this Plan that otherwise terminate without such Shares being issued; or (d) are surrendered pursuant to an Exchange Program.  To the extent an Award under this Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under this Plan.  Shares used to pay the exercise price of an Award or to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under this Plan. For the avoidance of doubt, Shares that otherwise become available for grant and issuance because of the provisions of this Section 2.2 shall not include Shares subject to Awards that initially became available because of the substitution clause in Section 21.2 hereof.

2.3 Minimum Share Reserve .  At all times the Company shall reserve and keep available a sufficient number of Shares as shall be required to satisfy the requirements of all outstanding Awards granted under this Plan.

2.4 Limitations .  No more than 20,000,000 Shares shall be issued pursuant to the exercise of ISOs.

2.5 Adjustment of Shares .  If the number of outstanding Shares is changed by a stock dividend, an extraordinary cash dividend, recapitalization, spin-off, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then (a) the number of Shares reserved for issuance and future grant under this Plan set forth in Section 2.1, (b) the Exercise Prices of and number of Shares subject to outstanding Options and SARs, (c) the number of Shares subject to other outstanding Awards, (d) the maximum number of shares that may be issued as ISOs set forth in Section 2.4, (e) the maximum number of Shares that may be issued to an individual or to a new Employee in any one calendar year set forth in Section 3 and (f) the number of Shares that are granted as Awards to Non-Employee Directors as set forth in Section 12, shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with applicable securities laws; provided that fractions of a Share will not be issued.

1


3. ELIGIBILITY .  ISOs may be granted only to Employees.  All other Awards may be granted to Employees, Consultants, Directors and Non-Employee Directors of the Company or any Parent or Subsidiary of the Company; provided such Consultants, Directors and Non ‑Employee Directors render bona fide services not in connection with the offer and sale of securities in a capital-raising transaction.  No Participant will be eligible to receive or be granted more than 500,000 Shares in any calendar year under this Plan pursuant to the grant of Awards except that new Employees of the Company or of a Parent or Subsidiary of the Company (including new Employees who are also officers and directors of the Company or any Parent or Subsidiary of the Company) are eligible to receive or be granted up to a maximum of 1,000,000 Shares in the calendar year in which they commence their employment.

4. ADMINISTRATION .

4.1 Committee Composition; Authority .  This Plan will be administered by the Committee or by the Board acting as the Committee.   Subject to the general purposes, terms and conditions of this Plan, and to the direction of the Board, the Committee will have full power to implement and carry out this Plan, except, however, the Board shall establish the terms for the grant of an Award to Non-Employee Directors.   The Committee will have the authority to:

(a) construe and interpret this Plan, any Award Agreement and any other agreement or document executed pursuant to this Plan;

(b) prescribe, amend and rescind rules and regulations relating to this Plan or any Award;

(c) select persons to receive Awards;

(d) determine the form and terms and conditions, not inconsistent with the terms of this Plan, of any Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised or settled (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, the method to satisfy tax withholding obligations or any other tax liability legally due and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Committee will determine;

(e) determine the number of Shares or other consideration subject to Awards;

(f) determine the Fair Market Value in good faith, if necessary;

(g) determine whether Awards will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other Awards under this Plan or any other incentive or compensation plan of the Company or any Parent or Subsidiary of the Company;

(h) grant waivers of Plan or Award conditions;

(i) determine the vesting, exercisability and payment of Awards;

(j) correct any defect, supply any omission or reconcile any inconsistency in this Plan, any Award or any Award Agreement;

(k) determine whether an Award has been earned;

(l) determine the terms and conditions of any, and to institute any Exchange Program;

(m) reduce or waive any criteria with respect to Performance Factors;

(n) adjust Performance Factors to take into account changes in law and accounting or tax rules as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships provided that such adjustments are consistent with the regulations promulgated under Section 162(m) of the Code with respect to persons whose compensation is subject to Section 162(m) of the Code; and

(o) delegate any of the foregoing to a subcommittee consisting of one or more officers pursuant to a specific delegation as permitted by applicable law; and

(p) make all other determinations necessary or advisable for the administration of this Plan.

2


4.2 Committee Interpretation and Discretion .  Any determination made by the Committee with respect to any Award shall be made in its sole discretion at the time of grant of the Award or, unless in contravention of any express term of this Plan or Award, at any later time, and such determination shall be final and binding on the Company and all persons having an interest in any Award under this Plan.   Any dispute regarding the interpretation of this Plan or any Award Agreement shall be submitted by the Participant or Company to the Committee for review.  The resolution of such a dispute by the Committee shall be final and binding on the Company and the Participant.  The Committee may delegate to one or more executive officers the authority to review and resolve disputes with respect to Awards held by Participants who are not Insiders, and such resolution shall be final and binding on the Company and the Participant.

4.3 Section 162(m) of the Code and Section 16 of the Exchange Act .  When necessary or desirable for an Award to qualify as “performance-based compensation” under Section 162(m) of the Code, the Committee shall include at least two persons who are “outside directors” (as defined under Section 162(m) of the Code) and at least two (or a majority if more than two then serve on the Committee) such “outside directors” shall approve the grant of such Award and timely determine (as applicable) the Performance Period and any Performance Factors upon which vesting or settlement of any portion of such Award is to be subject. When required by Section 162(m) of the Code, prior to settlement of any such Award at least two (or a majority if more than two then serve on the Committee) such “outside directors” then serving on the Committee shall determine and certify in writing the extent to which such Performance Factors have been timely achieved and the extent to which the Shares subject to such Award have thereby been earned. Awards granted to Participants who are subject to Section 16 of the Exchange Act must be approved by two or more “non-employee directors” (as defined in the regulations promulgated under Section 16 of the Exchange Act).  With respect to Participants whose compensation is subject to Section 162(m) of the Code, and provided that such adjustments are consistent with the regulations promulgated under Section 162(m) of the Code, the Committee may adjust the performance goals to account for changes in law and accounting and to make such adjustments as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships, including without limitation (i) restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring charges, (ii) an event either not directly related to the operations of the Company or not within the reasonable control of the Company’s management, or (iii) a change in accounting standards required by generally accepted accounting principles.

4.4 Foreign Award Recipients .  Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws in other countries in which the Company and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Committee, in its sole discretion, shall have the power and authority to:  (a) determine which Subsidiaries shall be covered by this Plan; (b) determine which individuals outside the United States are eligible to participate in this Plan; (c) modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws; (d) establish subplans and modify exercise procedures and other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable (and such subplans and/or modifications shall be attached to this Plan as appendices); provided, however, that no such subplans and/or modifications shall increase the share limitations contained in this Plan; and (e) take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals.  Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any other applicable United States governing statute or law.

4.5 Documentation .  The Award Agreement for a given Award, this Plan and any other documents may be delivered to, and accepted by, a Participant or any other person in any manner (including electronic distribution or posting) that meets applicable legal requirements.

5. OPTIONS .  The Committee may grant Options to Participants and will determine whether such Options will be Incentive Stock Options within the meaning of the Code (“ ISOs ”) or Nonqualified Stock Options (“ NQSOs ”), the number of Shares subject to the Option, the Exercise Price of the Option, the period during which the Option may be exercised, and all other terms and conditions of the Option, subject to the following:

5.1 Option Grant .  Each Option granted under this Plan will identify the Option as an ISO or an NQSO.  An Option may be, but need not be, awarded or vested upon satisfaction of such Performance Factors during any Performance Period as are set out in advance in the Participant’s individual Award Agreement.  If the

3


Option is being earned upon the satisfaction of Performance Factors, then the Committee will: (a) determine the nature, length and starting date of any Performance Period for each Option; and (b) select from among the Performance Factors to be used to measure the performance, if any.  Performance Periods may overlap and Participants may participate simultaneously with respect to Options that are subject to different performance goals and other criteria.

5.2 Date of Grant .  The date of grant of an Option will be the date on which the Committee makes the determination to grant such Option, or a specified future date.  The Award Agreement and a copy of this Plan will be delivered to the Participant within a reasonable time after the granting of the Option.

5.3 Exercise Period .  Options may be exercisable within the times or upon the conditions as set forth in the Award Agreement governing such Option; provided , however , that no Option will be exercisable after the expiration of ten (10) years from the date the Option is granted; and provided further that no ISO granted to a person who, at the time the ISO is granted, directly or by attribution owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Parent or Subsidiary of the Company (“ Ten Percent Stockholder ”) will be exercisable after the expiration of five (5) years from the date the ISO is granted.  The Committee also may provide for Options to become exercisable at one time or from time to time, periodically or otherwise, in such number of Shares or percentage of Shares as the Committee determines.

5.4 Exercise Price .  The Exercise Price of an Option will be determined by the Committee when the Option is granted; provided that: (i) the Exercise Price of an ISO will be not less than one hundred percent (100%) of the Fair Market Value of the Shares on the date of grant and (ii) the Exercise Price of any ISO granted to a Ten Percent Stockholder will not be less than one hundred ten percent (110%) of the Fair Market Value of the Shares on the date of grant.  Payment for the Shares purchased must be made in accordance with Section 11 and the Award Agreement and in accordance with any procedures established by the Company.  The Exercise Price of a NQSO may not be less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.

5.5 Method of Exercise .  Any Option granted hereunder will be exercisable according to the terms of this Plan and at such times and under such conditions as determined by the Committee and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share.  An Option will be deemed exercised when the Company receives: (a) notice of exercise (in such form as the Committee may specify from time to time) from the person entitled to exercise the Option, and (b) full payment for the Shares with respect to which the Option is exercised (together with applicable withholding taxes). Full payment may consist of any consideration and method of payment authorized by the Committee and permitted by the Award Agreement and this Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 2.5 of this Plan.  Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of this Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.

5.6 Termination .  The exercise of an Option will be subject to the following (except as may be otherwise provided in an Award Agreement):

(a) If the Participant is Terminated for any reason except for Cause or the Participant’s death or Disability, then the Participant may exercise such Participant’s Options only to the extent that such Options would have been exercisable by the Participant on the Termination Date no later than three (3) months after the Termination Date (or such shorter time period or longer time period not exceeding five (5) years as may be determined by the Committee, with any exercise beyond three (3) months after the Termination Date deemed to be the exercise of an NQSO), but in any event no later than the expiration date of the Options.

(b) If the Participant is Terminated because of the Participant’s death (or the Participant dies within three (3) months after a Termination other than for Cause or because of the Participant’s Disability), then the Participant’s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the Termination Date and must be exercised by the Participant’s legal representative, or authorized designee, as prescribed in the Award Agreement, no later than twelve (12) months after the Termination Date (or

4


such shorter time period not less than six (6) months or longer time period not exceeding five (5) years as may be determined by the Committee), but in any event no later than the expiration date of the Options.

(c) If the Participant is Terminated because of the Participant’s Disability, then the Participant’s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the Termination Date and must be exercised by the Participant (or the Participant’s legal representative or authorized designee) no later than twelve (12) months after the Termination Date (with any exercise beyond (a) three (3) months after the Termination Date when the Termination is for a Disability that is not a “permanent and total disability” as defined in Section 22(e)(3) of the Code, or (b) twelve (12) months after the Termination Date when the Termination is for a Disability that is a “permanent and total disability” as defined in Section 22(e)(3) of the Code, deemed to be exercise of an NQSO), but in any event no later than the expiration date of the Options.

(d) If the Participant is terminated for Cause, then Participant’s Options shall expire on such Participant’s Termination Date, or at such later time and on such conditions as are determined by the Committee, but in any no event later than the expiration date of the Options.

5.7 Limitations on Exercise .  The Committee may specify a minimum number of Shares that may be purchased on any exercise of an Option, provided that such minimum number will not prevent any Participant from exercising the Option for the full number of Shares for which it is then exercisable.

5.8 Limitations on ISOs .  With respect to Awards granted as ISOs, to the extent that the aggregate Fair Market Value of the Shares with respect to which such ISOs are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as NQSOs. For purposes of this Section 5.8, ISOs will be taken into account in the order in which they were granted. The Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted.  In the event that the Code or the regulations promulgated thereunder are amended after the Effective Date to provide for a different limit on the Fair Market Value of Shares permitted to be subject to ISOs, such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.

5.9 Modification, Extension or Renewal .  The Committee may modify, extend or renew outstanding Options and authorize the grant of new Options in substitution therefor, provided that any such action may not, without the written consent of a Participant, impair any of such Participant’s rights under any Option previously granted.  Any outstanding ISO that is modified, extended, renewed or otherwise altered will be treated in accordance with Section 424(h) of the Code.  Subject to Section 18 of this Plan, by written notice to affected Participants, the Committee may reduce the Exercise Price of outstanding Options without the consent of such Participants; provided , however , that the Exercise Price may not be reduced below the Fair Market Value on the date the action is taken to reduce the Exercise Price.

5.10 No Disqualification .  Notwithstanding any other provision in this Plan, no term of this Plan relating to ISOs will be interpreted, amended or altered, nor will any discretion or authority granted under this Plan be exercised, so as to disqualify this Plan under Section 422 of the Code or, without the consent of the Participant affected, to disqualify any ISO under Section 422 of the Code.

6. RESTRICTED STOCK AWARDS .

6.1 Awards of Restricted Stock .  A Restricted Stock Award is an offer by the Company to sell to a Participant Shares that are subject to restrictions (“ Restricted Stock ”).  The Committee will determine to whom an offer will be made, the number of Shares the Participant may purchase, the Purchase Price, the restrictions under which the Shares will be subject and all other terms and conditions of the Restricted Stock Award, subject to this Plan.

6.2 Restricted Stock Purchase Agreement .  All purchases under a Restricted Stock Award will be evidenced by an Award Agreement.  Except as may otherwise be provided in an Award Agreement, a Participant accepts a Restricted Stock Award by signing and delivering to the Company an Award Agreement with full payment of the Purchase Price, within thirty (30) days from the date the Award Agreement was delivered to the Participant.  If the Participant does not accept such Award within thirty (30) days, then the offer of such Restricted Stock Award will terminate, unless the Committee determines otherwise.

5


6.3 Purchase Price .  The Purchase Price for a Restricted Stock Award will be determined by the Committee, may be less than Fair Market Value on the date the Restricted Stock Award is granted, and may be zero.  Payment of the Purchase Price must be made in accordance with Section 11 of this Plan, and the Award Agreement and in accordance with any procedures established by the Company.

6.4 Terms of Restricted Stock Awards .  Restricted Stock Awards will be subject to such restrictions as the Committee may impose or are required by law. These restrictions may be based on completion of a specified number of years of service with the Company or upon completion of Performance Factors, if any, during any Performance Period as set out in advance in the Participant’s Award Agreement.  Prior to the grant of a Restricted Stock Award, the Committee shall: (a) determine the nature, length and starting date of any Performance Period for the Restricted Stock Award; (b) select from among the Performance Factors to be used to measure performance goals, if any; and (c) determine the number of Shares that may be awarded to the Participant.  Performance Periods may overlap and a Participant may participate simultaneously with respect to Restricted Stock Awards that are subject to different Performance Periods and having different performance goals and other criteria.

6.5 Termination of Participant .  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such Participant’s Termination Date (unless determined otherwise by the Committee).

7. STOCK BONUS AWARDS

7.1 Awards of Stock Bonuses .  A Stock Bonus Award is an award to an eligible person of Shares for services to be rendered or for past services already rendered to the Company or any Parent or Subsidiary.  All Stock Bonus Awards shall be made pursuant to an Award Agreement.  Except as otherwise determined by  the Committee, no payment from the Participant will be required for Shares awarded pursuant to a Stock Bonus Award.  If the Committee requires payment for Shares awarded pursuant to a Stock Bonus Award, the Purchase Price will be determined by the Committee and may be less than Fair Market Value on the date the Stock Bonus Award is granted.  Payment of the Purchase Price must be made in accordance with Section 11 of this Plan, and the Award Agreement and in accordance with any procedures established by the Company.

7.2 Terms of Stock Bonus Awards .  The Committee will determine the number of Shares to be awarded to the Participant under a Stock Bonus Award and the restrictions thereon (if any).  These restrictions may be based upon completion of a specified number of years of service with the Company or upon satisfaction of performance goals based on Performance Factors during any Performance Period as set out in advance in the Participant’s Stock Bonus Agreement.  Prior to the grant of any Stock Bonus Award subject to restrictions or performance goals, the Committee shall: (a) determine the nature, length and starting date of any Performance Period for the Stock Bonus Award; (b) select from among the Performance Factors to be used to measure performance goals; and (c) determine the number of Shares that may be awarded to the Participant.  Performance Periods may overlap and a Participant may participate simultaneously with respect to Stock Bonus Awards that are subject to different Performance Periods and different performance goals and other criteria.

7.3 Form of Payment to Participant .  Payment may be made in the form of cash, whole Shares, or a combination thereof, based on the Fair Market Value of the Shares earned under a Stock Bonus Award on the date of payment, as determined in the sole discretion of the Committee.

7.4 Termination of Participation .  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such Participant’s Termination Date (unless determined otherwise by the Committee).

8. STOCK APPRECIATION RIGHTS .

8.1 Awards of SARs .  A Stock Appreciation Right (“ SAR ”) is an award to a Participant that may be settled in cash, or Shares (which may consist of Restricted Stock), having a value equal to (a) the difference between the Fair Market Value on the date of exercise over the Exercise Price multiplied by (b) the number of Shares with respect to which the SAR is being settled (subject to any maximum number of Shares that may be issuable as specified in an Award Agreement).  All SARs shall be made pursuant to an Award Agreement.

6


8.2 Terms of SARs .  The Committee will determine the terms of each SAR including, without limitation: (a) the number of Shares subject to the SAR; (b) the Exercise Price and the time or times during which the SAR may be settled; (c) the consideration to be distributed on settlement of the SAR; and (d) the effect of the Participant’s Termination on each SAR.  The Exercise Price of the SAR will be determined by the Committee when the SAR is granted, and may not be less than Fair Market Value.  A SAR may be awarded upon satisfaction of Performance Factors, if any, during any Performance Period as are set out in advance in the Participant’s individual Award Agreement.  If the SAR is being earned upon the satisfaction of Performance Factors, then the Committee will: (x) determine the nature, length and starting date of any Performance Period for each SAR; and (y) select from among the Performance Factors to be used to measure the performance, if any.  Performance Periods may overlap and Participants may participate simultaneously with respect to SARs that are subject to different Performance Factors and other criteria.

8.3 Exercise Period and Expiration Date .  A SAR will be exercisable within the times or upon the occurrence of events determined by the Committee and set forth in the Award Agreement governing such SAR.  The SAR Agreement shall set forth the expiration date; provided that no SAR will be exercisable after the expiration of ten (10) years from the date the SAR is granted.  The Committee may also provide for SARs to become exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage of the Shares subject to the SAR as the Committee determines.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such Participant’s Termination Date (unless determined otherwise by the Committee).  Notwithstanding the foregoing, the rules of Section 5.6 also will apply to SARs.

8.4 Form of Settlement .  Upon exercise of a SAR, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying (i) the difference between the Fair Market Value of a Share on the date of exercise over the Exercise Price; times (ii) the number of Shares with respect to which the SAR is exercised. At the discretion of the Committee, the payment from the Company for the SAR exercise may be in cash, in Shares of equivalent value, or in some combination thereof.  The portion of a SAR being settled may be paid currently or on a deferred basis with such interest or dividend equivalent, if any, as the Committee determines, provided that the terms of the SAR and any deferral satisfy the requirements of Section 409A of the Code.

8.5 Termination of Participation .  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such Participant’s Termination Date (unless determined otherwise by the Committee).

9. RESTRICTED STOCK UNITS .

9.1 Awards of Restricted Stock Units .  A Restricted Stock Unit (“ RSU ”) is an award to a Participant covering a number of Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock).  All RSUs shall be made pursuant to an Award Agreement.

9.2 Terms of RSUs .  The Committee will determine the terms of an RSU including, without limitation: (a) the number of Shares subject to the RSU; (b) the time or times during which the RSU may be settled; and (c) the consideration to be distributed on settlement, and the effect of the Participant’s Termination on each RSU.  An RSU may be awarded upon satisfaction of such performance goals based on Performance Factors during any Performance Period as are set out in advance in the Participant’s Award Agreement.  If the RSU is being earned upon satisfaction of Performance Factors, then the Committee will: (x) determine the nature, length and starting date of any Performance Period for the RSU; (y) select from among the Performance Factors to be used to measure the performance, if any; and (z) determine the number of Shares deemed subject to the RSU.  Performance Periods may overlap and participants may participate simultaneously with respect to RSUs that are subject to different Performance Periods and different performance goals and other criteria.

9.3 Form and Timing of Settlement .  Payment of earned RSUs shall be made as soon as practicable after the date(s) determined by the Committee and set forth in the Award Agreement. The Committee, in its sole discretion, may settle earned RSUs in cash, Shares, or a combination of both.  The Committee also may permit a Participant to defer payment under a RSU to a date or dates after the RSU is earned provided that the terms of the RSU and any deferral satisfy the requirements of Section 409A of the Code.

9.4 Termination of Participant .  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such Participant’s Termination Date (unless determined otherwise by the Committee).

7


10. PERFORMANCE SHARES .

10.1 Awards of Performance Shares .  A Performance Share Award is an award to a Participant denominated in Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock).  Grants of Performance Shares shall be made pursuant to an Award Agreement.

10.2 Terms of Performance Shares .  The Committee will determine, and each Award Agreement shall set forth, the terms of each award of Performance Shares including, without limitation: (a) the number of Shares deemed subject to such Award; (b) the Performance Factors and Performance Period that shall determine the time and extent to which each award of Performance Shares shall be settled; (c) the consideration to be distributed on settlement, and the effect of the Participant’s Termination on each award of Performance Shares.  In establishing Performance Factors and the Performance Period the Committee will: (x) determine the nature, length and starting date of any Performance Period; (y) select from among the Performance Factors to be used; and (z) determine the number of Shares deemed subject to the award of Performance Shares.  Prior to settlement the Committee shall determine the extent to which Performance Shares have been earned.  Performance Periods may overlap and Participants may participate simultaneously with respect to Performance Shares that are subject to different Performance Periods and different performance goals and other criteria.

10.3 Value, Earning and Timing of Performance Shares .  Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant.  After the applicable Performance Period has ended, the holder of Performance Shares will be entitled to receive a payout of the number of Performance Shares earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding Performance Factors or other vesting provisions have been achieved. The Committee, in its sole discretion, may pay earned Performance Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned Performance Shares at the close of the applicable Performance Period) or in a combination thereof.

10.4 Termination of Participant .  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such Participant’s Termination Date (unless determined otherwise by the Committee).

11. PAYMENT FOR SHARE PURCHASES .

Payment from a Participant for Shares purchased pursuant to this Plan may be made in cash or by check or, where expressly approved for the Participant by the Committee and where permitted by law (and to the extent not otherwise set forth in the applicable Award Agreement):

(a) by cancellation of Participant’s indebtedness to the Company;

(b) by surrender of shares of the Company held by the Participant that have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Award will be exercised or settled;

(c) by waiver of compensation due or accrued to the Participant for services rendered or to be rendered to the Company or a Parent or Subsidiary of the Company;

(d) by consideration received by the Company pursuant to a broker-assisted or other cashless exercise program implemented by the Company in connection with this Plan;

(e) by any combination of the foregoing; or

(f) by any other method of payment as is permitted by applicable law.

12. GRANTS to Non-Employee directors .

12.1 Types of Awards .  Non-Employee Directors are eligible to receive any type of Award offered under this Plan except ISOs.  Awards pursuant to this Section 12 may be automatically made pursuant to policy adopted by the Board, or made from time to time as determined in the discretion of the Board.  The aggregate number of Shares subject to Awards granted to a Non-Employee Director pursuant to this Section 12 in any calendar year shall not exceed 250,000 shares.

8


12.2 Eligibility .  Awards pursuant to this Section 12 shall be granted only to Non ‑Employee Directors.  A Non-Employee Director who is elected or re-elected as a member of the Board will be eligible to receive an Award under this Section 12.

12.3 Vesting, Exercisability and Settlement .  Except as set forth in Section 21, Awards shall vest, become exercisable and be settled as determined by the Board.  With respect to Options and SARs, the exercise price granted to Non-Employee Directors shall not be less than the Fair Market Value of the Shares at the time that such Option or SAR is granted.

13. WITHHOLDING TAXES .

13.1 Withholding Generally .  Whenever Shares are to be issued in satisfaction of Awards granted under this Plan, the Company may require the Participant to remit to the Company an amount sufficient to satisfy applicable federal, state, local and international withholding tax requirements prior to the delivery of Shares pursuant to exercise or settlement of any Award.  Whenever payments in satisfaction of Awards granted under this Plan are to be made in cash, such payment will be net of an amount sufficient to satisfy applicable federal, state, local and international withholding tax requirements.

13.2 Stock Withholding .  The Committee, in its sole discretion and pursuant to such procedures as it may specify from time to time, may require or permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares having a Fair Market Value equal to the minimum statutory amount required to be withheld, (iii) delivering to the Company already‑owned Shares having a Fair Market Value equal to the minimum amount required to be withheld , or (iv) withholding from the proceeds of the sale of otherwise deliverable Shares acquired pursuant to an Award either through a voluntary sale or through a mandatory sale arranged by the Company. The Fair Market Value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld.

14. TRANSFERABILITY .  Unless determined otherwise by the Committee, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution.  If the Committee makes an Award transferable, such Award will contain such additional terms and conditions as the Committee deems appropriate.  All Awards shall be exercisable: (i) during the Participant’s lifetime only by (A) the Participant, or (B) the Participant’s guardian or legal representative; and (ii) after the Participant’s death, by the Participant’s designee, provided that such designee has been designated prior to the Participant’s death on a form prescribed by the Company.  In the absence of any such effective designation, such Awards may be exercised only by the beneficiary designated by the Participant with the largest beneficial interest; or, if there is no single beneficiary with a majority or plurality of interest, the then-acting trustee of the latest revocable trust established by the Participant of which Participant was a beneficiary or, if none, the executors or administrators of the Participant’s estate.  No transfer by will or the laws of descent and distribution of any Award shall be effective to bind the Company unless the Committee shall have been furnished with (a) written notice thereof and with a copy of the will and/or such evidence as the Committee may deem necessary to establish the validity of the transfer and (b) an agreement by the transferee to comply with all the terms and conditions of the Award that are or would have been applicable to the Participant and to be bound by the acknowledgements made by the Participant in connection with the grant of the Award.

15. PRIVILEGES OF STOCK OWNERSHIP; RESTRICTIONS ON SHARES .

15.1 Voting and Dividends .  No Participant will have any of the rights of a stockholder with respect to any Shares until the Shares are issued to the Participant except for any Dividend Equivalent Rights permitted by an applicable Award Agreement.  After Shares are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such Shares, including the right to vote and receive all dividends or other distributions made or paid with respect to such Shares; provided , that if such Shares are Restricted Stock, then any new, additional or different securities the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split or any other change in the corporate or capital structure of the Company will be subject to the same restrictions as the Restricted Stock; provided , further , that the Participant will have no right to retain such stock dividends or stock distributions with respect to Shares that are repurchased at the Participant’s Purchase Price or Exercise Price, as the case may be, pursuant to Section 15 .2. The Committee, in its discretion, may provide in the Award Agreement evidencing any Award that the Participant shall be entitled to Dividend Equivalent Rights with respect to the payment of cash dividends on Shares subject to such

9


Award during the period beginning on the date the Award is granted and ending, with respect to each Share subject to the Award, on the earlier of the date on which the Award is exercised or settled or the date on which they are forfeited;  provided , that under no circumstances may Dividend Equivalent Rights be granted for any Option or SAR. Such Dividend Equivalent Rights, if any, shall be credited to the Participant in the form of additional whole Shares as of the date of payment of such cash dividends on Shares.

15.2 Restrictions on Shares .  At the discretion of the Committee, the Company may reserve to itself and/or its assignee(s) a right to repurchase (a “ Right of Repurchase ”) a portion of any or all Unvested Shares held by a Participant following such Participant’s Termination at any time within ninety (90) days after the later of the Participant’s Termination Date and the date the Participant purchases Shares under this Plan, for cash and/or cancellation of purchase money indebtedness, at the Participant’s Purchase Price or Exercise Price, as the case may be.  The Company’s Right of Repurchase shall be automatic with respect to Unvested Shares awarded to the Participant for no Purchase Price.

16. CERTIFICATES .  All certificates for Shares or other securities delivered under this Plan will be subject to such stock transfer orders, legends and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable federal, state or foreign securities law, or any rules, regulations and other requirements of the SEC or any stock exchange or automated quotation system upon which the Shares may be listed or quoted.

17. ESCROW; PLEDGE OF SHARES .  To enforce any restrictions on a Participant’s Shares, the Committee may require the Participant to deposit all certificates representing Shares, together with stock powers or other instruments of transfer approved by the Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions have lapsed or terminated, and the Committee may cause a legend or legends referencing such restrictions to be placed on the certificates.  Any Participant who is permitted to execute a promissory note as partial or full consideration for the purchase of Shares under this Plan will be required to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of the Participant’s obligation to the Company under the promissory note; provided , however , that the Committee may require or accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full recourse against the Participant under the promissory note notwithstanding any pledge of the Participant’s Shares or other collateral.  In connection with any pledge of the Shares, the Participant will be required to execute and deliver a written pledge agreement in such form as the Committee will from time to time approve.  The Shares purchased with the promissory note may be released from the pledge on a pro rata basis as the promissory note is paid.

18. REPRICING; EXCHANGE AND BUYOUT OF AWARDS . Without prior stockholder approval, the Committee may (a) reprice Options or SARS (and where such repricing is a reduction in the Exercise Price of outstanding Options or SARS, the consent of the affected Participants is not required provided written notice is provided to them), and (b) with the consent of the respective Participants (unless not required pursuant to Section 5.9 of this Plan), pay cash or issue new Awards in exchange for the surrender and cancellation of any, or all, outstanding Awards.

19. SECURITIES LAW AND OTHER REGULATORY COMPLIANCE .  An Award will not be effective unless such Award is in compliance with all applicable federal and state securities laws, rules and regulations of any governmental body, and the requirements of any stock exchange or automated quotation system upon which the Shares may then be listed or quoted, as they are in effect on the date of grant of the Award and also on the date of exercise or other issuance.  Notwithstanding any other provision in this Plan, the Company will have no obligation to issue or deliver certificates for Shares under this Plan prior to: (a) obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and/or (b) completion of any registration or other qualification of such Shares under any state or federal law or ruling of any governmental body that the Company determines to be necessary or advisable.  The Company will be under no obligation to register the Shares with the SEC or to effect compliance with the registration, qualification or listing requirements of any state securities laws, stock exchange or automated quotation system, and the Company will have no liability for any inability or failure to do so.

10


20. NO OBLIGATION TO EMPLOY .  Nothing in this Plan or any Award granted under this Plan will confer or be deemed to confer on any Participant any right to continue in the employ of, or to continue any other relationship with, the Company or any Parent or Subsidiary of the Company or limit in any way the right of the Company or any Parent or Subsidiary of the Company to terminate Participant’s employment or other relationship at any time.

21. CORPORATE TRANSACTIONS .

21.1 Assumption or Replacement of Awards by Successor .  In the event of a Corporate Transaction any or all outstanding Awards may be assumed or replaced by the successor corporation, which assumption or replacement shall be binding on all Participants.  In the alternative, the successor corporation may substitute equivalent Awards or provide substantially similar consideration to Participants as was provided to stockholders (after taking into account the existing provisions of the Awards).  The successor corporation may also issue, in place of outstanding Shares of the Company held by the Participant, substantially similar shares or other property subject to repurchase restrictions no less favorable to the Participant.  In the event such successor or acquiring corporation (if any) refuses to assume, convert, replace or substitute Awards, as provided above, pursuant to a Corporate Transaction, then notwithstanding any other provision in this Plan to the contrary, such Awards will expire on such transaction at such time and on such conditions as the Board will determine;  the Board (or, the Committee, if so designated by the Board) may, in its sole discretion, accelerate the vesting of such Awards in connection with a Corporate Transaction.  In addition, in the event such successor or acquiring corporation (if any) refuses to assume, convert, replace or substitute Awards, as provided above, pursuant to a Corporate Transaction, the Committee will notify the Participant in writing or electronically that such Award will be exercisable for a period of time determined by the Committee in its sole discretion, and such Award will terminate upon the expiration of such period.  Awards need not be treated similarly in a Corporate Transaction.

Notwithstanding anything to the contrary in this Section 21.1, the Committee, in its sole discretion, may grant Awards that provide for acceleration upon a Corporate Transaction or in other events in the specific Award Agreements.

21.2 Assumption of Awards by the Company .  The Company, from time to time, also may substitute or assume outstanding awards granted by another company, whether in connection with an acquisition of such other company or otherwise, by either; (a) granting an Award under this Plan in substitution of such other company’s award; or (b) assuming such award as if it had been granted under this Plan if the terms of such assumed award could be applied to an Award granted under this Plan.  Such substitution or assumption will be permissible if the holder of the substituted or assumed award would have been eligible to be granted an Award under this Plan if the other company had applied the rules of this Plan to such grant.  In the event the Company assumes an award granted by another company, the terms and conditions of such award will remain unchanged ( except that the Purchase Price or the Exercise Price, as the case may be, and the number and nature of Shares issuable upon exercise or settlement of any such Award will be adjusted appropriately pursuant to Section 424(a) of the Code).  In the event the Company elects to grant a new Option in substitution rather than assuming an existing option, such new Option may be granted with a similarly adjusted Exercise Price. Substitute Awards shall not reduce the number of Shares authorized for grant under this Plan or authorized for grant to a Participant in a calendar year.

21.3 Non-Employee Directors’ Awards .  Notwithstanding any provision to the contrary herein, in the event of a Corporate Transaction, the vesting of all Awards granted to Non‑Employee Directors shall accelerate and such Awards shall become exercisable (as applicable) in full prior to the consummation of such event at such times and on such conditions as the Committee determines.

22. ADOPTION AND STOCKHOLDER APPROVAL .  This Plan shall be submitted for the approval of the Company’s stockholders, consistent with applicable laws, within twelve (12) months before or after the date this Plan is adopted by the Board.

23. TERM OF PLAN/GOVERNING LAW .  Unless earlier terminated as provided herein, this Plan will become effective on the Effective Date and will terminate ten (10) years from the date this Plan is adopted by the Board.  This Plan and all Awards granted hereunder shall be governed by and construed in accordance with the laws of the State of Delaware.

11


24. AMENDMENT OR TERMINATION OF PLAN .  The Board may at any time terminate or amend this Plan in any respect, including, without limitation, amendment of any form of Award Agreement or instrument to be executed pursuant to this Plan; provided , however , that the Board will not, without the approval of the stockholders of the Company, amend this Plan in any manner that requires such stockholder approval; provided further , that a Participant’s Award shall be governed by the version of this Plan then in effect at the time such Award was granted.

25. NONEXCLUSIVITY OF THE PLAN .  Neither the adoption of this Plan by the Board, the submission of this Plan to the stockholders of the Company for approval, nor any provision of this Plan will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of stock awards and bonuses otherwise than under this Plan, and such arrangements may be either generally applicable or applicable only in specific cases.

26. INSIDER TRADING POLICY .  Each Participant who receives an Award shall comply with any policy adopted by the Company from time to time covering transactions in the Company’s securities by Employees, officers and/or directors of the Company.

27. DEFINITIONS .   As used in this Plan, and except as elsewhere defined herein, the following terms will have the following meanings:

Award ” means any award under this Plan, including any Option, Restricted Stock, Stock Bonus, Stock Appreciation Right, Restricted Stock Unit or award of Performance Shares.

Award Agreement ” means, with respect to each Award, the written or electronic agreement between the Company and the Participant setting forth the terms and conditions of the Award, which shall be in substantially a form (which need not be the same for each Participant) that the Committee has from time to time approved, and will comply with and be subject to the terms and conditions of this Plan.

Board ” means the Board of Directors of the Company.

Cause ” means (except as may otherwise be defined in Participant’s employment or services agreement or Award Agreement) (a) the commission of an act of theft, embezzlement, fraud or dishonesty, (b) a breach of fiduciary duty to the Company or a Parent or Subsidiary, or (c) a failure to materially perform the customary duties of Employee’s employment.

Code ” means the United States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

Common Stock ” means the common stock of the Company.

Committee ” means the Compensation Committee of the Board or those persons to whom administration of this Plan, or part of this Plan, has been delegated as permitted by law.

Company ” means Imperva, Inc., or any successor corporation.

Consultant ” means any person, including an advisor or independent contractor, engaged by the Company or a Parent or Subsidiary to render services to such entity.

Corporate Transaction ” means the occurrence of any of the following events: (a) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) or “group” (two or more persons acting as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding, or disposing of the applicable securities referred to herein)  becomes the “beneficial owner” (as defined in Rule 13d‑3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then‑outstanding voting securities; (b) the consummation of the sale or other disposition by the Company of all or substantially all of the Company’s assets; (c) the consummation of a merger,

12


reorganization, consolidation or similar transaction or series of related transactions of the Company with any other corporation, other than a merger, reorganization, consolidation or similar transaction (or series of related transactions) which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least a majority of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger, reorganization, consolidation or similar transaction (or series of related transactions), or (d) any other transaction which qualifies as a “corporate transaction” under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company).

Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.

Director ” means a member of the Board.

Disability ” means total and permanent disability as defined in Section 22(e)(3) of the Code, provided, however, that except with respect to Awards granted as ISOs, the Committee in its discretion may determine whether a total and permanent disability exists in accordance with non-discriminatory and uniform standards adopted by the Committee from time to time, whether temporary or permanent, partial or total, as determined by the Committee.

Dividend Equivalent Right ” means the right of a Participant, granted at the discretion of the Committee or as otherwise provided by the Plan, to receive a credit for the account of such Participant in an amount equal to the cash dividends paid on one Share for each Share represented by an Award held by such Participant.

Effective Date ” means the date of the underwritten initial public offering of the Company’s Common Stock pursuant to a registration statement that is declared effective by the SEC.

Employee ” means any person, including Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company. Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company.

Exchange Act ” means the United States Securities Exchange Act of 1934, as amended.

Exchange Program ” means a program pursuant to which outstanding Awards are surrendered, cancelled or exchanged for cash, the same type of Award or a different Award (or combination thereof).

Exercise Price ” means, with respect to an Option, the price at which a holder may purchase the Shares issuable upon exercise of an Option, and with respect to a SAR, the price at which the SAR is granted to the holder thereof.

Fair Market Value ” means, as of any date, the value of a share of the Company’s Common Stock determined as follows:

(a) if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in The Wall Street Journal or such other source as the Board or the Committee deems reliable ;

13


(b) if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the Board or the Committee deems reliable ;

(c) in the case of an Option or SAR grant made on the Effective Date, the price per share at which shares of the Company’s Common Stock are initially offered for sale to the public by the Company’s underwriters in the initial public offering of the Company’s Common Stock pursuant to a registration statement filed with the SEC under the Securities Act; or

(d) if none of the foregoing is applicable, by the Board or the Committee in good faith.

Insider ” means an officer or director of the Company or any other person whose transactions in the Company’s Common Stock are subject to Section 16 of the Exchange Act.

Non-Employee Director ” means a Director who is not an Employee of the Company or any Parent or Subsidiary.

Option ” means an award of an option to purchase Shares pursuant to Section 5.

Parent ” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

Participant ” means a person who holds an Award under this Plan.

Performance Factors ” means the factors selected by the Committee, which may include, but are not limited to the, the following measures (whether or not in comparison to other peer companies) to determine whether the performance goals established by the Committee and applicable to Awards have been satisfied:

 

·

bookings and/or bookings growth;

 

·

net revenue and/or net revenue growth;

 

·

earnings per share and/or earnings per share growth;

 

·

earnings before income taxes and amortization and/or earnings before income taxes and amortization growth;

 

·

operating income and/or operating income growth;

 

·

net income and/or net income growth;

 

·

total stockholder return and/or total stockholder return growth;

 

·

return on equity;

 

·

operating cash flow return on income;

 

·

adjusted operating cash flow return on income;

 

·

economic value added;

 

·

control of expenses;

 

·

cost of goods sold;

 

·

profit margin;

 

·

stock price;

 

·

debt or debt-to-equity;

 

·

liquidity;

14


 

·

intellectual property (e.g., patents)/product development;

 

·

mergers and acquisitions or divestitures;

 

·

individual business objectives;

 

·

company-specific operational metrics; and

 

·

any other factor (such as individual business objectives or unit- specific operational metrics ) the Committee so designates .

Performance Period ” means the period of service determined by the Committee, not to exceed five (5) years, during which years of service or performance is to be measured for the Award.

Performance Share ” means an Award granted pursuant to Section 10 or Section 12 of this Plan.

Plan ” means this Imperva, Inc. 2011 Stock Option and Incentive Plan.

Purchase Price ” means the price to be paid for Shares acquired under this Plan, other than Shares acquired upon exercise of an Option or SAR.

Restricted Stock Award ” means an award of Shares pursuant to Section 6 or Section 12 of this Plan, or issued pursuant to the early exercise of an Option.

Restricted Stock Unit ” means an Award granted pursuant to Section 9 or Section 12 of this Plan.

SEC ” means the United States Securities and Exchange Commission.

Securities Act ” means the United States Securities Act of 1933, as amended.

Shares ” means shares of the Company’s Common Stock, as adjusted pursuant to Sections 2 and other applicable provisions hereof, and any successor security.

Stock Appreciation Right ” means an Award granted pursuant to Section 8 or Section 12 of this Plan.

Stock Bonus ” means an Award granted pursuant to Section 7 or Section 12 of this Plan.

Subsidiary ” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

Termination ” or “ Terminated ” means, for purposes of this Plan with respect to a Participant, that the Participant has for any reason ceased to provide services as an employee, officer, director, consultant, independent contractor or advisor to the Company or a Parent or Subsidiary of the Company.  An employee will not be deemed to have ceased to provide services in the case of (i) sick leave, (ii) military leave, or (iii) any other leave of absence approved by the Committee; provided , that such leave is for a period of not more than 90 days, unless reemployment upon the expiration of such leave is guaranteed by contract or statute or unless provided otherwise pursuant to formal policy adopted from time to time by the Company and issued and promulgated to employees in writing.  In the case of any employee on a leave of absence or a reduction in hours worked (for illustrative purposes only, a change in schedule from that of full-time to part-time), the Committee may make such provisions respecting suspension of or modification of vesting of the Award while on leave from the employ of the Company or a Parent or Subsidiary of the Company or during such change in working hours as it may deem appropriate, except that in no event may an Award be exercised after the expiration of the term set forth in the applicable Award Agreement.  The Committee will have sole discretion to determine whether a Participant has ceased to provide services and the effective date on which the Participant ceased to provide services (the “ Termination Date ”).

15


Unvested Shares ” means Shares that have not yet vested or are subject to a right of repurchase in favor of the Company (or any successor thereto).

16


APPENDIX A ISRAEL

TO THE 2011 STOCK OPTION AND INCENTIVE PLAN

 

 

1.

GENERAL

 

1.1

This appendix (the Appendix ”) shall apply only to Participants who are residents of the state of Israel or those who are deemed to be residents of the state of Israel for the payment of tax (the Israeli Participant(s) ”).

 

1.2

This Appendix is in accordance with and in continuation of Section 4.4 of the 2011 Stock Option and Incentive Plan (the " Plan ") of Imperva, Inc. (the " Company "). All the provisions specified hereunder shall form an integral part of the Plan.

 

1.3

This Appendix is effective with respect to Awards granted after the enactment of Amendment no. 132 of the Israeli Tax Ordinance, entering into force as of January 1, 2003.

 

1.4

This Appendix is to be read as a continuation of the Plan and modifies only Awards granted to Israeli Participants so that they comply with the requirements set by the Israeli law in general, and in particular with the provisions of Section 102 (as specified herein), as may be amended or replaced from time to time. For the avoidance of doubt, this Appendix does not add to or modify the Plan in respect of any other category of Participants.

 

1.5

The Plan and this Appendix are complimentary to each other and shall be deemed as one. In any case of contradiction, whether explicit or implied, between the provisions of this Appendix and the Plan, the provisions set out in this Appendix shall prevail.

 

1.6

Any capitalized terms not specifically defined in this Appendix shall be construed according to the interpretation given to it in the Plan.

 

2.

ISSUANCE OF AWARDS

 

2.1

The persons eligible for participation in the Plan as Israeli Participants shall include any Employees and/or Non-Employees of the Company or of any Affiliate; provided, however, that

(i) Employees may only be granted 102 Awards; and (ii) Non-Employees and/or Controlling Shareholders may only be granted 3(i) Awards.

 

2.2

The Company may designate Awards granted to Employees pursuant to Section 102 as Unapproved 102 Awards or Approved 102 Awards.

 

2.3

The grant of Approved 102 Awards shall be made under this Appendix, and shall be conditioned upon the approval of this Appendix by the ITA.

 

2.4

Approved 102 Awards may either be classified as CGAs or OIAs.

 

2.5

No Approved 102 Awards may be granted under this Appendix to any eligible Employee unless and until the Company’s election of the type of Approved 102 Awards as CGA or OIA granted to Employees (the “ Election ”) is appropriately filed with the ITA. The Election shall become effective beginning the first grant date of an Approved 102 Award under this Appendix and shall remain in effect at least until the end of the year following the year during which the Company first granted Approved 102 Awards. The Election shall obligate the Company to grant only the type of Approved 102 Award it has elected, and shall apply to all Israeli Participants who were granted Approved 102 Awards during the period indicated herein, all in accordance with the provisions of Section 102(g) of the Ordinance. For the avoidance of doubt, the Election shall not prevent the Company from granting Unapproved 102 Awards simultaneously.

 

2.6

All Approved 102 Awards must be held in trust by a Trustee, as described in Section 3 below.

 

2.7

For the avoidance of doubt, the designation of Unapproved 102 Awards and Approved 102 Awards shall be subject to the terms and conditions set forth in Section 102.

1


 

3.

TRUSTEE

 

3.1

Approved 102 Awards which shall be granted under this Appendix and/or any shares of Common Stock allocated or issued upon exercise of such Approved 102 Awards and/or other shares of Common Stock received subsequently following any realization of rights, including without limitation bonus shares, shall be allocated or issued to the Trustee and held for the benefit of the Employees for such period of time as required by Section 102 (the “ Holding Period ”). In the case the requirements for Approved 102 Awards are not met, then the Approved 102 Awards are to be regarded as Unapproved 102 Awards, all in accordance with the provisions of Section 102.

 

3.2

Notwithstanding anything to the contrary, the Trustee shall not release any shares of Common Stock allocated or issued upon exercise of Approved 102 Awards prior to the full payment of the Employee’s tax liabilities arising from Approved 102 Awards which were granted to him and/or any shares of Common Stock allocated or issued upon exercise of such Awards.

 

3.3

With respect to any Approved 102 Award, subject to the provisions of Section 102, an Employee shall not sell or release from trust any Share received upon the exercise of an Approved 102 Award and/or any share received subsequently following any realization of rights, including without limitation, bonus shares, until the lapse of the Holding Period required under Section 102. Notwithstanding the above, if any such sale or release occurs during the Holding Period, the sanctions under Section 102 shall apply to and shall be borne by such Employee.

 

3.4

Upon receipt of Approved 102 Award, the Employee will sign an undertaking to release the Trustee from any liability in respect of any action or decision duly taken and bona fide executed in relation with this Appendix, or any Approved 102 Award or Ordinary Share granted to him thereunder.

 

4.

THE AWARDS

The terms and conditions upon which the Awards shall be issued and exercised shall be as specified in the Award Agreement to be executed pursuant to the Plan and to this Appendix. Each Award Agreement shall state, inter alia, the number of shares of Common Stock to which the Award relates, the type of Award granted thereunder (whether a CGA, OIA, Unapproved 102 Award or a 3(i) Award), the vesting provisions and the exercise price.

 

5.

FAIR MARKET VALUE

Solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, if at the date of grant the Company’s shares are listed on any established stock exchange or a national market system or if the Company’s shares will be registered for trading within ninety (90) days following the date of grant of the CGAs, the fair market value of the shares of Common Stock at the date of grant shall be determined in accordance with the average value of the Company’s shares on the thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following the date of registration for trading, as the case may be.

 

6.

EXERCISE OF AWARDS

Awards shall be exercised by the Israeli Participant by giving a written notice to the Company and/or to any third party designated by the Company (the Representative ”), in such form and method as may be determined by the Company and, when applicable, by the Trustee, in accordance with the requirements of Section 102, which exercise shall be effective upon receipt of such notice by the Company and/or the Representative and the payment of the exercise price for the number of Common Stock with respect to which the Award is being exercised, at the Company’s or the Representative’s principal office. The notice shall specify the number of Common Stock with respect to which the Award is being exercised.

2


 

7.

ASSIGNABILITY AND SALE OF AWARDS

 

7.1.

Notwithstanding any other provision of the Plans, no Award or any right with respect thereto, purchasable hereunder, whether fully paid or not, shall be assignable, transferable or given as collateral or any right with respect to them given to any third party whatsoever, and during the lifetime of the Israeli Participant each and all of such Israeli Participant's rights to purchase Common Stock hereunder shall be exercisable only by the Israeli Participant. Any such action made directly or indirectly, for an immediate validation or for a future one, shall be void.

 

7.2

As long as Awards or shares of Common Stock purchased pursuant to thereto are held by the Trustee on behalf of the Israeli Participant, all rights of the Israeli Participant over the shares are personal, cannot be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution.

 

8.

INTEGRATION OF SECTION 102 AND TAX ASSESSING OFFICER’S PERMIT

 

8.1

With regards to Approved 102 Awards, the provisions of the Plans and/or the Appendix and/or the Award Agreement shall be subject to the provisions of Section 102 and the Tax Assessing Officer’s permit, and the said provisions and permit shall be deemed an integral part of the Plans, the Appendix and the Award Agreement.

 

8.2

Any provision of Section 102 and/or the said permit which is necessary in order to receive and/or to keep any tax benefit pursuant to Section 102, which is not expressly specified in the Plan or the Appendix or the Award Agreement, shall be considered binding upon the Company and the Israeli Participants.

 

9.

DIVIDEND

With respect to all shares of Common Stock (but excluding, for avoidance of any doubt, any unexercised Awards) allocated or issued upon the exercise of Awards purchased by the Israeli Participant and held by the Israeli Participant or by the Trustee, as the case may be, the Israeli Participant shall be entitled to receive dividends in accordance with the quantity of such shares of Common Stock, subject to the provisions of the Company’s Certificate of Incorporation (and all amendments thereto) and subject to any applicable taxation on distribution of dividends, and when applicable subject to the provisions of   Section 102.

 

10.

TAX CONSEQUENCES

 

10.1

Any tax consequences arising from the grant or exercise of any Award, from the payment for shares of Common Stock covered thereby or from any other event or act (of the Company, and/or its Affiliates, and the Trustee or the Israeli Participant), hereunder, shall be borne solely by the Israeli Participant. The Company and/or its Affiliates and/or the Trustee shall withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source. Furthermore, the Israeli Participant shall agree to indemnify the Company and/or its Affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Israeli Participant.

 

10.2

The Company and/or, when applicable, the Trustee shall not be required to release any share certificate to an Israeli Participant until all required payments have been fully made.

 

10.3

With respect to Unapproved 102 Award, if the Israeli Participant ceases to be employed by the Company or any Affiliate, the Israeli Participant shall extend to the Company and/or its Affiliate a security or guarantee for the payment of tax due at the time of sale of Shares, all in accordance with the provisions of Section 102.

3


 

11.

GOVERNING LAW & JURISDICTION

This Appendix shall be governed by and construed and enforced in accordance with the laws of the State of Delaware applicable to contracts made and to be performed therein, without giving effect to the principles of conflict of laws. The competent courts of the State of Delaware shall have sole jurisdiction in any matters pertaining to this Appendix.

 

12.

DEFINITION

 

12.1

Affiliate means any “employing company” within the meaning of Section 102(a) of the Ordinance.

 

12.2

Approved 102 Award means an Award granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of the Israeli Participant.

 

12.3

Award means any award under the Plan that may be granted to an Israeli Participant, including any Option, Restricted Stock, Stock Bonus, Stock Appreciation Right, Restricted Stock Unit or awards of Performance Shares.

 

12.4

“102 Award” means any Award granted to Employees pursuant to Section 102 of the Ordinance.

 

12.5

“3(i) Award” means an option granted pursuant to Section 3(i) of the Ordinance to any person who is a Non- Employee.

 

12.6

Capital Gain Award” or “CGA means an Approved 102 Award elected and designated by the Company to qualify under the capital gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance.

 

12.7

Controlling Shareholder shall have the meaning ascribed to it in Section 32(9) of the Ordinance.

 

12.8

Employee” means a person who is employed by the Company or its Affiliates, including an individual who is serving as a director or an office holder, but excluding any Controlling Shareholder.

 

12.9

ITA” means the Israeli Tax Authorities.

 

12.10

“Non-Employee” means a consultant, adviser, service provider, Controlling Shareholder or any other person who is not an Employee.

 

12.11

Ordinary Income Award” or “OIA means an Approved 102 Award elected and designated by the Company to qualify under the ordinary income tax treatment in accordance with the provisions of Section 102(b)(1) of the Ordinance.

 

12.12

Ordinance” means the Israeli Income Tax Ordinance [New Version] 1961, as now in effect or as hereafter amended.

 

12.13

“Section 102” means section 102 of the Ordinance and any regulations, rules, orders or procedures promulgated thereunder as now in effect or as hereafter amended or any regulations, rules or orders or procedures promulgated thereunder.

 

12.14

“Trustee” means any individual appointed by the Company to serve as a trustee and approved by the ITA, all in accordance with the provisions of Section 102(a) of the Ordinance.

 

12.15

Unapproved 102 Award means an Award granted pursuant to Section 102(c) of the Ordinance and not held in trust by a Trustee

 

*****

 

4


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF STOCK OPTION GRANT

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Stock Option Grant (the “ Notice ”).

 

Name:

 

Address:

 

You (“ Participant ”) have been granted an option to purchase Shares of Common Stock of the Company under the Plan subject to the terms and conditions of the Plan, this Notice and the Stock Option Award Agreement, including any country‑specific terms and conditions contained in the attached Appendix (together, the “ Agreement ”).

 

Date of Grant:

 

Vesting Commencement Date :

 

Exercise Price per Share :

 

Total Number of Shares :

 

Type of Option :

_____ Non‑Qualified Stock Option (________ Options)

 

_____ Incentive Stock Option (________ Options)

Expiration Date :

 

Post‑Termination Exercise Period :

Termination for Cause = None

 

Voluntary Termination = 3 Months

 

Termination without Cause = 3 Months

 

Disability = 12 Months

 

Death = 12 Months

Vesting Schedule :

Subject to the limitations set forth in this Notice, the Plan and the Agreement, the Option will vest and may be exercised, in whole or in part, in accordance with the following schedule: [INSERT VESTING SCHEDULE]

You acknowledge that the vesting of the Options pursuant to this Notice is earned only by continuing service as an active Employee, Director or Consultant of the Company.  You also understand that this Notice is subject to the terms and conditions of both the Agreement and the Plan, both of which are incorporated herein by reference.  By signing below or electronically accepting the Agreement, you confirm you have read and agreed to the terms and conditions of this Notice, the Agreement and the Plan.

 

PARTICIPANT:

 

IMPERVA, INC.

 

 

 

 

 

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

STOCK OPTION AWARD AGREEMENT

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same defined meanings in this Stock Option Award Agreement, including any country‑specific terms and conditions contained in the attached Appendix (together, the “ Agreement ”).

Participant has been granted an option to purchase Shares (the “ Option ”), subject to the terms and conditions of the Plan, the Notice of Stock Option Grant (the “ Notice ”) and this Agreement.

1. Vesting Rights .  Subject to the applicable provisions of the Plan and this Agreement, this Option may be exercised, in whole or in part, in accordance with the schedule set forth in the Notice.   In the event Participant’s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), Participant’s right to vest in the Option under the Plan, if any, will terminate effective as of the date that Participant is no longer actively providing services and will not be extended by any notice period (e.g., active services would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any); the Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Option grant (including whether Participant may still be considered to be providing services while on an approved leave of absence).

2. Termination Period .

(a) General Rule .  Except as provided below, and subject to the Plan, this Option may be exercised for three months after Participant’s Termination with the Company or any Parent or Subsidiary.  In no event shall this Option be exercised later than the Expiration Date set forth in the Notice.

(b) Death; Disability .  Unless provided otherwise in the Notice, upon Participant’s Termination by reason of his or her Disability or death, or if a Participant dies within three months of the Termination Date, this Option may be exercised for twelve months, provided that in no event shall this Option be exercised later than the Expiration Date set forth in the Notice.

(c) Cause .  Upon Participant’s Termination for Cause, the Option shall expire on such date of Participant’s Termination Date.

(d) Measurement Date .  In the event of Participant’s Termination (whether or not in breach of local labor laws), Participant’s right to exercise the Option after Termination, if any, will be measured by the date of termination of Participant’s active services and will not be extended by any notice period mandated under employment laws in the jurisdiction where Participant is employed or terms of Participant’s employment agreement, if any).

3. Grant of Option .  The Participant named in the Notice has been granted an Option for the number of Shares set forth in the Notice at the exercise price per Share set forth in the Notice (the “ Exercise Price ”).  In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement, the terms and conditions of the Plan shall prevail.  If designated in the Notice as an Incentive Stock Option (“ ISO ”), this Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code.  However, if this Option is intended to be an ISO, to the extent that it exceeds the $100,000 rule of Code Section 422(d) it shall be treated as a Nonqualified Stock Option (“ NSO ”).

4. Exercise of Option .

(a) Right to Exercise .  This Option is exercisable during its term in accordance with the Vesting Schedule set forth in the Notice and the applicable provisions of the Plan and this Agreement.  In the event of Participant’s death, Disability, Termination for Cause or other Termination, the exercisability of the Option is governed by the applicable provisions of the Plan, the Notice and this Agreement.

1


 

(b) Method of Exercise .  This Option is exercisable by delivery of an exercise notice (the “ Exercise Notice ”), which shall state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “ Exercised Shares ”), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan.  The Exercise Notice shall be delivered in person, by mail, via electronic mail or facsimile or by other authorized method to the Secretary of the Company or other person designated by the Company.  The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares.  This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price.

(c) Compliance with Laws .  No Shares shall be issued pursuant to the exercise of this Option unless such issuance and exercise complies with all relevant provisions of securities law and the requirements of any stock exchange or quotation service upon which the Shares are then listed.  Assuming such compliance, for tax purposes the Exercised Shares shall be considered transferred to the Participant on the date the Option is exercised with respect to such Exercised Shares.

(d) Death of Participant .  In the event that the Participant ceases to be employed by, or ceases to provide services to, the Company as a result of the Participant’s death, then the Option may be exercised up to twelve months after Participant’s death by the Participant’s designee, provided that such designee has been designated prior to the Participant’s death on a form prescribed by Company; in the absence of any such effective designation, the Option may be exercised by the beneficiary designated by the Participant with the largest beneficial interest; or, if there is no single beneficiary with a majority or plurality of interest, then the Option may be exercised by the then‑acting trustee of the latest revocable trust established by Participant of which Participant was a beneficiary or, if none, by the administrator or executor of the Participant’s estate.  

5. Method of Payment .  Unless provided otherwise by the Company, in its sole discretion, or in the Appendix, payment of the aggregate Exercise Price shall be by any of the following, or a combination thereof, at the election of the Participant:

(a) cash;

(b) check;

(c) a “broker‑assisted” or “same‑day sale” (as described in Section 11(d) of the Plan); or

(d) other method authorized by the Company.

6. Non‑Transferability of Option .  This Option may not be transferred in any manner other than by will or by the laws of descent or distribution or court order and may be exercised during the lifetime of Participant only by the Participant unless otherwise permitted by the Committee on a case‑by‑case basis.  The terms of the Plan and this Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Participant.  For any transfer by will or the laws of descent or distribution or court order to be binding, the  transferee must furnish the Company with (A) written notice of his or her status as transferee, (B) a copy of the will and/or such evidence as the Committee may deem necessary to establish the validity of the transfer, and (C) an agreement by the transferee to comply with all the terms and conditions of the Option that are or would be applicable to the Participant and to be bound by the acknowledgments made by the Participant hereunder.

7. Term of Option .  This Option shall in any event expire on the expiration date set forth in the Notice, which date is 10 years after the Date of Grant (five years after the Date of Grant if this Option is designated as an ISO in the Notice of Stock Option Grant and Section 5.3 of the Plan applies).

8. Tax Obligations .  Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant’s employer (the “ Employer ”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax related items related to Participant’s participation in the Plan and legally applicable to Participant (“ Tax‑Related Items ”), is and remains Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer.  Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax‑Related Items in connection with any aspect of the Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of

2


 

the Option to reduce or eliminate Participant’s liability for Tax ‑Related Items or achieve any particular tax result.  Further, if Participant is subject to Tax ‑Related Items in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax ‑Related Items in more than one jurisdiction.

Prior to the relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax‑Related Items.  In this regard, Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax‑Related Items by one or a combination of the following:

(a) withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or

(b) withholding from proceeds of the sale of Shares acquired at exercise of the Option either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization) without further consent.

Depending on the withholding method, the Company may withhold or account for Tax‑Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case Participant will receive a refund of any over‑withheld amount in cash and will have no entitlement to the Common Stock equivalent.

Finally, Participant agrees to pay to the Company or the Employer any amount of Tax‑Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if Participant fails to comply with his or her obligations in connection with the Tax‑Related Items.

9. Acknowledgement of Nature of the Grant .  The Company and Participant agree that the Option is granted under and governed by this Agreement and by the provisions of the Plan (incorporated herein by reference).  Participant acknowledges receipt of a copy of the Plan and the Plan prospectus, represents that Participant has carefully read and is familiar with their provisions and hereby accepts the Option subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.  Participant further acknowledges, understands and agrees that:

(a) the Plan is established voluntarily by the Company, it is discretionary in nature, and may be amended, suspended or Terminated by the Company at any time, to the extent permitted by the Plan;

(b) the grant of the Option is voluntary and occasional and does not create any contractual or other right to receive future grants of Options, or benefits in lieu of Options, even if Options have been granted in the past;

(c) all decisions with respect to future Option or other grants, if any, will be at the sole discretion of the Company;

(d) the Option grant and Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or service contract with the Company, the Employer or any Parent, Subsidiary or affiliate of the Company, and shall not interfere with the ability of the Company, the Employer or any Parent, Subsidiary or affiliate of the Company, as applicable, to terminate Participant’s employment or service relationship (if any);

(e) Participant is voluntarily participating in the Plan;

(f) the Option and any Shares acquired under the Plan are not intended to replace any pension rights or compensation;

(g) the Option and any Shares acquired under the Plan and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end‑of‑service payments, bonuses, long‑service awards, pension or retirement or welfare benefits or similar payments;

3


 

(h) the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty;

(i) if the underlying Shares do not increase in value, the Option will have no value;

(j) if Participant exercises the Option and acquires Shares, the value of such Shares of may increase or decrease in value, even below the Exercise Price;

(k) no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from Participant’s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), and in consideration of the grant of the Option to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, its Parent, or any of its Subsidiaries or affiliates or the Employer, waives his or her ability, if any, to bring any such claim, and releases the Company, its Parent, Subsidiaries and affiliates and the Employer from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim;

(l) unless otherwise provided in the Plan or by the Company in its discretion, the Option and the benefits evidenced by this Agreement do not create any entitlement to have the Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Shares; and

(m) the following additional provisions apply only if Participant is providing services outside the United States:

(i) the Option and the Shares subject to the Option are not part of normal or expected compensation or salary for any purpose;

(ii) Participant acknowledges and agrees that neither the Company, the Employer nor any Parent, Subsidiary or affiliate of the Company shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the exercise of the Option or the subsequent sale of any Shares acquired upon exercise.

10. No Advice Regarding Grant .  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares.  Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

11. Data Privacy .   Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Agreement and any other Option grant materials by and among, as applicable, the Employer, the Company and its Parent, Subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan.

Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

Participant understands that Data will be transferred to a designated Plan broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections than Participant’s country.  Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any

4


 

potential recipients of the Data by contacting his or her local human resources representative.  Participant authorizes the Company, its designed Plan broker and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing Participant’s participation in the Plan.  Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan.  Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative.  Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis.  If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant Options or other Awards or administer or maintain such Awards.  Therefore, Participant understands that refusing or withdrawing his or her consent may affect Participant’s ability to participate in the Plan.  For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.

12. Entire Agreement; Enforcement of Rights .  This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between the parties.  Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded.  Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant or any other Plan participant.

13. Compliance with Laws and Regulations .  Notwithstanding any other provision of the Plan or this Agreement, unless there is an available exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver any Shares issuable upon exercise of the Option prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. SEC or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable.  Participant understands that the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares.  Further, Participant agrees that the Company shall have unilateral authority to amend the Plan and the Agreement without Participant’s consent to the extent necessary to comply with securities or other laws applicable to issuance of Shares.

14. Governing Law and Venue; Severability .  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.  In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms.  This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law.  The Option grant and the provisions of this Agreement are governed by, and subject to, the laws of the State of Delaware, without regard to the conflict of law provisions.  For purposes of any action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of San Mateo County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.

15. Electronic Delivery and Acceptance .  The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  Participant hereby consents to

5


 

receive such documents by electronic delivery and agrees to participate in the Plan through an on ‑line or electronic system established and maintained by the Company or a third party designated by the Company.

16. Language .  If Participant has received this Agreement, or any other document related to the Option and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

17. Appendix .  Notwithstanding any provisions in this Agreement, the Option grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for Participant’s country.  Moreover, if Participant relocates to one of the countries included in the Appendix, the special terms and conditions for such country will apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  The Appendix constitutes part of this Agreement.

18. Imposition of Other Requirements .  The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Option and on any Shares acquired upon exercise of the Option, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

By the signature on, or electronic acceptance of, the Notice by each of the Participant and the Company’s representative, Participant and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement.  Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Notice, and fully understands all provisions of the Plan, the Notice and this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and the Agreement.  Participant further agrees to notify the Company upon any change in the residence address indicated on the Notice.

 

 

 

 

6


 

STOCK OPTION AGREEMENT – INTERNATIONAL

APPENDIX A

IMPERVA, INC. 2011 STOCK OPTION AND INCENTIVE PLAN

Special Terms and Conditions for Participants Outside the U.S.

This Appendix includes additional country‑specific terms and conditions that apply to Participants resident in countries listed below.  This Appendix is part of the Agreement and contains terms and conditions material to participation in the Plan.  Unless otherwise provided below, capitalized terms used but not defined herein shall have the same meanings assigned to them in the Plan and the Agreement.

This Appendix includes information regarding exchange controls and certain other issues of which Participant should be aware, and is current as of October 2013.  Participant acknowledges that local exchange control laws may apply to Participant as a result of the acquisition of Shares, opening of an off‑shore bank or brokerage account and acquisition of foreign currency.  By accepting the Options, Participant agrees to comply with applicable exchange control laws associated with participation in the Plan.  Participant further acknowledges that if he or she has any questions regarding his or her responsibilities in this regard, Participant will seek advice from his or her personal legal advisor, at Participant’s own cost, and further agrees that neither the Company, its Parent, any Subsidiary of affiliate or the Employer will be liable for any fines or penalties resulting from Participant’s failure to comply with applicable laws concerning the acquisition and disposition of Shares.

If Participant is a citizen or resident of a country other than the one in which Participant is currently working, transfers employment after the Options are granted or is considered resident of another country for local law purposes, the terms and conditions contained herein may not be applicable to Participant, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply to Participant.

Argentina

Securities Law Information .

Neither the Options nor the underlying Shares are publicly offered or listed on any stock exchange in Argentina.  The offer is private and not subject to the supervision of any Argentine governmental authority.

Method of Payment .

Notwithstanding Section 5.5 of the Plan or Sections 4 and 5 of the Agreement, Participant agrees to pay the Exercise Price and any Tax‑Related Items solely by means of a cashless sell‑all method of exercise.  To complete a cashless sell‑all exercise, Participant must provide irrevocable instructions to the broker to: (i) sell all of the Shares to be issued upon exercise; (ii) use the proceeds to pay the Exercise Price, brokerage fees and any applicable Tax‑Related Items; and (iii) remit the balance in cash to Participant.  Such delivery of the sales proceeds shall be subject to any obligation to satisfy Tax‑Related Items, if any.  Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price.  To the extent that regulatory requirements in Argentina change, the Company reserves the right to permit Participant to exercise the Option and pay the Exercise Price with cash, check, cash equivalent or cashless sell‑to‑cover exercise.

Exchange Control Information .

Provided proceeds from the sale of Shares are held in a U.S. bank or brokerage account for at least 10 days prior to transfer into Argentina, Participant should be able to freely transfer such proceeds into Argentina, although Participant should confirm this with his or her local bank.  Please be aware that the Argentine bank handling the transaction may request certain documentation in connection with the request to transfer sale proceeds into Argentina, including evidence of the sale.

A-1


 

Participant is solely responsible for complying with the exchange control rules that may apply in connection with participation in the Plan and/or transfer of proceeds from the sale of Shares acquired under the Plan into Argentina.  Prior to transferring sale proceeds into Argentina, Participant should consult his or her local bank and/or exchange control advisor to confirm what will be required by the bank as interpretations of the applicable Central Bank regulations vary by bank and exchange control rules and regulations are subject to change without notice.

Tax Reporting Information .

If Participant holds Shares as of December 31 of any year, Participant is required to report the holding of the Shares on his or her tax return for the relevant year.

Australia

Right to Exercise .

Notwithstanding any provision of the Notice or the Agreement, Participant may not exercise any portion of the Option until the Fair Market Value per Share underlying the Option exceeds the Exercise Price per Share.  If the Option vests when the Fair Market Value per Share is equal to or less than the Exercise Price per Share, the Option may be exercised only starting on the business day following the first day on which the Fair Market Value per Share exceeds the Exercise Price per Share.

For the avoidance of doubt, these restrictions on exercise also apply if Participant transfers to Australia from another jurisdiction and becomes subject to taxation in Australia before the Option is fully vested.

Option Term .

Notwithstanding the Expiration Date set forth in the Notice, or the Term of the Option as set forth in Section 7 of the Agreement, the Term/Expiration Date of the Option for Participants subject to tax in Australia will be the day which is the business day prior to the seventh (7th) anniversary of the Date of Grant.

Securities Law Information .

If Participant acquires Shares pursuant to the Option and Participant offers the Shares for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law.  Participant should obtain legal advice on disclosure obligations prior to making any such offer.

Exchange Control Information .

Exchange control reporting is required for cash transactions exceeding A$10,000 and international fund transfers.  The Australian bank assisting with the transaction will file the report.

Brazil

Compliance with Law .

By accepting the Option, Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the exercise of the Option and the sale of the Shares acquired pursuant thereto.

Exchange Control Information .

If Participant is a resident or domiciled in Brazil, he or she will be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank if the aggregate value of the assets and rights is equal to or greater than US$10,000.  Assets and rights that must be reported include Shares.

Canada

Method of Payment .

A-2


 

Notwithstanding Section 5.5 of the Plan, Participant acknowledges that due to regulatory requirements, Participant is prohibited from surrendering Shares that Participant owns and from attesting to the ownership of Shares to pay the Exercise Price and any Tax ‑Related Items under the Option.

Sale of Shares .

Participant acknowledges that he or she is permitted to sell the Shares acquired under the Plan through the designated broker appointed by the Company, provided the sale of the Shares takes place outside of Canada through facilities of a stock exchange on which the Shares are listed.

The following provision replaces Section 2(d) of the Agreement:

Measurement Date .

In the event that Participant’s service terminates (for any reason and whether or not later found to be invalid or in breach of Canadian laws or the terms of the Participant’s employment agreement, if any), any unvested portion of the Option shall be immediately forfeited without consideration.  For purposes of the preceding sentence, Participant’s right to vest in the Option will terminate effective as of the date that is the earlier of (i) the date of Participant’s termination, (ii) the date Participant receives notice of termination as an active Employee, Director or Consultant of the Company, or (iii) the date Participant is no longer actively providing service and will not be extended by any notice period (e.g., active service would not include any contractual notice period or any period of “garden leave” or similar period mandated under Canadian laws or the terms of Participant’s employment agreement, if any); the Company shall have the exclusive discretion to determine when Participant is no longer actively providing service for purposes of the Option.

Consent to Receive Information in English for Quebec Employees

Participant acknowledges that it is the express wish of the parties that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be written in English.

Le participant reconnaît que c’est son souhait exprès d’avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents exécutés, avis donnés et procédures judiciaries intentées, directement ou indirectement, relativement à ou suite à la présente convention.

Authorization to Release and Transfer Necessary Personal Information for Quebec Employees .

The following provision supplements Section 11 of the Agreement:

Participant hereby authorizes the Company and the Company’s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  Participant further authorizes the Company, any Parent, Subsidiary or affiliate and the administrator of the Plan to disclose and discuss the Plan with their advisors.  Participant further authorizes t he Company and any Parent, Subsidiary or affiliate to record such information and to keep such information in Participant’s Employee file.

Foreign Assets Reporting Information .

Participant is required to report to the tax authorities any foreign property (including the Option and Shares) on form T1135 (Foreign Income Verification Statement) if the total value of the foreign property exceeds C$100,000 at any time in the year.  The form must be filed by April 30 of the following year.  Participant is advised to consult with his or her personal legal advisor to ensure compliance with applicable reporting obligations.

Colombia

Labor Laws Acknowledgement .

Participant acknowledges that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not cons titute a component of “salary” for any purpose.

A-3


 

Exchange Control Information .

Investments in assets located abroad (including Shares) are subject to registration with the Bank of the Republic if the Participant’s aggregate investments held abroad (as of December 31 of the applicable calendar year) equal or exceed US$500,000.  Upon sale or other disposition of investments (including Shares) which have been registered with the Central Bank, the registration with the Central Bank must be cancelled no later than March 31 of the year following the sale or disposition (or a fine of up to 200% of the value of the infringing payment will apply).  If funds are remitted from Colombia through an authorized local financial institution, the authorized financial institution will automatically register the investment.

Denmark

Labor Law Acknowledgment .

This provision supplements Section 9 of the Agreement:

By signing or electronically accepting the Agreement, Participant acknowledges that he or she understands and agrees that the Option relates to future services to be performed and is not a bonus or compensation for past services.

Stock Option Act .

Participant acknowledges that he or she received an Employer Statement in Danish which sets forth the terms of the Option.

Foreign Bank Account Reporting .

If Participant establishes an account holding Shares or an account holding cash outside Denmark, Participant must report the account to the Danish Tax Administration.  The form which should be used in this respect can be obtained from a local bank.  (Please note that these obligations are separate from and in addition to the obligations described below.)

Exchange Control and Tax Reporting Notification .

Participant may hold Shares acquired under the Plan in a safety‑deposit account ( e.g. , a brokerage account) with either a Danish bank or with an approved foreign broker or bank.  If the Shares are held with a non‑Danish broker or bank, Participant is required to inform the Danish Tax Administration about the safety‑deposit account.  For this purpose, Participant must file a Declaration V (Erklaering V) with the Danish Tax Administration.  Both Participant and the bank/broker must sign the Declaration V.  By signing the Declaration V, the bank/broker undertakes an obligation, without further request each year not later than on February 1 of the year following the calendar year to which the information relates, to forward certain information to the Danish Tax Administration concerning the content of the safety‑deposit account.  In the event that the applicable broker or bank with which the safety‑deposit account is held does not wish to, or, pursuant to the laws of the country in question, is not allowed to assume such obligation to report, Participant acknowledges that he or she is solely responsible for providing certain details regarding the foreign brokerage or bank account and any Shares acquired at exercise and held in such account to the Danish Tax Administration as part of Participant’s annual income tax return.  By signing the Form V, Participant at the same time authorizes the Danish Tax Administration to examine the account.  A sample of the Declaration V can be found at the following website: http://www.skat.dk/getFile.aspx?Id=82915.

In addition, when Participant opens a deposit account or a brokerage account for the purpose of holding cash outside of Denmark, the bank or brokerage account, as applicable, will be treated as a deposit account because cash can be held in the account.  Therefore, Participant must also file a Declaration K (Erklaering K) with the Danish Tax Administration.  Both Participant and the bank/broker must sign the Declaration K.  By signing the Declaration K, the bank/broker undertakes an obligation, without further request each year, not later than on February 1 of the year following the calendar year to which the information relates, to forward certain information to the Danish Tax Administration concerning the content of the deposit account.  In the event that the applicable financial institution (broker or bank) with which the account is held, does not wish to, or, pursuant to the laws of the country in question, is not allowed to assume such obligation to report, Participant acknowledges that he or she is solely responsible for providing certain details regarding the foreign brokerage or bank account to the Danish Tax Administration as part

A-4


 

of Participants annual income tax return.  By signing the Declaration K, Participant at the same time authorizes the Danish Tax Administration to examine the account.  A sample of Declaration K can be found at the following website: http://www.skat.dk/getFile.aspx?Id=109434.

France

Consent to Receive Information in English .

By signing and/or electronically accepting the Agreement, Participant confirms having read and understood the documents relating to this grant (the Plan and this Agreement) which were provided in English language.  Participant accepts the terms of those documents accordingly.  Please note that Participant’s Options are not French qualified awards.

En signant et renvoyant le présent document décrivant les termes et conditions de l’attribution d’options, le participant confirme ainsi avoir lu et compris les documents relatifs à cette attribution (le Plan U.S. et ce contrat d’options) qui ont été communiqués en langue anglaise.  Le participant accepte les termes en connaissance de cause.

Exchange Control Information .

Participant may hold Shares purchased under the Plan outside of France provided that Participant annually declares all foreign bank and stock accounts, whether open, current or closed, together with Participant’s personal income tax returns.  Participant must also declare to the customs and excise authorities any cash or securities that Participant imports or exports without the use of a financial institution when the value of the cash or securities is equal to or exceeds €10,000.

Germany

Exchange Control Information .  Cross‑border payments in excess of €12,500, including any cross‑border payments received in connection with the sale of Shares acquired under the Plan or any dividends paid on such Shares, must be reported monthly to the German Federal Bank ( Bundesbank ).  In case of payments in connection with securities or financial derivatives, the report must be made by the 5th day of the month following the month in which the payment was received.  Effective from September 2013, the report must be filed electronically.  The form of report (“ Allgemeine Meldeportal Statistik ”) can be accessed via the Bundesbank’s website ( www.bundesbank.de ) and is available in both German and English.

Hong Kong

WARNING:    The Option and any Shares acquired upon exercise do not constitute a public offering of securities under Hong Kong law and are available only to eligible individuals employed or engaged by the Company, its Parent, or its Subsidiaries and affiliates.  The Plan, the Agreement, including this Appendix, and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong nor have the documents been reviewed by any regulatory authority in Hong Kong.  The Option is intended only for the personal use of Participant and may not be distributed to any other person.  Participant is advised to exercise caution in relation to the offer.  If Participant is in any doubt about any of the contents of the Plan, the Agreement, including this Appendix, or other incidental communication materials, Participant should obtain independent professional advice.

Exercise of Option.

The following provision supplements Section 4 of the Agreement:

In the event the Option is exercised and Shares are issued to Participant within six (6) months of the Date of Grant, Participant agrees not to sell or otherwise dispose of the Shares prior to the six (6) month anniversary of the Date of Grant.

A-5


 

India

Method of Payment.

To facilitate compliance with exchange control regulations in India, Participant agrees to pay the Exercise Price and any Tax‑Related Items solely by means of a cashless sell‑all method of exercise.  To complete a cashless sell‑all exercise, Participant must provide irrevocable instructions to the broker to: (i) sell all of the Shares to be issued upon exercise; (ii) use the proceeds to pay the Exercise Price, brokerage fees and any applicable Tax‑Related Items (see below); and (iii) remit the balance in cash to Participant.  Such delivery of the sales proceeds shall be subject to any obligation to satisfy Tax‑Related Items.  Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price.  To the extent that regulatory requirements in India change, the Company reserves the right to permit Participant to exercise the Option and pay the Exercise Price with cash, check, cash equivalent or cashless sell‑to‑cover exercise.

Exchange Control Notification .

If Participant remits funds out of India to exercise the Option, it is Participant’s responsibility to comply with applicable exchange control requirements of the Reserve Bank of India.  Regardless of the method of exercise used to purchase the Shares, Participant understands that Participant must repatriate any proceeds from the sale of Shares acquired under the Plan to India within 90 days of receipt.  Participant must obtain a foreign inward remittance certificate (“ FIRC ”) from the bank where Participant deposits the funds and must maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India, the Company or any Parent, Subsidiary or affiliate requests proof of repatriation.

Tax Obligations .

The following provision replaces Section 8 of the Agreement for independent contractors:

If Participant is serving as an independent contractor, not an Employee, he or she acknowledges and agrees to accept all liability for income tax, social insurance, payroll tax, fringe benefits, payment on account or other tax‑related items arising out of Participant’s participation in the Plan and the acquisition of Shares (“ Tax‑Related Items ”).  Participant agrees that the Company and any Parent, Subsidiary or affiliate to which Participant provides services have no obligation to withhold or otherwise satisfy any Tax‑Related Items due as a result of Participant’s participation in the Plan and the acquisition of Shares.  Participant further acknowledges that the Company and/or any Parent, Subsidiary or affiliate retaining Participant (1) make no representations or undertakings regarding the treatment of any Tax‑Related Items in connection with any aspect of the award of Shares, including, but not limited to, the issuance of the Shares and the sale of Shares; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Shares to reduce or eliminate Participant’s liability for Tax‑Related Items or achieve any particular tax result.

Participant agrees to pay or make adequate arrangements to satisfy all Tax‑Related Items.  If, notwithstanding this agreement, the Company and/or the Subsidiary are held liable for any Tax‑Related Items due on the Shares resulting from a determination that Participant is not an independent contractor or any other reason, Participant agrees to indemnify and hold harmless the Company and any Parent, Subsidiary or affiliate to the extent of any obligation imposed on the Company or any Parent, Subsidiary or affiliate to pay any Tax‑Related Items due on the Shares.

Foreign Asset/Account Reporting Information .

Participant is required to declare any foreign bank accounts and any foreign financial assets (including Shares held outside India) in Participant’s annual tax return.  Participant is responsible for complying with this reporting obligation and is advised to confer with his or her personal tax advisor in this regard.

Israel

Trust Arrangement .

Participant understands and agrees that the Options awarded under the Agreement are awarded subject to and in accordance with the terms and conditions of the Plan, the Appendix A to the Plan for Israel (the “ Sub‑Plan ”), the

A-6


 

Trust Agreement (the “ Trust Agreement ”) between the Company and the Company’s trustee appointed by the Company or its Subsidiary in Israel (the “ Trustee ”) and the Agreement, or any successor trustee.  In the event of any inconsistencies between the Sub ‑Plan, the Agreement and/or the Plan, the Sub ‑Plan will govern.

Nature of Grant .

The following provisions supplement Section 9 of the Agreement:

The Options are intended to qualify for favorable tax treatment in Israel as a “ Capital Gain Award ” (as defined in the Sub‑Plan) subject to the terms and conditions of Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 (“ Section 102 ”) and the rules promulgated thereunder.  Notwithstanding the foregoing, by accepting the Options, Participant acknowledges that the Company cannot guarantee or represent that the favorable tax treatment under Section 102 will apply to the Options.

By accepting the Options, Participant: (a) acknowledges receipt of and represents that Participant has read and is familiar with the terms and provisions of Section 102, the Plan, the Sub‑Plan, the Trust Agreement and the Agreement; (b) accepts the Options subject to all of the terms and conditions of the Agreement, the Plan, the Sub‑Plan, the Trust Agreement and Section 102 and the rules promulgated thereunder; and (c) agrees that the Options and/or any Shares issued in connection therewith, will be registered for the benefit of Participant in the name of the Trustee as required to qualify under Section 102.

Participant hereby undertakes to release the Trustee from any liability in respect of any action or decision duly taken and bona fide executed in relation to the Plan, or any Options or Share granted thereunder.  Participant agrees to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102 and the Income Tax Ordinance (New Version) – 1961 (“ ITO ”).

Payment .

Notwithstanding Section 4 of the Agreement, if the exercise of the Options occurs during the “ Holding Period ” (as defined in the Sub‑Plan), the Shares issued upon the exercise of the Options shall be issued to Participant and held in trust for the Holding Period.  After termination of the Holding Period, the Trustee may release the Options and any Shares issued with respect thereto under the terms set forth in the Sub‑Plan, and in accordance with the terms and conditions of the 102 Capital Gains Track, the ITO and any approval by the Israeli Tax Authority (“ ITA ”).

In the event that such exercise occurs after the end of the Holding Period, the Shares issued upon exercise of the Options shall either (i) be deposited with the Trustee, or (ii) be transferred to Participant directly or into a brokerage account in his or her name, provided that Participant first complies with his or her obligations for Tax‑Related Items.

In the event that Participant elects to have the Shares transferred to Participant without selling such Shares, Participant shall become liable to pay Tax‑Related Items immediately in accordance with the provisions of the ITO.  Participant will not be entitled to receive the Shares prior to the full payment of Tax‑Related Items and neither the Company nor the Trustee shall be required to release any Shares to Participant until all payments required to be made under the ITO have been fully satisfied.

Data Privacy .

The following provision supplements Section 11 of the Agreement:

Without derogating from the scope of Section 11 of the Agreement, Participant hereby explicitly consents to the transfer of Data between the Company, the Trustee, and/or a designated Plan broker, including any requisite transfer of such Data outside of the Participant’s country and further transfers thereafter as may be required to a broker or other third party.

A-7


 

Electronic Delivery and Acceptance .

The following provision supplements Section 15 of the Agreement.

To the extent required pursuant to Israeli tax law and/or by the Trustee, Participant consents and agrees to deliver hard‑copy written notices and/or actual copies of any notices or confirmations provided by Participant related to his or her participation in the Plan.

Securities Law Information

The Options are offered in accordance with an exemption from the requirement to publish a prospectus which the Company received from the Israel Securities Authority on January 26, 2012, under Section 15D of the Israeli Securities Law, 1968.

The Shares available under the Plan are registered in the U.S. pursuant to the Form S‑8 registration statement which was filed with the U.S. Securities and Exchange Commission on February 21, 2013.

Participant may obtain a copy of the Plan and the Form S‑8s, including the documents referenced therein, from the Company’s intranet site located at: https://compass.imperva.com/community/legal/ stock_plan_prospectuses

These documents are also available at Participant’s local office.

Italy

Method of Payment .

Notwithstanding Section 5.5 of the Plan or Sections 4 and 5 of the Agreement, Participant agrees to pay the Exercise Price and any Tax‑Related Items solely by means of a cashless sell‑all method of exercise.  To complete a cashless sell‑all exercise, Participant must provide irrevocable instructions to the broker to: (i) sell all of the Shares to be issued upon exercise; (ii) use the proceeds to pay the Exercise Price, brokerage fees and any applicable Tax‑Related Items; and (iii) remit the balance in cash to Participant.  Such delivery of the sales proceeds shall be subject to any obligation to satisfy Tax‑Related Items.  Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price.  To the extent that regulatory requirements in Italy change, the Company reserves the right to permit Participant to exercise the Option and pay the Exercise Price with cash, check, cash equivalent or cashless sell‑to‑cover exercise.

Authorization to Release and Transfer Necessary Personal Information .

The following provision replaces in its entirety Section 11 of the Agreement:

Participant understands that the Employer and/or the Company may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social security number (or any other social or national identification number), salary, nationality, job title, number of Shares held and the details of all Options or any other entitlement to Shares awarded, cancelled, exercised, vested, unvested or outstanding (the “Data”) for the purpose of implementing, administering and managing Participant’s participation in the Plan.  Participant is aware that providing the Company with Participant’s Data is necessary for the performance of the Agreement and that Participant’s refusal to provide such Data would make it impossible for the Company to perform its contractual obligations and may affect Participant’s ability to participate in the Plan.

The Controller of personal data processing is Imperva, Inc., 1194 3400 Bridge Parkway, Suite 200, Redwood Shores, CA 94065, U.S.A., and, pursuant to D.lgs 196/2003, its representative in Italy is Imperva Italy s.r.l., Via Felice Casati 20, 20124 Milan o, Italy.  Participant understands that the Data may be transferred to the Company or any of its Parent, Subsidiaries or affiliates, or to any third parties assisting in the implementation, administration and management of the Plan, including any transfer required to a broker or other third party with whom Shares acquired pursuant to the vesting of the Options or cash from the sale of such Shares may be deposited.  Furthermore, the recipients that may receive, possess, use, retain and transfer such Data for the above

A-8


 

mentioned purposes may be located in Italy or elsewhere, including outside of the European Union and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than Participant’s country.  The processing activity, including the transfer of Participant’s personal data abroad, outside of the European Union, as herein specified and pursuant to applicable laws and regulations, does not require Participant’s consent thereto as the processing is necessary for the performance of contractual obligations related to the implementation, administration and management of the Plan.  Participant understands that Data processing relating to the purposes above specified shall take place under automated or non ‑automated conditions, anonymously when possible, that comply with the purposes for which Data are collected and with confidentiality and security provisions as set forth by applicable laws and regulations, with specific reference to D.lgs. 196/2003.

Participant understands that Data will be held only as long as is required by law or as necessary to implement, administer and manage Participant’s participation in the Plan.  Participant understands that pursuant to art.7 of D.lgs 196/2003, Participant has the right, including but not limited to, access, delete, update, request the rectification of Participant’s Data and cease, for legitimate reasons, the Data processing.  Furthermore, Participant is aware that Participant’s Data will not be used for direct marketing purposes.  In addition, the Data provided can be reviewed and questions or complaints can be addressed by contacting a local human resources representative.

Plan Document Acknowledgment .

In accepting the Options, Participant acknowledges that Participant has received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement, including this Appendix, in their entirety and fully understands and accepts all provisions of the Plan and the Agreement, including this Appendix.  Participant further acknowledges that Participant has read and specifically and expressly approves the following sections of the Agreement:  Section 1: Vesting Rights, Section 2: Termination Period, Section 3: Grant of Options, Section 4: Exercise of Option, Section 6: Non‑Transferability of Options, Section 7: Term of Option, Section 8: Tax Obligations, Section 9: Acknowledgement of Nature of the Grant, Section 10: No Advice Regarding Grant, Section 12:  Entire Agreement, Enforcement of Rights, Section 13: Compliance with Laws and Regulations, Section 14: Governing Law and Venue; Severability, Section 15: Electronic Delivery and Acceptance, Section 16: Language, Section 17: Appendix, Section 18: Imposition of Other Requirements and the Data Privacy provisions above.

Exchange Control Information .

Participant is required to report the following on his or her annual tax return (Form UNICO, Schedule RW) or on a special form if no tax return is required: (1) any transfers of cash or Shares to or from Italy exceeding €10,000, (2) any foreign investments or investments held outside of Italy at the end of the calendar year exceeding €10,000 if such investments (cash or Shares) may result in income taxable in Italy, and (3) the amount of the transfers to and from abroad which have had an impact during the calendar year on Participant’s foreign investments or investments held outside of Italy, to the extent that the overall amount of the transfers exceed €10,000.  Under certain circumstances, Participant may be exempt from the requirement under (1) above if the transfer or investment is made through an authorized broker resident in Italy.

Tax on Foreign Financial Assets .

Effective from 2011, a tax on the value of the financial assets held outside of Italy by individuals resident of Italy has been introduced.  Such tax is levied at an annual rate of 1.5 per thousand (0.15%) starting from 2013.  The taxable amount will be the fair market value of the financial assets (including Shares) assessed at the end of the calendar year.

Japan

Exchange Control Information .

If Participant pays more than ¥30,000,000 for the purchase of Shares in any one transaction, he or she must file an ex post facto Payment Report with the Ministry of Finance (through the Bank of Japan or the bank carrying out the transaction).  The precise reporting requirements vary depending on whether the relevant payment is made through a

A-9


 

bank in Japan.  If Participant acquires Shares whose value exceeds ¥100,000,000 in a single transaction, he or she must also file an ex post facto Report Concerning Acquisition of Shares with the Ministry of Finance through the Bank of Japan within 20 days of acquiring the Shares.  The forms to make these reports can be acquired at the Bank of Japan.

A Payment Report is required independently of a Report Concerning Acquisition of Securities.  Consequently, if the total amount that Participant pays on a one‑time basis at exercise of the Option exceeds ¥100,000,000, he or she must file both a Payment Report and a Report Concerning Acquisition of Securities.

Foreign Asset/Account Reporting .

Participant is required to report details of any assets held outside Japan as of December 31 (including Shares acquired under the Plan), to the extent such assets have a total net fair market value exceeding ¥50,000,000.  Such report will be due by March 15 each year.  Participant should consult with his or her personal tax advisor to determine if the reporting obligation applies in Participant’s situation.

Korea

Exchange Control Information .

Exchange control laws require Korean residents who realize US$500,000 or more from the sale of Shares or the receipt of dividends in a single transaction to repatriate the sale proceeds back to Korea within eighteen months of the sale/receipt.

Mexico

Acknowledgements .

This provision supplements Section 9 of the Agreement:

By accepting the Option, Participant acknowledges that he or she has received a copy of the Plan and the Agreement, including this Exhibit B, which he or she has reviewed.  Participant further acknowledges that he or she accepts all the provisions of the Plan and the Agreement, including this Appendix.  Participant also acknowledges that he or she has read and specifically and expressly approves the terms and conditions set forth in Section 9 of the Agreement, which clearly provide as follows:

 

1.

Participant’s participation in the Plan does not constitute an acquired right;

 

2.

The Plan and Participant’s participation in it are offered by the Company on a wholly discretionary basis;

 

3.

Participant’s participation in the Plan is voluntary; and

 

4.

The Company and its Subsidiaries are not responsible for any decrease in the value of any Shares acquired upon exercise of the Option.

Service Acknowledgement and Policy Statement .

By accepting the Option, Participant acknowledges that Imperva, Inc. with registered offices at 3400 Bridge Parkway, Suite 200, Redwood Shores, CA  94065, U.S.A, is solely responsible for the administration of the Plan.  Participant further acknowledges that his or her participation in the Plan, the grant of the Option and any acquisition of Shares under the Plan do not constitute a service contract and does not guarantee Participant the right to continue his or her service with the Company because Participant is participating in the Plan on a wholly commercial basis.  Based on the foregoing, Participant expressly acknowledges that the Plan and the benefits that he or she may derive from participation in the Plan do not establish any rights between Participant and the Company, and do not form part of any service contract between the Participant and the Company or any Parent or Subsidiary of the Company, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of Participant’s service contract.

A-10


 

Participant further understands that his or her participation in the Plan is the result of a unilateral and discretionary decision of the Company and, therefore, the Company reserves the absolute right to amend and/or discontinue Participant’s participation in the Plan at any time, without any liability to Participant.

Finally, Participant hereby declares that he or she does not reserve to him or herself any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and that he or she therefore grants a full and broad release to the Company, any Parent or Subsidiaries, affiliates, branches, representation offices, shareholders, officers, agents and legal representatives, with respect to any claim that may arise.

Spanish Translation

Reconocimientos .

Esta disposición suplementa la sección 9 del Contrato:

Al aceptar la Opción, el Partícipe reconoce que ha recibido una copia del Plan y del Contrato, incluyendo este Anexo B, que ha sido revisado por el Partícipe.  El Partícipe reconoce, además, que acepta todas las disposiciones del Plan y del Contrato, incluyendo este Anexo.  El Partícipe también reconoce que ha leído la sección 9 del Contrato y específica y expresamente aprueba los términos y condiciones establecidos en dicha Sección, que claramente establece lo siguiente:

 

1.

La participación del Partícipe en el Plan no constituye un derecho adquirido;

 

2.

El Plan y la participación del Partícipe en el Plan se ofrecen por la Compañía de manera totalmente discrecional;

 

3.

La participación del Partícipe en el Plan es voluntaria; y

 

4.

La Compañía y sus Subsidiarias no son responsables por cualquier disminución en el valor de las Acciones adquiridas al ejercer la Opción.

Reconocimiento de Ley Laboral y Declaración de Política .

Al aceptar la Opción, el Partícipe reconoce que Imperva, Inc., con oficinas registradas en 3400 Bridge Parkway, Suite 200, Redwood Shores, CA  94065, EE.UU., es únicamente responsable por la administración del Plan.  Además, el Partícipe reconoce que su participación en el Plan, el otorgamiento de la Opción y cualquier adquisición de Acciones de conformidad con el Plan no constituyen un contrato de servicios y no garantizan el derecho del Partícipe de continuar prestando sus servicios a la Compañía, ya que el Partícipe está participando en el Plan en sobre una base exclusivamente comercial.  Con base en lo anterior, el Partícipe  expresamente reconoce que el Plan y los beneficios que le deriven de la participación en el Plan no establecen derecho alguno entre el Partícipe y la Compañía y no forman parte de ningún contrato de servicios celebrado entre el Partícipe y la Compañía o cualquier Matriz o Subsidiaria de la Compañía, y cualquier modificación del Plan o su terminación no constituirá un cambio o deterioro de los términos y condiciones del contrato de servicios del Partícipe.

Además, el Partícipe entiende que su participación en el Plan es resultado de una decisión unilateral y discrecional de la Compañía y, por lo tanto, la Compañía se reserva el derecho absoluto de modificar y/o discontinuar la participación del Partícipe en el Plan en cualquier momento, sin responsabilidad alguna para con el Partícipe.

Finalmente, el Partícipe en este acto manifiesta que no se reserva ninguna acción o derecho para interponer una demanda o reclamación en contra de la Compañía por cualquier compensación o daño o perjuicio en relación con cualquier disposición del Plan o los beneficios derivados del Plan y, en consecuencia, otorga un amplio y total finiquito a la Compañía, cualesquier Matriz o Subsidiarias, afiliadas, sucursales, oficinas de representación, accionistas, directores, funcionarios, agentes y representantes con respecto a cualquier demanda o reclamación que pudiera surgir.

A-11


 

Netherlands

Consent to Comply with Dutch Securities Law .

Participant has been granted Options under the Plan, pursuant to which Participant may acquire Shares.  Participants who are residents of the Netherlands should be aware of the Dutch Insider trading rules, which may impact the sale of such Shares.  In particular, Participant may be prohibited from effecting certain Share transactions if Participant has Insider information regarding the Company.

Below is a discussion of the applicable restrictions.  Participant is advised to read the discussion carefully to determine whether the Insider rules apply to Participant.  If it is uncertain whether the Insider rules apply, the Company recommends that Participant consult with his or her personal legal advisor.  Please note that the Company cannot be held liable if Participant violates the Dutch Insider rules.  Participant is responsible for ensuring compliance with these rules.

By entering into the Agreement and participating in the Plan, Participant acknowledges having read and understood the notification below and acknowledges that it is his or her own responsibility to comply with the Dutch Insider trading rules, as discussed herein.

Prohibition Against Insider Trading .

Dutch securities laws prohibit Insider trading.  Under Article 5:56 of the Dutch Financial Supervision Act, anyone who has “Inside information” related to the Company is prohibited from effectuating a transaction in securities in or from the Netherlands.  “Inside information” is knowledge of specific information concerning the issuer to which the securities relate that is not public and which, if published, would reasonably be expected to affect the Share price, regardless of the actual effect on the price.  The Insider could be any Employee of the Company or its Dutch Subsidiary who has inside information as described above.

Given the broad scope of the definition of inside information, certain Employees of the Company working at its Dutch Subsidiary may have inside information and thus, would be prohibited from effectuating a transaction in securities in the Netherlands at a time when he or she had such Inside information.

Panama

Securities Law Notification .

The Options and any Shares which may be issued to Participant upon exercise are not subject to registration under Panamanian law as they are not intended for the public, but solely for Participant’s benefit.

Poland

Exchange Control Information .

Polish residents holding foreign securities (including Shares) and maintaining accounts abroad must report information to the National Bank of Poland on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets held abroad) exceeds a specified threshold (currently PLN7,000,000).  If required, the reports are due on a quarterly basis on special forms available on the website of the National Bank of Poland.  Further, any transfer of funds in excess of a specified threshold (currently €15,000) must be effected through a bank account in Poland.  Participant should maintain evidence of such foreign exchange transactions for five (5) years, in case of a request for their production by the National Bank of Poland.

Russia

U.S. Transaction .

A-12


 

Participant understands that the grant of the Options is a right to receive Shares if certain conditions are met and that the offer is made by the Company in the United States.  Upon exercise of the Option, any Shares to be issued to Participant shall be delivered to Participant through a brokerage account in the United States.

Exchange Control Information .

Upon the sale of Shares acquired under the Plan, Participant must repatriate the proceeds of the sale back to Russia within a reasonably short time after receipt.  Participant may remit proceeds to Participant’s foreign currency account at an authorized bank in Russia or in a foreign bank account opened in accordance with Russian exchange control laws.  Participant is encouraged to contact Participant’s personal advisor before remitting Participant’s sale proceeds to Russia.

Securities Law Information .

Participant is not permitted to sell Shares directly to other Russian legal entities or residents.

The grant of the Option and the distribution of the Plan and all other materials Participant may receive regarding participation in the Plan do not constitute an offering or the advertising of securities in Russia.  The issuance of Shares pursuant to the Plan has not and will not be registered in Russia and, therefore, the Shares may not be used for an offering or public circulation in Russia.  In no event will Shares be delivered to Participant in Russia; all Shares acquired under the Plan will be maintained on Participant’s behalf in the United States.

Labor Law Information .

If Participant continues to hold Shares after involuntary Termination, Participant may not be eligible to receive unemployment benefits in Russia.

Singapore

Securities Law Notice .

The Options are being granted pursuant to the “Qualifying Person” exemption under Section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (“ SFA ”).  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Participant should note that such Option grant is subject to Section 257 of the SFA and the Participant will not be able to make any subsequent sale in Singapore, or any offer of such subsequent sale of the Shares in Singapore, or any offer of the Shares underlying the Options unless such sale or offer in Singapore is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than Section 280) of the SFA.

Director Reporting Notice .

If Participant is a director, associate director or shadow director of a Singapore Subsidiary of the Company, as the terms are used in the Singapore Companies Act (the “ SCA ”), Participant agrees to comply with notification requirements under the SCA.  Among these requirements is an obligation to notify the Singapore Subsidiary in writing when Participant receives an interest ( e.g ., Options, Shares) in the Company or any related companies (including when Participant sells Shares acquired through exercise of the Option).  In addition, Participant must notify the Singapore Subsidiary when Participant sells or receives Shares of the Company or any related company (including when Participant sells or receives Shares acquired under the Plan).  These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company.  In addition, a notification must be made of Participant’s interests in the Company or any related company within two business days of becoming a director.

Insider Trading Notice .

Participant should be aware of the Singaporean Insider‑trading rules, which may impact Participant’s acquisition or disposal of Shares or rights to Shares under the Plan.  Under the Singaporean Insider‑trading rules, Participant is prohibited from acquiring or selling Shares or rights to Shares ( e.g., an Option under the Plan) when Participant is in

A-13


 

possession of information that is not generally available and that Participant knows or should know will have a material effect on the price of Shares once such information is generally available.

South Africa

Tax Obligations .

The following provision supplements Section 8 of the Agreement:

If Participant is an Employee, he or she must notify the Employer of the amount of any gain realized at exercise of the Option.  If Participant fails to advise the Employer of the gain realized at exercise of the Option, he or she may be liable for a fine.  Participant will be responsible for paying any difference between the actual tax liability and the amount withheld.

Tax Clearance for Cash Exercises .    If Participant pays the Exercise Price by cash or check (or other cash equivalent), Participant may need to obtain and provide to the Company or a third party designated by the Company, a Tax Clearance Certificate (with respect to Foreign Investments) bearing the official stamp and signature of the Exchange Control Department of the South African Revenue Service (“ SARS ”).  Participant must renew this Tax Clearance Certificate every six (6) months, or at such other interval as may be required by the SARS.  If Participant pays the Exercise Price by way of a “broker assisted” or “same‑day sale” (cashless) exercise whereby no funds are remitted out of South Africa, no Tax Clearance Certificate is required.

Exchange Control Information .

South African residents may invest a maximum of ZAR4,000,000 per annum 1 in offshore investments, including Shares.  This is a cumulative allowance; therefore, Participant’s ability to remit funds to exercise the Option and purchase Shares will be reduced if his or her allowance is utilized for offshore investments that are unrelated to the Plan.  If Participant wishes to pay the Exercise Price by cash or check (or cash equivalent) and the ZAR4,000,000 limit will be exceeded upon making such payment, Participant may still transfer funds for the purchase of Shares provided that the Shares are immediately sold and the full proceeds are repatriated to South Africa.  There is no repatriation requirement on the sale proceeds if the ZAR4,000,000 limit is not exceeded.  If Participant pays the Exercise Price by a “broker assisted” or “same‑day sale” (cashless) exercise method, the value of the Shares purchased will not count against the offshore investment allowance.

Participant should consult his or her personal advisor to ensure compliance with applicable exchange control regulations in South Africa, as such regulations are subject to frequent change.  Participant is solely responsible for complying with all exchange control laws in South Africa, and neither the Company nor any Parent or Subsidiary will be liable for any fines or penalties resulting from Participant’s failure to comply with South African exchange control laws.

Spain

No Entitlement for Claims or Compensation .

The following provisions supplement Sections 1, 2 and 9 of the Agreement:

By accepting the Option, Participant consents to participation in the Plan and acknowledges that Participant has received a copy of the Plan document.

Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant Options under the Plan to individuals who may be Employees, Directors or Consultants throughout the world.  The decision is limited and entered into based upon the express assumption and condition that any Options will not

 

1  

Pursuant to recent legislative changes, the allowances available to individuals (such as foreign investment) will be consolidated into one amount of ZAR5,000,000 per annum, with the first ZAR1,000,000 requiring no prior authorization.

 

A-14


 

economically or otherwise bind the Company or any Parent, Subsidiary or affiliate, including the Employer, on an ongoing basis, other than as expressly set forth in the Agreement.  Consequently, Participant understands that the Options are granted on the assumption and condition that the Option shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or affiliate, including the Employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Furthermore, Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the grant of the Option, which is gratuitous and discretionary, since the future value of the Option and the underlying Shares is unknown and unpredictable.  Participant also understands that the grant of the Option would not be made but for the assumptions and conditions set forth hereinabove; thus, Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Option and any right to the underlying Shares shall be null and void.

Subject to the applicable provisions of the Plan and this Agreement, P articipant understands and agrees that Termination of Participant’s status as an Employee for any reason (including for the reasons listed below) prior to the vesting date will automatically result in the loss of the unvested Options that may have been granted to Participant.  In particular, Participant understands and agrees that any unvested Options shall be forfeited without entitlement to the underlying Shares or to any amount as indemnification in the event of a Termination of status as an Employee, including, but not limited to: resignation, disciplinary dismissal adjudged to be with Cause, disciplinary dismissal adjudged or recognized to be without Cause, individual or collective layoff on objective grounds, whether adjudged to be with Cause or adjudged or recognized to be without Cause, material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Employer, and under Article 10.3 of Royal Decree 1382/1985.

 

Securities Law Notice .

No “offer of securities to the public”, as defined under Spanish law, has taken place or will take place in the Spanish territory with respect to the Option.  No public offering prospectus has been, nor will it be registered with the Comisión Nacional del Mercado de Valores (Spanish Securities Exchange Commission) (“ CNMV ”).  Neither the Plan nor the Agreement constitute a public offering prospectus and they have not been, nor will they be, registered with the CNMV.

Exchange Control Information .

It is Participant’s responsibility to comply with exchange control regulations in Spain.  Participant must declare the acquisition of Shares for statistical purposes to the Spanish Direccion General de Comercio e Inversiones (the “ DGCI ”) of the Ministry of Economy and Competitiveness.  In addition, Participant must also file a Form D‑6 with the Directorate of Foreign Transaction each January in which the Shares are owned.  In addition, the sale of Shares must be declared on Form D‑6 filed with the DGCI in January, unless the sale proceeds exceed the applicable threshold (currently €1,502,530), in which case, the filing is due within one month after the sale.

When receiving foreign currency payments in excess of €50,000 derived from the ownership of Shares (e.g., as a result of the sale of the Shares), Participant must inform the financial institution receiving the payment of the basis upon which such payment is made.  Participant will likely need to provide the institution with the following information: (i) Participant’s name, address, and fiscal identification number; (ii) the name and corporate domicile of the Company; (iii) the amount of the payment; (iv) the currency used; (v) the country of origin; (vi) the reasons for the payment; and (vii) any additional information that may be required.

Foreign Asset/Account Reporting Information .  Effective January 1, 2013, Participant is required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), as well as the Shares held in such accounts if the value of the transactions during the prior tax year or the balances in such accounts as of December 31 of the prior tax year exceed €1,000,000.

Further, effective January 1, 2013, to the extent that Participant holds Shares and/or has bank accounts outside Spain with a value in excess of €50,000 (for each type of asset) as of December 31, Participant will be required to report

A-15


 

information on such assets on his or her tax return (tax form 720) for such year.  After such Shares and/or accounts are initially reported, the reporting obligation will apply for subsequent years only if the value of any previously ‑reported Shares or accounts increases by more than €20,000.

Sweden

No special provisions.

Switzerland

Securities Law Information .

The grant of the Option under the Plan is considered a private offering in Switzerland and is, therefore, not subject to registration in Switzerland.

Taiwan

Data Privacy Acknowledgement .

Participant hereby acknowledges that he or she has read and understands the terms regarding collection, processing and transfer of Data contained in Section 11 of the Agreement and by participating in the Plan, Participant agrees to such terms.  In this regard, upon request of the Company or the Employer, Participant agrees to provide an executed data privacy consent form to the Employer or the Company (or any other agreements or consents that may be required by the Employer or the Company) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws in Participant’s country, either now or in the future.  Participant understands that he or she will not be able to participate in the Plan if he or she fails to execute any such consent or agreement.

Securities Law Information .

The Option and the Shares to be issued pursuant to Option are available only for employees of the Company and its Parents, Subsidiaries and affiliates.  The Option grant is not a public offer of securities by a Taiwanese company.

Exchange Control Information .

Participant may acquire and remit foreign currency (including proceeds from the sale of Shares and may be required to cash dividends) up to US$5,000,000 per year without justification.  If the transaction amount is TWD500,000 or more in a single transaction, Participant must submit a Foreign Exchange Transaction Form to the remitting bank.  If the transaction amount is US$500,000 or more in a single transaction, Participant may be required to provide additional supporting documentation to the satisfaction of the remitting bank.

Turkey

Securities Law Information .

Participant must sell Shares acquired under the Plan outside Turkey.  The Shares are currently traded on the New York Stock Exchange in the U.S. under the ticker symbol “IMPV” and may be sold on this exchange.

Financial Intermediary Information .

Pursuant to Decree No. 32 on the Protection of the Value of the Turkish Currency (“Decree 32”) and Communiqué No. 2008‑32/34 on Decree No. 32, any activity related to investments in foreign securities ( e.g. , the sale of Shares under the Plan) must be conducted through a bank or financial intermediary institution licensed by the Turkish Capital Markets Board and should be reported to the Turkish Capital Markets Board.  Participant is solely responsible for complying with this requirement and is advised to contact his or her personal legal advisor for further information regarding Participant’s obligations in this respect.

Exchange Control Notification .

A-16


 

Turkish residents are permitted to purchase and sell securities or derivatives traded on exchanges abroad only through a financial intermediary licensed in Turkey.  Therefore, Participant may be required to appoint a Turkish broker to assist Participant with the sale of the Shares acquired under the Plan.   Participant should consult his or her personal legal advisor before selling any Shares acquired under the Plan to confirm the applicability of this requirement to Participant .

United Kingdom

Joint Election .

As a condition of the purchase of Shares under the Plan, Participant agrees to accept any liability for secondary Class 1 National Insurance Contributions (“ Employer NICs ”) which may be payable by the Company or the Employer with respect to the purchase of the Shares or otherwise payable in connection with the right to acquire Shares.  To accomplish the foregoing, Participant agrees to execute a joint election with the Company and/or the Employer (the “ Election ”), the form of such Election being formally approved by HM Revenue and Customs (“ HMRC ”), and any other consent or elections required to accomplish the transfer of the Employer NICs to Participant.  Participant further agrees to execute such other joint elections as may be required between Participant and any successor to the Company and/or the Employer.  Participant agrees to enter into an Election prior to the exercise of any Options.  Participant further agrees that the Company and/or the Employer may collect the Employer NICs by any of the means set forth in Section 8 of the Agreement.

Tax Obligations

The following provisions supplement Section 8 of the Agreement:

Participant shall pay to the Company or the Employer any amount of income tax that the Company or the Employer may be required to account to HMRC with respect to the event giving rise to the income tax (the “ Taxable Event ”) that cannot be satisfied by the means described in Section 8 of the Agreement.  If payment or withholding of the income tax due is not made within ninety (90) days of the Taxable Event or such other period as required under U.K. law (the “ Due Date ”), Participant agrees that the amount of any uncollected income tax shall constitute a loan owed by Participant to the Employer, effective on the Due Date.  Participant agrees that the loan will bear interest at the then‑current HMRC Official Rate, it will be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in the Agreement.  If Participant fails to comply with his or her obligations in connection with the income tax as described in this section, the Company may refuse to deliver the Shares acquired under the Plan.

Notwithstanding the foregoing, if Participant is a Director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), Participant shall not be eligible for a loan from the Company to cover the income tax.  In the event that Participant is a Director or executive officer and income tax not collected from or paid by Participant by the Due Date, the amount of any uncollected income tax may constitute a benefit to Participant on which additional income tax and National Insurance contributions (“ NICs ”) may be payable.  Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self‑assessment regime and for reimbursing the Company or the Employer for the value of any employee NICs due on this additional benefit.

 

 

 

A-17


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF RESTRICTED STOCK UNIT AWARD

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Restricted Stock Unit Award (the “ Notice ”).

 

Name:

 

Address:

 

You (“ Participant ”) have been granted an award of Restricted Stock Units (“ RSUs ”) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units), including any country‑specific terms and conditions contained in the attached Appendix (together, the “ Agreement ”).

 

Number of RSUs:

 

Date of Grant:

 

Vesting Commencement Date :

 

Expiration Date :

The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.

Vesting Schedule :

Subject to the limitations set forth in this Notice, the Plan and the Agreement, the RSUs will vest in accordance with the following schedule: [INSERT VESTING SCHEDULE]

You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an active Employee, Director or Consultant of the Company.  You also understand that this Notice is subject to the terms and conditions of both the Agreement and the Plan, both of which are incorporated herein by reference.  By signing below or electronically accepting the Agreement, you confirm you have read and agreed to the terms and conditions of this Notice, the Agreement and the Plan.

 

PARTICIPANT

 

IMPERVA, INC.

 

 

 

 

 

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

AWARD AGREEMENT (RESTRICTED STOCK UNITS)

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same defined meanings in this Award Agreement (Restricted Stock Units), including any country‑specific terms and conditions contained in the attached Appendix (together, the “ Agreement ”).

Participant has been granted Restricted Stock Units (“ RSUs ”) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the “ Notice ”) and this Agreement.

1. Settlement .   Settlement of RSUs shall be made within 30 days following the applicable date of vesting under the vesting schedule set forth in the Notice .  Settlement of RSUs shall be in Shares, unless provided otherwise in the Appendix.

2. No Stockholder Rights .   Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote such Shares.

3. Dividend Equivalents .   Dividends, if any (whether in cash or Shares), shall not be credited to Participant until he or she has acquired Shares in the Company.

4. No Transfer .   The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of in any manner other than as permitted under the Plan and this Agreement.  For any such transfer to be binding, the transferee must furnish the Company with (A) written notice of his or her or its status as transferee, (B) a copy of the will and/or such evidence as the Committee may deem necessary to establish the validity of the transfer, and (C) an agreement by the transferee to comply with all the terms and conditions of the RSUs that are or would be applicable to the Participant and to be bound by the acknowledgments made by the Participant hereunder.

5. Termination .   Upon Participant’s Termination (for any reason whatsoever, whether or not later to be found invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such unvested RSUs shall immediately terminate and will not be extended by any notice period ( e.g ., active services would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any).  In case of any dispute as to whether Termination has occurred (including whether Participant may still be considered to be providing services while on an approved leave of absence), the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.  In the event that Participant’s Termination is a result of the Participant’s death, then any delivery of Shares to be made to the Participant will be made to the Participant’s designee, provided that such designee has been designated prior to the Participant’s death on a form prescribed by the Company; in the absence of any such effective designation, the shares will be delivered to the beneficiary designated by the Participant with the largest beneficial interest; or, if there is no single beneficiary with a majority or plurality of interest, then to the latest revocable trust established by the Participant of which the Participant was a beneficiary or, if none, to the Participant’s estate.

1


 

6. Tax Obligations .  Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant’s employer (the “ Employer ”) the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax ‑related items related to Participant’s participation in the Plan and legally applicable to Participant (“ Tax ‑Related Items ”), is and remains Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer.  Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax ‑Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends and/or any dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate Participant’s liability for Tax ‑Related Items or achieve any particular tax result.  Further, if Participant is subject to Tax ‑Related Items in more than one jurisdiction, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax ‑Related Items in more than one jurisdiction.

Prior to any relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax‑Related Items.  In this regard, Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax‑Related Items by one or a combination of the following:

(i) withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or

(ii) withholding from proceeds of the sale of Shares acquired upon vesting/settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization); or

(iii) withholding in Shares to be issued upon settlement of the RSUs, provided, however that if Participant is a Section 16 officer of the Company under the Exchange Act, then the Committee shall establish the method of withholding from alternatives (i)‑(iii) herein and, if the Committee does not exercise its discretion prior to the Tax‑Related Items withholding event, then Participant shall be entitled to elect the method of withholding from the alternatives above.

Depending on the withholding method, the Company may withhold or account for Tax‑Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case Participant will receive a refund of any over‑withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax‑Related Items is satisfied by withholding in Shares, for tax purposes, Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax‑Related Items.

Finally, Participant agrees to pay to the Company or the Employer any amount of Tax‑Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax‑Related Items.

7. U.S. Tax Consequences .   If Participant is a U.S. taxpayer, Participant acknowledges that there will be tax consequences upon the vesting and/or settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant’s tax obligations prior to such vesting, settlement or disposition.  Upon vesting of the RSUs, the Fair Market Value of the Shares subject to the RSUs is subject to payroll taxes (e.g., FICA), and when the Shares are released following vesting, the Fair Market Value of the Shares is subject to U.S. federal, state and local income taxes.  Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short‑term or long‑term capital gain or loss, depending on whether the Shares are held for more than 12 months from the date of settlement.  Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code.  Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation.  Participant should consult his or her personal tax advisor for more information on the actual and potential tax consequences of this RSU.

2


 

8. Acknowledgement of Nature of the Grant .   The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan.  Participant acknowledges receipt of a copy of the Plan and the Plan prospectus, represents that Participant has carefully read and is familiar with their provisions, and hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.  Participant further acknowledges, understands and agrees that:

(a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;

(b) the grant of the RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;

(c) all decisions with respect to future RSUs or other grants, if any, will be at the sole discretion of the Company;

(d) the RSU grant and Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or services contract with the Company, the Employer, its Parent, Subsidiary or affiliate of the Company and shall not interfere with the ability of the Company, the Employer, its Parent, Subsidiary or affiliate of the Company, as applicable, to terminate Participant’s employment or service relationship (if any) for any reason;

(e) Participant is voluntarily participating in the Plan;

(f) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not intended to replace any pension rights or compensation;

(g) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end‑of‑service payments, bonuses, long‑service awards, pension or retirement or welfare benefits or similar payments;

(h) the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(i) except for RSUs granted to Non-Employee Directors and Shares subject to such RSUs, unless otherwise agreed with the Company in writing, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not granted as consideration for, or in connection with, any service Participant may provide as a director of the Company or any Subsidiary or affiliate;

(j) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from Participant’s Termination (for any reason whatsoever whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), and in consideration of the grant of the RSUs to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, its Parent, any of its Subsidiaries, affiliates or the Employer, waives his or her ability, if any, to bring any such claim, and releases the Company, its Parent,  Subsidiaries and affiliates and the Employer from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim;

(k) unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits evidenced by this Agreement do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Shares of the Company; and

3


 

(l) the following additional provisions apply only if Participant is providing services outside the United States:

(i) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of normal or expected compensation or salary for any purpose;

(ii) neither the Company, the Employer, its Parent, nor any Subsidiary or affiliate of the Company shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares of acquired upon settlement.

9. No Advice Regarding Grant .  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares.  Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

10. Data Privacy .   Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company, its Parent, Subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan.

Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, vested, unvested or outstanding in Participant’s favor(“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

Participant understands that Data will be transferred to a designated Plan broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  Participant understands that the recipients of Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than Participant’s country.  Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of Data by contacting his or her local human resources representative.  Participant authorizes the Company, its designated Plan broker, and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing his or her participation in the Plan.  Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan.  Participant understands if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative.  Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis.  If Participant does not consent, or if Participant later seeks to revoke his or her consent, Participant’s employment status and/or career with the Employer will not be adversely affected; the only consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant RSUs or other Awards or administer or maintain such Awards.  Therefore, Participant understands that refusing or withdrawing his or her consent may affect Participant’s ability to participate in the Plan.  For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.

4


 

11. Entire Agreement; Enforcement of Rights .   This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them.  Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement.  Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant or any other Plan participant.

12. Compliance with Laws and Regulations .   Notwithstanding any other provision of the Plan or this Agreement, unless there is an available exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver any Shares issuable upon settlement of the RSUs prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. SEC or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable.  Participant understands that the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares.  Further, Participant agrees that the Company shall have unilateral authority to amend the Plan and the Agreement without Participant’s consent to the extent necessary to comply with securities or other laws applicable to issuance of Shares.

13. Governing Law and Venue; Severability .  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.  In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of this Agreement shall be interpreted as if such provision were so excluded and (c) the balance of this Agreement shall be enforceable in accordance with its terms.  This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.  For purposes of any action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of San Mateo County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.

14. Electronic Delivery and Acceptance .  The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on‑line or electronic system established and maintained by the Company or a third party designated by the Company.

15. Language .  If Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

16. Appendix .  Notwithstanding any provisions in this Agreement, the RSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for Participant’s country.  Moreover, if Participant relocates to one of the countries included in the Appendix, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  The Appendix constitutes part of this Agreement.

17. Imposition of Other Requirements .  The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

5


 

18. Insider Trading/Market Abuse Laws .  Participant acknowledges that, depending on his or her country, Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect his or her ability to acquire or sell Shares or rights to Shares ( e.g. , RSUs) under the Plan during such times as Participant is considered to have “inside information” regarding the Company (as defined by the laws in his or her country).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s insider trading policy.  Participant acknowledges that it is his or her responsibility to comply with any applicable restrictions, including those imposed under the Company’s insider trading policy, and Participant should consult with his or her own personal legal and financial advisors on this matter before taking any action related to the Plan.

19. Foreign Asset/Account Reporting Requirements .  Participant acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect his or her ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends received or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside his or her country.  Participant understands that he or she may be required to report such accounts, assets or transactions to the tax or other authorities in his or her country.  Participant also may be required to repatriate sale proceeds or other funds received as a result of his or her participation in the Plan to his or her country through a designated bank or broker and/or within a certain time after receipt.  Participant acknowledges that it is his or her responsibility to comply with all such requirements, and that Participant should consult his or her personal legal and tax advisors, as applicable, to ensure compliance.

By the signature on, or electronic acceptance of, the Notice by each of the Participant and the Company’s representative, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement.  Participant has reviewed the Plan, the Notice and this Agreement in its entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement.  Participant further agrees to notify the Company upon any change in Participant’s residence address.

 

6


 

AWARD AGREEMENT (RESTRICTED STOCK UNITS) – INTERNATIONAL

APPENDIX A

IMPERVA, INC. 2011 STOCK OPTION AND INCENTIVE PLAN

Special Terms and Conditions for Participants Outside the U.S.

This Appendix includes additional country‑specific terms and conditions that apply to Participant’s resident in countries listed below.  This Appendix is part of the Agreement and contains terms and conditions material to participation in the Plan.  Unless otherwise provided below, capitalized terms used but not defined herein shall have the same meanings assigned to them in the Plan and the Agreement.

This Appendix includes information regarding exchange controls and certain other issues of which Participant should be aware, and is current as of December 2015.  Participant acknowledges that local exchange control laws may apply to Participant as a result of the acquisition of Shares, opening of an off‑shore bank or brokerage account and acquisition of foreign currency.  By accepting the RSUs, Participant agrees to comply with applicable exchange control laws associated with participation in the Plan.  Participant further acknowledges that if he or she has any questions regarding his or her responsibilities in this regard, Participant will seek advice from his or her personal legal advisor, at Participant’s own cost, and further agrees that neither the Company, its Parent, any Subsidiary or affiliate or the Employer will be liable for any fines or penalties resulting from Participant’s failure to comply with applicable laws concerning the acquisition and disposition of Shares.

If Participant is a citizen or resident of a country other than the one in which Participant is currently working, transfers employment and/or residency after the RSUs are granted or is considered resident of another country for local law purposes, the terms and conditions contained herein may not be applicable to Participant, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply to Participant.

Argentina

Securities Law Information .

Neither the RSUs nor the underlying Shares are publicly offered or listed on any stock exchange in Argentina.  The offer is private and not subject to the supervision of any Argentine governmental authority.

Exchange Control Information .

Following the sale of Shares or the receipt of any cash dividends, Participant may be subject to certain restrictions in bringing such funds back into Argentina.  The Argentine bank handling the transaction may request certain documentation in connection with the request to transfer proceeds into Argentina ( e.g. , evidence of the sale, etc.) and under certain circumstances may require that 30% of the amount transferred into Argentina be placed in a non‑interest bearing U.S. dollar deposit account for a holding period of 365 days.

Participant is solely responsible for complying with the exchange control rules that may apply in connection with participation in the Plan and/or transfer of proceeds from the sale of Shares acquired under the Plan into Argentina.  Prior to transferring sale proceeds into Argentina, Participant should consult his or her local bank and/or exchange control advisor to confirm what will be required by the bank as interpretations of the applicable Argentine Central Bank regulations vary by bank and exchange control rules and regulations are subject to change without notice.

A-1


 

Tax Reporting Information .

If Participant holds Shares as of December 31 of any year, Participant is required to report the holding of the Shares on his or her tax return for the relevant year.

Australia

Securities Law Information .

If Participant acquires Shares pursuant to the RSUs and Participant offers the Shares for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law.  Participant should obtain legal advice on disclosure obligations prior to making any such offer.

Exchange Control Information .

Exchange control reporting is required for cash transactions exceeding A$10,000 and for international fund transfers.  If an Australian bank is assisting with the transaction, the bank will file the report on Participant’s behalf.

Bra zil

Compliance with Law .

By accepting the RSUs, Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the RSUs and the sale of the Shares acquired pursuant thereto.

Acknowledgement of Nature of the Grant.

This provision supplements Section 8 of the Agreement:

By accepting the RSUs, Participant agrees that he or she is making an investment decision, the Shares will be issued to Participant only if the vesting conditions are met and any necessary services are rendered by Participant over the vesting period, and the value of the underlying Shares is not fixed and may increase or decrease in value over the vesting period without compensation to Participant.

Exchange Control Information .

If Participant is a resident of or domiciled in Brazil, he or she will be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank of Brazil if the aggregate value of the assets and rights is equal to or greater than US$100,000.  Assets and rights that must be reported include Shares acquired under the Plan.

Tax on Financial Transactions (IOF) .

Repatriation of funds ( e.g. , sale proceeds) into Brazil and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions.  It is Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from Participant’s participation in the Plan.  Participant should consult with his or her personal tax advisor for additional details.

Canada

Securities Law Information .

Participant acknowledges that he or she is permitted to sell the Shares acquired under the Plan through the designated broker appointed by the Company, provided the sale of the Shares takes place outside of Canada through facilities of a stock exchange on which the Shares are listed ( i.e. , the NYSE).

A-2


 

Termination of Service.

The following provision replaces Section 5 of the Agreement:

In the event that Participant’s service terminates (for any reason and whether or not later found to be invalid or in breach of Canadian laws or the terms of the Participant’s employment agreement, if any), all unvested RSUs shall be immediately forfeited without consideration.  For purposes of the preceding sentence, Participant’s right to vest in the RSUs will terminate effective as of the date that is the earlier of (i) the date of Participant’s Termination, (ii) the date Participant receives notice of Termination as an active Employee, Director or Consultant of the Company, or (iii) the date Participant is no longer actively providing service and will not be extended by any notice period (e.g., active service would not include any contractual notice period or any period of “garden leave” or similar period mandated under Canadian laws or the terms of Participant’s employment agreement, if any); the Company shall have the exclusive discretion to determine when Participant is no longer actively providing service for purposes of the RSUs.

Foreign Asset/Account Reporting Information .

Canadian residents are required to report to the tax authorities any foreign property on Form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds C$100,000 at any time in the year.  The form must be filed by April 30 of the following year.  The RSUs must be reported‑‑generally at a nil cost‑‑if the C$100,000 cost threshold is exceeded because of other foreign property Participant holds.  If Shares are acquired, their cost generally is the adjusted cost base (“ACB”) of the Shares.  The ACB would normally equal the fair market value of the Shares at vesting, but if Participant owns other shares, this ACB may have to be averaged with the ACB of the other shares.  Participant should consult with his or her personal legal advisor to ensure compliance with applicable reporting obligations.

The Following Provisions Apply for Participants Resident in Quebec :

Consent to Receive Information in English .

Participant acknowledges that it is the express wish of the parties that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be written in English.

Les parties reconnaissent avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents, avis et procédures judiciaires, exécutés, donnés ou intentés en vertu de, ou liés directement ou indirectement à, la présente convention.

Authorization to Release and Transfer Necessary Personal Information .

The following provision supplements Section 10 of the Agreement:

Participant hereby authorizes the Company and the Company’s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  Participant further authorizes the Company, any Parent, Subsidiary or affiliate and the administrator of the Plan to disclose and discuss the Plan with their advisors.  Participant further authorizes the Company and any Parent, Subsidiary or affiliate to record such information and to keep such information in Participant’s Employee file.

Colombia

Labor Law Acknowledgement .

Participant acknowledges that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of “salary” for any legal purpose.  Therefore, they will not be included and / or considered for purposes of calculating any and all labor benefits, such as legal / fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and / or any other labor‑related amount which may be payable.

A-3


 

Securities Law Information .

The Shares are not and will not be registered in the Colombian registry of publicly traded securities ( Registro Nacional de Valores y Emisores ) and therefore the Shares may not be offered to the public in Colombia.  Nothing in this document should be construed as the making of a public offer of securities in Colombia.

Exchange Control Information .

Investments in assets located abroad (including Shares) are subject to registration by Participant with the Central Bank (Banco de la República) if Participant’s aggregate investments held abroad (as of December 31 of the applicable calendar year) equal or exceed US$500,000.  When Participant sells Shares acquired under the Plan (or other investments) held abroad, Participant may either choose to keep the resulting sums abroad, or to repatriate them to Colombia.  If Participant chooses to repatriate funds to Colombia and has not registered the investment with Banco de la República, Participant will need to file with Banco de la República Form No. 5 upon conversion of funds into local currency, which should be duly completed to reflect the nature of the transaction.  If Participant has registered the investment with Banco de la República, then Participant will need to file with Banco de la República Form No. 4 upon conversion of funds into local currency, which should be duly completed to reflect the nature of the transaction.  If Participant receives Shares at vesting and immediately sells such Shares, then no registration is required because no Shares are held abroad.  Participant should obtain proper legal advice in order to ensure compliance with applicable Colombian regulations.

Denmark

Labor Law Acknowledgement .

This provision supplements Section 8 of the Agreement:

By accepting the RSUs, Participant acknowledges that he or she understands and agrees that the RSUs relates to future services to be performed and is not a bonus or compensation for past services.

Stock Option Act .

Participant acknowledges that he or she received an Employer Statement in Danish which sets forth the terms of the RSUs.

Foreign Bank Account Reporting .

If Participant establishes an account holding Shares or an account holding cash outside Denmark, Participant must report the account to the Danish Tax Administration.  The form which should be used in this respect can be obtained from a local bank.  (Please note that these obligations are separate from and in addition to the obligations described below.)

Exchange Control and Tax Reporting Notification .

Participant may hold Shares acquired under the Plan in a safety‑deposit account ( e.g. , a brokerage account) with either a Danish bank or with an approved foreign broker or bank.  If the Shares are held with a non‑Danish broker or bank, Participant is required to inform the Danish Tax Administration about the safety‑deposit account.  For this purpose, Participant must file a Form V (Erklaering V) with the Danish Tax Administration.  Both Participant and the broker/bank must sign the Form V, unless an exemption from the broker/bank signature requirement is obtained from the Danish Tax Administration.  It is possible to seek an exemption on the Form V, which Participant should do at the time he or she submits the Form V.  By signing the Form V, the bank/broker undertakes an obligation, without further request each year not later than on February 1 of the year following the calendar year to which the information relates, to forward certain information to the Danish Tax Administration concerning the content of the safety‑deposit account.  In the event that the applicable broker or bank with which the safety‑deposit account is held does not wish to, or, pursuant to the laws of the country in question, is not allowed to assume such obligation to report, Participant acknowledges that he or she is solely responsible for providing certain details regarding the foreign brokerage or bank account and any Shares acquired at vesting and held in such account to the Danish Tax Administration as part of Participant’s annual income tax return.  By signing the Form V, Participant at the same time authorizes the Danish Tax Administration to examine the account.  A sample of the Form V can be found at the following website: http://www.skat.dk.

A-4


 

In addition, when Participant opens a brokerage account or bank account with a U.S. bank, the account will be treated as a “deposit account” because cash can be held in the account.  Therefore, Participant must also file a Form K ( Erklaering K ) with the Danish Tax Administration.  Both Participant and the broker/bank must sign the Form K, unless an exemption from the broker/bank signature requirement is granted by the Danish Tax Administration.  It is possible to seek the exemption on the Form K, which Participant should do at the time he or she submits the Form K.  By signing the Form K, the broker/bank undertakes to forward information to the Danish Tax Administration concerning the content of the deposit account without further request each year not later than February 1 of the year following the relevant calendar year.  In the event that the broker/bank does not wish to, or, pursuant to the laws of the country in question, is not allowed to assume such obligation to report, Participant acknowledges that he or she is solely responsible for providing the necessary information to the Danish Tax Administration as part of Participant’s annual income tax return.  By signing the Form K, Participant at the same time authorizes the Danish Tax Administration to examine the account.  A sample of Form K can be found at the following website: http://www.skat.dk.

France

Consent to Receive Information in English .

By accepting the grant of the RSUs, Participant confirms having read and understood the Plan and the Agreement, which were provided in English language.  Participant accepts the terms of these documents accordingly.

En acceptant cette attribution gratuite d’actions, le Participant confirme avoir lu et compris le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont été transmis en langue anglaise.  Le Participant accepte les dispositions de ces documents en connaissance de cause.

Foreign Asset/Account Reporting Information .

Participant may hold Shares acquired under the Plan outside of France provided that Participant annually declares all foreign bank and stock accounts, whether open, current or closed, together on Participant’s personal income tax return.  Participant must also declare to the customs and excise authorities any cash or securities that Participant imports or exports without the use of a financial institution when the value of the cash or securities is equal to or exceeds €10,000.

Germany

Exchange Control Information .

Cross‑border payments in excess of €12,500, including any cross‑border payments received in connection with the sale of Shares acquired under the Plan or any dividends paid on such Shares, must be reported monthly to the German Federal Bank ( Bundesbank ).  For payments made in connection with securities or financial derivatives (including any proceeds from the sale of Shares acquired under the Plan), the report must be made by the 5th day of the month following the month in which the payment was received.  The report must be filed electronically.  The form of report (“ Allgemeines Meldeportal Statistik ”) can be accessed via the Bundesbank’s website ( www.bundesbank.de ) and is available in both German and English.  In addition, in the unlikely event that Participant holds Shares exceeding 10% of the total capital of the Company, Participant must report such holdings in the Company on an annual basis.  Participant is responsible for complying with applicable reporting requirements.

A-5


 

Hong Kong

WARNING:    The contents of this document have not been reviewed by any regulatory authority in Hong Kong.  Participant should exercise caution in relation to the offer.  If Participant is in any doubt about any of the contents of the Plan, the Agreement, including this Appendix, or other incidental communication materials, Participant should obtain independent professional advice.  The RSUs and any Shares acquired upon vesting do not constitute a public offering of securities under Hong Kong law and are available only to eligible individuals employed or engaged by the Company, its Parent, or its Subsidiaries and affiliates.  The Plan, the Agreement, including this Appendix, and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong.  The RSUs are intended only for the personal use of each Participant and may not be distributed to any other person.

Settlement .

This provision supplements Section 1 of the Agreement:

Shares received at vesting are accepted as a personal investment.  Notwithstanding anything to the contrary in the Plan, the RSUs do not entitle Participant to receive a cash payment, and will only be settled in Shares.  Further, in the event the RSUs vest and Shares are issued within six (6) months of the Date of Grant, Participant agrees not to sell or otherwise dispose of the Shares prior to the six (6) month anniversary of the Date of Grant.

India

Settlement .

The following provision supplements Section 1 of the Agreement:

Due to local regulatory requirements, upon the settlement of the RSUs, Participant agrees to the immediate sale of any Shares issued to Participant.  Participant further agrees that the Company is authorized to instruct its designated broker to assist with the mandatory sale of such Shares (on Participant’s behalf pursuant to this authorization) and Participant expressly authorizes the Company’s designated broker to complete the sale of such Shares.  Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price.  Upon the sale of the Shares, the Company agrees to pay to Participant the cash proceeds from the sale of the Shares, less any brokerage fees or commissions, and subject to any obligation to satisfy Tax‑Related Items (see below).

Exchange Control Information .

Participant understands that the RSUs are subject to compliance with the exchange control requirements of the Reserve Bank of India.  Participant understands that Participant must repatriate any proceeds from the sale of Shares acquired under the Plan to India within 90 days of receipt and  any dividends within 180 days of receipt.  Participant must obtain a foreign inward remittance certificate (“ FIRC ”) from the bank where Participant deposits the funds and must maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Company or any Parent, Subsidiary or affiliate requests proof of repatriation.

A-6


 

Tax Obligations .

The following provision replaces Section 6 of the Agreement for independent contractors:

If Participant is serving as an independent contractor, not an Employee, he or she acknowledges and agrees to accept all liability for income tax, social insurance, payroll tax, fringe benefits, payment on account or other tax related items arising out of Participant’s participation in the Plan and the acquisition of Shares (“ Tax‑Related Items ”).  Participant agrees that the Company and any Parent, Subsidiary or affiliate to which Participant provides services have no obligation to withhold or otherwise satisfy any Tax‑Related Items due as a result of Participant’s participation in the Plan and the acquisition of Shares.  Participant further acknowledges that the Company and/or any Parent, Subsidiary or affiliate retaining Participant (1) make no representations or undertakings regarding the treatment of any Tax‑Related Items in connection with any aspect of the award of Shares, including, but not limited to, the issuance of the Shares, the sale of Shares and the receipt of any dividends or any distributions paid on such Shares; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Shares to reduce or eliminate Participant’s liability for Tax‑Related Items or achieve any particular tax result.

Participant agrees to pay or make adequate arrangements to satisfy all Tax‑Related Items.  If, notwithstanding this agreement, the Company and/or any Parent,  Subsidiary or affiliate are held liable for any Tax‑Related Items due on the Shares resulting from a determination that Participant is not an independent contractor or any other reason, Participant agrees to indemnify and hold harmless the Company and any Parent, Subsidiary or affiliate to the extent of any obligation imposed on the Company or any Parent, Subsidiary or affiliate to pay any Tax‑Related Items due on the Shares.

Foreign Asset/Account Reporting Information .

Participant is required to declare any foreign bank accounts and any foreign financial assets (including Shares held outside India) in Participant’s annual tax return.  Participant is responsible for complying with this reporting obligation and is advised to confer with his or her personal tax advisor in this regard.

Israel

Trust Arrangement .

Participant understands and agrees that the RSUs awarded under the Agreement are awarded subject to and in accordance with the terms and conditions of the Plan, the Appendix A to the Plan for Israel (the “ Sub‑Plan ”), the Trust Agreement (the “ Trust Agreement ”) between the Company and the Company’s trustee appointed by the Company or its Subsidiary in Israel (the “ Trustee ”) and the Agreement, or any successor trustee.  In the event of any inconsistencies between the Sub‑Plan, the Agreement and/or the Plan, the Sub‑Plan will govern.

Nature of Grant .

The following provisions supplement Section 8 of the Agreement:

The RSUs are intended to qualify for favorable tax treatment in Israel as a “ Capital Gain Award ” (as defined in the Sub‑Plan) subject to the terms and conditions of Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 (“ Section 102 ”) (as defined in the Sub‑Plan) and the rules promulgated thereunder.  Notwithstanding the foregoing, by accepting the RSUs, Participant acknowledges that the Company cannot guarantee or represent that the favorable tax treatment under Section 102 will apply to the RSUs.

By accepting the RSUs, Participant: (a) acknowledges receipt of and represents that Participant has read and is familiar with the terms and provisions of Section 102, the Plan, the Sub‑Plan, the Trust Agreement and the Agreement; (b) accepts the RSUs subject to all of the terms and conditions of the Agreement, the Plan, the Sub‑Plan, the Trust Agreement and Section 102 and the rules promulgated thereunder; and (c) agrees that the RSUs and/or any Shares issued in connection therewith, will be registered for the benefit of Participant in the name of the Trustee as required to qualify under Section 102.

A-7


 

Participant hereby undertakes to release the Trustee from any liability in respect of any action or decision duly taken and bona fide executed in relation to the Plan, or any RSUs or Share granted thereunder.  Participant agrees to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102 and the Income Tax Ordinance (New Version) – 1961 (“ ITO ”).

Payment .

Notwithstanding the Vesting Schedule set forth on the Notice, if the vesting of the RSUs occurs during the “ Holding Period ” (as defined in the Sub‑Plan), the Shares issued upon the vesting of the RSUs shall be issued to and deposited with the Trustee for the benefit of Participant and shall be held in trust for the Holding Period.  After termination of the Holding Period, the Trustee may release the RSUs and any Shares issued with respect thereto under the terms set forth in the Sub‑Plan, and in accordance with the terms and conditions of Section 102, the ITO and any approval by the Israeli Tax Authority (“ ITA ”).

In the event that such vesting occurs after the end of the Holding Period, the Shares issued upon the vesting of the RSUs shall either (i) be deposited with the Trustee, or (ii) be transferred to Participant directly or into a brokerage account in his or her name, provided that Participant first complies with his or her obligations for Tax‑Related Items.

In the event that Participant elects to have the Shares transferred to Participant without selling such Shares, Participant shall become liable to pay Tax‑Related Items immediately in accordance with the provisions of the ITO.  Participant will not be entitled to receive the Shares prior to the full payment of Tax‑Related Items and neither the Company not the Trustee shall be required to release any Shares to Participant until all payments required to be made under the ITO have been fully satisfied.

Data Privacy .

The following provision supplements Section 10 of the Agreement:

Without derogating from the scope of Section 10 of the Agreement, Participant hereby explicitly consents to the transfer of Data between the Company, the Trustee, and/or a designated Plan broker, including any requisite transfer of such Data outside of the Participant’s country and further transfers thereafter as may be required to a broker or other third party.

Electronic Delivery and Acceptance .  

The following provision supplements Section 15 of the Agreement.

To the extent required pursuant to Israeli tax law and/or by the Trustee, Participant consents and agrees to deliver hard‑copy written notices and/or actual copies of any notices or confirmations provided by Participant related to his or her participation in the Plan.

Securities Law Information .

The RSUs are offered in accordance with an exemption from the requirement to publish a prospectus which the Company received from the Israel Securities Authority on January 26, 2012, under Section 15D of the Israeli Securities Law, 1968.

The Shares available under the Plan are registered in the U.S. pursuant to the Form S‑8 registration statement which was filed with the U.S. Securities and Exchange Commission on February 21, 2013.

Participant may obtain a copy of the Plan and the Forms S ‑8, including the documents referenced therein, from the Company’s intranet site located at: https://compass.imperva.com/community/legal/stock_plan_prospectuses.  These documents are also available at Participant’s local office.

A-8


 

Italy

Authorization to Release and Transfer Necessary Personal Information .

The following provision replaces in its entirety Section 10 of the Agreement:

Participant understands that the Employer and/or the Company may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social security number (or any other social or national identification number), salary, nationality, job title, number of Shares held and the details of all RSUs or any other entitlement to Shares awarded, cancelled, exercised, vested, unvested or outstanding (the “Data”) for the purpose of implementing, administering and managing Participant’s participation in the Plan.  Participant is aware that providing the Company with Participant’s Data is necessary for the performance of the Agreement and that Participant’s refusal to provide such Data would make it impossible for the Company to perform its contractual obligations and may affect Participant’s ability to participate in the Plan.

The Controller of personal data processing is Imperva, Inc., 1194 3400 Bridge Parkway, Suite 200, Redwood Shores, CA 94065, U.S.A., and, pursuant to D.lgs 196/2003, its representative in Italy is Imperva Italy s.r.l., c/o Regus Business Center, Via Senigallia, 18/2 Torre A, 20161 Milano,  Italy.  Participant understands that the Data may be transferred to the Company or any of its Parent, Subsidiaries or affiliates, or to any third parties assisting in the implementation, administration and management of the Plan, including any transfer required to a broker or other third party with whom Shares acquired pursuant to the vesting of the RSUs or cash from the sale of such Shares may be deposited.  Furthermore, the recipients that may receive, possess, use, retain and transfer such Data for the above mentioned purposes may be located in Italy or elsewhere, including outside of the European Union and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than Participant’s country.  The processing activity, including the transfer of Participant’s personal data abroad, outside of the European Union, as herein specified and pursuant to applicable laws and regulations, does not require Participant’s consent thereto as the processing is necessary for the performance of contractual obligations related to the implementation, administration and management of the Plan.  Participant understands that Data processing relating to the purposes above specified shall take place under automated or non‑automated conditions, anonymously when possible, that comply with the purposes for which Data are collected and with confidentiality and security provisions as set forth by applicable laws and regulations, with specific reference to D.lgs. 196/2003.

Participant understands that Data will be held only as long as is required by law or as necessary to implement, administer and manage Participant’s participation in the Plan.  Participant understands that pursuant to art.7 of D.lgs 196/2003, Participant has the right, including but not limited to, access, delete, update, request the rectification of Participant’s Data and cease, for legitimate reasons, the Data processing.  Furthermore, Participant is aware that Participant’s Data will not be used for direct marketing purposes.  In addition, the Data provided can be reviewed and questions or complaints can be addressed by contacting a local human resources representative.

Plan Document Acknowledgement .

In accepting the RSUs, Participant acknowledges that Participant has received a copy of the Plan and the Agreement and has reviewed the Plan and the Agreement, including this Appendix, in their entirety and fully understands and accepts all provisions of the Plan and the Agreement, including this Appendix.  Participant further acknowledges that Participant has read and specifically and expressly approves the following sections of the Agreement:  Section 1: Settlement, Section 4: No Transfer; Section 5:  Termination, Section 6: Tax Obligations, Section 8:  Acknowledgement of Nature of the Grant;   Section 9:  No Advice Regarding Grant,  Section 11:  Entire Agreement; Enforcement of Rights, Section 12:  Compliance with Laws and Regulations; Section 13: Governing Law and Venue; Severability, Section 14: Electronic Delivery and Acceptance; Section 15: Language, Section 16:  Appendix, Section 17: Imposition of Other Requirements and the Data Privacy provisions above.

A-9


 

Foreign Asset/Account Reporting Information .

Italian residents who, during the fiscal year, hold investments abroad or foreign financial assets (e.g., cash, Shares and Options) which may generate income taxable in Italy are required to report such on their annual tax returns (UNICO form, RW Schedule) or on a special form if no tax return is due.  The same reporting obligations apply to Italian residents who, even if they do not directly hold investments abroad or foreign financial assets (e.g., cash, Shares and RSUs), are beneficial owners of the investment pursuant to Italian money laundering provisions.

Tax on Foreign Financial Assets .

The value of the financial assets held outside of Italy by Italian residents is subject to a foreign asset tax at an annual rate of 2 per thousand (0.2%).  The taxable amount will be the fair market value of the financial assets (including Shares) assessed at the end of the calendar year.  No tax payment duties arise if the amount of the foreign assets tax calculated on all financial assets held abroad does not exceed €12.

Japan

Foreign Asset/Account Reporting Information .

Participant is required to report details of any assets held outside of Japan as of December 31 (including Shares acquired under the Plan), to the extent such assets have a total net fair market value exceeding ¥50 million.  Such report will be due by March 15 each year.  Participant should consult with his or her personal tax advisor to determine if the reporting obligation applies to his or her personal situation.

Korea

Exchange Control Information .

Exchange control laws require Korean residents who realize US$500,000 or more from the sale of Shares or the receipt of dividends in a single transaction to repatriate the sale proceeds back to Korea within three years of the sale/receipt.

Foreign Asset/Account Reporting Information .

If Participant is a Korean resident, Participant must declare all of his or her foreign financial accounts (including any brokerage account) to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 1 billion (or an equivalent amount in foreign currency).  Participant should consult with his or her personal tax advisor as to whether the reporting obligation applies.

Mexico

Acknowledgements .

This provision supplements Section 8 of the Agreement:

By accepting the RSUs, Participant acknowledges that he or she has received a copy of the Plan and the Agreement, including this Appendix, which he or she has reviewed.  Participant further acknowledges that he or she accepts all the provisions of the Plan and the Agreement, including this Appendix.  Participant also acknowledges that he or she has read and specifically and expressly approves the terms and conditions set forth in Section 8 of the Agreement, which clearly provide as follows:

 

1.

Participant’s participation in the Plan does not constitute an acquired right;

 

2.

The Plan and Participant’s participation in it are offered by the Company on a wholly discretionary basis;

 

3.

Participant’s participation in the Plan is voluntary; and

 

4.

The Company and its Subsidiaries are not responsible for any decrease in the value of any Shares acquired upon exercise of the RSUs.

A-10


 

Service Acknowledgement and Policy Statement for Employees .

By accepting the RSUs, Participant acknowledges that Imperva, Inc. with registered offices at 3400 Bridge Parkway, Suite 200, Redwood Shores, CA 94065, U.S.A, is solely responsible for the administration of the Plan.  Participant further acknowledges that his or her participation in the Plan, the grant of the RSUs and any acquisition of Shares under the Plan do not constitute an employment agreement and does not guarantee Participant the right to continue his or her service with the Company because Participant is participating in the Plan on a wholly commercial basis.  Based on the foregoing, Participant expressly acknowledges that the Plan and the benefits that he or she may derive from participation in the Plan do not establish any rights between Participant and the Company, and do not form part of any employment agreement between the Participant and the Company or any Parent or Subsidiary of the Company, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of Participant’s employment.

Participant further understands that his or her participation in the Plan is the result of a unilateral and discretionary decision of the Company and, therefore, the Company reserves the absolute right to amend and/or discontinue Participant’s participation in the Plan at any time, without any liability to Participant.

Finally, Participant hereby declares that he or she does not reserve to him or herself any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and that he or she therefore grants a full and broad release to the Company, any Parent or Subsidiaries, affiliates, branches, representation offices, shareholders, officers, agents and legal representatives, with respect to any claim that may arise.

Service Acknowledgement and Policy Statement for Consultants .

By accepting the RSUs, Participant acknowledges that Imperva, Inc. with registered offices at 3400 Bridge Parkway, Suite 200, Redwood Shores, CA 94065, U.S.A, is solely responsible for the administration of the Plan.  Participant further acknowledges that his or her participation in the Plan, the grant of the RSUs and any acquisition of Shares under the Plan do not constitute a service contract and does not guarantee Participant the right to continue his or her service with the Company because Participant is participating in the Plan on a wholly commercial basis.  Based on the foregoing, Participant expressly acknowledges that the Plan and the benefits that he or she may derive from participation in the Plan do not establish any rights between Participant and the Company, and do not form part of any service contract between the Participant and the Company or any Parent or Subsidiary of the Company, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of Participant’s service contract.

Participant further understands that his or her participation in the Plan is the result of a unilateral and discretionary decision of the Company and, therefore, the Company reserves the absolute right to amend and/or discontinue Participant’s participation in the Plan at any time, without any liability to Participant.

Finally, Participant hereby declares that he or she does not reserve to him or herself any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and that he or she therefore grants a full and broad release to the Company, any Parent or Subsidiaries, affiliates, branches, representation offices, shareholders, officers, agents and legal representatives, with respect to any claim that may arise.

A-11


 

Reconocimientos .

Esta disposición suplementa la sección 8 del Contrato:

Al aceptar las Unidades de Acciones Restringidas, el Partícipe reconoce que ha recibido una copia del Plan y del Contrato, incluyendo este Anexo, que ha sido revisado por el Partícipe. El Partícipe reconoce, además, que acepta todas las disposiciones del Plan y del Contrato, incluyendo este Anexo.  El Partícipe también reconoce que ha leído la sección 8 del Contrato y específica y expresamente aprueba los términos y condiciones establecidos en dicha Sección, que claramente establece lo siguiente:

 

1.

La participación del Partícipe en el Plan no constituye un derecho adquirido;

 

2.

El Plan y la participación del Partícipe en el Plan se ofrecen por la Compañía de manera totalmente discrecional;

 

3.

La participación del Partícipe en el Plan es voluntaria; y

 

4.

La Compañía y sus Subsidiarias no son responsables por cualquier disminución en el valor de las Acciones adquiridas al ejercer las Unidades de Acciones Restringidas.

Reconocimiento de Ley Laboral y Declaración de Política de Empleados .

Al aceptar las Unidades de Acciones Restringidas, el Partícipe reconoce que Imperva, Inc., con oficinas registradas en 3400 Bridge Parkway, Suite 200, Redwood Shores, CA 94065, EE.UU., es únicamente responsable por la administración del Plan.  Además, el Partícipe reconoce que su participación en el Plan, el otorgamiento de las Unidades de Acciones Restringidas y cualquier adquisición de Acciones de conformidad con el Plan no constituyen un contrato laboral, ni garantizan el derecho del Partícipe de continuar prestando sus servicios a la Compañía, toda vez que el Partícipe está participando en el Plan sobre una base exclusivamente comercial.  Con base en lo anterior, el Partícipe  expresamente reconoce que el Plan y los beneficios que deriven de la participación en el Plan no establecen derecho alguno entre el Partícipe y la Compañía y no forman parte de ningún contrato laboral entre el Participe y la Compañía o Matriz o Subsidiaria de la Compañía, y cualquier modificación del Plan o su terminación no constituirá un cambio o deterioro de los términos y condiciones del contrato laboral del Partícipe.

Además, el Partícipe entiende que su participación en el Plan es resultado de una decisión unilateral y discrecional de la Compañía y, por lo tanto, la Compañía se reserva el derecho absoluto de modificar y/o discontinuar la participación del Partícipe en el Plan en cualquier momento, sin responsabilidad alguna para con el Partícipe.

Finalmente, el Partícipe en este acto manifiesta que no se reserva ninguna acción o derecho para interponer una demanda o reclamación en contra de la Compañía por cualquier compensación o daño o perjuicio en relación con cualquier disposición del Plan o de los beneficios derivados del Plan y, en consecuencia, otorga un amplio y total finiquito a la Compañía, Matriz o Subsidiaria de la Compañía,, afiliadas, sucursales, oficinas de representación, accionistas, directores, funcionarios, agentes y representantes legales con respecto a cualquier demanda o reclamación que pudiera surgir.

Reconocimiento de Ley Laboral y Declaración de Política de Consultores .

Al aceptar las Unidades de Acciones Restringidas, el Partícipe reconoce que Imperva, Inc., con oficinas registradas en 3400 Bridge Parkway, Suite 200, Redwood Shores, CA 94065, EE.UU., es únicamente responsable por la administración del Plan.  Además, el Partícipe reconoce que su participación en el Plan, el otorgamiento de las Unidades de Acciones Restringidas y cualquier adquisición de Acciones de conformidad con el Plan no constituyen un contrato de servicios y no garantizan el derecho del Partícipe de continuar prestando sus servicios a la Compañía, ya que el Partícipe está participando en el Plan en sobre una base exclusivamente comercial.  Con base en lo anterior, el Partícipe  expresamente reconoce que el Plan y los beneficios que le deriven de la participación en el Plan no establecen derecho alguno entre el Partícipe y la Compañía y no forman parte de ningún contrato de servicios Subsidiaria de la Compañía, y cualquier modificación del Plan o su terminación no constituirá un cambio o deterioro de los términos y condiciones del contrato de servicios del Partícipe.

A-12


 

Además, el Partícipe entiende que su participación en el Plan es resultado de una decisión unilateral y discrecional de la Compañía y, por lo tanto, la Compañía se reserva el derecho absoluto de modificar y/o discontinuar la participación del Partícipe en el Plan en cualquier momento, sin responsabilidad alguna para con el Partícipe.

Finalmente, el Partícipe en este acto manifiesta que no se reserva ninguna acción o derecho para interponer una demanda o reclamación en contra de la Compañía por cualquier compensación o daño o perjuicio en relación con cualquier disposición del Plan o los beneficios derivados del Plan y, en consecuencia, otorga un amplio y total finiquito a la Compañía, cualesquier Matriz o Subsidiarias, afiliadas, sucursales, oficinas de representación, accionistas, directores, funcionarios, agentes y representantes con respecto a cualquier demanda o reclamación que pudiera surgir.

Netherlands

No special provisions.

Panama

Securities Law Information .

The RSUs and any Shares which may be issued to Participant upon vesting and settlement are not subject to registration under Panamanian law as they are not intended for the public, but solely offered in a private transaction for Participant’s benefit.

Poland

Exchange Control Information .

Polish residents holding foreign securities (including Shares) and maintaining accounts abroad (including any brokerage account) must report information to the National Bank of Poland on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (calculated individually or together with all other assets/liabilities held abroad) exceeds a specified threshold (currently PLN7,000,000).  If required, the reports are due on a quarterly basis on special forms available on the website of the National Bank of Poland.  Further, any transfer of funds in excess of a specified threshold (currently €15,000) must be effected through a bank account in Poland.  Participant should maintain evidence of such foreign exchange transactions for five (5) years, in case of a request for their production by the National Bank of Poland.

Russia

U.S. Transaction .

Participant understands that the grant of the RSUs is a right to receive Shares if certain conditions are met and that the offer is made by the Company in the United States.  Upon vesting of the RSUs, any Shares to be issued to Participant shall be delivered to Participant through a brokerage account in the United States.

Exchange Control Information .

Upon the sale of Shares acquired under the Plan, Participant must repatriate the proceeds of the sale back to Russia within a reasonably short time after receipt.  Participant may remit proceeds to Participant’s foreign currency account at an authorized bank in Russia or in a foreign bank account opened in accordance with Russian exchange control laws.  Participant is encouraged to contact Participant’s personal advisor before remitting Participant’s sale proceeds to Russia.

A-13


 

Securities Law Information .

Participant is not permitted to sell Shares directly to other Russian legal entities or residents.

The grant of the RSUs and the distribution of the Plan and all other materials Participant may receive regarding participation in the Plan do not constitute an offering or the advertising of securities in Russia.  The issuance of Shares pursuant to the Plan has not and will not be registered in Russia and, therefore, the Shares may not be used for an offering or public circulation in Russia.  In no event will Shares be delivered to Participant in Russia; all Shares acquired under the Plan will be maintained on Participant’s behalf in the United States.

Data Privacy Acknowledgement .

Participant hereby acknowledges that he or she has read and understands the terms regarding collection, processing and transfer of Data contained in the Agreement and by participating in the Plan, Participant agrees to such terms.  In this regard, upon request of the Company or the Employer, Participant agrees to provide an executed data privacy consent form to the Company or the Employer (or any other agreements or consents that may be required by the Company or the Employer) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws of Russia, either now or in the future.

Labor Law Information .

If Participant continues to hold Shares after involuntary Termination, Participant may not be eligible to receive unemployment benefits in Russia.

Singapore

Securities Law Information .

The RSUs are being granted pursuant to the “Qualifying Person” exemption under Section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (“ SFA ”) under which the grant is exempt from prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party.   The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  Participant should note that such RSU grant is subject to Section 257 of the SFA and Participant should not make any subsequent sale in Singapore, or any offer of such subsequent sale of the Shares in Singapore, or any offer of the Shares underlying the RSUs unless such sale or offer in Singapore is made more than six months from the Date of Grant or pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than Section 280) of the SFA.

Chief Executive Officer and Director Reporting Notice .

If Participant is the chief executive officer (“ CEO ”), a director, associate director or shadow director of a Singapore Subsidiary or affiliate of the Company, as the terms are used in the Singapore Companies Act (the “ SCA ”), Participant agrees to comply with notification requirements under the SCA.  Among these requirements is an obligation to notify the Singapore Subsidiary or affiliate in writing when Participant receives an interest ( e.g ., RSUs, Shares) in the Company or any related companies (including when Participant sells Shares acquired from the RSUs).  In addition, Participant must notify the Singapore Subsidiary or affiliate when Participant sells or receives Shares of the Company or any related company (including when Participant sells or receives Shares acquired under the Plan).  These notifications must be made within two business days of (i) acquiring or disposing of any interest in the Company or any related company, (ii) any change in the previously disclosed interest ( e.g. , when the RSUs vest), or (iii) becoming CEO or a director, associate director or shadow director if such an interest exists that that time.  Participant should consult with his or her personal legal advisor regarding his or her notification obligations under the SCA.

A-14


 

South Africa

Securities Law Information .

In compliance with South African securities laws, the documents listed below are available for review on the Company’s “Investor Relations” website at http://www.imperva.com/company/investors .

(i) a copy of the Company’s most recent annual report (i.e., Form 10 ‑K); and

(ii) a copy of the Plan Prospectus.

A copy of the above documents will be sent to Participant free of charge on written request to Imperva, Inc., Stock Plan Administrator, 3400 Bridge Parkway, Suite 200, Redwood Shores, California 94065, U.S.A.

Participant should read the materials provided before making a decision whether to participate in the Plan.  In addition, Participant should contact Participant’s tax advisor for specific information concerning his or her personal tax situation with regard to the Plan participation.

Tax Obligations .

The following provision supplements Section 6 of the Agreement:

If Participant is an Employee, he or she must notify the Employer of the amount of any gain realized upon vesting of the RSUs.  If Participant fails to advise the Employer of the gain realized upon vesting, then Participant may be liable for a fine.  Participant will be responsible for paying any difference between the actual tax liability and the amount withheld.

Exchange Control Information .

Participant should consult his or her personal advisor prior to the acquisition or sale of Shares under the Plan to ensure compliance with applicable exchange control regulations in South Africa, as such regulations are subject to frequent change.  Participant is solely responsible for complying with all exchange control laws in South Africa, and neither the Company nor any Parent or Subsidiary will be liable for any fines or penalties resulting from Participant’s failure to comply with South African exchange control laws.

Spain

No Entitlement for Claims or Compensation .

The following provisions replace Section 5 of the Agreement:

By accepting the RSUs, Participant consents to participation in the Plan and acknowledges that Participant has received a copy of the Plan document.

Participant understands and agrees that, as a condition of the grant of the RSUs, if Participant’s service Terminates (for any reason whatsoever, whether or not later to be found invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate and will not be extended by any notice period ( e.g ., active services would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any).  In particular, Participant understands and agrees that any unvested RSUs shall be forfeited without entitlement to the underlying Shares or to any amount as indemnification in the event of a Termination, including, but not limited to: resignation, disciplinary dismissal adjudged to be with Cause, disciplinary dismissal adjudged or recognized to be without Cause, individual or collective layoff on objective grounds, whether adjudged to be with Cause or adjudged or recognized to be without Cause, material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Employer, and under Article 10.3 of Royal Decree 1382/1985.  In case of any dispute as to whether Termination has occurred (including whether Participant may still be considered to be providing services while on an approved leave of absence), the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.

A-15


 

Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant RSUs under the Plan to individuals who may be Employees, Directors or Consultants throughout the world.  The decision is limited and entered into based upon the express assumption and condition that any RSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or affiliate, including the Employer, on an ongoing basis, other than as expressly set forth in the Agreement.  Consequently, Participant understands that the RSUs are granted on the assumption and condition that the RSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or affiliate, including the Employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Furthermore, Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the grant of RSUs, which is gratuitous and discretionary, since the future value of the RSUs and the underlying Shares is unknown and unpredictable.  Participant also understands that the grant of RSUs would not be made but for the assumptions and conditions set forth hereinabove; thus, Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the RSUs and any right to the underlying Shares shall be null and void.

Securities Law Information .

No “offer of securities to the public”, as defined under Spanish law, has taken place or will take place in the Spanish territory with respect to the RSUs.  No public offering prospectus has been nor will be registered with the Comisión Nacional del Mercado de Valores (Spanish Securities Exchange Commission) (“ CNMV ”).  Neither the Plan nor the Agreement constitute a public offering prospectus and they have not been, nor will they be, registered with the CNMV.

Exchange Control Information .

It is Participant’s responsibility to comply with exchange control regulations in Spain.  Participant must declare the acquisition of Shares for statistical purposes to the Spanish Direccion General de Comercio e Inversiones (the “ DGCI ”) of the Ministry of Economy and Competitiveness.  In addition, Participant must also file a Form D‑6 with the Directorate of Foreign Transaction each January in which the Shares are owned.  The sale of Shares also must be declared on Form D‑6 filed with the DGCI in January, unless the sale proceeds exceed the applicable threshold (currently €1,502,530), in which case, the filing is due within one month after the sale.

Foreign Asset/Account Reporting Information .  Participant is required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), as well as the Shares held in such accounts if the value of the transactions during the prior tax year or the balances in such accounts as of December 31 of the prior tax year exceed €1,000,000.

Further, to the extent that Participant holds Shares and/or has bank accounts outside Spain with a value in excess of €50,000 (for each type of asset) as of December 31, Participant will be required to report information on such assets on his or her tax return (tax form 720) for such year.  After such Shares and/or accounts are initially reported, the reporting obligation will apply for subsequent years only if the value of any previously‑reported Shares or accounts increases by more than €20,000 or if Participant sells or otherwise disposes of any previously‑reported Shares or accounts.

Sweden

No special provisions.

Switzerland

Securities Law Information .

The grant of the RSUs under the Plan is considered a private offering in Switzerland and is, therefore, not subject to registration in Switzerland.  Neither this document nor any other material related to the RSUs constitutes a prospectus as such term is understood pursuant to Article 652a of the Swiss Code of Obligations, and neither this document nor any other materials related to the RSUs may be publicly distributed or otherwise made publicly available in Switzerland.

A-16


 

Taiwan

Data Privacy Acknowledgement .

Participant hereby acknowledges that he or she has read and understands the terms regarding collection, processing and transfer of Data contained in Section 10 of the Agreement and by participating in the Plan, Participant agrees to such terms.  In this regard, upon request of the Company or the Employer, Participant agrees to provide an executed data privacy consent form to the Employer or the Company (or any other agreements or consents that may be required by the Employer or the Company) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws in Participant’s country, either now or in the future.  Participant understands that he or she will not be able to participate in the Plan if he or she fails to execute any such consent or agreement.

Securities Law Information .

The RSUs and the Shares to be issued pursuant to RSUs are available only for employees of the Company and its Parents, Subsidiaries and affiliates.  The grant of RSUs is not a public offer of securities by a Taiwanese company.

Exchange Control Information .

Participant may acquire and remit foreign currency (including proceeds from the sale of Shares and any cash dividends) up to US$5,000,000 per year without justification.  If the transaction amount is TWD500,000 or more in a single transaction, Participant must submit a Foreign Exchange Transaction Form to the remitting bank and may also be required to provide additional supporting documentation to the satisfaction of the remitting bank.

Turkey

Securities Law Information .

The RSUs are made available only to Employees or Consultants of the Company, its Parent, Subsidiaries or affiliates, and the offer of participation in the Plan is a private offering.  The grant of RSUs and the issuance of Shares at vesting take place outside of Turkey.  Participant must sell Shares acquired under the Plan outside Turkey.  The Shares are currently traded on the New York Stock Exchange in the U.S. under the ticker symbol “IMPV” and may be sold on this exchange.

United Arab Emirates

Securities Law Information .

The RSUs under the Plan are granted only to select Employees of the Company and its Parent, Subsidiaries and affiliates and are in the nature of providing employee equity incentives in the United Arab Emirates, including the Dubai Creative Clusters Authority.  The Plan and the Agreement are intended for distribution only to such Employees and must not be delivered to, or relied on by, any other person.  Prospective purchasers of the securities offered should conduct their own due diligence on the securities.  If Participant does not understand the contents of the Plan and the Agreement, he or she should consult an authorized financial adviser.  The Emirates Securities and Commodities Authority and the Dubai Financial Services Authority have no responsibility for reviewing or verifying any documents in connection with the Plan.  Neither the Ministry of Economy, the Dubai Department of Economic Development nor the Dubai Financial Services Authority have approved the Plan or the Agreement nor taken steps to verify the information set out therein, and have no responsibility for such documents.

This statement also relates to any Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority.

United Kingdom

Employees Only .

In the United Kingdom, only Employees are eligible to be granted RSUs pursuant to the following additional terms:

A-17


 

Joint Election .

As a condition of the vesting of the RSUs under the Plan, Participant agrees to accept any liability for secondary Class 1 National Insurance contributions (“ Employer NICs ”) which may be payable by the Company or the Employer with respect to the vesting of the RSUs or otherwise payable in connection with the issuance of Shares.  To accomplish the foregoing, Participant agrees to execute a joint election with the Company and/or the Employer (the “ Election ”), the form of such Election being formally approved by HM Revenue and Customs (“ HMRC ”), and any other consent or elections required to accomplish the transfer of the Employer NICs to Participant.  Participant further agrees to execute such other joint elections as may be required between Participant and any successor to the Company and/or the Employer.  Participant agrees to enter into an Election prior to the vesting of the RSUs.  Participant further agrees that the Company and/or the Employer may collect the Employer NICs by any of the means set forth in Section 6 of the Agreement.

Tax Obligations .

The following supplements Section 6 of the Agreement:

Participant shall pay to the Company or the Employer any amount of income tax that the Company or the Employer may be required to account to HMRC with respect to the event giving rise to the income tax (the “ Taxable Event ”) that cannot be satisfied by the means described in Section 6 of the Agreement.  If payment or withholding of the income tax due is not made within ninety (90) days of the end of the U.K. tax year in which the Taxable Event occurs or such other period as required under U.K. law (the “ Due Date ”), Participant agrees that the amount of any uncollected income tax shall constitute a loan owed by Participant to the Employer, effective on the Due Date.  Participant agrees that the loan will bear interest at the then‑current HMRC Official Rate, it will be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in Section 6 of the Agreement.  If Participant fails to comply with his or her obligations in connection with the income tax as described in this section, the Company may refuse to deliver the Shares acquired under the Plan.

Notwithstanding the foregoing, if Participant is a Director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), Participant shall not be eligible for a loan from the Company to cover income tax.  In the event that Participant is a Director or executive officer and income tax is not collected from or paid by Participant by the Due Date, the amount of any uncollected income tax may constitute a benefit to Participant on which additional income tax and National Insurance contributions (“ NICs ”) may be payable.  Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self‑assessment regime and for reimbursing the Company or the Employer for the value of any employee NICs due on this additional benefit, which the Company or the Employer may recover by any of the means referred to in Section 6 of the Agreement.

 

A-18


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF STOCK BONUS AWARD

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Stock Bonus Award (the “ Notice ”).

 

Name:

 

Address:

 

You (“ Participant ”) have been granted an award of Shares under the Plan subject to the terms and conditions of the Plan, this Notice, and the attached Stock Bonus Award Agreement (the “ Stock Bonus Agreement ”) to the Plan.

 

Number of Shares:

 

 

 

 

Date of Grant:

 

 

 

 

Vesting Commencement Date:

 

 

 

 

Expiration Date:

 

The date on which all the Shares granted hereunder become vested, with earlier expiration upon the Termination Date

Vesting Schedule:

 

Subject to the limitations set forth in this Notice, the Plan and the Stock Bonus Agreement, the Shares will vest in accordance with the following schedule:   [INSERT VESTING SCHEDULE]

You understand that your employment or consulting relationship or service with the Company is for an unspecified duration, can be terminated at any time (i.e., is “at-will”), and that nothing in this Notice, the Stock Bonus Agreement or the Plan changes the at-will nature of that relationship. You acknowledge that the vesting of the Shares pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company. You also understand that this Notice is subject to the terms and conditions of both the Stock Bonus Agreement and the Plan, both of which are incorporated herein by reference. You have read both the Stock Bonus Agreement and the Plan.

 

PARTICIPANT

 

IMPERVA, INC.

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

STOCK BONUS AWARD AGREEMENT

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same defined meanings in this Stock Bonus Agreement (the “ Agreement ”).

Participant has been granted a Stock Bonus Award (“ Stock Bonus Award ”) subject to the terms, restrictions and conditions of the Plan, the Notice of Stock Bonus Award (the “ Notice ”) and this Agreement.

1. Issuance . Stock Bonus Awards shall be issued in Shares, and the Company’s transfer agent shall record ownership of such Shares in Participant’s name as soon as reasonably practicable.

2. Stockholder Rights . Participant shall have no right to dividends or to vote Shares until Participant is recorded as the holder of such Shares on the stock records of the Company and its transfer agent.

3. No-Transfer . Unvested Shares, and unvested Stock Bonus Awards, and any interest in either shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of by Participant or any person whose interest derives from Participant’s interest. “ Unvested Shares ” are Shares that have not yet vested pursuant to the terms of the vesting schedule set forth in the Notice.

4. Termination . Upon Participant’s Termination for any reason, all Unvested Shares shall immediately be forfeited to the Company, and all rights of Participant to such Unvested Shares shall immediately terminate as of Participant’s Termination Date. In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.

5. U.S. Tax Consequences . Upon vesting of Shares, Participant will include in taxable income the difference between the fair market value of the vesting Shares, as determined on the date of their vesting, and the price paid for the Shares. This will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. Before any Shares subject to this Agreement are issued the Company shall withhold a number of Shares with a fair market value (determined on the date the Shares are issued) equal to the minimum amount the Company is required to withhold for income and employment taxes. Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement.

6. Acknowledgement . The Company and Participant agree that the Stock Bonus Award is granted under and governed by the Notice, this Agreement and by the provisions of the Plan (incorporated herein by reference). Participant: (a) acknowledges receipt of a copy of the Plan and the Plan prospectus, (b) represents that Participant has carefully read and is familiar with their provisions, and (c) hereby accepts the Stock Bonus Award subject to all of the terms and conditions set forth herein and those set forth in the Plan, this Agreement and the Notice.

7. Entire Agreement; Enforcement of Rights . This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.

8. Compliance with Laws and Regulations . The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Common Stock may be listed or quoted at the time of such issuance or transfer.

1


 

9 . Governing Law; Severability . If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of this Agreement shall be interpreted as if such provision were so excluded, and (c) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.

10. No Rights as Employee, Director or Consultant . Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Purchaser s service, for any reason, with or without cause.

By the signature on, or electronic acceptance of, the Notice by each of the Participant and the Company’s representative, Participant and the Company agree that this Stock Bonus Award is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement. Participant further agrees to notify the Company upon any change in Participant’s residence address.

 

 

 

2


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF RESTRICTED STOCK AWARD

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Restricted Stock Award (the “ Notice ”).

 

Name:

 

Address:

 

You (“ Participant ”) have been granted an award of Restricted Shares of Common Stock of Imperva, Inc. (the “ Company ”) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Restricted Stock Agreement (the “ Restricted Stock Purchase Agreement ”).

 

Total Number of Restricted Shares Awarded:

 

 

Fair Market Value per Restricted Share:

 

$

 

 

Total Fair Market Value of Award:

 

$

 

 

Purchase Price per Restricted Share:

 

$

 

 

Total Purchase Price for all Restricted Shares:

 

$

 

 

Date of Grant:

 

 

Vesting Commencement Date:

 

 

 

 

Vesting Schedule: Subject to the limitations set forth in this Notice, the Plan and the Restricted Stock Purchase Agreement, the Restricted Shares will vest and the right of repurchase shall lapse, in whole or in part, in accordance with the following schedule: [INSERT VESTING SCHEDULE]

You understand that your employment or consulting relationship with the Company is for an unspecified duration, can be terminated at any time (i.e., is “at-will”), and that nothing in this Notice, the Restricted Stock Agreement or the Plan changes the at-will nature of that relationship. You acknowledge that the vesting of the Restricted Shares pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company. You also understand that this Notice is subject to the terms and conditions of both the Restricted Stock Agreement and the Plan, both of which are incorporated herein by reference. You have read both the Restricted Stock Agreement and the Plan. If the Restricted Stock Purchase Agreement is not executed or accepted electronically by you within thirty (30) days of the Date of Grant above, then this grant shall be void.

 

RECIPIENT

 

IMPERVA, INC.

 

 

 

 

 

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

RESTRICTED STOCK AGREEMENT

THIS RESTRICTED STOCK AGREEMENT (this “ Agreement ”) is made as of              , 20           by and between Imperva, Inc., a Delaware corporation (the “ Company ”), and                      (“ Participant ”) pursuant to the Company’s 2011 Stock Option and Incentive Plan (the “ Plan ”). Unless otherwise defined herein, the terms defined in the Plan shall have the same meanings in this Agreement.

1. Sale of Stock . Subject to the terms and conditions of this Agreement, on the Purchase Date (as defined below) the Company will issue and sell to Participant, and Participant agrees to purchase from the Company the number of Shares shown on the Notice of Restricted Stock Award (the “ Notice ”) at a purchase price of $            per Share. The per Share purchase price of the Shares shall be not less than the par value of the Shares as of the date of the offer of such Shares to the Participant. The term “Shares” refers to the purchased Shares and all securities received in replacement of or in connection with the Shares pursuant to stock dividends or splits, all securities received in replacement of the Shares in a recapitalization, merger, reorganization, exchange or the like, and all new, substituted or additional securities or other properties to which Participant is entitled by reason of Participant’s ownership of the Shares.

2. Time and Place of Purchase . The purchase and sale of the Shares under this Agreement shall occur at the principal office of the Company simultaneously with the execution of this Agreement by the parties, or on such other date as the Company and Participant shall agree (the “ Purchase Date ”). On the Purchase Date, the Company will issue in Participant’s name a stock certificate representing the Shares to be purchased by Participant against payment of the purchase price therefor by Participant by (a) check made payable to the Company, (b) cancellation of indebtedness of the Company to Participant, (c) Participant’s personal services that the Committee has determined have already been rendered to the Company and have a value not less than aggregate par value of the Shares to be issued Participant, or (d) a combination of the foregoing.

3. Restrictions on Resale . By signing this Agreement, Participant agrees not to sell any Shares acquired pursuant to the Plan and this Agreement at a time when applicable laws, regulations or Company or underwriter trading policies prohibit exercise or sale. This restriction will apply as long as Participant is providing service to the Company or a Subsidiary of the Company.

3.1 Repurchase Right on Termination Other Than for Cause . For the purposes of this Agreement, a “ Repurchase Event ” shall mean an occurrence of one of the following:

(i) termination of Participant’s service, whether voluntary or involuntary and with or without cause;

(ii) resignation, retirement or death of Participant; or

(iii) any attempted transfer by Participant of the Shares, or any interest therein, in violation of this Agreement.

Upon the occurrence of a Repurchase Event, the Company shall have the right (but not an obligation) to purchase the Shares of Participant at a price equal to the Purchase Price per Share (the “ Repurchase Right ”). The Repurchase Right shall lapse in accordance with the vesting schedule set forth in the Notice. For purposes of this Agreement, “ Unvested Shares ” means Stock pursuant to which the Company’s Repurchase Right has not lapsed.

1


 

3.2 Exercise of Repurchase Right . Unless the Company provides written notice to Participant within 90 days from the date of termination of Participant’s service to the Company that the Company does not intend to exercise its Repurchase Right with respect to some or all of the Unvested Shares, the Repurchase Right shall be deemed automatically exercised by the Company as of the 90th day following such termination, provided that the Company may notify Participant that it is exercising its Repurchase Right as of a date prior to such 90th day. Unless Participant is otherwise notified by the Company pursuant to the preceding sentence that the Company does not intend to exercise its Repurchase Right as to some or all of the Unvested Shares, execution of this Agreement by Participant constitutes written notice to Participant of the Company’s intention to exercise its Repurchase Right with respect to all Unvested Shares to which such Repurchase Right applies at the time of Termination of Participant. The Company, at its choice, may satisfy its payment obligation to Participant with respect to exercise of the Repurchase Right by either (a) delivering a check to Participant in the amount of the purchase price for the Unvested Shares being repurchased, or (b) in the event Participant is indebted to the Company, canceling an amount of such indebtedness equal to the purchase price for the Unvested Shares being repurchased, or (c) by a combination of (a) and (b) so that the combined payment and cancellation of indebtedness equals such purchase price. In the event of any deemed automatic exercise of the Repurchase Right by canceling an amount of such indebtedness equal to the purchase price for the Unvested Shares being repurchased, such cancellation of indebtedness shall be deemed automatically to occur as of the 90th day following termination of Participant’s employment or consulting relationship unless the Company otherwise satisfies its payment obligations. As a result of any repurchase of Unvested Shares pursuant to the Repurchase Right, the Company shall become the legal and beneficial owner of the Unvested Shares being repurchased and shall have all rights and interest therein or related thereto, and the Company shall have the right to transfer to its own name the number of Unvested Shares being repurchased by the Company, without further action by Participant.

3.3 Acceptance of Restrictions . Acceptance of the Shares shall constitute Participant’s agreement to such restrictions and the legending of his or her certificates with respect thereto. Notwithstanding such restrictions, however, so long as Participant is the holder of the Shares, or any portion thereof, he or she shall be entitled to receive all dividends declared on and to vote the Shares and to all other rights of a stockholder with respect thereto.

3.4 Non-Transferability of Unvested Shares . In addition to any other limitation on transfer created by applicable securities laws or any other agreement between the Company and Participant, Participant may not transfer any Unvested Shares, or any interest therein, unless consented to in writing by a duly authorized representative of the Company. Any purported transfer is void and of no effect, and no purported transferee thereof will be recognized as a holder of the Unvested Shares for any purpose whatsoever. Should such a transfer purport to occur, the Company may refuse to carry out the transfer on its books, set aside the transfer, or exercise any other legal or equitable remedy. In the event the Company consents to a transfer of Unvested Shares, all transferees of Shares or any interest therein will receive and hold such Shares or interest subject to the provisions of this Agreement, including, insofar as applicable, the Repurchase Right. In the event of any purchase by the Company hereunder where the Shares or interest are held by a transferee, the transferee shall be obligated, if requested by the Company, to transfer the Shares or interest to the Participant for consideration equal to the amount to be paid by the Company hereunder. In the event the Repurchase Right is deemed exercised by the Company, the Company may deem any transferee to have transferred the Shares or interest to Participant prior to their purchase by the Company, and payment of the purchase price by the Company to such transferee shall be deemed to satisfy Participant’s obligation to pay such transferee for such Shares or interest, and also to satisfy the Company’s obligation to pay Participant for such Shares or interest.

3.5 Assignment . The Repurchase Right may be assigned by the Company in whole or in part to any persons or organization.

4. Restrictive Legends and Stop Transfer Orders .

4.1 Legends . The certificate or certificates representing the Shares shall bear the following legend (as well as any legends required by applicable state and federal corporate and securities laws):

THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.

2


 

4.2 Stop-Transfer Notices . Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

4.3 Refusal to Transfer . The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as the owner or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

5. No Rights as Employee, Director or Consultant . Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant s service, for any reason, with or without cause.

6. Miscellaneous .

6.1 Acknowledgement . The Company and Participant agree that the Restricted Shares are granted under and governed by the Notice, this Agreement and by the provisions of the Plan (incorporated herein by reference). Participant: (a) acknowledges receipt of a copy of the Plan and the Plan prospectus, (b) represents that Participant has carefully read and is familiar with their provisions, and (c) hereby accepts the Restricted Shares subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.

6.2 Entire Agreement; Enforcement of Rights . This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.

6.3 Compliance with Laws and Regulations . The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Common Stock may be listed or quoted at the time of such issuance or transfer.

6.4 Governing Law; Severability . If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of this Agreement shall be interpreted as if such provision were so excluded and (c) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.

6.5 Construction . This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto.

6.6 Notices . Any notice to be given under the terms of the Plan shall be addressed to the Company in care of its principal office, and any notice to be given to the Participant shall be addressed to such Participant at the address maintained by the Company for such person or at such other address as the Participant may specify in writing to the Company.

6.7 Counterparts . This Agreement may be executed in two or more counterparts, each of which shall he deemed an original and all of which together shall constitute one instrument.

3


 

6.8 U.S. Tax Consequences . Upon vesting of Shares, Participant will include in taxable income the difference between the fair market value of the vesting Shares, as determined on the date of their vesting, and the price paid for the Shares. This will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. In the absence of an Election (defined below), the Company shall withhold a number of vesting Shares with a fair market value (determined on the date of their vesting) equal to the minimum amount the Company is required to withhold for income and employment taxes. If Participant makes an Election, then Participant must, prior to making the Election, pay in cash (or check) to the Company an amount equal to the amount the Company is required to withhold for income and employment taxes.

7. Section 83(b) Election . Participant hereby acknowledges that he or she has been informed that, with respect to the purchase of the Shares, an election may be filed by the Participant with the Internal Revenue Service, within 30 days of the purchase of the Shares, electing pursuant to Section 83(b) of the Code to be taxed currently on any difference between the purchase price of the Shares and their Fair Market Value on the date of purchase (the “ Election ”). Making the Election will result in recognition of taxable income to the Participant on the date of purchase, measured by the excess, if any, of the Fair Market Value of the Shares over the purchase price for the Shares. Absent such an Election, taxable income will be measured and recognized by Participant at the time or times on which the Company’s Repurchase Right lapses. Participant is strongly encouraged to seek the advice of his or her own tax consultants in connection with the purchase of the Shares and the advisability of filing of the Election. PARTICIPANT ACKNOWLEDGES THAT IT IS SOLELY PARTICIPANT’S RESPONSIBILITY, AND NOT THE COMPANY’S RESPONSIBILITY, TO TIMELY FILE THE ELECTION UNDER SECTION 83(b) OF THE CODE, EVEN IF PARTICIPANT REQUESTS THE COMPANY, OR ITS REPRESENTATIVE, TO MAKE THIS FILING ON PARTICIPANT’S BEHALF.

4


 

The parties have executed or electronically accepted this Agreement as of the date first set forth above.

 

IMPERVA, INC.

By:

 

 

 

Its:

 

 

 

RECIPIEN:

 

 

 

Signature

 

 

 

Please Print Name

 

 

 

 

 

5


 

RECEIPT

Imperva, Inc. hereby acknowledges receipt of (check as applicable):

o   A check in the amount of $                

o   The cancellation of indebtedness in the amount of $                

given by                 as consideration for Certificate No. -            for             shares of Common Stock of Imperva, Inc.

Dated:                     

 

IMPERVA, INC.

 

By:

 

 

Its:

 

 

 


 

RECEIPT AND CONSENT

The undersigned Participant hereby acknowledges receipt of a photocopy of Certificate No. -              for              shares of Common Stock of Imperva, Inc. (the “ Company ”)

The undersigned further acknowledges that the Secretary of the Company, or his or her designee, is acting as escrow holder pursuant to the Restricted Stock Agreement that Participant has previously entered into with the Company. As escrow holder, the Secretary of the Company, or his or her designee, holds the original of the aforementioned certificate issued in the undersigned’s name. To facilitate any transfer of Shares to the Company pursuant to the Restricted Stock Agreement, Participant has executed the attached Assignment Separate from Certificate.

 

Dated:

 

 

Signature:

 

 

Please Print Name:

 

 

 

 


 

STOCK POWER AND ASSIGNMENT

SEPARATE FROM STOCK CERTIFICATE

FOR VALUE RECEIVED and pursuant to that certain Restricted Stock Agreement dated as of             ,             , [ COMPLETE AT THE TIME OF PURCHASE ] (the “ Agreement ”), the undersigned Participant hereby sells, assigns and transfers unto             ,             shares of the Common Stock $0.0001, par value per share, of Imperva, Inc., a Delaware corporation (the “ Company ”), standing in the undersigned’s name on the books of the Company represented by Certificate No(s).              [ COMPLETE AT THE TIME OF PURCHASE ]   delivered herewith, and does hereby irrevocably constitute and appoint the Secretary of the Company as the undersigned’s attorney-in-fact, with full power of substitution, to transfer said stock on the books of the Company. THIS ASSIGNMENT MAY ONLY BE USED AS AUTHORIZED BY THE AGREEMENT AND ANY EXHIBITS THERETO.

Dated:             ,             

 

PARTICIPANT

 

(Signature)

 

(Please Print Name)

 

Instructions to Participant : Please do not fill in any blanks other than the signature line. The purpose of this document is to enable the Company and/or its assignee(s) to acquire the shares upon exercise of its “Repurchase Right” set forth in the Agreement without requiring additional action by the Participant.

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF PERFORMANCE SHARES AWARD

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Performance Shares Award (the “ Notice ”).

 

Name:

 

Address:

 

 

You (“ Participant ”) have been granted an award of Performance Shares under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Performance Shares Award Agreement (hereinafter “ Performance Shares Agreement ” ).

 

Number of Shares:

 

 

 

 

Date of Grant:

 

 

 

 

Vesting Commencement Date:

 

 

 

 

Expiration Date:

 

The date on which all the Shares granted hereunder become vested, with earlier expiration upon the Termination Date

Vesting Schedule:

 

Subject to the limitations set forth in this Notice, the Plan and the Performance Shares Agreement, the Shares will vest in accordance with the following schedule:   [INSERT VESTING SCHEDULE]

You understand that your employment or consulting relationship or service with the Company is for an unspecified duration, can be terminated at any time (i.e., is “at-will”), and that nothing in this Notice, the Performance Shares Agreement or the Plan changes the at-will nature of that relationship. You acknowledge that the vesting pursuant to this Notice is earned only upon the applicable certification of attainment of the requisite Performance Factors enumerated above while still in service as an Employee, Director or Consultant of the Company. You also understand that this Notice is subject to the terms and conditions of both the Performance Shares Award Agreement and the Plan, both of which are incorporated herein by reference. You also have read both the Performance Shares Agreement and the Plan.

 

PARTICIPANT

 

IMPERVA, INC.

 

 

 

 

 

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

PERFORMANCE SHARES AGREEMENT

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same defined meanings in this Performance Shares Agreement (the “ Agreement ”).

Participant has been granted a Performance Shares Award (“ Performance Shares Award ”) subject to the terms, restrictions and conditions of the Plan, the Notice of Performance Shares Award (“ Notice ”) and this Agreement.

1. Settlement . Performance Shares shall be settled in Shares and the Company’s transfer agent shall record ownership of such Shares in Participant’s name as soon as reasonably practicable after achievement of the Performance Factors enumerated in the Notice.

2. Stockholder Rights . Participant shall have no right to dividends or to vote Shares until Participant is recorded as the holder of such Shares on the stock records of the Company and its transfer agent.

3. No-Transfer . Participant’s interest in this Performance Shares Award shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.

4. Termination . Upon Participant’s Termination for any reason, all of Participant’s rights under the Plan, this Agreement and the Notice in respect of this Award shall immediately terminate. In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.

5. U.S. Tax Consequences . Participant acknowledges that there will be tax consequences upon issuance of the Shares, and Participant should consult a tax adviser regarding Participant’s tax obligations prior to such settlement or disposition. Upon vesting of the Shares, Participant will include in income the fair market value of the Shares. The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. Before any Shares subject to this Agreement are issued the Company shall withhold a number of Shares with a fair market value (determined on the date the Shares are issued) equal to the minimum amount the Company is required to withhold for income and employment taxes. Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of issuance.

6. Acknowledgement . The Company and Participant agree that the Performance Shares Award is granted under and governed by the Notice, this Agreement and by the provisions of the Plan (incorporated herein by reference). Participant: (a) acknowledges receipt of a copy of the Plan and the Plan prospectus, (b) represents that Participant has carefully read and is familiar with their provisions, and (c) hereby accepts the Performance Shares Award subject to all of the terms and conditions set forth herein and those set forth in the Plan, this Agreement and the Notice.

7. Entire Agreement; Enforcement of Rights . This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.

8. Compliance with Laws and Regulations . The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Common Stock may be listed or quoted at the time of such issuance or transfer.

 


 

9. Governing Law; Severability . If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of this Agreement shall be interpreted as if such provision were so excluded and (c) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.

10. No Rights as Employee, Director or Consultant . Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Purchaser s service, for any reason, with or without cause.

By the signature on, or electronic acceptance of, the Notice by each of the Participant and the Company’s representative, Participant and the Company agree that this Performance Shares Award is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement. Participant further agrees to notify the Company upon any change in Participant’s residence address.

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF STOCK APPRECIATION RIGHT AWARD

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Stock Appreciation Right Award (the “ Notice ”).

 

Name:

 

Address:

 

 

You (“ Participant ”) have been granted an award of Stock Appreciation Rights (“ SARs ”) of the Company under the Plan subject to the terms and conditions of the Plan, this Notice and the Stock Appreciation Right Award Agreement (the “ SAR Agreement ”).

 

Date of Grant:

 

 

Vesting Commencement Date:

 

 

Fair Market Value on Date of Grant:

 

 

Total Number of Shares:

 

 

Expiration Date:

 

 

 

Post-Termination Exercise Period:

 

            Termination for Cause = None

 

 

            Voluntary Termination = 3 Months

 

 

            Termination without Cause = 3 Months

 

 

            Disability = 12 Months

 

 

            Death = 12 Months

 

Vesting Schedule:

 

Subject to the limitations set forth in this Notice, the Plan and the Stock Appreciation Right Agreement, the SAR will vest and may be exercised, in whole or in part, in accordance with the following schedule:   [INSERT VESTING SCHEDULE]

 

 

 

You understand that your employment or consulting relationship or service with the Company is for an unspecified duration, can be terminated at any time (i.e., is “at-will”), and that nothing in this Notice, the SAR Agreement or the Plan changes the at-will nature of that relationship. You acknowledge that the vesting of the SARs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company. You also understand that this Notice is subject to the terms and conditions of both the SAR Agreement and the Plan, both of which are incorporated herein by reference. You have read both the SAR Agreement and the Plan.

 

PARTICIPANT

 

IMPERVA, INC.

 

 

 

 

 

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

STOCK APPRECIATION RIGHT AWARD AGREEMENT

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Stock Appreciation Right Award Agreement (the “ Agreement ”).

Participant has been granted Stock Appreciation Rights (“ SARs ”), subject to the terms and conditions of the Plan, the Notice of Stock Appreciation Right Award (the “ Notice ”) and this Agreement.

1. Vesting Rights . Subject to the applicable provisions of the Plan and this Agreement, this SAR may be exercised, in whole or in part, in accordance with the schedule set forth in the Notice.

2. Termination Period .

(a) General Rule . Except as provided below, and subject to the Plan, this SAR may be exercised for 3 months after Participant’s Termination. In no event shall this SAR be exercised later than the Expiration Date set forth in the Notice.

(b) Death; Disability . Unless provided otherwise in the Notice, upon Participant’s Termination by reason of his or her Disability or death, or if a Participant dies within three months of the Termination Date, this SAR may be exercised for twelve months, provided that in no event shall this SAR be exercised later than the Expiration Date set forth in the Notice.

(c) Cause . Upon Participant’s Termination for Cause, the SAR shall expire on such date of Participant’s Termination Date.

3. Grant of SAR . The Participant named in the Notice has been granted a SAR for the number of Shares set forth in the Notice at the fair market value set forth in the Notice. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement, the terms and conditions of the Plan shall prevail.

4. Exercise of SAR .

(a) Right to Exercise . This SAR is exercisable during its term in accordance with the Vesting Schedule set forth in the Notice and the applicable provisions of the Plan and this Agreement. In the event of Participant’s death, Disability, Termination for Cause or other Termination, the exercisability of the SAR is governed by the applicable provisions of the Plan, the Notice and this Agreement.

(b) Method of Exercise . This SAR is exercisable by delivery of an exercise notice (the “ Exercise Notice ”), which shall state the election to exercise the SAR, the number of SARS to be exercised (the “ Exercised SARs ”), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice shall be delivered in person, by mail, via electronic mail or facsimile or by other authorized method to the Secretary of the Company or other person designated by the Company. This SAR shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice.

(c) No Shares shall be issued pursuant to the exercise of this SAR unless such issuance and exercise complies with all relevant provisions of law and the requirements of any stock exchange or quotation service upon which the Shares are then listed. Assuming such compliance, for income tax purposes the Exercised Shares shall be considered transferred to the Participant on the date the SAR is exercised with respect to such Exercised Shares.

5. Non-Transferability of SAR . This SAR may not be transferred in any manner other than by will or by the laws of descent or distribution or court order and may be exercised during the lifetime of Participant only by the Participant unless otherwise permitted by the Committee on a case-by-case basis. The terms of the Plan and this Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Participant.

6. Term of SAR . This SAR shall in any event expire on the expiration date set forth in the Notice, which date is 10 years after the Date of Grant.

 


 

7. U.S. Tax Consequences . For Participants subject to U.S. income tax, some of the federal tax consequences relating to this SAR, as of the date of this SAR, are set forth below. All other Participants should consult a tax advisor for tax consequences relating to this SAR in their respective jurisdiction. THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. THE PARTICIPANT SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS SAR. The Participant will incur federal ordinary income tax liability upon exercise of the SAR. The Participant will be treated as having received compensation income (taxable at ordinary income tax rates) equal to the excess, if any, of the Fair Market Value of the Exercised Shares on the date of exercise over their Fair Market Value on the date of grant. If the Participant is an Employee or a former Employee, the Company will be required to withhold from his or her compensation an amount equal to the minimum amount the Company is required to withhold for income and employment taxes or collect from Participant and pay to the applicable taxing authorities an amount in cash equal to a percentage of this compensation income at the time of exercise, and may refuse to honor the exercise and refuse to deliver Shares if such withholding amounts are not delivered at the time of exercise. If the Participant holds the Shares received upon exercise of the SAR for at least one year, any gain realized on disposition of the Shares will be treated as long-term capital gain for federal income tax purposes.

8. Acknowledgement . The Company and Participant agree that the SAR is granted under and governed by the Notice, this Agreement and the provisions of the Plan (incorporated herein by reference). Participant: (a) acknowledges receipt of a copy of the Plan and the Plan prospectus, (b) represents that Participant has carefully read and is familiar with their provisions, and (c) hereby accepts the SAR subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.

9. Entire Agreement; Enforcement of Rights . This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.

10. Compliance with Laws and Regulations . The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Common Stock may be listed or quoted at the time of such issuance or transfer.

11. Governing Law; Severability . If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.

12. No Rights as Employee, Director or Consultant . Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant’s service, for any reason, with or without cause.

By the signature on, or electronic acceptance of, the Notice by each of the Participant and the Company’s representative, Participant and the Company agree that this SAR is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing or electronically accepting the Notice, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and the Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated on the Notice.

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

NOTICE OF RESTRICTED STOCK UNIT AWARD

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same meanings in this Notice of Restricted Stock Unit Award (the “ Notice ”).

 

Name:

 

Address:

 

You (“ Participant ”) have been granted an award of Restricted Stock Units (“ RSUs ”) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units), including any country-specific terms and conditions contained in the attached Appendix (together, the “ Agreement ”).

 

Number of RSUs:

 

 

 

 

Date of Grant:

 

 

 

 

Vesting Commencement Date:

 

 

 

 

Expiration Date:

 

The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.

Vesting Schedule:

 

Subject to the limitations set forth in this Notice, the Plan and the Agreement, the RSUs will vest in accordance with the following schedule: 25% of Eligible Shares (as defined in Appendix A attached hereto) shall vest when the Participant completes twelve months of continuous service after the Vesting Commencement Date and 6.25% of such shares shall vest when the Participant completes each three month period of continuous service thereafter; provided that no RSU shall vest unless an Acquisition (as defined in Appendix A) is not consummated by June 30, 2014, provided further that no RSUs shall settle earlier than the RSU Determination Date (as defined in Appendix A); it being understood that with respect to the service-based component of vesting, there shall be no separate requirement of continued service through the RSU Determination Date.

You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an active Employee, Director or Consultant of the Company through the date of such vesting and except as otherwise provided in this Agreement. No portion of the RSUs will become vested after Participant’s Termination; provided that, if Participant’s Termination occurs prior to the RSU Determination Date, the portion of the RSUs that are vested at the time of Participant’s Termination will not settle until following the occurrence of the RSU Determination Date, in accordance with the terms and the conditions hereof. You also understand that this Notice is subject to the terms and conditions of both the Agreement and the Plan, both of which are incorporated herein by reference. By signing below or electronically accepting the Agreement, you confirm you have read and agreed to the terms and conditions of this Notice, the Agreement and the Plan.

 

PARTICIPANT

 

IMPERVA, INC.

 

 

 

 

 

Signature:

 

 

By:

 

Print Name: 

 

 

Its:

 

Date:

 

 

Date: 

 

 

 

 

 


 

IMPERVA, INC.

2011 STOCK OPTION AND INCENTIVE PLAN

AWARD AGREEMENT (RESTRICTED STOCK UNITS)

Unless otherwise defined herein, the terms defined in the Imperva, Inc. (the “ Company ”) 2011 Stock Option and Incentive Plan (the “ Plan ”) shall have the same defined meanings in this Award Agreement (Restricted Stock Units), including any country-specific terms and conditions contained in the attached Appendix (together, the “ Agreement ”).

Participant has been granted Restricted Stock Units (“ RSUs ”) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the “ Notice ”) and this Agreement.

1. Settlement . Subject to Appendix A, settlement of RSUs shall be made within 7 days following the later of (a) the RSU Determination Date; and (b) the applicable date of vesting under the vesting schedule set forth in the Notice. Settlement of RSUs shall be in Shares.

2. No Stockholder Rights . Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote such Shares.

3. Dividend Equivalents . Dividends, if any (whether in cash or Shares), shall not be credited to Participant until he or she has acquired Shares in the Company through settlement of RSUs.

4. No Transfer . The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.

5. Termination . If Participant’s Termination (for any reason whatsoever, whether or not later to be found invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any, but without prejudice to the Participant’s right to claim damages for such Participant’s Termination), all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate and will not be extended by any notice period ( e.g ., active services would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any) unless during such notice period Participant has actively continued to provide services to the Company. In case of any dispute as to whether Termination has occurred (including whether Participant may still be considered to be providing services while on an approved leave of absence), the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.

6. Tax Obligations . Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant’s employer (the “ Employer ”) the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to Participant’s participation in the Plan and legally applicable to Participant (“ Tax-Related Items ”), is and remains Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends and/or any dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if Participant is subject to Tax-Related Items in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

1


 

Prior to any relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following:

(i) withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or

(ii) withholding from proceeds of the sale of Shares acquired upon vesting/settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization); or

(iii) withholding in Shares to be issued upon settlement of the RSUs, provided, however that if Participant is a Section 16 officer of the Company under the Exchange Act, then the Committee shall establish the method of withholding from alternatives (i)-(iii) herein and, if the Committee does not exercise its discretion prior to the Tax-Related Items withholding event, then Participant shall be entitled to elect the method of withholding from the alternatives above.

Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case Participant will receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.

Finally, Participant agrees to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items.

7. U.S. Tax Consequences . If Participant is a U.S. taxpayer, Participant acknowledges that there will be tax consequences upon the vesting and/or settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant’s tax obligations prior to such vesting, settlement or disposition. Upon vesting of the RSUs, the Fair Market Value of the Shares subject to the RSUs is subject to payroll taxes (e.g., FICA), and when the Shares are released following vesting, the Fair Market Value of the Shares is subject to U.S. federal, state and local income taxes. Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than 12 months from the date of settlement. Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code. Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation. You should consult your personal tax advisor for more information on the actual and potential tax consequences of this RSU.

8. Acknowledgement of Nature of the Grant . The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan. Participant acknowledges receipt of a copy of the Plan and the Plan prospectus, represents that Participant has carefully read and is familiar with their provisions, and hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice. Participant further acknowledges, understands and agrees that:

(a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan, provided that any such modification, amendment, suspension or termination may not, without the written consent of a Participant, impair any of such Participant’s rights under any RSUs previously granted;

(b) the grant of the RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;

2


 

(c) all decisions with respect to future RSUs or other grants, if any, will be at the sole discretion of the Company;

(d) the RSU grant and Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an employment or services contract with the Company, the Employer, its Parent, Subsidiary or affiliate of the Company and shall not interfere with the ability of the Company, the Employer, its Parent, Subsidiary or affiliate of the Company, as applicable, to terminate Participant’s employment or service relationship (if any) for any reason;

(e) Participant is voluntarily participating in the Plan;

(f) the RSUs and the Shares subject to the RSUs are not intended to replace any pension rights or compensation;

(g) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;

(h) the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(i) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from Participant’s Termination (for any reason whatsoever whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), and in consideration of the grant of the RSUs to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, its Parent, any of its Subsidiaries, affiliates or the Employer, waives his or her ability, if any, to bring any such claim, and releases the Company, its Parent, Subsidiaries and affiliates and the Employer from any such claim (which release, for the avoidance of doubt, will not extend to (a) any of Participant’s rights to receive consideration pursuant to the terms of an Acquisition or Corporate Transaction in Participant’s capacity as a holder of capital stock of the Company, or (b) impair Participant’s ability to receive any capital stock of the Company upon settlement of the RSUs, or prohibit participant from making a claim related to or arising out of the foregoing (a) and (b)); if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim;

(j) unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits evidenced by this Agreement do not create any entitlement to have any unvested RSUs or any such benefits transferred to, or assumed by, another company nor be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Shares of the Company (for the avoidance of any doubt, any RSUs which are vested (due to the lapsing of time-based vesting conditions) at the time of a Corporate Transaction affecting the Shares of the Company shall be assumed or be exchanged for cash at such time, or provision for be made for the assumption or cashout thereof following the RSU Determination Date); and

(k) the following provisions apply only if Participant is providing services outside the United States:

(i) the RSUs and the Shares subject to the RSUs are not part of normal or expected compensation or salary for any purpose;

(ii) Participant acknowledges and agrees that neither the Company, the Employer, its Parent, nor any Subsidiary or affiliate of the Company shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares of acquired upon settlement.

9. No Advice Regarding Grant . The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

3


 

10. Data Privacy . Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company, its Parent, Subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan.

Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares of stock or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, vested, unvested or outstanding in Participant’s favor(“Data”), for the exclusive purpose of implementing, administering and managing the Plan.

Participant understands that Data will be transferred to a designated Plan broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the Company, its designated Plan broker, and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing his or her participation in the Plan. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan. Participant understands if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, Participant’s employment status and/or career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant RSUs or other Awards or administer or maintain such Awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect Participant’s ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.

11. Entire Agreement; Enforcement of Rights . This Agreement, the Plan, the Notice, and the Share Exchange Agreement (as defined in Appendix hereto) constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant or any other Plan participant.

12. Compliance with Laws and Regulations . Notwithstanding any other provision of the Plan or this Agreement, unless there is an available exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver any Shares issuable upon settlement of the RSU prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. SEC or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable. Participant understands that the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares. Further, Participant agrees that the Company shall have unilateral authority to amend the Plan and the Agreement without Participant’s consent to the extent necessary to comply with securities or other laws applicable to issuance of Shares.

4


 

13. Governing Law and Venue; Severability . If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of this Agreement shall be interpreted as if such provision were so excluded and (c) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware without reference to such state’s principles of conflicts of law. Participant hereby acknowledges and agrees that any dispute with regard to or arising under this Agreement, including, for the avoidance of doubt, the calculation of the number of “Eligible Shares” (and any other condition relating to the “Acquisition” under Appendix A) shall be resolved by arbitration in accordance with Section 10.10(a) of the Share Exchange Agreement (as defined below), with the actions and agreements of the Sellers’ Representative with respect thereto (including whether to pursue or settle such claim) binding on the Participant,   mutatis mutandis . Subject to the foregoing agreement to arbitrate, the parties hereto hereby irrevocably submit to the exclusive jurisdiction of the state courts of the State of California located within the County of San Mateo in the State of California and the Federal courts of the United States of America located within the Northern District of California in respect of the interpretation and enforcement of the provisions of this Agreement and in respect of the transactions contemplated hereby, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement hereof or thereof, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that it is inconvenient ( forum non conveniens ) or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims with respect to such action or proceeding shall be heard and determined in such a California State or Federal court. The parties hereto hereby consent to and grant any such court jurisdiction over the person of such parties and over the subject matter of such dispute. With respect to any particular action, suit or proceeding, venue shall lie solely in the County of San Mateo, California with respect to state court matters or in the Northern District of California with respect to Federal court matters.

14. Electronic Delivery and Acceptance . The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

15. Language . If Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

16. Appendices . Notwithstanding any provisions in this Agreement, the RSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for Participant’s country. Moreover, if Participant relocates to one of the countries included in any Appendix, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. Any Appendix attached hereto constitutes part of this Agreement.

17. Imposition of Other Requirements . The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company reasonably determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

By the signature on, or electronic acceptance of, the Notice by each of the Participant and the Company’s representative, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in its entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement. Participant further agrees to notify the Company upon any change in Participant’s residence address.

 

 

 

5


 

AWARD AGREEMENT (RESTRICTED STOCK UNITS)

APPENDIX A

IMPERVA, INC. 2011 STOCK OPTION AND INCENTIVE PLAN

RSU Terms of Vesting and Settlement

All capitalized terms used in this Appendix but not defined in this Appendix shall have the definitions ascribed to such terms in the Share Exchange Agreement and the Plan (each as defined herein). As used in this Agreement, the following terms shall have the following meanings:

(a) 2014 Revenue Amount means the sum of (i) the revenue (determined in accordance with GAAP) actually recognized by the Company, on a consolidated basis with the Israeli Subsidiary, during the twelve (12) month period ending December 31, 2014; and (ii) the revenue (determined in accordance with GAAP) actually recognized by Buyer, on a consolidated basis with the its direct or indirect subsidiaries (other than the Company and the Israeli Subsidiary), during the twelve (12) month period ending December 31, 2014, from the sale, license or other transaction or disposition of any Company Products and/or Company Intellectual Property and/or any products, services or Intellectual Property to the extent evidenced by or embodied in and/or related to Company Intellectual Property created by or on behalf of such Persons before or after the Closing (as defined in the Share Exchange Agreement), including managed services to the extent that they relate to Company Products and/or Company Intellectual Property, and including, without limitation, any enhancements, modifications and derivatives thereof (in each case, net of any refunds and/or returns or related reversals in revenue). Notwithstanding anything in the foregoing to the contrary, 2014 Revenue Amount shall not include any intercompany revenues resulting from sales between or among any of the Buyer, the Company, and the Israeli Subsidiary during the time periods indicated nor shall it include any revenue actually recognized or derived in connection with the sale, license or other transaction or disposition of any Buyer or other product that do not incorporate or are not based on any Company Intellectual Property, irrespective of whether it is bundled or otherwise sold with Company Products or products based on Company Intellectual Property.

(b) “Acquisition” means the consummation of the Share Exchange in accordance with and subject to the terms and conditions of the Share Exchange Agreement.

(c) “Actual 2014 Revenue Amount” means the 2014 Revenue Amount as finally determined pursuant to the procedure set forth Section 1.8 of the Share Exchange Agreement, mutatis mutandis (which, for purposes hereof, shall be read to replace all references to “2013” with “2014”).

(d) Actual Aggregate (Gross) RSU Amount means the number of RSUs obtained by dividing (i) the Actual Aggregate (Gross) RSU Value by (ii) the Collared Buyer Stock Price Per Share (RSU Determination Date).

(e) Actual Aggregate (Gross) RSU Value means (i) the dollar ($) amount obtained by multiplying (i) the Actual 2014 Revenue Amount by   (ii) eight (8)  less   (ii) Buyer Loan Amount.

(f) Actual Aggregate (Net) RSU Amount means the number of RSUs obtained by dividing (i) the Actual Aggregate (Net) RSU Value by (ii) the Collared Buyer Stock Price Per Share (RSU Determination Date).

(g) Actual Aggregate (Net) RSU Value means the dollar ($) amount obtained by subtracting (i) the lesser of (a) the Actual Indemnity Excess Claims Value and (b) the Actual RSU Indemnity Value, from (ii) the RSU Holder Portion of the Actual Aggregate (Gross) RSU Value; provided that for the avoidance of doubt that there shall not be a duplication of recovery of Indemnifiable Damages by Buyer hereunder and under the Share Exchange Agreement.

1


 

(h) “ Actual Aggregate Seller and Optionholder Consideration Value ” means the dollar ($) amount that is the sum of (i) the Transaction Expenses and (ii) the amount obtained by multiplying (a) the number of shares of Buyer Common Stock obtained by adding (i) the Actual Aggregate Seller Amount (less the portion of the Actual Aggregate Seller Amount attributable to non-employee Sellers) and (ii) the aggregate number of shares of Buyer Common Stock issuable upon exercise of all Company Options assumed by Buyer (after the determination of the Actual Equity Exchange Ratio) pursuant to Section 1.2(b) of the Share Exchange Agreement)   by   (b) the Buyer Stock Price Per Share.

(i) “ Actual Eligible RSU Percentage ” means the quotient obtained by dividing (i) the Actual Aggregate (Net) RSU Amount by (ii) the RSU Holder Portion of Maximum Estimated Aggregate RSU Amount, not to exceed 100%.

(j) “ Actual Indemnity Claims Value ” means the sum of (i) any Indemnifiable Damages actually recovered by any Indemnified Person(s) pursuant (and subject to the terms, conditions and limitations) set forth in ARTICLE 9 of the Share Exchange Agreement, if any (with shares of Buyer Common Stock valued at the Buyer Stock Price Per Share (as defined in the Share Exchange Agreement), and (ii) the Pending Claims Value.

(k) “ Actual Indemnity Excess Claim Value ” means the greater of (i) zero (0) and (ii) the dollar ($) amount obtained by subtracting   (a) the dollar ($) amount obtained by multiplying   (1) the Indemnity Holdback Amount by (2) the Buyer Stock Price Per Share, from (b) the Actual Indemnity Claims Value.

(l) “ Actual RSU Indemnity Amount ” means the number of RSUs obtained by multiplying (i) the RSU Holder Portion of the Actual Aggregate (Gross) RSU Amount by (ii) the Indemnity Holdback Percentage.

(m) “ Actual RSU Indemnity Value ” means the sum of (i) the dollar ($) amount obtained by multiplying (x) the Actual RSU Indemnity Amount by (y) the Collared Buyer Stock Price Per Share (RSU Determination Date), plus (ii) any portion of the Actual Indemnity Claims Value that is attributable to breach of Fundamental Claims to the extent such amount plus the amount of item (i) of this definition (if any) exceeds the Indemnity Holdback Amount (without duplication),   provided , however , that any such excess amount shall be forfeited from the PRSUs granted hereunder on a pro rata share amongst the Participants and in any event up to each Participant’s pro rata share of the RSU Holder Portion of Maximum Estimated Aggregate RSU Value.”

(n) Agreement Date ” has the meaning set forth in the Share Exchange Agreement.

(o) “ Buyer ” means Imperva, Inc., a Delaware corporation.

(p) “ Buyer Stock Price Per Share Collar Percentage ” means twenty percent (20%).

(q) “ Buyer Stock Price Per Share Lower Collar ” means the price per share of Buyer Common Stock obtained by multiplying (i) the difference of (a) one (1)  less   (b) the Buyer Stock Price Per Share Collar Percentage (expressed as a fractional number), by   (ii) the Buyer Stock Price Per Share (Initial).

(r) “ Buyer Stock Price Per Share (RSU Determination Date) ” means the average of the closing prices of Buyer Common Stock as quoted on the New York Stock Exchange for the ten (10) consecutive trading days ending with the trading day that is the last day prior to the RSU Determination Date.

(s) “ Buyer Stock Price Per Share (Initial) ” means the average of the closing prices of Buyer Common Stock as quoted on the New York Stock Exchange for the ten (10) consecutive trading days ending with November 7, 2013.

(t) “ Buyer Stock Price Per Share Upper Collar ” means the price per share of Buyer Common Stock obtained by multiplying (i) the sum of (a) one (1)  plus   (b) the Buyer Stock Price Per Share Collar Percentage (expressed as a fractional number), by   (ii) the Buyer Stock Price Per Share (Initial).

(u) “ Collared Buyer Stock Price Per Share (RSU Determination Date) ” means the price per share of Buyer Common Stock that is equal to the Buyer Stock Price Per Share (RSU Determination Date), but not less than the Buyer Stock Price Per Share Lower Collar and not more than the Buyer Stock Price Per Share Upper Collar.

(v) “ Company ” means Incapsula, Inc., a Delaware corporation (for purposes of this Appendix A only).

2


 

(w) “ Eligible Shares ” means RSUs covering a number of shares of Buyer Common Stock obtained by multiplying (i) the Number of RSUs set forth in the Notice by (ii) the Actual Eligible RSU Percentage. For the avoidance of any doubt, to the extent any of the total Number of RSUs set forth in the Notice do not become Eligible Shares (such shares, the “ Forfeited Shares ”) upon the RSU Determination Date, the Forfeited Shares shall, immediately following the RSU Determination Date, be forfeited by the Participant and returned to the pool of shares of Buyer Common Stock available for future grant under the Plan and the Additional PRSU Agreements (as such term is defined in the Share Exchange Agreement). Notwithstanding anything in the foregoing to the contrary, Forfeited Shares shall in no case include any shares of Buyer Common Stock or RSU’s subject to a Pending Claim until the resolution of such Pending Claim in accordance with the terms hereof and the Share Exchange Agreement; and, in such event, such shares or RSUs shall be inchoate and will not be forfeited or become Eligible Shares, as the case may be following resolution of the Pending Claim, until the determination of the Pending Claim in accordance with the terms of the Share Exchange Agreement (at which time the operation hereof shall become effective).

(x) “ Israeli Subsidiary ” means Incapsula, Ltd., the Company’s wholly owned subsidiary incorporated under the laws of the State of Israel.

(y) “ Maximum Estimated 2014 Revenue Amount ” means $12,000,000.

(z) “ Maximum Estimated Aggregate RSU Amount ” means the number of RSUs obtained by dividing (i) the Maximum Estimated Aggregate RSU Value by (ii) the Buyer Stock Price Per Share Lower Collar.

(aa) “ Maximum Estimated Aggregate RSU Value ” means the dollar ($) amount obtained by multiplying (i) the Maximum Estimated 2014 Revenue Amount by   (ii) eight (8).

(bb) “ Maximum Estimated RSU Indemnity Amount ” means the number of RSUs obtained by multiplying (i) the RSU Holder Portion of the Maximum Estimated Aggregate RSU Amount by (ii) the Indemnity Holdback Percentage.

(cc) “ Maximum Estimated RSU Indemnity Value ” means the dollar ($) amount obtained by multiplying (i) the RSU Holder Portion of the Maximum Estimated Aggregate RSU Value by   (ii) the Indemnity Holdback Percentage.

(dd) “ Pending Claims ” means any unresolved or unsatisfied claims for Indemnifiable Damages specified in any Claim Certificate delivered by Buyer in accordance with ARTICLE 9 of the Share Exchange Agreement, irrespective of any limitation on the amount of Indemnifiable Damages in the Share Exchange Agreement (other than time based limitations).

(ee) “ Pending Claims Value ” means the dollar ($) amount obtained by multiplying (a) the total number of shares of Buyer Common Stock subject to any Pending Claims, by   (b) the Buyer Stock Price Per Share (as defined in the Share Exchange Agreement).

(ff) “ RSU Determination Date ” means the later of (i) the date on which the 2014 Revenue Amount is finally determined pursuant to this Appendix A (being the procedure set forth Section 1.8 of the Share Exchange Agreement, mutatis mutandis , which, for purposes hereof, shall be read to replace all references to “2013” with “2014”) and (ii) the expiration of the Claims Period.

(gg) “ RSU Holder Portion of Maximum Estimated Aggregate RSU Amount ” means the number of RSUs obtained by dividing (i) the RSU Holder Portion of Maximum Estimated Aggregate RSU Value by (ii) the Buyer Stock Price Per Share Lower Collar.

(hh) “ RSU Holder Portion of Maximum Estimated Aggregate RSU Value ” means the dollar ($) amount obtained by subtracting (a) the Actual Aggregate Seller and Optionholder Consideration Value from   (b) the dollar ($) amount obtained by multiplying   (i) the Maximum Estimated Aggregate RSU Value by (ii) the RSU Holder Pro Rata Share.

(ii) “ RSU Holder Portion of Actual Aggregate (Gross) RSU Amount ” means the number of RSUs obtained by multiplying (i) the Actual Aggregate (Gross) RSU Amount by (ii) the RSU Holder Pro Rata Share.

(jj) “ RSU Holder Portion of Actual Aggregate (Gross) RSU Value ” means the dollar ($) amount obtained by subtracting (a) the Actual Aggregate Seller and Optionholder Consideration Value   from   (b) the dollar ($) amount obtained by multiplying (i) the Actual Aggregate (Gross) RSU Value by (ii) the RSU Holder Pro Rata Share.

3


 

(kk) “ RSU Holder Pro Rata Share ” means the quotient obtained by dividing (a) the Actual Aggregate Seller and Optionholder Consideration Value by (ii) the Actual Aggregate Consideration Value.

(ll) “ Sellers ” mean the holders of shares of Company Common Stock listed on Schedule A to the Share Exchange Agreement, comprising all Company stockholders other than Buyer.

(mm) “ Share Exchange Agreement ” means that certain Share Exchange Agreement expected to be dated on or about February 2014, by and among Buyer, the Company, the Israeli Subsidiary, the Sellers and Gur Shatz, in his separate capacity as the Sellers’ Representative (in the form attached hereto as Annex A ).

The determination and resolution of indemnification claims shall be subject to determination and resolution as set forth in the Share Exchange Agreement, mutatis mutandis to cover, to the extent and as it relates to, the determination of Eligible Shares relating to indemnification (including that not more than 10% of the RSU Holder Portion of Actual Gross Aggregate RSU Value will be reduced for General Claims, and not more than 15% for claims related to Special Claims, with the thresholds for indemnification of such claims to be cumulative with those provided in Section 9.3 of the Share Exchange Agreement). Participant acknowledges and agrees that all disputes regarding indemnification matters, the calculation of the number of Eligible Shares and any other condition relating to the Acquisition will be subject to the decisions of the Sellers’ Representative and the dispute resolutions provisions and the mechanisms in the Share Exchange Agreement, mutatis mutandis.

In addition to the foregoing terms, to the extent any Pending Claims are outstanding as of the RSU Determination Date, a number of RSUs (or shares subject thereto) equal to the quotient obtained by dividing   (a) the Pending Claims Value   by   (b) the Buyer Stock Price Per Share (RSU Determination Date) shall be deemed not to be Eligible Shares (the “ Reserved Shares ”) and Holder’s pro rata portion of such Reserved Shares shall be included in the RSU Holder Portion of Actual Aggregate (Gross) RSU Amount and issued, if applicable, to Holder within seven (7) days following resolution of the Pending Claim in accordance with the terms of the Share Exchange Agreement. Promptly following the resolution of any Pending Claims, in accordance with the Share Exchange Agreement, the portion of the RSUs subject to such formerly Pending Claims shall promptly become Eligible Shares to the extent the other provisions of this Appendix would have resulted in them being Eligible Shares during the pendency of such Pending Claims but for the fact that they were Reserved Shares pursuant to this paragraph.

For the avoidance of any doubt, by Holder’s acceptance of the RSU’s and entering into this Agreement, Holder is appointing Sellers’ Representative as the agent for and on behalf of the Holder in the same manner and to the same effect the Sellers have appointed the Sellers’ Representative with respect to the Share Exchange Agreement,   mutatis mutandis , including, but not limited, to: (i) give and receive notices, instructions, and communications permitted or required under this Agreement for and on behalf of Holder to or from the Buyer relating to this Agreement or any of the transactions and other matters contemplated hereby or thereby; (ii) consent or agree to, negotiate, enter into, or, if applicable, contest, prosecute or defend, settlements and compromises of, and demand arbitration and comply with orders of courts and awards of arbitrators with respect to, any and all claims, resolve any such claims, take any actions in connection with the resolution of any dispute relating hereto or to the transactions contemplated hereby; (iii) take or forego any or all actions permitted or required or necessary in the judgment of the Sellers’ Representative for the accomplishment of the foregoing and all of the other terms, conditions and limitations of this Agreement; (iv) consult with legal counsel, independent public accountants and other experts selected by it; (v) consent or agree to any amendment to this Agreement or to waive any terms and conditions of this Agreement; and (vi) take all actions necessary or appropriate in the judgment of the Sellers’ Representative for the accomplishment of the foregoing, in each case without having to seek or obtain the consent of any Holder under any circumstance.

4


 

AWARD AGREEMENT (RESTRICTED STOCK UNITS) – INTERNATIONAL

APPENDIX B

IMPERVA, INC. 2011 STOCK OPTION AND INCENTIVE PLAN

Special Terms and Conditions for Participants Outside the U.S.

This Appendix includes additional country-specific terms and conditions that apply to Participant’s resident in countries listed below. This Appendix is part of the Agreement and contains terms and conditions material to participation in the Plan. Unless otherwise provided below, capitalized terms used but not defined herein shall have the same meanings assigned to them in the Plan and the Agreement.

Participant acknowledges that local exchange control laws may apply to Participant as a result of the acquisition of Shares, opening of an off-shore bank or brokerage account and acquisition of foreign currency. By accepting the RSUs, Participant agrees to comply with applicable exchange control laws associated with participation in the Plan. Participant further acknowledges that if he or she has any questions regarding his or her responsibilities in this regard, Participant will seek advice from his or her personal legal advisor, at Participant’s own cost, and further agrees that neither the Company, its Parent, any Subsidiary of affiliate or the Employer will be liable for any fines or penalties resulting from Participant’s failure to comply with applicable laws concerning the acquisition and disposition of Shares.

If Participant is a citizen or resident of a country other than the one in which Participant is currently working, transfers employment after the RSUs are granted or is considered resident of another country for local law purposes, the terms and conditions contained herein may not be applicable to Participant, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply to Participant.

Israel

Trust Arrangement .

Participant understands and agrees that the RSUs awarded under the Agreement are awarded subject to and in accordance with the terms and conditions of the Plan, Appendix B (the “ Sub-Plan ”), the Trust Agreement (the “ Trust Agreement ”) between the Company and the Company’s trustee appointed by the Company or its Subsidiary in Israel (the “ Trustee ”) and the Agreement, or any successor trustee. In the event of any inconsistencies between the Sub-Plan, the Agreement and/or the Plan, the Sub-Plan will govern.

Nature of Grant .

The following provisions supplement section 8 of the Agreement:

The RSUs are intended to qualify for favorable tax treatment in Israel as a “ Capital Gain Award ” (as defined in the Sub-Plan) subject to the terms and conditions of Section 102(b)(2) of the Income Tax Ordinance (New Version) – 1961 (“ Section 102 ”)(as defined in the Sub-Plan) and the rules promulgated therunder. Notwithstanding the foregoing, by accepting the RSUs, Participant acknowledges that the Company cannot guarantee or represent that the favorable tax treatment under Section 102 will apply to the RSUs.

By accepting the RSUs, Participant: (a) acknowledges receipt of and represents that Participant has read and is familiar with the terms and provisions of Section 102, the Plan, the Sub-Plan, the Trust Agreement and the Agreement; (b) accepts the RSUs subject to all of the terms and conditions of the Agreement, the Plan, the Sub-Plan, the Trust Agreement and Section 102 and the rules promulgated thereunder; and (c) agrees that the RSUs and/or any Shares issued in connection therewith, will be registered for the benefit of Participant in the name of the Trustee as required to qualify under Section 102.Participant hereby undertakes to release the Trustee from any liability in respect of any action or decision duly taken and bona fide executed in relation to the Plan, or any RSUs or Share granted thereunder. Participant agrees to execute any and all documents which the Company or the Trustee may reasonably determine to be necessary in order to comply with Section 102 and the Income Tax Ordinance (New Version) – 1961 (“ ITO ”).

5


 

Payment .

Notwithstanding the Vesting Schedule set forth on the Notice, if the vesting of the RSUs occurs during the “ Holding Period ” (as defined in the Sub-Plan), the Shares issued upon the vesting of the RSUs shall be issued to and deposited with the Trustee for the benefit of Participant and shall be held in trust for the Holding Period. After termination of the Holding Period, the Trustee may release the RSUs and any Shares issued with respect thereto under the terms set forth in the Sub-Plan, and in accordance with the terms and conditions of Section 102, the ITO and any approval by the Israeli Tax Authority (“ ITA ”).

In the event that such vesting occurs after the end of the Holding Period, the Shares issued upon the vesting of the RSUs shall either (i) be deposited with the Trustee, or (ii) be transferred to Participant directly or into a brokerage account in his or her name, provided that Participant first complies with his or her obligations for Tax-Related Items.

In the event that Participant elects to have the Shares transferred to Participant without selling such Shares, Participant shall become liable to pay Tax-Related Items immediately in accordance with the provisions of the ITO. Participant will not be entitled to receive the Shares prior to the full payment of Tax-Related Items and neither the Company not the Trustee shall be required to release any Shares to Participant until all payments required to be made under the ITO have been fully satisfied.

Data Privacy .

The following provision supplements section 10 of the Agreement:

Without derogating from the scope of section 10 of the Agreement, Participant hereby explicitly consents to the transfer of Data between the Company, the Trustee, and/or a designated Plan broker, including any requisite transfer of such Data outside of the Participant’s country and further transfers thereafter as may be required to a broker or other third party.

Electronic Delivery and Acceptance .

The following provision supplements section 15 of the Agreement.

To the extent required pursuant to Israeli tax law and/or by the Trustee, Participant consents and agrees to deliver hard-copy written notices and/or actual copies of any notices or confirmations provided by Participant related to his or her participation in the Plan.

Securities Law Information.

The RSUs are offered in accordance with an exemption from the requirement to publish a prospectus which the Company received from the Israel Securities Authority on January 26, 2012,under Section 15D of the Israeli Securities Law, 1968.

The Shares available under the Plan are registered in the U.S. pursuant to the Form S-8 registration statement which was filed with the U.S. Securities and Exchange Commission on November 9, 2011.

A copy of the Plan and the Forms S-8, including the documents referenced therein, was provided to Participant concurrently with the Agreement. Following the Acquisition, Participant may obtain a copy of such documents from the Company’s intranet site located at: https://compass.imperva.com/community/legal/stock_plan_prospectuses. These documents are also available at Participant’s local office.

 

 

 

6


 

ANNEX A

SHARE EXCHANGE AGREEMENT

[Filed as Exhibit 2.1 to the Registrant’s Current Report Form 8-K, filed on February 11, 2014 and incorporated herein by reference]

 

 

 

Exhibit 10.15

 

 

 

3400 Bridge Parkway

Redwood Shores, CA 94065

Tel:  +1 (650) 345-9000

Fax: +1 (650) 240-0500

www.imperva.com

 

 

 

 

December 12, 2014

 

Sunil Nagdev

[address]

 

Dear Sunil:

 

Imperva, Inc. (the “Company”) is pleased to offer you employment on the following terms:

 

1. Position . Your title will be SVP, Worldwide Services and Support and you will report to the Company’s President & CEO, Anthony Bettencourt.  This is a full-time position based out of Redwood Shores HQ .  By signing this letter agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company.

 

2. Cash Compensation . The Company will pay you a starting salary at the rate of $21,500 per month ($258,000 per year) , payable in accordance with the Company’s standard payroll schedule. This salary will be subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time. In addition, you will be eligible to participate in the Company’s bonus plan as in effect from time to time. Initially, your annual bonus goal will be $99,000 (38% of base salary) at target and paid quarterly in accordance with the Company’s 2014 Management Bonus Plan.  

 

3. Employee Benefits . As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits as in effect from time to time. The Company does not maintain a vacation or paid time off accrual policy with a fixed number of days for exempt, salaried staff and will not formally track the amount of personal time you spend away from the office, and you are free to take personal time at your discretion, with pay, subject to coordination with and approval from your manager and in accordance with the Company’s Time Off Policy;  however, you will be expected to manage your time away from the office in such a way as to ensure that your work responsibilities are adequately addressed.

 

4. Equity . The Company shall, subject to the approval of its Board of Directors or a committee of the Board of Directors, grant to you (a) a stock option to purchase 40,000 shares of Common Stock of the Company (the Option ) and (b) restricted stock units for 40,000 shares of Common Stock of the Company (the “RSUs”). The Option and the RSUs will be granted pursuant to and will be subject to the terms of the Company’s 2011 Stock Option and Incentive Plan, as well the Option Agreement and the Restricted Stock Unit Agreement.  The Option and the RSUs also will be subject to the terms of the Company’s Change in Control Plan (as filed on EDGAR with the Securities and Exchange Commission).

 

5. Proprietary Information and Inventions Agreement . Like all Company employees, you will be required, as a condition of your employment with the Company, to sign the Company’s standard Proprietary Information and Inventions Agreement, a copy of which is attached hereto as Exhibit A .

 

6. Employment Relationship . Employment with the Company is for no specific period of time. Your employment with the Company will be “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause. Any contrary representations that may have been made to you are superseded by this letter agreement. This is the full and complete agreement between you and the Company on this

Confidential Offer Letter – Sunil Nagdev Page 1

 

 


 

 

term. Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and the Company’s Chief Executive Officer.

 

7. Outside Activities . While you render services to the Company, you agree that you will not engage in any other employment, consulting or other business activity without the prior written consent of the Company. While you render services to the Company, you also will not assist any person or entity in competing with the Company, in preparing to compete with the Company or in hiring any employees or consultants of the Company.

 

8. Withholding Taxes . All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable withholding and payroll taxes and other deductions required by law.

 

9. Proof of Employment Eligibility and Background Check .  This offer is contingent upon your completion and execution of all employment documents, as well as your ability to provide proof of identification and authorization to work in the United States (within two business days of your start date) and upon passing the Company’s mandatory background verification, even if this information is not known until after your employment commences.

 

10. Entire Agreement . This Agreement and Exhibit A supersede and replace any prior agreements, representations or understandings (whether written, oral, implied or otherwise) between you and the Company and constitute the complete agreement between you and the Company regarding the subject matter set forth herein.  This Agreement may not be amended or modified, except by an express written agreement signed by both you and the Chief Executive Officer of the Company.  

 

**********

 

 

Confidential Offer Letter – Sunil Nagdev Page 2

 


 

We hope that you will accept our offer to join the Company. You may indicate your agreement with these terms and accept this letter agreement by signing and dating both the enclosed duplicate original of this letter agreement and the enclosed Proprietary Information and Inventions Agreement and returning them to me. This offer, if not accepted, will expire at the close of business on December 16, 2014. Your employment is also contingent upon your starting work with the Company on or before December 29, 2014.

 

 

 

Very truly yours,

IMPERVA, INC.

 

 

By _ /s/ Kristie Castellini __________

Kristie Castellini

 

Title: Senior Director, Human Resources

 

Dated: _____ 12/15/2014 __________

 

 

 

 

 

 

I have read and accept this employment offer:

 

__ /s/ Sunil Nagdev _______________________

Signature of Sunil Nagdev

 

 

Dated: __________ 12/12/14 ________________

 

 

 

 

 

 

 

Attachment

 

Exhibit A: Proprietary Information and Inventions Agreement

 

 

 

 

 

 


 

PROPRIETARY INFORMATION AND INVENTION AGREEMENT

 

In consideration of, and as a condition of my employment with Imperva, Inc., a Delaware corporation (the “ Company ”), I, as the “ Employee ” signing this Proprietary Information and Invention Agreement (this “ Agreement ”), hereby represent to the Company, and the Company and I hereby agree as follows:

1. Purpose of Agreement .   I understand that the Company is engaged in a continuous program of research, development, production and/or marketing in connection with its current and projected business and that it is critical for the Company to preserve and protect its proprietary information, its rights in certain inventions and works and in related intellectual property rights.  Accordingly, I am entering into this Agreement, whether or not I am expected to create inventions or other works of value for the Company.  As used in this Agreement, “ Inventions ” means inventions, improvements, designs, original works of authorship, formulas, processes, compositions of matter, computer software programs, databases, mask works, confidential information and trade secrets.

2. Disclosure of Inventions .   I will promptly disclose in confidence to the Company, or to any person designated by it, all Inventions that I make, create, conceive or first reduce to practice, either alone or jointly with others, during the period of my employment, whether or not in the course of my employment, and whether or not patentable, copyrightable or protectable as trade secrets.

3. Work for Hire; Assigned Inventions .   I acknowledge and agree that any copyrightable works prepared by me within the scope of my employment will be “works made for hire” under the Copyright Act and that the Company will be considered the author and owner of such copyrightable works.  I agree that all Inventions that I make, create, conceive or first reduce to practice during the period of my employment, whether or not in the course of my employment, and whether or not patentable, copyrightable or protectable as trade secrets, and that (i) are developed using equipment, supplies, facilities or trade secrets of the Company; (ii) result from work performed by me for the Company; or (iii) relate to the Company’s business or actual or demonstrably anticipated research or development (the “ Assigned Inventions ”), will be the sole and exclusive property of the Company.

4. Excluded Inventions and Other Inventions . Attached hereto as Exhibit A is a list describing all existing Inventions, if any, that may relate to the Company’s business or actual or demonstrably anticipated research or development and that were made by me or acquired by me prior to the Effective Date (as defined in Section 25, below), and which are not to be assigned to the Company (“ Excluded Inventions ”).  If no such list is attached, I represent and agree that it is because I have no rights in any existing Inventions that may relate to the Company’s business or actual or demonstrably anticipated research or development.  For purposes of this Agreement, “ Other Inventions ” means Inventions in which I have or may have an interest, as of the Effective Date or thereafter, other than Assigned Inventions and Excluded Inventions.  I acknowledge and agree that if, in the scope of my employment, I use any Excluded Inventions or any Other Inventions, or if I include any Excluded Inventions or Other Inventions in any product or service of the Company or if my rights in any Excluded Inventions or Other Inventions may block or interfere with, or may otherwise be required for, the exercise by the Company of any rights assigned to the Company under this Agreement, I will immediately so notify the Company in writing.  Unless the Company and I agree otherwise in writing as to particular Excluded Inventions or Other Inventions, I hereby grant to the Company, in such circumstances (whether or not I give the Company notice as required above), a perpetual, irrevocable, nonexclusive, transferable, world-wide, royalty-free license to use, disclose, make, sell, offer for sale, import, copy, distribute, modify and create works based on, perform, and display such Excluded Inventions and Other Inventions, and to sublicense third parties in one or more tiers of sublicensees with the same rights.

5. Exception to Assignment .   I understand that the Assigned Inventions will not include, and the provisions of this Agreement requiring assignment of inventions to the Company do not apply to, any invention that qualifies fully for exclusion under the provisions of Section 2870 of the California Labor Code, which are attached hereto as Exhibit B .

6. Assignment of Rights .   I agree to assign, and do hereby irrevocably transfer and assign, to the Company:  (i) all of my rights, title and interests in and with respect to any Assigned Inventions; (ii) all patents, patent applications, copyrights, mask works, rights in databases, trade secrets, and other intellectual property rights, worldwide, in any Assigned Inventions, along with any registrations of or applications to register such rights; and

 


 

(iii) to the extent assignable, any and all Moral Rights (as defined below) that I may have in or with respect to any Assigned Inventions.  I also hereby forever waive and agree never to assert any Moral Rights I may have in or with respect to any Assigned Inventions and any Excluded Inventions or Other Inventions licensed to the Company under Section 4, even after termination of my employment with the Company.  “ Moral Rights ” means any rights to claim authorship of a work, to object to or prevent the modification or destruction of a work, to withdraw from circulation or control the publication or distribution of a work, and any similar right, regardless of whether or not such right is denominated or generally referred to as a “moral right.”    

7. Assistance .   I will assist the Company in every proper way to obtain and enforce for the Company all patents, copyrights, mask work rights, trade secret rights and other legal protections for the Assigned Inventions, worldwide.  I will execute and deliver any documents that the Company may reasonably request from me in connection with providing such assistance.  My obligations under this section will continue beyond the termination of my employment with the Company; provided that the Company agrees to compensate me at a reasonable rate after such termination for time and expenses actually spent by me at the Company’s request in providing such assistance.  I hereby appoint the Secretary of the Company as my attorney-in-fact to execute documents on my behalf for this purpose.  I agree that this appointment is coupled with an interest and will not be revocable.

8. Proprietary Information .   I understand that my employment by the Company creates a relationship of confidence and trust with respect to any information or materials of a confidential or secret nature that may be made, created or discovered by me or that may be disclosed to me by the Company or a third party in relation to the business of the Company or to the business of any parent, subsidiary, affiliate, customer or supplier of the Company, or any other party with whom the Company agrees to hold such information or materials in confidence (the “ Proprietary Information ”).  Without limitation as to the forms that Proprietary Information may take, I acknowledge that Proprietary Information may be contained in tangible material such as writings, drawings, samples, electronic media, or computer programs, or may be in the nature of unwritten knowledge or know-how.  Proprietary Information includes, but is not limited to, Assigned Inventions, marketing plans, product plans, designs, data, prototypes, specimens, test protocols, laboratory notebooks, business strategies, financial information, forecasts, personnel information, contract information, customer and supplier lists, and the non-public names and addresses of the Company’s customers and suppliers, their buying and selling habits and special needs.

9. Confidentiality .   At all times, both during my employment and after its termination, I will keep and hold all Proprietary Information in strict confidence and trust.  I will not use or disclose any Proprietary Information without the prior written consent of the Company in each instance, except as may be necessary to perform my duties as an employee of the Company for the benefit of the Company.  Upon termination of my employment with the Company, I will promptly deliver to the Company all documents and materials of any nature pertaining to my work with the Company, and I will not take with me or retain in any form any documents or materials or copies containing any Proprietary Information.

10. Physical Property .   All documents, supplies, equipment and other physical property furnished to me by the Company or produced by me or others in connection with my employment will be and remain the sole property of the Company.  I will return to the Company all such items when requested by the Company, excepting only my personal copies of records relating to my employment or compensation and any personal property I bring with me to the Company and designate as such.  Even if the Company does not so request, I will upon termination of my employment return to the Company all Company property, and I will not take with me or retain any such items.

11. No Breach of Prior Agreements .   I represent that my performance of all the terms of this Agreement and my duties as an employee of the Company will not breach any invention assignment, proprietary information, confidentiality, non-competition, or other agreement with any former employer or other party.  I represent that I will not bring with me to the Company or use in the performance of my duties for the Company any documents or materials or intangibles of my own or of a former employer or third party that are not generally available for use by the public or have not been legally transferred to the Company.

12. “At Will” Employment .   I understand that this Agreement does not constitute a contract of employment or obligate the Company to employ me for any stated period of time.  I understand that I am an “at will” employee of the Company and that my employment can be terminated at any time, with or without notice and with or without cause, for any reason or for no reason, by either the Company or by me.  I acknowledge that any

2

 


 

statements or representations to the contrary are ineffective, unless put into a writing signed by the Company.  I further acknowledge that my participation in any stock option or benefit program is not to be construed as any assurance of continuing employment for any particular period of time.  

13. Company Opportunities; Duty Not to Compete .   During the period of my employment, I will at all times devote my best efforts to the interests of the Company, and I will not, without the prior written consent of the Company, engage in, or encourage or assist others to engage in, any other employment or activity that: (i) would divert from the Company any business opportunity in which the Company can reasonably be expected to have an interest; (ii) would directly compete with, or involve preparation to compete with, the current or future business of the Company; or (iii) would otherwise conflict with the Company’s interests or could cause a disruption of its operations or prospects.

14. Non-Solicitation of Employees/Consultants .   During my employment with the Company and for a one (1) year period thereafter, I will not directly or indirectly solicit away employees or consultants of the Company for my own benefit or for the benefit of any other person or entity, nor will I encourage or assist others to do so.

15. Use of Name & Likeness .   I hereby authorize the Company to use, reuse, and to grant others the right to use and reuse, my name, photograph, likeness (including caricature), voice, and biographical information, and any reproduction or simulation thereof, in any form of media or technology now known or hereafter developed, both during and after my employment, for any purposes related to the Company’s business, such as marketing, advertising, credits, and presentations.

16. Notification .   I hereby authorize the Company, during and after the termination of my employment with the Company, to notify third parties, including, but not limited to, actual or potential customers or employers, of the terms of this Agreement and my responsibilities hereunder.

17. Injunctive Relief .   I understand that a breach or threatened breach of this Agreement by me may cause the Company to suffer irreparable harm and that the Company will therefore be entitled to injunctive relief to enforce this Agreement.

18. Governing Law; Severability . This Agreement is intended to supplement, and not to supersede, any rights the Company may have in law or equity with respect to the duties of its employees and the protection of its trade secrets.  This Agreement will be governed by and construed in accordance with the laws of the State of California without giving effect to any principles of conflict of laws that would lead to the application of the laws of another jurisdiction.  If any provision of this Agreement is invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible, given the fundamental intentions of the parties when entering into this Agreement.  To the extent such provision cannot be so enforced, it will be stricken from this Agreement and the remainder of this Agreement will be enforced as if such invalid, illegal or unenforceable provision had never been contained in this Agreement.

19. Counterparts .   This Agreement may be executed in any number of counterparts, each of which when so executed and delivered will be deemed an original, and all of which together will constitute one and the same agreement.

20. Entire Agreement .   This Agreement and the documents referred to herein constitute the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersede all prior understandings and agreements, whether oral or written, between the parties hereto with respect to such subject matter.

21. Amendment and Waiver.   This Agreement may be amended only by a written agreement executed by each of the parties to this Agreement.  No amendment or waiver of, or modification of any obligation under, this Agreement will be enforceable unless specifically set forth in a writing signed by the party against which enforcement is sought.  A waiver by either party of any of the terms and conditions of this Agreement in any

3

 


 

instance will not be deemed or construed to be a waiver of such term or condition with respect to any other instance, whether prior, concurrent or subsequent.  

22. Successors and Assigns; Assignment .   Except as otherwise provided in this Agreement, this Agreement, and the rights and obligations of the parties hereunder, will bind and benefit the parties and their respective successors, assigns, heirs, executors, administrators, and legal representatives.  The Company may assign any of its rights and obligations under this Agreement.  I understand that I will not be entitled to assign or delegate this Agreement or any of my rights or obligations hereunder, whether voluntarily or by operation of law, except with the prior written consent of the Company.

23. Further Assurances .   The parties will execute such further documents and instruments and take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement.  Upon termination of my employment with the Company, I will execute and deliver a document or documents in a form reasonably requested by the Company confirming my agreement to comply with the post-employment obligations contained in this Agreement.  

24. Acknowledgement .   I certify and acknowledge that I have carefully read all of the provisions of this Agreement and that I understand and will fully and faithfully comply with this Agreement.

25. Effective Date of Agreement .  This Agreement is and will be effective on and after the first day of my employment by the Company, which is December 29, 2014 (the “ Effective Date ”).  

Imperva, Inc.:  

Employee:

By:

/s/ Kristie Castellini

/s/ Sunil Nagdev

 

 

Signature

Name:

Kristie Castellini

Sunil Nagdev

 

 

Name (Please Print)

Title:

Sr. Dir. Human Resources

 

 

 

4

 


 

Exhibit A

LIST OF EXCLUDED INVENTIONS UNDER SECTION 4

 

Title:

Date:

Identifying Number

or Brief Description

 

 

 

 

 

 

 

 

 

x

No inventions, improvements, or original works of authorship

 

Additional sheets attached

 

Signature of Employee:

/s/ Sunil Nagdev

Print Name of Employee:

Sunil Nagdev

Date:

12/12/14

 

 

 


 

Exhibit B

CALFORNIA LABOR CODE 2870 NOTICE :

California Labor Code Section 2870 provides as follows:

Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either:  (1) relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or (2) result from any work performed by the employee for the employer.  To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under California Labor Code Section 2870(a), the provision is against the public policy of this state and is unenforceable.

 

 

 

EXHIBIT 10.17

 

2016 SENIOR Management Bonus Plan

A. Cash Bonus Plan

All Imperva, Inc. (the “Company”) executive officers are eligible to participate in the Cash Bonus Plan.  

The cash bonus payable to executive officers will be calculated quarterly. At the end of each fiscal quarter, the quarterly revenue target (the “Quarterly Revenue Target”), as provided in the Company’s annual operating plan, will be compared to the Company’s actual quarterly performance.  The amount of bonus payable with respect to each quarter is the Quarterly Bonus.  The “Quarterly Bonus” is equal to the Quarterly Bonus Amount multiplied by the Cash Bonus Payout Percentage, as set forth in the tables below.

Executive Officer

Quarterly Bonus Amount at Target

President and Chief Executive Officer

$100,000

Chief Financial Officer

$46,500

SVP and GM of Enterprise Solutions

$37,500

Chief Revenue Officer

$77,187.50

Chief Technology Officer

NIS60,556.20

SVP, Services and Support

$33,125

SVP and General Counsel

$34,875

SVP, Cloud Services

$40,625

 

 

Below Threshold


Threshold (1)


Target


Maximum

Performance Achieved

< 85%

85%

100%

107.5%

Cash Bonus Payout Percentage (2)

0%

50%

100%

115%

1 The Company’s actual quarterly revenue must be at least 85% of the Quarterly Revenue Target in order for any bonuses to be paid out.

2 If actual quarterly revenue is less than 85% of the Quarterly Revenue Target, the Cash Bonus Payout Percentage is 0%.  If actual quarterly revenue is 85% of the Quarterly Revenue Target, the Cash Bonus Payout Percentage is 50%.  If actual quarterly revenue is 100% of the Quarterly Revenue Target, the Cash Bonus Payout Percentage is 100%.  If actual quarterly revenue is 107.5% or more of the Quarterly Revenue Target, the Cash Bonus Payout Percentage is 115%.  If actual quarterly revenue is between 85% and 100% of the Quarterly Revenue Target, the Cash Bonus Payout Percentage will be between 50% and 100%, calculated on a straight line basis between those two percentages.  For example, if actual revenue is 91% of the Quarterly Revenue Target, the Cash Bonus Payout Percentage would be 70% of the Quarterly Bonus Amount [(((91% – 85%) / (100% – 85%)) x (100%-50%)) + 50%].  If actual quarterly revenue is between 100% and 107.5% of the Quarterly Revenue Target, the Cash Bonus Payout Percentage will be between 100% and 115%, calculated on a straight line basis between those two percentages. For example, at the 104% achievement level, the Cash Bonus Payout Percentage would be 108% of the Quarterly Bonus Amount [(((104% – 100%) / (107.5% – 100%)) x (115%-100%)) + 100%].

 

It is anticipated that each Quarterly Bonus, if any, will be paid to executive officers promptly following the Compensation Committee’s confirmation of actual quarterly performance relative to the Quarterly Revenue Target for such quarter.  However, the Compensation Committee may determine to reduce such bonus, including upon a


determination that the Company did not substantially meet its operating margin or operating expense targets (as provided in the Company’s annual operating plan) taking into account the actual revenue level in such quarter .

For purposes of computing whether operating margins were met or exceeded, expenses actually paid or accrued by the Company related to the payment of commissions and bonuses to the Company’s personnel above the 100% level allocated for such expenses in the Company’s annual operating plan shall not be included as expenses.

 

 

B. Equity BONUS Plan

Executive officers will be eligible to participate in an equity pool of shares of common stock (in the form of restricted stock units and performance-based restricted stock units).  The size of the equity pool will be determined by the Compensation Committee in connection with the fiscal year‑end review, based on the number of executive officers participating, the cumulative achievement of quarterly targets within the fiscal year, compensation information based on peer analysis and survey data, and other factors.  The Compensation Committee will determine the maximum number of shares to be allocated to the Company’s Chief Executive Officer and then the Compensation Committee, with input from the Company’s Chief Executive Officer, will determine the allocation of the remainder of the shares among the rest of the senior management team.  Such restricted stock units and performance-based restricted stock units will vest according to standard vesting terms as determined by the Compensation Committee.

 

2

 

EXHIBIT 21.1

 

 

 

Subsidiaries of Imperva, Inc.

 

 

 

 

 

Name of Subsidiary*

  

Jurisdiction of Incorporation

  

Imperva Ltd.

  

Israel

  

Imperva UK Ltd

  

United Kingdom

  

Imperva Italy SRL

  

Italy

  

Imperva France SARL

  

France

  

Imperva B.V.

  

The Netherlands

  

Imperva Singapore Pte. Ltd.

  

Singapore

  

Imperva Japan K.K.

  

Japan

  

Imperva Australia Pty Ltd

  

Australia

  

Incapsula, Inc.

  

Delaware

  

Incapsula, Ltd.

  

Israel

  

Skyfence Networks Ltd.

  

Israel

  

 

  

* Each of the registrant’s subsidiaries conducts business under the name listed in this column.

 

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1) Form S-8 No. 333-177845, pertaining to the Imperva, Inc. 2003 Stock Option Plan,  the Imperva, Inc. 2011 Stock Option and Incentive Plan and the Imperva, Inc. 2011 Employee Stock Purchase Plan,

(2) Form S-8 No. 333-179552, pertaining to the Imperva, Inc. 2011 Stock Option and Incentive Plan and the Imperva, Inc. 2011 Employee Stock Purchase Plan,

(3) Form S-8 No. 333-186779, pertaining to the Imperva, Inc. 2011 Stock Option and Incentive Plan and the Imperva, Inc. 2011 Employee Stock Purchase Plan,

(4) Form S-8 No. 333-194208, pertaining to the Imperva, Inc. 2011 Stock Option and Incentive Plan and the Imperva, Inc. 2011 Employee Stock Purchase Plan,

(5) Form S-8 No. 333-194955, pertaining to the Incapsula, Inc. 2010 Stock Incentive Plan and the SkyFence Networks Ltd. 2013 Share Incentive Plan,

(6) Form S-8 No. 333-198216, pertaining to the Imperva, Inc. Inducement Stock Option Plan and Agreement and the Imperva Inc. Inducement Restricted Stock Unit Plan and Agreement,

(7) Form S-8 No. 333-202423, pertaining to the Imperva, Inc. 2011 Stock Option and Incentive Plan and the Imperva, Inc. 2011 Employee Stock Purchase Plan,

(8) Form S-8 No. 333-206243, pertaining to the Inducement Stock Option Plan and Agreement and the Inducement Restricted Stock Unit Plan and Agreement, and

(9) Form S-8 No. 333-207825, pertaining to the Imperva, Inc. 2015 Equity Inducement Plan

of our reports dated February 26, 2016, with respect to the consolidated financial statements of Imperva, Inc., and the effectiveness of internal control over financial reporting of Imperva, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2015.

/s/ Ernst & Young LLP

San Jose, California

February 26, 2016  

 

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) OF

THE SECURITIES EXCHANGE ACT AND SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Anthony Bettencourt, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Imperva, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 26, 2016

 

/s/ Anthony Bettencourt

 

 

 

Anthony Bettencourt

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) OF THE

SECURITIES EXCHANGE ACT AND SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Terrence Schmid, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Imperva, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

Date: February 26, 2016

 

/s/ Terrence Schmid

 

 

 

Terrence Schmid

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

 

 

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. §1350

The undersigned, Anthony Bettencourt, the President and Chief Executive Officer of Imperva, Inc. (the “Company”), pursuant to 18 U.S.C. §1350, hereby certifies that:

(i) the Annual Report on Form 10-K for the period ended December 31, 2015 of the Company (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 26, 2016

 

By:

/s/ Anthony Bettencourt

 

 

 

 

Anthony Bettencourt

 

 

 

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO §18 U.S.C. SECTION 1350

The undersigned, Terrence Schmid, the Senior Vice President, Chief Financial Officer and Chief Administrative Officer of Imperva, Inc. (the “Company”), pursuant to 18 U.S.C. §1350, hereby certifies that:

(i) the Annual Report on Form 10-K for the period ended December 31, 2015 of the Company (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and.

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 26, 2016

 

By:

/s/ Terrence Schmid

 

 

 

 

Terrence Schmid

 

 

 

Chief Financial Officer

 

 

 

(Principal Financial Officer)